UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

for the fiscal year ended December 31 2017, 2023

or

Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from to .

Commission file number 0-21810

GENTHERM INCORPORATED

(Exact name of registrant as specified in its charter)

Michigan

95-4318554

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

21680 Haggerty Road, Northville, MI

48167

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (248) (248) 504-0500

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Nameof each exchange on which registered

Common Stock, no par value

THRM

The NASDAQ Global Select Stock MarketNasdaq

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K    

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No

The aggregate market value of the registrant’s Common Stock held by non-affiliates of the registrant, computed by reference to the average bid and asked pricesclosing price of such Common Stock on The Nasdaq Global Select Market as of the last business day of the registrant’s most recently completed second fiscal quarter, June 30, 2017,2023, was $1,047,947,000.$1,841,068,675. For purposes of this computation, the registrant has excluded the market value of all shares of its Common Stock reported as being beneficially owned by executive officers and directors and holders of more than 10% of the Common Stock on a fully diluted basis of the registrant;directors; such exclusion shall not, however, be deemed to constitute an admission that any such person is an “affiliate” of the registrant.

As of February 22, 2018,15, 2024, there were 36,762,71031,544,181 issued and outstanding shares of Common Stock of the registrant.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the proxy statement for the 20182024 annual meeting of shareholders are incorporated by reference into Part III of this Annual Report to the extent described herein.



TABLE OF CONTENTS

Part I

Item 1:

Business

3

Item 1A:

Risk Factors

  1416

Item 1B:

Unresolved Staff Comments

  2930

Item 2:1C:

PropertiesCybersecurity

  2930

Item 3:2:

Legal ProceedingsProperties

  2932

Item 4:3:

Mine Safety DisclosuresLegal Proceedings

  2932

Item 4:

Part IIMine Safety Disclosures

  3032

Item 5:Part II

33

Item 5:

Market for the Registrant’s Common Stock, Related Stockholder Matters and Issuer Purchases of Equity Securities

  3033

Item 6:

Selected Financial DataReserved

  3135

Item 7:

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  3136

Item 7A:

Quantitative and Qualitative Disclosures About Market Risk

  4550

Item 8:

Financial Statements and Supplementary Data

  4852

Item 9:

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

  4952

Item 9A:

Controls and Procedures

  4952

Item 9B:

Other Information

  5052

Item 9C:

Part IIIDisclosure Regarding Foreign Jurisdictions that Prevent Inspections

  5153

Item 10:Part III

54

Item 10:

Directors, Executive Officers and Corporate Governance

  5154

Item 11:

Executive Compensation

  5154

Item 12:

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

  5154

Item 13:

Certain Relationships and Related Transactions and Director Independence

  5154

Item 14:

Principal Accounting Fees and Services

  5154

Part IV

  5255

Item 15:

Exhibits and Financial Statement Schedules

  5255


GENTHERM INCORPORATED

PART I

ITEM 1.

Item 16:

Form 10-K SummaryBUSINESS

58


Unless otherwise indicated, references to “Gentherm”, “the Company”, “we”, “our” and “us” in thisGENTHERM INCORPORATED

PART I

Forward-Looking Statements

This Annual Report on Form 10-K refer to Gentherm Incorporated and its consolidated subsidiaries.

Except tofor the extent expressly noted herein, the content of our website or the websites of other third parties noted herein are not incorporated by reference in this Report.

Forward-Looking Statements

This Reportyear ended December 31, 2023 (this “Annual Report”) contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such asas: the expected light vehicle production in the Company’s key markets; the integration of acquisitions; the impact of macroeconomic and geopolitical conditions; the components of and our ability to finance sufficient working capital,execute our updated strategic plan and 2023 manufacturing footprint rationalization restructuring plan; long-term consumer and technological trends in the amountAutomotive industry and our related market opportunity for our existing and new products and technologies; the competitive landscape; the impact of availability under our credit facility, our ability to continue to maintain or increase sales and profits of our operations, andglobal tax reform legislation; the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource needs.needs; and our ability to finance sufficient working capital. Reference is made in particular to forward-looking statements included in “Item 1. Business,”, “Item 1A. Risk Factors” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms.

The forward-looking statements included in this Annual Report are made as of the date hereof or as of the date specified and are based on management’s currentreasonable expectations and beliefs. Such forward-looking statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors which are set forththat may cause the Company’s actual results or performance to differ materially from that described in “Item 1A. Risk Factors” and elsewhere in this Report, and subsequent reports filed with or furnished toindicated by the Securities and Exchange Commission, and whichforward-looking statements. Important factors that could cause actual results to differ materially from that describedthose in the forward looking statements.forward-looking statements include, but are not limited to those discussed in Part 1, Item 1A of this Form 10-K under the heading "Risk Factors," which are incorporated herein by reference.

In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s business and financial results. Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

GeneralITEM 1. BUSINESS

Unless otherwise indicated, references to “Gentherm”, “the Company”, “we”, “our” and “us” in this Annual Report refer to Gentherm Incorporated and its consolidated subsidiaries.

Except to the extent expressly noted herein, the content of our website or the websites of other third parties noted herein are not incorporated by reference in this Annual Report.

Overview

Gentherm Incorporated is athe global technology and industrymarket leader in the design, development, and manufacturing of innovative thermal management technologies.  Our products provide solutionsand pneumatic comfort technologies for the automotive passenger comfortindustry and convenience, battery thermal management, remote power generation,a leader in medical patient temperature management, environmental product testingmanagement. Automotive products include variable temperature Climate Control Seats® (“CCS”), heated automotive interior systems (including heated seats, steering wheels, armrests and other consumercomponents), battery performance solutions, cable systems, lumbar and industrial temperature control needs.massage comfort solutions, fuel management valves and other valves for brake and engine systems, and other electronic devices. Our automotive products can be found on the vehicles ofmanufactured by nearly all the major automotiveoriginal equipment manufacturers ("OEMs") operating in North America and Europe, and several major OEMs in Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilitiescapabilities. Medical products include patient temperature management systems. Our medical products can be found in hospitals throughout the world, primarily in the U.S., China, Germany and to identify future thermal technology product opportunities in both automotive and other markets.   We concentrate our research on the developmentBrazil. The Company is also developing a number of new technologies and new applications fromproducts that will help enable improvements to existing technologiesproducts, improve health, wellness and patient outcomes and will lead to create product and market opportunities for a wide array of thermal management solutions.  

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial.

Automotive

The Automotive reporting segment is comprised of the results from our global automotive businesses and individual convenience products. Operating results from our automotive seat comfort systems, specialized automotive cable systems and other automotive and non-automotive thermal convenience products are all reported in the Automotive segment because of their complementary focus on automotive content and/or individual comfort and convenience.  All of our activities with respect to electronics are also included in our Automotive segment because a majority of these activities relate to the manufacture of electronic components for our automotive products or the automotive products of third parties. Etratech’s operating results are included within Gentherm’s Automotive segment due to the concentration ofnew product applications within the automotive, RVfor existing and marine industries.

3


Automotive seat comfort systems include seat heaters, variable temperature Climate Control Seats  (“CCS”) designed to provide individualized thermal comfort to automobile passengers,new and integrated electronic components, such as blowers and electronic control units, that utilize our proprietary electronics technology.  Specialized automotive cable system products include ready-made wire harnesses and related wiring products. Other automotive products include the automotive steering wheel heater, heated door and armrests, heated and cooled cup holders and thermal storage bins.adjacent markets.

Industrial3


The Industrial reporting segment represents the combined results from our remote power generation systems business, our patient temperature management systems business, our environmental testing equipment business and our advanced research and product development division.  Our remote power generation systems business is managed by our subsidiary Gentherm Global Power Technologies (“GPT”) and our patient temperature management and environment test equipment businesses are managed by our subsidiary Cincinnati Sub-Zero (“CSZ”). The advanced research and product development division is engaged in projects to improve the efficiency of thermal management technologies and to develop, market, and distribute products based on these new technologies.  The operating results from these businesses and division are presented together as one reporting segment because of their joint concentration on identifying new, non-automotive markets and product applications based on thermal management technologies. See “Research and Development” below for a description of our internal and external research and development initiatives.

See Note 11 of the consolidated financial statements for information regarding the Company’s segment revenues from external customers, including geographic composition, operating income, depreciation and amortization, and goodwill. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at the segment level.

Corporate Information

We are incorporated under the laws of the State of Michigan. We were originally incorporated in California in 1991 and we reincorporated in Michigan in 2005. Our internet website is www.gentherm.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are made available free of charge through our website, www.gentherm.com, as soon as reasonably practicable after we electronically file them with or furnish them to the Securities and Exchange Commission.Commission (“SEC”). These reports are also available on the SecuritiesSEC’s website, www.sec.gov.

Segments

The Company has two reportable segments for financial reporting purposes: Automotive and Exchange Commission’s website, www.sec.gov.Medical.

Business StrategyAutomotive

We are strivingThe Automotive reporting segment is comprised of the results from our global automotive businesses, including the design, development, manufacturing and sales of automotive climate comfort systems, lumbar and massage comfort solutions, automotive cable systems, battery performance solutions, valve systems, and automotive electronic and software systems.

Climate comfort systems include seat heaters, blowers and thermoelectric devices for variable temperature CCS and steering wheel heaters designed to provide individualized thermal comfort to automobile passengers, and integrated electronic components, such as electronic control units that utilize our proprietary electronics technology and software. Other climate comfort systems include neck and shoulder conditioners and climate control system products for door panels and armrests.

Lumbar and massage comfort solutions include lumbar support, side bolster adjustment, multi-contour seats and massage systems that can be regulated according to the world leader invehicle occupant.

Automotive cable systems include ready-made individual cables and ready-to-install cable networks used to connect automotive components to power sources.

Battery performance solutions consist of cell connecting devices and battery cable technologies used for various types of automotive batteries and thermal management technologiesproducts for applicationheating or cooling 12 volts, 48 volts and high voltage batteries and battery modules.

Valve systems consist of applications that offer solutions in automotivefuel management, ranging from the design of tank ventilation and certainfilling functions to the closed-coupled fuel regulation. The modular systems allow for customizable adaptations. Valve systems also includes other markets. We believe achieving this goal depends on our ability to anticipatevalves for brake and engine systems.

Automotive electronic and software systems include electronic control units for climate comfort systems, electronic control units for memory seat modules and other devices.

Medical

The Medical reporting segment is comprised of the results from the patient temperature management business in the medical industry.

Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.

Business Strategy

Globally, we develop, manufacture, and deliver differentiated solutions for automotive and patient thermal management markets that make meaningful differences in everyday life by improving health, wellness, comfort and energy efficiency.

Our business strategy consists of four major pillars:

Leverage World Class Talent and Culture

We have built a remarkably talented global team by ingraining throughout the organization four Winning Culture Behaviors: Customer Focus, Global Mindset, Employee Engagement & Inclusion, and Performance & Accountability. Combined with a culture that values diversity, equity, inclusion and belonging ("DEI&B") as a cornerstone of the company, we have laid a strong foundation for future growth across the company.

4


Extend Technology Leadership

We will continue to expand our customers and integrate those needs into our advanced products.  Our strategy includes the followingtechnology leadership with focused investments in key elements:

Expanding the depth and breadth of our core technologies and the portfolio of products derived from these technologies;competencies, including advanced sensing, human-centric science-based design, system engineering, and software and electronics.

Focused Growth

The focused growth strategy includes four key goals:

Accelerate thermal comfort growth by leveraging human thermophysiology and smart ClimateSense® control algorithms to increase personalized passenger comfort and improve energy efficiency;

Increasing global penetration with automotive companies through an expanded arrayGrow pneumatic comfort business by leveraging the thermal products market share and customer relationships, as well as introducing products and technologies featuring the benefits of combined thermal management products;

and pneumatic solutions;

LeveragingContinue to bring to market and expand our global product developmentindustry leading and production capabilities to streamline the delivery of services to our customers and offer enhanced local support;

Improving capabilities to be a full service provider in design, development, testing and validation, and manufacturing of all required sub-system components;

Utilizing in-house electronics expertise to developproprietary next generation intelligentsolutions through innovation; and

Expand patient thermal management products;

Penetrating new markets and industries by creating new innovative solutions and products such as battery thermal management, waste heat recovery, remote power generation, medical patient temperature management, customized testing systems, and heated and cooled mattresses and office furniture, among others;

Continuing to expand our intellectual property portfolio; and

Acquiring other companies that enhance our other strategic business elements.

4


Recent Acquisitions

As part of our plan to acquire other companies to further our strategic goals, we have completed the following significant acquisitions in the recent past:

On April 1, 2014, we acquired Global Thermoelectric Inc., now known as Gentherm Global Power Technologies Inc., to enhanceleverage our expertise in thethermophysiology and drive synergies from our automotive climate and comfort businesses, as well as introducing new products and technologies.

These areas of thermoelectricsthe focused growth strategy are underpinned and enter new, non-automotive marketsenabled by our electronic and software systems.

Deliver Financial Excellence

We will continue to build a culture of performance that use thermoelectric devices (“TEDs”).

On April 1, 2016,includes a focus on high-return growth opportunities. In recent years, we acquired Cincinnati Sub-Zero Products, LLCundertook restructuring actions to reduce global overhead costs to improve Selling, general and administrative expenses. We are continuing to strengthen our operational discipline and striving to expand our temperature management activities into the medical, industrialmargins and testing fields.return on invested capital through manufacturing productivity, sourcing excellence and cash flow generation.

On November 1, 2017, we acquired Etratech Enterprises Inc. to expand our electronics capabilities, including in the automotive, consumerResearch, Development and commercial markets.Partnerships

Research and Development

Our research, development and developmentpartnerships activities are an essential part of our efforts to develop new or improved innovative products and introduce them to the market.products. Through both internal and external research and development programs, we are working to develop a comprehensive knowledge of thermal management and pneumatic comfort systems that can demonstratedemonstrates functionality and performance. These activities are critical to optimizingoptimize energy utilization and production efficiencies, and to improvingimprove effectiveness in our products making them less complex, easierand minimize the cost to package and less expensive to manufacture and install while improving the customer experience.integrate our products with those of our customers.

We perform advanced research and development on thermal and pneumatic comfort technologies, including thermal management systems includingthat utilize new proprietary comfort software algorithms, to enhance the development and testing of new materials, to achieve increased efficiency and reliability. We engineer new applicationsfunctionality of our existing products in order to meet design criteria compatible with each of our customers’ unique requirements.automotive heating and cooling products. We believe there are substantial prospects foropportunities to expand our human-centric value proposition beyond thermal in comfort, health and wellness. Through the designintegration of pneumatic comfort technologies with our thermal technologies, and developmentapplication of innovative thermal management systemssoftware algorithms, we hope to deliver heightened value to our consumers through an experience that goes beyond traditional comfort regulation and more directly helps to promote individual health and well-being.

To offer our customers cutting-edge products and technologies, our strategy includes partnering with key technology leaders in applications both insideour industry. Our advanced partnership with global automakers and outsidemanufacturers address and work to solve industry preferences of the industries servedtoday and tomorrow by leveraging our current product lines.  expertise in human thermophysiology and physiotherapy.

Research and development activities are expensed as incurred. These expenses include direct expenses for wages, materials and services associated with particular engineering activities, net of reimbursements from customers and research sponsors.  Any related reimbursements for costs, whether for advanced research or a specific product application, are accounted for as a reduction of research and development expense.  

Research and development is conducted around the globe, includingglobally and predominantly at our world headquarters in Northville, Michigan, our test laboratoryTechnology Center in Farmington Hills, Michigan, our advanced batteryEuropean research facility in Irvine, California, our advanced materials research facilities in Azusa, California, our European research facilities in Odelzhausen, Germany and Budapest, Hungary, our industrial applicationAsian research facility in Calgary, Canada, our medical application research facility in Cincinnati, Ohio and our electronicsShanghai, China.

Product design and advanced testing facilities in Shanghai, China and Burlington, Canada.  Additional product development also is performed at all of our manufacturing facilities to support our geographically diverse customers. We believe the localized development model employed at our global design and manufacturing facilities improves our ability to effectively serve our customers and increases our innovative capacity incapacity.

5


Core Technologies

In Automotive, Gentherm is the future.

Net researchglobal market leader of innovative thermal management and development expense in 2017, 2016 and 2015 was $82,478,000, $72,923,000, and $59,604,000, respectively. Because of changing levels of research and development activity,pneumatic comfort technologies. For our research and development expenses fluctuate from period to period.

Technologies

Gentherm’sMedical business, our expertise in thermal management is focused on two general areas: managing the thermal conditions of people and objects and managing the thermal energy conversion to electrical energy.  people.

Thermoelectric Technologies

Many of our thermal products manage the thermal conditions of people and objects using our internally developed advanced TED technology. A TED is a solid state circuit that has the capability to produce both hot and cold thermal conditions by use of the

5


Peltier effect. The advantages of advanced TEDs over conventional compressed gas systems are that they are environmentally friendly and less complex as they have no moving parts and are compact and light weight.  For the last 17 years, our work on this technology has yielded great improvements in areas of efficiency, durability and performance.

Thermoelectric generator (“TEG”) technologies have the reciprocal capability to the Peltier effect, known as the Seebeck effect, whereby thermal energy is converted into electrical power.  Our current research and development activities are concentrated on improving the efficiency of this process, by improving design and adapting new materials that are better suited for TEG commercialization.  These efforts, together with previously sponsored research which focused on the recovery of waste heat from vehicle exhaust and other sources, has led us to introduce this technology to certain specialty markets.    

Resistive Heaters

Resistive heater technologies are comprised of wire, carbon fiber or positive thermal coefficient (“PTC”) heating elements whichthat quickly and effectively deliver heat to people and objects. Wire heating elements are designed from stainless steel, copper, our proprietary carbon fiber woven lattice technology called Carbotex® or printed circuit PTC heaters based on the specifications for a particular product application. Resistive heaters have multiple automotive applications, including seat heating, steering wheel heating, interior panel heating and battery heating.

ElectronicsThermoelectric Technologies

Gentherm manufactures and supplies electronics to our core thermal seat comfort, interior comfort and thermal convenience products.  We also supply electronics for products outside this core set and have a contract to supply value-added electronic products to third parties for adjacent areas within the automotive interior, which is scheduled to launch in 2019.  In November 2017, we acquired Canadian-based Etratech Enterprises to expand our electronics capabilities in automotive, consumer and commercial products.

Automotive Cable Systems

Gentherm produces automotive cable systems used to connect automotive components to sources of power. The automotive cable systems are an important element in the production of virtually allMany of our thermal products manage the thermal conditions of people using our internally developed advanced thermoelectric device technology (“TED”). A TED is a solid-state circuit that has the capability to produce both hot and formcold thermal conditions by use of the Peltier effect. The advantages of advanced TED over conventional compressed gas systems include a significant componentreduced environmental impact and less complexity as they have no moving parts and are compact and light weight. Our work on this technology has yielded improvements in how we generate value to our customers by being an efficient, low-costareas of functionality, efficiency, durability and high quality manufacturer. We offer cable systems as integrated parts of our products and also as stand-alone components for other automotive applications, such as oxygen sensors.  Our cable systems business includes both ready-made individual cables and ready-to-install cable networks. Sales of products that utilize our automotive cable systems technology represent 9%, 9% and 10% of our total product revenues for the twelve-month periods ending December 31, 2017, 2016 and 2015, respectively.performance.

Air Moving Devices

Our highly durable and quiet air moving devices, includingsome of which include our proprietary blower and fan designs, are essential to all of our products that require air movement. ProductionWe have a broad portfolio of integratedthese products that are tailored to various automotive applications, including seat ventilation and electric vehicle battery cooling.

Pneumatic

Pneumatic massage and lumbar systems operate by inflation and deflation of air moving devicesbladders to achieve desired comfort effect. Our products' differentiation is that our underlying valve technology for regulating air flow is based on shape memory alloy valves ("SMA"). Gentherm has developed actuators and valves with SMA technology that replace heavy, noisy and less accurate electromagnetic valves. Our innovative control elements produce precise mechanical forces and movements using the finest wires made of memory metals and without the labor-intensive use of additional sensors.

Electronics

The electronics in our core climate comfort solution products are primarily designed and manufactured by us. We also supply value-added electronic products to third parties for adjacent areas within the automotive interior. In addition, Gentherm manufacturers and supplies electronic control units for memory seat modules that include electric motor position sensing technology. This technology further applies to other automotive products requiring fine motor controls.

WellSense™

In January 2024, Gentherm introduced WellSense™, a software defined consumer experience that delivers customized in-cabin comfort sensations that promote wellness and well-being. The technology we are developing leverages science-based physiology research as the foundation for proprietary software that orchestrates heating, cooling, lumbar and massage comfort effectors. WellSense™ delivers enhanced wellness and well-being sensations in product offerings suitable for software defined vehicles and over-the-air feature upgrades for all vehicle configurations. The WellSense™ software development kit can be combined with additional vehicle features like in-cabin audio, visual and aromatic stimulation to deliver unique sensations that go beyond traditional comfort regulation to help promote individual wellness and well-being.

ClimateSense®

ClimateSense® is an exampleintegrated comfort system we are designing to create a personalized microclimate for passengers using localized convective, conductive and radiative heating and cooling products. Using automatic regulation technology in combination with our unique occupant-centric control algorithm, ClimateSense® offers the ability to personalize and improve overall occupant thermal comfort, improve time to comfort with (all-electric) pre-conditioning, provide comfort with less energy consumption thereby lowering greenhouse gas emissions by conventional internal combustion and hybrid powertrains, and extend range for electrified

6


powertrains through a reduction in central heating, ventilation and air conditioning system usage. Our first production vehicle award for our ClimateSense® technology has launched on the all-new 2024 Cadillac CELESTIQ, and will be followed by a battery electric version of our expanding manufacturing capabilities and is an important step toward our goal of becoming a full service provider of sub-systems.popular SUV launching in 2025.

Refrigeration SystemsProducts

Refrigeration systems are used in environmental test chambers to cool various products. In most cases the products are heated to a higher temperature (85°C and up) and then cooled down. The heat up and cool down rates are important to thoroughly test the product. Generally products are cooled to -40°C or below. To accomplish this, specialized refrigeration systems are required. Single stage refrigeration systems can cool chambers to -34°C. Two-stage refrigeration systems can achieve -50°C . Cascade refrigeration systems can cool down to -85°C. The customers’ applications determine the temperature range needed.  

Other Technologies

We are developing new technologies that will help enable improvements to existing products and create new product applications.

6


Products

Climate & Comfort Solutions – Seat Comfort

Climate Control Seat®Systems

OurCCS

Gentherm offers a range of CCS products utilize exclusive patented technology to regulateutilizing proprietary technologies for regulating temperature and enhanceenhancing the comfort of vehicle passengers. The most advancedOur ventilated CCS models use one or moreproducts move air through the seat to provide conditioning. Our active CCS products utilize TEDs to generate heating or cooling depending uponheat and cool air used to condition the direction of the current applied to the device.

A TED is the heart of a compact heat pump used in our active CCS products. Air is forced through the heat pump and thermally conditioned in response to electronic switch input from the seat occupant.seat. The conditionedconditioning air circulates by one of our specially designed air moving devices through a proprietaryan air distribution system installed in the seat cushion and seat back, so that the seat surface can be heated, ventilated or cooled. Each seat has individual electronic controls to adjust the level of heating, ventilating or cooling. ActiveOur CCS products substantially improve comfort compared with conventional vehicle cabin air conditioners by focusing heating and cooling directly on the passenger through the seat rather than waiting until ambient air cools the seat surface beneath the passenger.  A heated and ventilated variant of theseat. Our CCS utilizes ambient cabin air to provide cooling comfort instead of a TED to actively cool the seat. In the heating mode, the vent-only system is supplementedproducts can be combined with our resistive heating elements.  elements to increase heating capacity and reduce time to comfort.

Heated and ventilated CCS products, which are targeted for lower cost vehicle models, provide a lower level of cooling capability than our active CCS solution, but at a lower price. By offering different models of the CCS product, our customers have the opportunity to purchase a wider range of climate control products at different price points. Sales of CCS products, primarily ventilated CCS products, contributed 39%33%, 45%35% and 47%38% to our total product revenues for the twelve-month periods endingyears ended December 31, 2017, 20162023, 2022 and 2015,2021, respectively.

Heated Seat

Heated seats, based on our resistive heater core technology, are seamlessly integrated into automotive seat designs, and are constructed using materials that offer the best capacity, installation characteristics and durability. Our design and manufacturing capabilities allow customers to choose among a variety of resistive heater materials based on their individual vehicle specifications. Sales of heated seat products contributed 31%21%, 32%24% and 32%26% to our total product revenues for the twelve-month period endingyears ended December 31, 2017, 20162023, 2022 and 2015,2021, respectively.

Thermal ConvenienceIntelligent Neck Conditioner

TrueThermTM Cup Holder

The TrueTherm cup holder applies Gentherm’s patented TED technologies to keep beverages of automobile drivers and passengers eitherIntelligent neck conditioning systems ventilate warm or cool.  We have developedtemperature-controlled air directly onto the passenger’s neck and shoulder area. The system combines electronics, air moving device technologies and a range of cup holder models with varying degrees of functionality, designed to be packaged in multiple configurations to accommodate different console environments.  Our dual independentheating element into a compact, integrated headrest design provides separate temperature settings in each holder allowing the driver and passenger to individually maintain a heated or cooled beverage.  

TrueThermTM Storage Unit

Gentherm’s TrueTherm storage units provide for food or beverage cooling for the global automotive market.  Using patented TED or refrigeration technologies, the TrueTherm cool storage unit provides temperature control independently from a vehicle’s heating and air conditioning system.  Itthat can be custom designedadjusted to accommodate tight interior spaces, such assuit the front floor consolebody size of a sport utility vehicle (SUV), and provide additional cooling capacity to those who have long work commutes or transport multiple passengers.  the passenger.

InteriorClimate & Comfort Solutions – Surface Climate Control Systems

Heated Steering Wheel

Heated steering wheels deliver heating comfort to automobile drivers through resistive wire elements, similar to those used in our seat heater products.elements. This product can be applied to both leather and wood steering wheels. A solution for drivers in cold and mild weather climates, the heated steering wheel is designed for the global automotive market.

7


Heated Door and ArmrestSurfaces

Gentherm’s thermally conductive or radiative surfaces, such as door panel armrest and center console armrest products, are powered by technologies used in our advanced seat heating products.core technologies. The system is thermally managed by a heating control system which can be discretely located in the door panel or seat of the vehicle. Heated door panels and armrests complement our climate controlledclimate-controlled seat and steering wheel products and provide a superior level of thermal comfort to the driving experience.

Climate & Comfort Solutions – Pneumatic Seat Massage

Gentherm's seat ergonomics system consists primarily of pneumatic lifting elements (air bladders) which are mounted under the surface of seat cushion and back. Through the cyclical inflation and deflation of the lifting elements, the contour of the seat cushion is selectively modified. The lifting elements are controlled by valves, utilizing software that can be enabled in modes by the vehicle occupant in accordance with their preferences and specific body types.

7


Climate & Comfort Solutions – Electronics Solutions

Memory Seat Modules

Gentherm has developed a unique way to control certain electrical motors in a vehicle. Our Intelligent Positioning System (IPS®) product suite utilizes proprietary software to determine the position of a power seat and control the memory seat module.

Hands-On Detection

All vehicles manufactured with autonomous driving level 2 or higher capabilities are required to ensure that the driver stays in control of the vehicle during operation. In order to accomplish this task, Gentherm developed PilotSenseTM – a sensor integrated into the steering wheel that monitors whether the driver’s hands are maintaining contact with the steering wheel. This product is available for both heated and non-heated steering wheels.

Battery Performance Solutions

Cell Connecting Systems

Cell connecting systems provide secure connections between advanced automotive batteries to transmit a continuous flow of information about battery temperature and cell voltage during the charging and discharging process to monitor battery system performance. Gentherm has developed a range of cell connecting system products, including flexible foil cell connecting boards that offer improved packaging, weight and functionality. We offer these products in a variety of materials to cover customers’ requirements.

Thermoelectric Battery Thermal Management (“BTM”)

Thermal management is critically important for the long-term operation of advanced automotive batteries. The expansion of electrified vehicle applications, such as 48-volt electrical networks, start-stop systems, regenerative braking systemselectric vehicles, plug-in hybrids and other micro-hybrid battery implementations,mild hybrids, have drastically increased the demand for BTMbattery thermal management(“BTM”) systems solutions whichthat enable wider operating temperature ranges, enhanced driving range and prolonged life of the battery. Gentherm’s BTM system can provide precision battery cooling of 48-volt mild hybrid systems on pack or cell-level using patented TED technology. The BTM system maintains the temperature of the lithium-ion battery or other advanced chemistry battery within an acceptable temperature range without the use of chilled liquids or refrigerant loops, making it a light weight, highly scalable, compact solution ideal for automotive applications. Gentherm’s proprietary BTM system is compact and energy efficient, resulting in a minimal energy budget,usage, which is important for an electrified vehicle.  The performance improvements realized with this product have been validated through the award of production

Aside from battery cooling, Gentherm’s BTM systems by two flagship original equipment manufacturers (“OEMs”). We are currently working with other OEMs in an effort to secure more production contracts.

Remote Power Generation

Gentherm is a leading provider of remote electric power generation systems, primarily serving large upstream and midstream oil and gas markets.  Usingportfolio includes battery heating applications. Based on our unique industrial TEG technologies, our generation systems deliver ultra-reliable power for long-term unattended operation in geographically remote applications that are criticalproprietary technology, we offer solutions to our customers’ operations,customers that enable efficient heating of lithium-ion batteries for most electrified vehicles.

Thermal Convenience Solutions

TrueThermTM Cup Holder

The TrueThermTM Cup Holder applies Gentherm’s patented TED technologies to keep beverages of automobile drivers and passengers either warm or cool. We have developed a range of cup holder models with varying degrees of functionality, designed to be manufactured in multiple configurations to accommodate different console environments. Our dual independent design provides separate temperature settings in each holder allowing the driver and passenger to individually maintain a heated or cooled beverage.

TrueThermTM Storage Unit

Gentherm’s TrueThermTM Storage Unit provide for food or beverage cooling for the global automotive market. Using patented TED or refrigeration technologies, the TrueThermTM Storage Unit provides temperature control independently from a vehicle’s heating and air conditioning system. It can be custom designed to accommodate tight interior spaces, such as wellhead automation, valve automationthe front floor console of a sport utility vehicle and cathodic protectionprovide additional cooling capacity to those who have long work commutes or transport multiple passengers.

8


Automotive Cable Systems

Gentherm manufactures automotive cable systems used to connect automotive components to power sources. The automotive cable systems are an important element in the production of pipelines.many of our products and form a significant component in how we generate value to our customers by being an efficient, low-cost and high-quality manufacturer. We designoffer cable systems as integrated parts of our products and produce turnkeyalso as stand-alone components for other automotive applications, such as oxygen sensors. Our cable systems that are highly customizedbusiness includes both ready-made individual cables and ready-to-install cable networks.

Valve Systems Technologies

Gentherm has deep expertise in automotive fluid management, providing intelligent solutions for application, load, powerapplications in engine systems, brake systems and fuel source,management such as actuators, thermal management valves, crank case ventilation valves, non-return valves, mechanical switching valves, servo assistance valves, fuel limit vent valves, roll over valves and locationdrain valves. We have many years of experience in precision injection molding and valve technology, which include innovative technologies such as the SMA actuating elements. Due to our modular systems, we implement customized adaptations at attractive costs and are prepared to address future global regulatory emissions requirements.  Other applications for our remote power generation systems include mobile telecommunications, security and surveillance and scientific monitoring.  Our revenues from this product include large custom systems projects ranging from $200,000 to over $2,000,000.  Quarterly results from our remote power generation business can vary significantly due to delivery timing of these custom systems to customers, among other factors.

Patient Temperature Management Systems

Gentherm providesaspires to provide healthcare professionals with superior temperature management solutions and clinical expertise that improve patient outcomes, increase the standard of care and enhance patient satisfaction. We provide a full line of patient temperature management systems including ourthat utilizes air, water and resistive technologies across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities. Our core brands include Blanketrol®/Kool-Kit® hyper-hypothermia system, designed to manageWarmAir®/FilteredFlo® convective warming system, ASTOPAD® resistive patient body temperatureswarming system (leveraging technology used in operating rooms, recovery rooms, intensive care unitsour automotive products), Electri-Cool®/Micro-Temp® localized cooling/warming systems, ASTOTHERM®/ASTOFLO® IV fluid and other areas of hospitals, as well as for use in the home healthcare market.  Ourblood warming systems, offer simple programmable body temperature regulations to establish and maintain stable patient temperature. We also offer the industry-leading Hemotherm® blood temperature management solutionscardiovascular cooling/warming system that delivers reliable, effectiveprecise blood temperature management control during cardiopulmonary by-pass and other related cardiovascular procedures. Revenues from the sale of patient temperature management systems began in April 2016 in connection with the acquisition of CSZ.

Environmental Testing Equipment and Testing ServicesAutomotive Customers

Gentherm provides standard and custom designed environmental test chambers that execute reliability tests by subjecting products to environmental extremes like temperature, humidity, altitude, and vibration.  Our chambers are available in a variety of sizes with capabilities ranging from basic temperature cycling to accelerated stress testing.  Gentherm designs and sells environmental test chambers for a variety of industries, which include the pharmaceutical, automotive, electronics, medical, telecommunications, aerospace and defense industries.  Revenues from the sale of environment testing equipment and testing services began in April 2016 in connection with the acquisition of CSZ.

8


Heated and Cooled Sleep Systems

Our heated and cooled sleep system solution incorporates our proprietary Climate Control Sleep SystemTM (“CCSS”) technology. The CCSS represents an adaptation of the TED technology used in our active CCS system. The CCSS directs warmed or cooled air to the surface of a mattress through our proprietary air distribution system. Two independently controlled temperature zones have their own heat or cool settings for a personalized microclimate sleep environment. There are five available settings in each of the heat and cool modes as well as an ambient setting. The sleep system is controlled by the user through a Master Control Unit or hand-held remote controls. In addition, our Heat Vent Sleep System (HVSS) provides similar comfort features at a lower price point. Integration solutions for both CCSS and HVSS exist for foam, innerspring and air bed mattresses and we are working with mattress manufacturers and retailers to bring CCSS technology to markets around the world. Beds featuring CCSS technology is available from Symbol Mattress and their brand SleepFreshTM  (www.sleepfreshbeds.com).

Heated and Cooled Office Chair

Gentherm has adapted our innovative automotive-grade thermal technology to office chairs. Our design and integration solutions provide personalized temperature control whether at home or in the office. With the ability to provide heat or cool to one or both of the back and seat surfaces, we are able to provide manufactures and retailers a range of product and pricing options that best meets their customers’ needs. Combined with our occupant sensor switch, the rechargeable lithium-ion battery is capable of providing over 8 hours of thermally controlled comfort, granting users the freedom of movement without being tethered by an electrical cord. Office chairs featuring our technology are currently marketed and sold by National Business Furniture and Klӧber, and are also available at www.amazon.com.

Heated Lift Assist Chair

Gentherm’s heated seat technology has recently been added to a lift assist chair. The chair, produced by Windermere Motion and marketed as the Ultimate Power ReclinerTM (www.ultimatepowerrecliner.com), uses dual zones allowing for the back and seat/legs to be set at different temperatures. The chair is available through Windermere Motion’s network of dealers.

Sponsored Research  

In April 2016, the Company was selected as a subcontractor in a U.S. Air Force sponsored program award for the engineering and development of a non-invasive warming and cooling device. The device will be incorporated as medical equipment in the Air Force Expeditionary Medicine Support and Air Force Theater Hospital units supporting overseas contingency operations. Once operational testing is complete and the manufacturing processes for initial production are fully matured, the device will be submitted to the U.S. Food and Drug Administration for certification. The 30-month, $5.7 million project will be fully funded by the U.S. Air Force. As a subcontractor, Gentherm’s share of the award is approximately $2.6 million. Gentherm received $1.2 million and $300,000 in program funding during 2017 and 2016, respectively.

During 2015, Gentherm was selected by the U.S. Navy to lead the development of an energy efficient, portable patient warming system based on proprietary thermal management technologies. The objectives for the program include improving the current standard of care for patient warming in support of expeditionary health services and advanced medical development.  The patient warming system is intended to be compatible with existing medical care systems and will be used for treating patients in field hospitals or in transport by ground, ship or air to traditional, better-equipped treatment centers.  Our approach, which is based on new research, leverages the body’s natural methods for thermal exchange and temperature management.  The $2.75 million project was granted a one-year extension and is fully funded by the U.S. Navy.  Total funding received from this program during 2017, 2016 and 2015 was $836,000, $1.1 million and $140,000, respectively. The portion of funding pertaining to Gentherm’s project contributions  during 2017, 2016 and 2015 was $648,000, $403,000 and $140,000, respectively.

Marketing, Customers and Sales

Our Automotive segment customers include primarily light vehicle OEMs commercial vehicle OEMs, and first tier (“Tier 1”) suppliers to the automotive OEMs,1s, including automotive seat manufacturers. We also directly supply CCS and seat heatersproducts to aftermarket seat distributors and installers.

9


The Company’s automotive marketing is directed primarily at automotive manufacturersthe OEMs and their Tier 1 suppliers1s and focuses on the enhanced value consumers attribute to vehicles with seat comfort, thermal convenience and interior comfort products.  If interested,pneumatic solutions. In many cases, the manufacturersOEMs direct us to work with their suppliers, primarily their Tier 1s, to integrate our products into the vehicle’s seat or interior design. These customers will sell our product, as a componentAs an independent supplier we can work with any OEM and any seat manufacturer, to create scores of an entire seat or seating system, to automotive OEMs. innovative and unique configurations for all of their applications.

Once the integration work is complete, prototypes are sent to the manufacturerOEMs for evaluation and testing. If a manufacturean OEM accepts our product, a program can then be launched for a particular model on a production basis, but it normally takes twoone to three years from the time a manufactureran OEM decides to include any of our products in a vehicle model to actual volume production for that vehicle. During this process, we derive funding from prototype sales but obtain no significant revenue until mass production begins. Upon commencement of mass production, our products are sold by Tier 1s to the OEMs. Inherent to the automotive supplier market are costs and commitments that are incurred well in advance of the receipt of orders and resulting revenues from customers.

As automobile products comprise a majority of our current revenue, theThe volume of products we sell is significantly affected by theglobal and regional automotive production levels of new vehicle sales and the general business conditions in the automotive industry. Our product revenues are generally based upon purchase orders issued by our customers, with updated production schedules for volume adjustments. As such, we typically do not have a backlog of firm orders at any point in time. Once we are selected to supply products for a particular platform, we typically supply those products for the platform life, which is normally five to ten years, although there is no guarantee that this will occur. In addition, when we are the incumbent supplier to a given platform, we believe we have a competitive advantage in winning the redesign or replacement platform, although there is no guarantee that this will occur.

9


For 2017,2023, our revenues from sales to our threetwo largest customers, Lear Corporation (“Lear”) and Adient plc (“Adient”) were $217 million and Bosch Automotive were $192,756,000, $173,964,000, and $75,370,000,$189 million, respectively, representing 20%, 18%,15% and 8%13% of our totalproduct revenues, respectively. Revenues from AdientLear and LearAdient represent sales of our seatclimate comfort thermal conveniencesolutions, pneumatic comfort solutions, battery performance solutions and interiorcable technology products. Lear acquired the Interior Comfort Systems business unit of Kongsberg Automotive ASA in February 2022, and acquired I.G. Bauerhin in April 2023, which are both key competitors of the Company’s climate comfort and pneumatic comfort products. Revenues from Bosch represent product sales basedIn 2023, we believe there was an immaterial impact to our business as a result of these acquisitions. Lear has expressed an intent to become a leading provider of thermal comfort solutions as part of a vertical integration strategy, and the magnitude of the future adverse impact on our automobile cable system technologybusiness and are used primarily in the production of automotive oxygen sensors. financial statements remains subject to significant uncertainty.

The loss of any oneor significant reduction of these customers isbusiness from Lear or Adient, or direct competition from them, would likely to have a material adverse impact on our business; however,business, results of operations and cash flows. However, as noted above, our strategy is to market our seat comfort and thermal convenience products to thein many cases automotive OEMs who then direct their suppliers such as AdientLear and Lear,Adient to work with us.  Therefore itus for our climate comfort solutions, pneumatic comfort solutions, battery performance solutions and cable technology products. It is, therefore, relevant to understand how our revenues are divided among the OEMs, as shown below.

Our total product revenues including those from sales of our automotive cable systems products, for each of the past three years were divided among automotivethe OEMs as follows:

 

 

2023

 

 

2022

 

 

2021

 

General Motors

 

 

13

%

 

 

15

%

 

 

14

%

Hyundai

 

 

10

%

 

 

11

%

 

 

13

%

Volkswagen

 

 

9

%

 

 

9

%

 

 

10

%

Mercedes-Benz

 

 

8

%

 

 

7

%

 

 

5

%

BMW

 

 

8

%

 

 

7

%

 

 

6

%

Ford Motor Company

 

 

7

%

 

 

8

%

 

 

8

%

Stellantis(a)

 

 

6

%

 

 

8

%

 

 

8

%

Honda

 

 

4

%

 

 

4

%

 

 

5

%

Global EV manufacturer

 

 

4

%

 

 

2

%

 

 

1

%

Jaguar/Land Rover

 

 

3

%

 

 

3

%

 

 

2

%

Other (including Medical)

 

 

28

%

 

 

26

%

 

 

28

%

Total

 

 

100

%

 

 

100

%

 

 

100

%

(a)
Reflective of the 2021 merger of Peugeot S.A. and Fiat Chrysler Automobiles N.V.

Automotive Market Trends

The Gentherm automotive product portfolio aligns well with near-term and long-term consumer and technological trends:

Manufacturer

 

2017

 

 

2016

 

 

2015

 

General Motors

 

 

15

%

 

 

18

%

 

 

18

%

Ford Motor Company

 

 

11

 

 

 

12

 

 

 

13

 

Volkswagen

 

 

10

 

 

 

10

 

 

 

10

 

Fiat Chrysler Automobiles

 

 

9

 

 

 

10

 

 

 

10

 

Hyundai

 

 

8

 

 

 

10

 

 

 

12

 

Honda

 

 

6

 

 

 

6

 

 

 

4

 

Renault/Nissan

 

 

6

 

 

 

6

 

 

 

6

 

BMW

 

 

5

 

 

 

6

 

 

 

6

 

Daimler

 

 

4

 

 

 

4

 

 

 

4

 

Toyota Motor Corporation

 

 

4

 

 

 

4

 

 

 

4

 

Jaguar/Land Rover

 

 

3

 

 

 

2

 

 

 

3

 

Other

 

 

19

 

 

 

12

 

 

 

10

 

Total

 

 

100

%

 

 

100

%

 

 

100

%

Non-automotive revenues

Increased efficiency and electric range – Our technology is best-in-class and provides a unique, innovative, and energy efficient automotive seating experience, which is key to vehicles of 11%the future. Our solutions, including the ClimateSense® and pneumatic comfort systems that we continue to develop, help reduce weight and overall energy consumption of a vehicle, resulting in 2017, 8%improved fuel consumption for vehicles with an internal combustion engine, and increased range for electric vehicles. Our Battery Performance Solutions products help improve the life and efficiency of batteries, contributing to increased adoption of powertrain electrification.
Increased demand for comfort products – We believe increased consumer demand for personalized comfort in 2016a vehicle is driving increased adoption of our thermal and 6% for 2015pneumatic comfort products. We are included withinstriving continuously to bring to market products and technologies that improve the Other category.  

Our power generation systemswell-being of vehicle occupants. From improved performance of our seat heating and cooling devices, to our introduction of the neck climate control system, heated surface products, and pulsating massage treatment – our focus is to make vehicle comfort an integral part of vehicle occupants' experience. The thermal and pneumatic comfort market is growing at a much faster pace than the automobile market and, in particular, OEM customers are used by oilseeking the combined thermal and gas customers for cathodic pipeline protection and other remote applications around the world.  

Patient temperature management systems customers include hospitals and other health care service providers.  Customers purchasepneumatic lumbar product. Given this trend we expect to see a much higher rate of adoption of our products into vehicles, and we are poised to take advantage of that through the leveraging of Gentherm’s strong customer relationships to introduce Alfmeier’s industry leading technologies.

10


Growth of connected/smart devices – One of the most important objectives in achieving comfort is to create a system that is able to sense the needs of vehicle occupants and make performance adjustments based on personalized needs. We utilize machine learning to create and optimize state of the art algorithms to make our products smarter and more advanced with each generation.
Focus on health and wellness – Consumers have an increased focus on personal health and wellness and trends are shifting towards consumers using their vehicles as a third living space, outside the home or office. Our technologies are at prices negotiated by exclusive medical equipment distributors or, if they arethe nexus of health, wellness and comfort, where our solutions adjust to enable vehicle occupants to address their health and wellness needs, including the recently introduced WellSense™ system.
Emergence of shared mobility – As the world transitions from vehicle ownership to mobility as a named participant,service model, our focus on individual personalized comfort becomes even more important. Our focus is to create microclimate solutions, in which each vehicle occupant can create a group purchasing organization.

Our environmental testing equipment and testing services are soldpersonalized thermal experience tailored to a wide variety of customer in many different industries.

individual needs.

We supply heated and cooled sleep systems to mattress manufactures and their distribution channels and heated and cooled office chairs to catalog and on-line retailers.  

10


Our non-automotive electronics products are sold to a variety of industrial customers, including an elevator door manufacturer and an irrigation systems company.

Outsourcing, Production and Suppliers

Our global manufacturing and distribution facilities are located close to our key customers.  Our Europeancustomers and strategically in low cost regions. In Automotive, we operate four manufacturing operations aresites in Europe located at our Hungarian, Macedonianwithin North Macedonia, Ukraine, Germany and Ukrainian sites.Czech Republic and one distribution center located in Hungary. In North America, we operate twothree manufacturing production sites in Acuña, Mexico one in Celaya, Mexico, one in Cincinnati, Ohio, one in Alberta, Canada and one manufacturing site in Ontario, Canada.the United States. In Asia, we operate production facilitiesthree manufacturing sites in Langfang, China and Ha Nam,one in Vietnam, and one distribution center in South Korea. Further, we are in the process of expanding our footprint with investments in two electronics production facilitiesnew manufacturing plants, one in Shenzhen, China. Morocco and one in Monterrey, Mexico. See Note 5, “Restructuring and Impairments” to the consolidated financial statements included in this Annual Report for additional information.

For Medical, we operate three manufacturing sites within China, Germany and the United States.

We continue to growprocure our in-house manufacturing capabilities, reducing the number of components outsourced to contract manufacturers.  

We rely on various domestic and foreign vendors and suppliers to supply components for our products through purchase orders, with no guaranteed supply arrangements. Components for certain products, including TEDs, are only availableraw materials from a limited numbervariety of suppliers around the world. In the normal course of business, we do not carry substantial inventories of these raw materials in excess of levels reasonably required to meet our near-term production requirements.

In 2023, the automotive industry continued to experience inflationary pressures with respect to raw materials, labor, and associated freight costs as a result of a supply-constrained environment and general economic conditions. In response to the inflationary cost increases, the Company has taken several actions to reduce any potential and actual adverse impacts by working closely with its suppliers and customers to mitigate the impact of these inflationary pressures in the world. The lossfuture. While these actions are designed to offset the impact of any significant supplier, in the absence ofinflationary pressures, we expect to have a timely and satisfactory alternative arrangement, or an inability to obtain essential componentscontinued adverse impact on reasonable terms or at all, could materially adversely affect our business operations and cash flows. Ourfinancial performance for the foreseeable future. Accordingly, the significance of the future adverse impact on our business and operations could also be materially adversely affected by delays in deliveries from our suppliers.financial statements remains subject to significant uncertainty.

Proprietary Rights and Patents

The development of new or improved technologies is critical to the execution of our business strategy. PatentsCurrently owned patents and patents obtained for new or improved technologies form an important basis for the success of the Company and underpin the success of our research and development efforts. We have adopted a policy of obtaining, where practical, the exclusive rights to use technology related to our products through patents or licenses for proprietary technologies or processes. We adapt and commercialize such technologies in products for mass production. We also have developed technologies or furthered the development of acquired technologies through internal research and development efforts.

As of December 31, 2017,2023, Gentherm held 565459 issued patents, of which 233226 were U.S. patents and 332233 were non-U.S. patents. A total of 27 patents were held jointly with other companies.  Gentherm held 399177 patents directed to climate control products and thermoelectric technologies 126(including 36 patents directed at heating elementsto ClimateSense®), 64 patents directed to battery cell connecting and cable technologies, 2652 patents directed to massage and lumbar technologies, 31 patents directed to air moving devices, 1328 patents directed at patient temperature management systemsto medical technologies, 48 patents directed to heating elements and 1technologies, 40 patents directed to occupant sensing technologies, 11 patents directed to fluid valve technologies, and 8 patents directed to electronics technologies. The Company continuously evaluates its patents and makes strategic decisions to reduce low-value patents and patents unrelated to current or planned business strategies, while still increasing patent directed at refrigeration systems technologies.use in-line with our current and planned business strategies.

11


Competition

Competition

TheGentherm faces competition from other automotive componentssuppliers and, systems business is highly competitive. We have several important competitors in the heated seat business andwith respect to certain vehicle manufacturers have, for some time, offered options on certain models that combine heated seats with circulation of ambient air or cooled airproducts, from the car’s air conditioning system which works similar to our heatedOEMs and ventilated seat system products.  It is possible that our competitors will be able to expandTier 1s who manufacture or modify their current products to more directly compete with our CCS products. We believe that there are other potential competitors that are working to develop systems for heating and cooling of automotive car seats.

We may experience additional competition directly from automobile manufacturers or other major suppliers, most of which have the capability to manufacture competing products. We believecertain products that our products will compete successfullyGentherm manufactures and supplies. The automotive supply industry competes on the basis of performance,technology, quality, reliability of supply, design, engineering capability and price.competitive pricing. Although the overall number of our automotive competitors has decreased in recent years due to ongoing industry consolidation, the automotive technology and components industry remains extremely competitive. The competitive landscape for patient temperature management systems includes patient thermal management medical device manufactures.

Additionally, we may experience competition from non-traditional participants that introduce new technologies, such as advanced driver assistanceWe believe our expertise in core thermal management and pneumatic comfort technologies, as well as new products or services, such as autonomous vehicles, car-our capability in applying specific component design, global footprint and ride-sharingbroad product offerings, make us well positioned to compete against the traditional thermal management systems and transportation aspneumatic comfort suppliers, global Tier 1s and component specialists. OEM customers are expressing a service.desire for a combined thermal and pneumatic lumbar product, especially from an independent supplier who integrates with many seating providers. This is one of the unique value propositions that Gentherm offers.

See further discussion of the risks relating to competition in Item 1A, “Risk Factors” for further information regarding the significant competition in the automotive industry.this Annual Report.

Our power generation systems compete with other technologies, such as photovoltaic solar panels and fuel cells, to deliver power to different types of oil and gas market applications.  Our products have earned a reputation for delivering highly reliable power under extreme climatic and weather conditions to locations that do not offer access to an electrical grid.  In addition to quality andSeasonality

11


performance, our ability to design and support custom solutions that integrate directly with an application’s existing infrastructure gives our products a competitive advantage over products based on other technologies.

The patient temperature management market has seven segments: convective warming, blood warming, fluid warming, surface warming, invasive warming, non-invasive cooling and invasive cooling.  Gentherm specializes in the convective warming, blood warming, surface warming and non-invasive cooling.  We compete based on the quality of our products and service to our customers and are working to develop and market the next generation of advanced temperature management systems that complies with the rules and regulations of the U.S. Food and Drug Administration and other government regulatory bodies.

Gentherm’s environment test chamber business competes globally on the basis of performance, customization, quality and service. Our ability to modify our standard product lines to meet customer specifications helps differentiate Gentherm’s chambers from other competitive offerings.

Risk Attendant to Foreign Operations

We internally manufacture the majority of our products at our production facilities in foreign countries.  Other products we sell are manufactured by third parties in foreign countries.  See “Risk Factors” for a description of risks attendant to our foreign operations.

See Note 11 of the consolidated financial statements for information regarding the Company’s segment revenues by geographic composition.

Seasonality

Our principal operations are directly related to the automotive industry. Consequently, we have historically experienced seasonal fluctuations to the extent automotive vehicle production slows, such as in the summer months when many customer plants close for model year changeovers and in December when many customer plants close for the holidays. See Item 8 “Financial Statements

Human Capital Management

Employees

At Gentherm, our mission is to “create and Supplementary Data”deliver extraordinary thermal solutions that make meaningful differences in everyday life, by improving health, wellness, comfort and energy efficiency.” Our people are the foundation for selected quarterly financial data.  making our mission come to life every day. Our human capital strategy is focused on creating the right working environment and the right skillsets to advance our performance culture and support our growth strategy. Our goals are to inspire our people to achieve their aspirations and achieve strong business results. We also strive to promote a safe work environment and a culture that values diversity, equity, inclusion and belonging.

EmployeesBoard Oversight

Our Board of Directors and its Committees provide oversight on a broad range of human capital management topics, including corporate culture, DEI&B, pay equity, health and safety, training and development and total rewards.

People Demographics

Our global workforce creates a competitive advantage and operates in more than 30 locations across 13 countries. As of December 31, 20172023, and 2016,2022, Gentherm’s employment levels worldwide were as follows:

 

 

2023

 

 

2022

 

Mexico

 

 

5,013

 

 

 

5,047

 

North Macedonia

 

 

2,677

 

 

 

2,503

 

China

 

 

1,916

 

 

 

2,070

 

Ukraine

 

 

1,684

 

 

 

1,761

 

Vietnam

 

 

1,142

 

 

 

986

 

Germany

 

 

643

 

 

 

739

 

United States

 

 

635

 

 

 

676

 

Czech Republic

 

 

361

 

 

 

351

 

Hungary

 

 

355

 

 

 

352

 

Korea

 

 

44

 

 

 

49

 

Japan

 

 

20

 

 

 

20

 

Malta

 

 

8

 

 

 

10

 

United Kingdom

 

 

6

 

 

 

4

 

Total

 

 

14,504

 

 

 

14,568

 

12


Notable statistics as of December 31, 2023:

Region

 

2017

 

 

2016

 

United States and Canada

 

 

1,155

 

 

 

931

 

Mexico

 

 

4,693

 

 

 

4,198

 

Germany

 

 

255

 

 

 

238

 

Hungary

 

 

251

 

 

 

218

 

United Kingdom

 

 

3

 

 

 

 

Ukraine

 

 

2,219

 

 

 

2,534

 

Malta

 

 

12

 

 

 

12

 

Macedonia

 

 

1,358

 

 

 

669

 

China

 

 

2,392

 

 

 

2,268

 

Korea

 

 

45

 

 

 

40

 

Japan

 

 

20

 

 

 

16

 

Vietnam

 

 

666

 

 

 

561

 

 

 

 

13,069

 

 

 

11,685

 

39% of our workforce resides in North America; 39% of our workforce resides in Europe; and 22% of our workforce resides in Asia.

Gentherm retains

We have cooperative relationships in our facilities where we operate with unions and workers councils. Approximately 33% of the servicesCompany's workforce are members of outside contractors from time to time. Noneindustrial trade unions or works councils and are employed under the terms of various labor agreements.
Three of nine Board members are female and one is African American. Four of ten executive committee members are female and two are ethnically diverse.
Over 57% of our global workforce is female.
We experienced a 3.6% growth of diversity representation (global females and minorities in the U.S.) for our global Director and VP population of Legacy Gentherm
Within the United States, over 37% of our employees isself-disclose as racially or ethnically diverse.

Racially and Ethnically Diverse (Self-reported)

 

2023

 

 

2022

 

All Employees

 

 

37

%

 

 

36

%

Leadership

 

 

28

%

 

 

23

%

Key Highlights of our Human Capital Strategy

In November 2023, we completed our second global engagement survey with a rate of 89%, inclusive of employees from our Alfmeier and Dacheng acquisitions for the first time. In 2024, we will develop leader driven action plans to build on momentum made from our engagement surveys. In recent years we have made progress in performance management, manager relationship and growth and development for our employees.

Health and Safety

At Gentherm, our “Safety Culture” has become a core strength. Our Vision Zero strategy helped us achieve significant progress in reducing accidents across our sites.

Diversity, Equity, Inclusion and Belonging (DEI&B)

Our DEI&B mission “Embracing Diversity Inspires Innovation” cascades from our corporate mission. Our Diversity, Equity, Inclusion & Belonging Council has built strong momentum. We took another step forward on our DEI&B journey with scaling our inclusion training globally, joining the GM Supplier Inclusion Board and improving the diversity of our workforce by over 3%. We also held several sessions to educate our employees on unconscious bias. Our goals are ensuring all team members are educated to consistent standards, identifying feedback mechanisms to solve conflicts, and creating a culture of belonging.

Total Rewards

Gentherm’s compensation and benefits programs are designed to attract and retain our employees in the locations where we compete for talent using a mix of elements that allow us to achieve our Company’s short and long-term goals.

We provide employee wages that are competitive and consistent with employee positions, skill levels, experience, knowledge and geographic location.
We align our executives’ and eligible employees’ annual bonus opportunity and long-term equity compensation with our shareholders’ interests by linking realizable pay with company financial and stock performance.
We have refreshed our overall compensation structure to ensure we are providing contemporary and equitable total rewards across our business.
We completed a global pay equity study as part of our efforts to ensure fairness with respect to employee pay. The study found minimal pay gaps between groups of employees.

13


Total Talent Development

At Gentherm, we provide foundational leadership development programs to ensure our current and future people leaders are well equipped to engage and lead in today’s complex business environment. We have offered additional training programs to provide on-demand, flexible learning solutions for our global workforce. We continue to invest in our Accelerator program for high potential employee development to retain our future leaders. In 2023, our workforce completed over 500,000 hours of training with our employees.

Environmental, Social, and Governance

In 2023, we issued our annual sustainability report and continued to incorporate sustainability into our everyday business operations and future strategies. Our sustainability efforts are based on three pillars: People, Planet, and Places.

People: Our leaders prioritize a culture of respect and a secure workplace for our employees. We offer career growth opportunities, professional development, support, and much more. We firmly believe that our people are the cornerstone of our success.
Planet: We are committed to reducing our environmental footprint. Our product lineup features innovative solutions that lower the environmental impact of automobiles. We enhance our operations by focusing on optimizing resource usage and reducing emissions for a more sustainable future. As part of this pillar, we also focus on our products – what materials go into them, what are the impacts of our products, both upstream and downstream, and even how our products are dealt with at the end of their useful life.
Places: As a global company, we aim to make a positive impact in our local communities. Our teams contribute to causes like STEM education, provide financial support to local charities, and engage in community initiatives tailored to local needs and culture. Types of community involvement and support vary across our sites, based on local needs, requirements, and culture.

These actions indicate the strength of our commitment to sustainability across Gentherm.

Environmental and Regulatory Compliance

Applicable laws and regulations, and significant changes to such laws and regulations, will potentially lead to increases in costs and complexity, and failure to comply with global and specific country regulations could subject us to collective bargaining agreements.civil penalties, production disruptions, or limitations on the sale of affected products. We consider our employee relationsbelieve we are materially in compliance with substantially all these requirements or expect to be satisfactory.materially in compliance by the required dates.

12Chemical Regulation


Executive OfficersThere are numerous global laws and regulations that prohibit or restrict the selection and use of certain chemicals for product development and manufacturing and potentially impact an automobile manufacturer’s responsibility for vehicle components at the Registrant

Our current executive officers areend of a vehicle’s life. New chemical regulations continue to be introduced and passed, such as follows:

Phillip Eyler, 46, was appointed Presidentthe new European requirements that require suppliers of parts and Chief Executive Officer, andvehicles to the Company’s BoardEuropean market to disclose certain substances of Directors,concern in December, 2017. Prior to joining Gentherm, Mr. Eyler served as President of the Connected Car division at Harman, a subsidiary of Samsung since 2015. The Connected Car division included infotainment, telematics, connected safety and cyber security solutions, among others. Mr. Eyler joined Harmon in 1997 and held various senior management positions, including Senior Vice-President and General Manager of Harman’s Global Automotive Audio business from 2011 to 2015. Mr. Eyler received a Bachelor of Science degree in mechanical engineering from Purdue University and an MBA from the Fuqua School of Business at Duke University.

Frithjof Oldorff, 51, was appointed President of the Automotive business unit in July, 2013.  Prior to this appointment, Mr. Oldorff served as the Chief Operating Officer of Gentherm GmbH since 2008. He previously was a Director of Operations for Freudenberg from 2005 to 2007 and held various positions at Faurecia from 1995 to 2005. Mr. Oldorff received a master’s degree from Darmstadt Technical University (Germany) in Industrial and Mechanical Engineering.

Barry G. Steele, 47, was appointed Vice President Finance and Chief Financial Officer in 2004 and Treasurer in 2005. Prior to joining Gentherm, Mr. Steele worked since 1997 in a number of senior financial management positions, including Chief Financial Officer for Advanced Accessory Systems, LLC, a global supplier of specialty accessories to the automotive industry. Prior to 1997, Mr. Steele worked for PriceWaterhouse LLP. Mr. Steele received a bachelor’s degree from Hillsdale College and is a Certified Public Accountant.

Kenneth J. Phillips, 44, was appointed Vice-President, General Counsel and Secretary in June, 2012. Prior to joining Gentherm, Mr. Phillips was a Partnerparts. Further, increases in the Detroit, Michigan officeuse of circuit boards and other electronics may require additional assessment under the law firm Honigman Miller Schwartzdirectives related to certain hazardous substances and Cohn LLP. Mr. Phillips graduatedwaste from electrical and electronic equipment.

14


Vehicle Safety

In the U.S., the National Traffic and Motor Vehicle Safety Act of 1966 (the “Safety Act”) regulates motor vehicle equipment that we manufacture and sell as well as vehicles. The Safety Act prohibits the sale in the United States of any new vehicle or equipment that does not conform to applicable federal motor vehicle safety standards established by the National Highway Traffic Safety Administration (“NHTSA”). The Safety Act further requires that if a vehicle manufacturer or NHTSA determine a vehicle or an item of vehicle equipment does not comply with a J.D. from Wayne State Universitysafety standard, or that vehicle or equipment contains a defect that poses an unreasonable safety risk, the vehicle manufacturer must conduct a safety recall to remedy that condition in the affected vehicles. Should a vehicle manufacturer or NHTSA determine a safety defect or noncompliance issue exists with respect to any of our products, the cost of such recall campaigns could be substantial. Further, many other countries have established vehicle and a bachelor’s degree in Accountingvehicle equipment safety standards and Finance from Oakland University. Mr. Phillipsregulations. Meeting or exceeding the many safety standards is also a Certified Public Accountant.costly as global compliance and non-governmental assessment requirements continue to evolve and grow more complex, and lack harmonization globally.

15


ITEM 1A. RISK FACTORS

Darren Schumacher, 50, was appointed President of Gentherm Technologies in July, 2016 after serving as the Company’s Vice-President of Product Development since 2013.  Prior to joining Gentherm, Dr. Schumacher worked since 2009 at Bosch as Business Segment Vice President of Engineering.  Prior to 2009, Dr. Schumacher worked at Eaton Corporation where he had a series of executive management roles including Director of Product Engineering.  Dr. Schumacher graduated with a Ph.D., MSE and BSE in Aerospace Engineering from the University of Michigan and an MBA from Regis University.

Erin E. Ascher, 54, was appointed Vice-President Talent Development and Chief Human Resources Officer in February, 2015.  Prior to joining Gentherm, Ms. Ascher worked since 2012 as Chief Human Resources Officer at the University of Cincinnati. From 2010 to 2012, Ms. Ascher was Senior Vice President of Human Resources for Omnicare Inc., a Fortune 500 company that provides pharmaceutical services to patients and providers across the U.S.   Prior to Omnicare, from 1998 to 2007, Ms. Ascher was Vice President Human Resources, Latin America and Asia Pacific for Ecolab, a publicly-owned developer and provider of water, hygiene and energy technologies and services. Ms. Ascher received a bachelor’s degree from Miami University in Ohio and a master’s degree in Personnel and Employee Relations from Georgia State University.

Ryan Gaul, 42, was appointed Vice President of Business Development in November, 2014. Mr. Gaul has spent most of his professional career with Gentherm, serving in diverse roles in Gentherm’s locations in North America, Europe and Asia. He started his career in IT, and moved into roles of increasing responsibility within the IT organization, finally serving as CIO from 2005 to 2009. From 2009 to 2014, he served as Managing Director of Operations for Gentherm’s Asian business. Mr. Gaul received his bachelor’s degree from the University of Missouri.

Officers of the Company serve at the pleasure of the Board of Directors and, to the extent applicable, in accordance with the terms of their individual Service Agreements.

13


ITEM 1A.

RISK FACTORS

You should carefully consider each of the risks, assumptions, uncertainties and other factors described below and elsewhere in this Annual Report, as well as any amendments or updates reflected in subsequent filings or furnishings with the SEC. We believe these risks, assumptions, uncertainties and other factors, individually or in the aggregate, could cause our actual results to differ materially from expected and historical results and could materially and adversely affect our business operations, results of operations, financial condition and liquidity.

Industry and Operational Risks Relating to Our Business

Numerous general economic and industry factors which we do not control have significant impacts on theThe automotive industry, our primary market, is cyclical and resulting difficultiesis significantly impacted by macroeconomic, geopolitical and similar global factors, and a decline in the automotive industry or forproduction levels of our keymajor customers and suppliers would have a material and adverse effect onOEMs, particularly with respect to models for which we supply significant amounts of product, could adversely affect our business, results of operations and financial conditioncondition.

Our Automotive segment represents 89%97%, 92%96% and 95%96% of our product revenues for the years ended December 31, 2017, 20162023, 2022 and 2015,2021, respectively. Demand for our automotive products is directly related to automotive vehicle production, which is impactedultimately dependent on consumer demand for automotive vehicles, our content per vehicle, and other factors that may limit or otherwise impact production by numerous general economicus, our supply chain and our customers. Automotive sales and production are cyclical and are materially affected by macroeconomic, geopolitical and industry factors which we do notconditions that are outside of our control and is highly cyclical.  In particular, the automotive industry has been susceptible historicallycontrol of our customers and suppliers. These conditions include monetary fiscal policy, economic recessions, inflation, political instability, labor relations issues, energy prices, regulatory requirements, government initiatives, trade restrictions and agreements, capital and liquidity constraints, ongoing geopolitical conflicts, acts or war and terrorism, and natural and man-made disasters, such as the current conflicts between Russia and Ukraine, and between Israel and Hamas, heightened tensions in the U.S.Red Sea, and globally to economic recessions, labor disputes, volatile fuel prices, complexpotential tensions in the South China Sea. We, like other manufacturers, have a high proportion of fixed structural costs, and evolving regulatory requirements, trade agreements and government initiatives and uncertain availability and cost of credit. In addition to the continuation of these trends, future automotivetherefore relatively small changes in industry vehicle production may be materially impacted by additional industry or consumer behaviors, including the development and use of autonomous vehicles and increasing use of car- and ride-sharing and transportation as a service. Further, disruptions in the global economy and volatility in the financial markets may cause, among other things, lower levels of liquidity, increased borrowing rates, increased rates of default and bankruptcy, lower consumer and business spending, and lower consumer net worth, all of which may reduce demand for our products andcan have a materialsubstantial effect on our financial results. If industry vehicle sales were to decline to levels significantly below our planning assumption, the decline could have a substantial adverse effect on our financial condition, results of operations, and cash flow. Our operational costs are similarly impacted by such macroeconomic, geopolitical and industry conditions, which has and may continue to adversely impact our margins and profitability.

We operate in a highly competitive industry and efforts by our competitors, as well as new non-traditional entrants to the industry could adversely affect our business, results of operations and financial condition.  We are also limited in our ability to reduce costs to offset the results of a prolonged or severe economic downturn given certain fixed costs associated with our operations, difficulties if we overstrain our resources, and our long-term business approach that necessitates we remain in position to respond when market conditions improve.

Unfavorable economic or industry conditions could result in the financial distress of our customers and suppliers.  If our customers experience an actual decline or project a future decline in vehicle sales generally, or in sales of models for which we supply products, we may experience reductions in orders from these customers, experience difficulties in obtaining new business, incur write-offs of accounts receivable, incur impairment charges or require restructuring actions.  In addition, if any of our significant customers experiences a material work stoppage, the customer may halt or limit the purchase of our products.  This could require us to shut down or significantly reduce production at facilities relating to such products, which could have a material adverse effect on our business and harm our profitability.  

The automotive component supply industry as well as the automotive industry generally, is subject to intense competition and our current automotive products may be rendered obsolete by future technological developments

The automotive component industry, from which we derive a substantial majority of our revenues, is subject to intense competition. Business is typically awarded to the supplier offering the most favorable combination of cost, quality, timely delivery, technological innovation and service. In addition, customers often demand periodic price reductions during a vehicle’s lifeThere can be no assurance that require uswe will be able to continually assess, redefinecompete successfully with the products of our competitors. Further, our competitors’ efforts to grow market share could exert downward pressure on our product pricing and improve our operations, products and manufacturing capabilities to maintain and improve profitability.margins. Many of our competitors and potential competitors are substantially larger in size and have substantially greater financial, marketing and other resources than we do, and therefore may be more effective in adapting to customer requirements while being more profitable.

We must also be responsive In addition, Lear has confirmed its intent to, the entranceand other of non-traditional participants in the automotive industry. These non-traditional participantsour customers may, seek to disrupt the historic business modelincrease levels of the industry through the introductionproduction insourcing and compete directly with us for a variety of new technologies,reasons, such as advanced driver assistance technologies,shifts in business strategies or the emergence of low-cost production opportunities in other countries, which may adversely affect our sales as well as the profit margins on our products. Further, we are experiencing increased competition from Chinese-based component suppliers that are developing relationships with Chinese-based OEMs, which are growing market share in China and may expand in global markets.

Our inability to effectively manage the development, timing, quality and costs of new product launches could adversely affect our financial performance.

Gentherm continues to invest significantly in developing and launching new products or services, such as autonomous vehicles, car- and ride-sharing and transportation as a service. As our business evolves, the pressure to innovate will encompass a wider range of products and services, including products and services that may be outside of our historically core business. If we do not accurately predict, prepare for and respond to new kinds of technological innovations, market developments and changing customer needs, our sales, profitability and long-term competitiveness may be harmed.  In addition, there can be no assurance that we will successfully differentiate our products from those of our competitors, that the marketplace will consider our current or proposed products to be superior or even comparable

14


to those of our competitors, or that we can succeed in establishing new or maintaining existing relationships with automobile manufacturers.

Due to the rapid pace of technological change, as with any technology-based product, our ability to compete successfully will depend on our ability to develop and license improved technologies on a rapid and cost-efficient basis. Our business will therefore require extensive capital expenditures and investment in product development, manufacturing and management information systems.  Further, certain of our products may be rendered obsolete by futurerelated technologies, including software, through internal research and development, and from competitorsacquisitions and investments in our products or widespread use of autonomous vehicles, or consumer preferences.  Our operations, financial resultsjoint ventures. Further, winning new business awards will include specific customer requirements regarding, among other things, timing, performance and competitive position would be materially and adversely affected if we were unable to anticipate such future developments and develop, or obtain access to, critical new technologies at a reasonable cost, or adapt to changes in the automotive industry generally.  An inability to compete successfully may also hinder our ability to complete acquisitions or financings on reasonable terms or at all.

We are investing significant capital and employee resources to research, develop, commercialize, market and sell additional products in non-automotive industries, and we are increasingly reliant on market acceptancequality standards. The launch of new products and innovations for continued revenue and earnings growth

Although non-automotive applications represented only 11%technologies is complex, the success of our total revenues in 2017, we are currently investing significant capital and utilizing key employees to improve existing products and to develop products and research technologies to be used inwhich depends on a wide range of non-automotive industries. For example, we are working to generate and increase salesfactors, including the capacity of our productsinternal teams, robustness of our product and manufacturing process development, success in the sleep system, office chair, cup holder, environmental test chamber, patient temperature management systemssourcing new components and electronic control unitscommodities with suitable suppliers, readiness of our and systems. Developing products beyond our historical core business is speculative and complex, and commercial success will depend on a number of risks, opportunities and uncertainties specific to each industry. As we continue to expand into new markets, we will also face new sources of competition, including, in certain of these markets, from existing manufacturers with established customer bases and greater brand recognition. To be successful, we need to cultivate new relationships with customers, suppliers and other partners in each of these markets. In addition, there can be no assurance that technological advances from our research and development effort will occur in a timely or feasible way, that the funds that we have budgeted for these purposes will be adequate, or that we will be able to establish our proprietary right to the technologies. Further, there is no certainty that new product applications leveraging the technology will be commercially viable or that we will be successful in generating significant revenues, operating margins and profitability from sales of non-automotive products in the near term or at all and the operating margins and profitability may be lower than our automotive products.

If our expansion efforts are not successfully implemented, they may adversely impact our business and results of operations

As a result of a significant increase in demand for our products over the past few years and to support our customers’ global platform initiatives, we have opened or acquired newsuppliers' manufacturing facilities in Vietnam, Macedonia, Mexico and China, and thereby significantly increased our capacity to manufacture our products.

Opening new or acquiring existing manufacturing facilities entail a number of risks, including our ability to successfully manage the demands placed on our management resources and engineering and quality teams, our ability to begin production at levels, quality and within the cost and timeframe estimated, the implementation of internal controls and compliance, and our ability to attract and maintain a sufficient number of skilled workers at the requisite locations to meet the needs of the new facilities.  Our results of operations could also be adversely impacted by start-up costs until production levels at the new facilities reach planned levels,processes, as well as any legacy issues with acquired facilities.  

These newly developed or acquired facilities, as well as ourfactors related to tooling, equipment, employees, initial product quality and other production facilities aroundfactors. New

16


launches have become more frequent and even more complicated given the world, could have significant unused capacity if our revenues do not continue to increase as they have in recent years.  Significant unused capacity would result in overhead costsincreased use of advanced electronics that would need to be absorbed by a smaller than expected revenue base, which could materially and adversely impact our financial results.

While there are currently no active projects to construct new manufacturing facilities, or agreements to acquire other manufacturing facilities, we regularly consider such development or acquisition opportunities and any future construction or acquisition activities, particularly in foreign countries, could entail a number of other risks.  If we experience construction or regulatory delays or increased costs, our estimates and assumptions are incorrect, or other unforeseen events occur, our business, financial conditions and results of operations could be adversely impacted.  

15


Our ability to market our automotive products is subject to a lengthy sales and acceptance cycle, which requires significant investment prior to significant sales revenue, and non-automotive products may be subject to similar time lags

The sales cycle for our automotive products is lengthy because an automobile manufacturer must develop a high degree of assurance that the products it buys will meet consumer needs, interface as easily as possible with the other parts of a vehicle and with the automobile manufacturer’s production and assembly process, and have minimal warranty, safety and service problems. As a result, from the time that a manufacturer develops a strong interest in our products for a specified vehicle, it normally will take several years before our products are available to consumers in that vehicle.

In the automotive components industry, products typically proceed through five stages of research and development. Initial research on the product concept comes first, to assess its technical feasibility and economic costs and benefits. This stage often includes development of an internal prototype for the component supplier’s own evaluation. If the product appears feasible, the component supplier manufactures a functioning prototype to demonstrate and test the product’s features. These prototypes are then marketed and sold to automotive companies for testing and evaluation. If an automobile manufacturer shows interest in the product, it typically works with the component supplier to refine the product, then purchases second and subsequent generation engineering prototypes for further evaluation. Finally, the automobile manufacturer either decides to purchase the component for a production vehicle or terminates the program.  

The time required to progress through these five stages to commercialization varies widely. Generally, the more a component must be integrated with other vehicle systems,throughout a vehicle. Given the longercomplexity of new product and technology launches, we may experience difficulties managing product quality, timeliness and associated costs.

The process of designing and developing new technology, products and services is costly and uncertain and requires extensive capital investment. In addition, new program launches require a significant ramp up of costs up to a few years prior to sales of such products. However, our sales related to these new programs generally are dependent upon the process takes. Further, products that are installed bytiming and success of our customers’ introduction of new vehicles. Our inability to effectively manage the factory usually require extra time for evaluation because other vehicle systems are affected,timing, quality and a decision to introduce the product into the vehicle is not easily reversed. Because our automotive products affect other vehicle systems and are factory-installed items, the process usually takes several years from conception to commercialization.

While we currently have active development programs with various seat manufacturers and automotive OEMs for our thermal management products, no assurance can be given that our products will be implemented in any particular vehicles.  During this development process, we derive minimal funding from prototype sales but generally obtain no significant revenue until mass production begins, whichcosts of these new program launches could have a materialmaterially adverse effect on our liquidity.  If our products are not selected after a lengthy development process, ourbusiness, results of operations and financial conditioncondition.

To the extent we are not able to successfully launch new business, or if we are unable to prevent or effectively remedy errors, bugs, vulnerabilities or defects in our new products and technologies, vehicle production at our customers could be materiallysignificantly delayed or shut down. Such operating failures could result in significant financial penalties to us or a diversion of personnel and adversely affected.  financial resources to improving or fixing launches rather than investment in continuous process improvement or other growth initiatives, and could result in our customers shifting work away from us to a competitor. Any of the foregoing matters could result in a significant loss of revenue and market share and could have an adverse effect on our profitability and cash flows.

Non-automotive products that we develop or significantly update are also likely to have a lengthy sales cycle. Because the use of our proprietary technology in other markets is new and evolving, and because customers will likely require any new product or significantly changed product that we develop to pass certain feasibility, safety and economic viability tests before committing to purchase, it is expected that any new or significantly changed products we develop in non-automotive markets also will take several years before they are sold to customers, if at all.

Our ability to market our products successfully depends on acceptance of our products by existing and potential customers and consumers, as well as the success of our customerscustomers.

We have been, and will continue to be, required to educate potential customers and demonstrate that the merits of our existing products justify the costs associated with them. Similar and enhanced efforts will be required with existing and potential customers for additional products we develop usingand technologies we develop, acquire or license. ManufacturersCustomers will only includeadopt our products if there appears to be demandconsumer demand. Further, some of our new technologies and products require OEMs to adopt new ways of developing climate control systems for our products from the consumers.vehicle interiors, and some OEMs may be slow to adopt or may never adopt such technologies and products. For our automotive products, we rely on OEMs and applicable dealer networks to market our products to consumers, and we do not have any control over the marketing budget or messaging nor the training of employees and agents regarding our products. Further, OEMs and dealer networks may market products offered by our competitors, including products manufactured by such OEMs. If customers or consumers conclude that temperature control seats or our other automotive products are unnecessary or too expensive or that our competitors offer more favorable sales terms or better products, OEMs and other manufacturerscustomers may reduce availability or decline to include our products in their vehicles.

In addition,There is ongoing significant competition to address the vehicle market is highly competitive among OEMs, which drives continual cost-cutting initiatives by our customers.  It is possible that pricing pressures beyond our expectations could intensify as OEMs pursue restructuringfast evolution of the automotive industry, including development and cost cutting initiatives.  If we are unable to generate sufficient production cost savings in the future to offset such price reductions, our gross margin, rateuse of profitability and cash flows could be materially and adversely affected.  

16


We must also satisfy the timing, performance and quality standards of our customers and consumers during mass production.  Further, we are dependent upon the timing and success of our customers’ continuation of existingelectric vehicles, autonomous vehicles and introduction of new vehicles which include our products.  If such vehicles are not successful in the marketplace, our results of operationsmobility on demand services and financial condition could be materially and adversely affected.

Significant increases in the market prices and restrictions on the availability of certain raw materials may materially and adversely affect our business

Many of our products include TEDs which contain certain raw materials that generally cannot be substituted. The prices for these raw materials fluctuate depending on market conditions.  We generally have no contractual price protections with our suppliers and customers regarding raw material costs.  Substantial increases in the prices for our raw materials increase our operating costs and could reduce our profitability if we cannot recover these increases from our customers.  As an example, Tellurium is a raw material used in TEDs. If the market price for this raw material significantly increases, as it has in the past, our gross profit may be adversely impacted as our suppliers pass those price increases on to us. Other key raw materials include copper, silver and petroleum based engineered plastics. In addition, the availability of raw materials fluctuates from time to time due to factors outside our control, including as a result of catastrophic events, which may adversely impact our ability to meet customer commitments or needs. Our business, results of operations and financial condition could be materially and adversely affected by shortages or significant price increases of key raw materials.  

The disruption or loss of relationships with vendors and suppliers for the components for our products could materially and adversely affect our business

Our ability to manufacture and market our products successfully is dependent on relationships with both third party vendors and suppliers. We rely on various vendors and suppliers for the components of ourrelated software products, and procure these components through purchase orders, with no guaranteed supply arrangements. Certain components are only available from a limited number of suppliers. The loss of any significant supplier, in the absence of a timely and satisfactory alternative arrangement, or an inability to obtain essential components on reasonable terms or at all, could materially and adversely affect our business, results of operations and financial condition.

Our business also could be materially and adversely affected by delays in deliveries from suppliers because we carry minimal inventory of product components.  Automobile manufacturers, in particular, demand on-time delivery of quality products, and some have required the payment of substantial financial penalties for failure to deliver components to their plants on a timely basis.  Such penalties, as well as costs to avoid them, such as overtime costsadapt our strategies and overnight air freighting of parts that normally are shipped by other less expensive means of transportation due to our global production operations successfully could have a material adverse effect on our business, results of operations and financial condition. Moreover,

The global automotive industry is experiencing a period of significant technological change, and we are making significant investments to develop, acquire and properly scale the inabilitymanufacturing of technologies and products that will enhance our competitiveness. Future automotive vehicle production is expected to meet demand forbe affected significantly by additional industry or consumer behaviors, including the development and use of autonomous and electric vehicles and increasing use of car and ridesharing and on-demand transportation as a service and related software products, as well as complex new regulations. Our future success is dependent on our ability to execute our long-term strategies addressing the evolution of the automotive industry and customer utilization of personal transportation. The rapidly evolving nature of the markets in which we compete has attracted, and may continue to attract, new entrants, including new entrants from outside the traditional automotive supply industry. Further, in comparison to us, our competitors may foresee the course of market developments and customer preferences more accurately, develop superior products and technologies, produce similar products at a lower cost, or adapt quicker to new industry technologies.

As common in periods of rapid technological change, recently there has been lower-than-anticipated industrywide electric vehicle adoption rates and near-term pricing pressures, which has led many OEMs and the automotive component supply industry to adjust spending, production, and/or product launches to better match the pace of such adoption. In addition, there have been certain technology barriers that are detrimental to electric vehicles reaching pricing parity with ICE vehicles. Future electric vehicle adoption may also be impacted by, among other factors: perceptions about EV features, quality, safety, performance and cost relative to ICE vehicles; the range over which EVs may be driven on a timely basis would materiallygiven battery charge; the proliferation and adversely affect our reputationspeed of charging infrastructure; cost and future commercial prospects.

In addition, financial difficultiesavailability of high fuel-economy ICE vehicles; volatility, or solvency problems with our suppliers, which may be exacerbated bya sustained decrease, in the cost of remediating quality issues with these items, could lead to uncertainty in our supply chain or cause supply disruptions for us which could, in turn, disrupt our operations, including production.petroleum-based fuel; and

Further, we engage outside contractors to perform product assembly17


the failure by governments and other production functions for certain of our products. Our reliance upon third party contractors for certain production functions reduces our control over the manufacture of our products and makes us dependent in part upon such third parties to deliver our products in a timely manner, with satisfactory quality controls and on a competitive basis.  make the investments necessary to make infrastructure improvements or to provide economic incentives promoting the adoption of EVs.

If we are unabledo not accurately predict, prepare for and respond to meet commitments tonew kinds of technological innovations, market developments and changing customer needs or if OEMs significantly lower production of EVs or change the mix of EV and ICE production, our customers due to third party services in production,long-term competitiveness could be harmed significantly and our business, results of operations and financial condition and reputation could be materially and adversely affected.impacted.

17The global automotive supply chain has been adversely impacted by raw material and component shortages, manufacturing disruptions and delays, logistics challenges and inflationary and other cost pressures, and we expect such conditions to continue to adversely affect our business, profitability and results of operations.


Our businessproducts contain a significant number of components that we source globally from suppliers who, in turn, source components from their global suppliers. The availability of raw materials and product components fluctuates due to factors outside of our control, including supply and demand imbalances, geopolitical and macroeconomic factors, labor disruptions or shortages, trade laws and tariffs, natural disasters, and global pandemics, which has and we expect will continue to impact the ability of our supply chain to meet our production requirements and therefore our ability to meet the production demands of our customers. In some instances, we purchase components, raw materials and parts that are ultimately derived from a single source and may be at an increased risk for supply disruptions. If our supply chain fails to deliver products to us in sufficient quality and quantity on a timely basis, we will be challenged to meet our production schedules and fulfill our orders due to the “just-in-time” manufacturing process that is subjectbroadly utilized in our industry, which would decrease sales and profits and could damage our commercial reputation and customer relationships. Furthermore, sudden changes in the production schedules of OEMs and Tier 1s caused by raw material and component shortages also have resulted and may continue to risks associated with manufacturing processesresult in operating inefficiencies, which could adversely affect our profitability and results of operations. Additionally, if we are the primary cause for a customer being forced to halt production, the customer may seek to recoup all of its losses and expenses from the Company. Similarly, OEMs and Tier 1s to whom we supply our products are dependent on an ever-greater number of global suppliers to manufacture and sell their products to consumers, which drives sales of our products.

We internally manufacture a largealso have experienced and growing portionwe may continue to experience margin pressure due to the pricing of components and certain other raw materials, including due to inflation or supply-demand imbalances. Some of our products contain certain components, such as semiconductor chips, and other key raw materials including copper, silver and petroleum-based engineered plastics and raw materials, which generally cannot be substituted. The prices for these components and raw materials fluctuate depending on market conditions. The automotive industry has seen a period of sustained price increases for commodities, primarily related to steel, and to a lesser extent petrochemicals. If the market prices and related logistics costs (in particular for imported goods) for these components and raw materials remain higher than normal or they further increase, our gross profit may continue to be adversely impacted, including to the extent our suppliers pass cost increases on to us that we cannot pass on in full to our customers in spite of our mitigation efforts.

We and our customers, and our respective supply chains, have operated in a supply-constrained environment for more than two years and are continuing to manage through, although to a lesser degree, raw material and component shortages (including recently from a significant shortage of semiconductors), manufacturing disruptions and delays, logistics challenges and inflationary and other operational challenges and costs pressures. More recently, our supply chain transportation has been adversely impacted by conflicts in the Middle East and heightened tensions in the Red Sea and South China Sea as well as shipping company consolidation, in particular since we have shifted significant manufacturing production around the world as part of our manufacturing rationalization strategy. The foregoing challenges have adversely affected, and is expected to continue to adversely effect, our business, profitability, cash flow and results of operations.

Our ability to attract and retain talented, diverse and highly skilled employees is critical to our success and competitiveness, and attracting and retaining such employees has caused and could continue to cause an increase in labor costs.

Our success depends on our ability to recruit and retain talented and diverse employees who are highly skilled in their areas. In particular, our technologies and products increasingly rely on software and hardware that is highly technical and complex and the market for highly skilled workers and leaders in our industry is extremely competitive and costly. While compensation considerations remain important, current and potential employees are increasingly placing a premium on working for companies with strong brand

18


reputation, flexible work arrangements, and other considerations, such as embracing sustainability and diversity, equity, and inclusion initiatives. The difficulty of attracting, hiring, developing, motivating and retaining highly qualified and diverse employees throughout our Company has caused and could continue to cause increases in the cost of labor due to wage inflation. Failure to continue attracting and retaining such highly qualified and diverse employees could further increase labor costs, disrupt our operations and adversely affect our strategic plans. Further, prolonged labor shortages that we have experienced and may continue to experience can adversely impact existing employees, which enhances the challenges of retention and labor expense.

Labor shortages, work stoppages and additional workforce disruptions impacting us, our suppliers or customers periodically have disrupted our operations and our growth strategies, and resulting increases in labor and related operating costs may adversely impact our financial performance.

Labor shortages, work stoppages and additional workforce disruptions due to illness, quarantines and absenteeism, including ours and those at our fourteensuppliers or customers, periodically have disrupted our business and adversely impacted our financial performance. Because the automotive industry relies heavily on “just-in-time” delivery of components, labor shortages or work stoppages at one or more of Gentherm's production facilities.  See Item 2. belowfacilities or those of our suppliers could have adverse effects on the business and financial results. Similarly, the purchase of our products may be limited if one or more of our direct customers or an OEM were to experience labor shortages or work stoppages, such as what occurred during the General Motors labor strike occurring in the Fall of 2023 or the prolonged work stoppages that occurred in the first half of 2020 as a result of the COVID-19 pandemic, which could result in the temporary shutdown of the related Gentherm production facilities or other restructuring initiatives.

Approximately 33% of the Company's workforce are members of industrial trade unions and we believe a significant percentage of employees of our largest customers and suppliers are members of industrial trade unions, all of whom are employed under the terms of various labor agreements. A union strike or inability to enter into a new labor agreement prior to expiration of an existing agreement could have an adverse impact on us or our suppliers or customers.

Inflationary pressures impacting our transportation companies and other third parties have increased our costs to deliver our products, and therefore adversely impacted our margins and profitability.

The automotive industry has experienced a period of sustained price increases for various transportation and other logistics services. These price increases are expected to continue into the foreseeable future due to continuing challenges with supply-demand imbalances. Although the Company has developed and implemented strategies to mitigate the impact of higher transportation and other logistics costs, these strategies, together with commercial negotiations with Gentherm's customers and suppliers, have not historically and may not in the future fully offset our price increases, which may result in adverse impacts to the Company’s profitability and results of operations. We generally have been unable to raise prices to address in full the foregoing inflationary pricing pressures, together with price downs for our products that are customary in our industry, and therefore our margins and profitability have been and may continue to be adversely impacted.

If we fail to manage our growth effectively or to integrate successfully any new or future business ventures, acquisitions, investments or strategic alliance into our business, including our recent acquisitions, or realize the benefits from divestitures or business exits, our business and financial performance could be materially adversely harmed.

We regularly consider opportunities to pursue business ventures, acquisitions, investments and strategic alliances that could leverage our products, technologies and capabilities, as well as, enhance our customer base, geographic penetration and scale, to complement our current businesses, some of which could be material. We completed two acquisitions in 2022, Alfmeier and Dacheng, and we have completed other acquisitions and investments in recent years. Finding and assessing a potential growth opportunity and completing a transaction involves extensive due diligence, management time and expense; however, the amount of information we can obtain about a potential growth opportunity may be limited, and we may not be able to identify suitable candidates, negotiate appropriate terms, obtain financing on acceptable terms, complete proposed acquisitions, or expand into new geographies or markets. Further, we can give no assurance that new business ventures, acquisitions, investments and strategic alliances will positively affect our financial performance or will perform as planned, including regarding anticipated synergies or other financial or operational benefits. For significant transactions, we would expect to incur additional debt, issue equity and/or increase capital expenditures, which may increase leverage risks, result in dilution or reduce capital available for other investments in ongoing operations. If we fail to identify and complete suitable acquisition and investment opportunities in a timely and successful manner, our business, growth strategy reputation and results of operations could be materially impacted.

19


Furthermore, the success of our acquisitions is dependent, in part, on our ability to realize the expected benefits from the integration of the acquired businesses or assets. We may incur an unexpected amount of liabilities or make incorrect estimates regarding the planned accounting for acquisitions, such as the need to record non-recurring charges or write-off of significant amounts of goodwill or other assets that could adversely affect our results of operations, and we could have unexpected challenges due to the limitations of our due diligence process or contractual provisions. Further, the integration of acquired businesses is a complex, costly and time-consuming process that requires significant management attention and resources. It is possible that the integration process could result in the loss of key employees, the disruption of our operations, the inability to maintain or increase its competitive presence, inconsistencies in and incompatibility of information technology and accounting systems, as well as other compliance standards, controls, procedures and policies, difficulties in achieving anticipated cost savings, synergies, business opportunities and growth prospects from the acquisition, additional litigation, compliance or regulatory risk, the diversion of management’s attention to integration matters and difficulties in the assimilation of employees and corporate cultures, especially if the acquisition involves a business, supply chain or operations in one or more countries in which we have a limited history and lack of experience. Any or all of these factors and our increased debt leverage following the closing of any significant transaction, such as the acquisition of Alfmeier, could have an adverse effect on our business and financial performance. In addition, many of these factors are outside of our control, and any one of these factors could result in increased costs, decreases in the amount of expected revenues and additional diversion of management’s time and energy, which could materially adversely impact our business, financial condition and results of operations. Likewise, our failure to integrate and manage acquired companies successfully may lead to reduced profitability and future impairment of any associated goodwill and intangible asset balances.

Periodically, we also evaluate opportunities to divest or shut-down non-core businesses and assets, and the Company may consider strategic dispositions and shut-downs in the future. However, we may not achieve some or all of the targeted benefits we originally anticipated at the time of disposition or shut-down, we may continue to retain material liabilities by contract or applicable law, and we may incur impairment charges. For example, on December 31, 2022, the Company approved a plan to exit its non-automotive electronics business, and the Company has since recorded non-cash impairment charges of $15.5 million, $5.6 million and $0.7 million for write-downs of inventory, intangible assets, and property and equipment, respectively. Further, for dispositions, we may need to provide material transition services following the transaction, any of which could have an adverse impact on our returns and our overall profitability.

Our inability to achieve product cost reductions which offset customer-imposed price reductions could adversely affect our financial performance.

Downward pricing pressure is customarily applied by automotive manufacturers to the automotive supply chain. Our customer contracts generally provide for annual price reductions over the production life of the vehicle, while requiring us to assume significant responsibility for the design, development and engineering of our products, as well as the costs incurred through our supply chain. Prices may also be adjusted on an ongoing basis to reflect changes in product content/costs and other commercial factors. Our inability to achieve product cost reductions that offset customer-imposed price reductions could adversely affect our financial condition, results of operations and cash flows.

Security breaches and other disruptions to our information technology networks and systems, including a disruption related to cybersecurity, could interfere with our operations and could compromise the confidentiality of our proprietary information or personal information.

We rely on our information technology, communication networks, enterprise applications, accounting and financial reporting platforms and related systems in connection with many of our business activities. Some of these networks and systems are managed by third-party service providers and are not under our direct control. Our operations routinely involve receiving, storing, processing and transmitting sensitive information pertaining to our business, customers, suppliers, employees and other sensitive matters. We rely upon the capacity, reliability and security of our IT and data security infrastructure, as well as our ability to expand and continually update this infrastructure in response to the changing needs of our business. If we experience a problem with the functioning of an important IT system or a security breach of our IT systems, due to failure to timely upgrade systems or during system upgrades and/or new system implementations, or resulting from failures of our third-party service providers, the resulting disruptions could have an adverse effect on our business.

20


As with most companies, we have experienced cybersecurity incidents, attempts to breach our systems and other similar incidents, none of which were material in 2023. With more of our employees working part-time remotely and in periods of significant acquisition integration activity, there may be increased opportunities for unauthorized access and cybersecurity incidents.

Any future cybersecurity incidents could, however: materially disrupt operational systems; result in loss of trade secrets or other proprietary or competitively sensitive information; compromise personally identifiable information regarding customers or employees; delay our ability to deliver products to customers; and jeopardize the security of our facilities. A cybersecurity incident could be caused by malicious outsiders (including state-sponsored espionage or cyberwarfare, which has become commonplace) or insiders using sophisticated methods to circumvent firewalls, encryption and other security defenses. Because techniques used to obtain unauthorized access or to sabotage systems change frequently and generally are not recognized until they are launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. Information technology security threats, including security breaches, computer malware, “ransomware” and other cybersecurity incidents, are increasing in frequency, diversity and sophistication, which may cause cybersecurity incidents to be more difficult to detect for periods of time. Many victims of ransomware are forced to pay significant properties.  Other productsransoms to regain access to their critical business data, and we sell are manufactured by third parties.  A catastrophic lossmay not be permitted under various regulations and laws to make such payments.

We continuously seek to maintain a robust program of information security and controls that we believe is designed to detect, reduce, and mitigate the userisk of cybersecurity incidents; however, we may not be aware of all vulnerabilities or might not accurately assess the risks of incidents, and such preventative measures cannot provide absolute security and may not be sufficient in all circumstances or mitigate all potential risks, including potential production disruption or the loss or disclosure of sensitive information. The impact of a portion of our facilities duematerial cybersecurity incident could subject us to accident, fire, explosion, labor issues, civil unrest, weather conditions, other natural disasterlegal or otherwise, whether short or long-term, couldregulatory sanctions and have a material adverse effect on our business,competitive position, reputation, results of operations, financial condition and cash flows.

We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical systems and our proprietary, strategic or competitive data, which we review for quality and effectiveness on a regular basis, but despite our implementation of security processes, our IT systems, like those of other companies, are vulnerable to intrusion or damages from computer viruses or worms, natural disasters (which may become more frequent due to climate change), unauthorized access, cybersecurity incidents, breaches due to errors, negligence or malfeasance by employees, contractors or others who have access to these systems and other similar disruptions. Any system failure, accident or security breach could result in disruptions to our operations and include the theft of our intellectual property, trade secrets, customer information, human resources information or other confidential information. The foregoing matters could cause significant damage to our reputation, affect our relationships with its customers, lead to claims against us, fines and other penalties assessed upon us by governmental authorities, and ultimately harm our business and financial condition.  This risk is exacerbatedperformance. In addition, we may be required to incur significant costs to remediate and protect against damage caused by these disruptions or security breaches in the factfuture.

Our operations within Ukraine subject us to risks that may harm our primary manufacturing locations are in Mexico, China, Vietnam, Macedoniaoperations and financial results.

The conflict between Russia and Ukraine all countries thatand certain measures taken in response have historically experiencedimpacted the availability and prices of certain raw materials and energy (especially in Europe) and have led to various economic sanctions, which could have a heightened degree of political, civillasting impact on regional and labor uncertainty.

Political conflict and related demonstrations and violence in Ukraine in recent years, for example, highlights the risks to our foreign manufacturing facilities.  Although our manufacturingglobal economies. Our facility in UkraineVynohradiv is located approximately 700 miles by road from Kiev, and approximatelyon the same distance fromfar western corner within the activities along the borderTranscarpathia region of Ukraine near the Hungary border. In 2023, products manufactured at our Ukraine facility represented approximately 6% of the Company’s total revenue, including automotive cables, seat heaters and Russia where fighting has occurred,steering wheel heaters, compared to 8% in 2022. At this time, our Ukraine facility is operating at normal levels and we cannot becontinue to execute contingency plans and, in coordination with certain that similar demonstrations, unrestcustomers, specific equipment and international tensions will not affectproduction relocations leveraging our facility in the future, including due to electrical outages and periodic battles with separatists closer to our facility. In addition, certainflexible global manufacturing footprint. Certain of our employees in Ukraine are routinely conscripted into the military and/or sent to the Russian border to fight in the ongoing conflict. Furthermore,We have incurred, and will likely continue to incur costs to support our employees and relocate equipment and production based on customer and company needs. We have also experienced and may continue to experience interruptions in power supply at our Ukraine facility. We have contingency measures in place to address intermittent power supply interruptions, however, extended interruptions could significantly impact our ability to operate the facility. Further, most of our products manufactured in Ukraine are shipped across the border from Ukraine to Hungary for further delivery to our customers. If that border crossing were to be closed or restricted for any reason, we would essentiallymay experience a significant disruption to our operations. Our response to the ongoing conflict is based on a severity level contingency response plan that has been developed with certain customers. As the situation in Ukraine is very fluid, we continue to monitor its effects on our business and we continue to work closely with our customers to adjust our contingency response as necessary.

21


Although the length and impact of the ongoing military conflict is highly unpredictable, the conflict in Ukraine has led to and could lead to further market disruptions, including significant volatility in the prices and availability of certain commodities and energy, volatility in credit and capital markets, interruptions in our supply chain, increased costs and reduced availability of labor, materials and components, result in impairment of tangible assets and implementation of restructuring activities, and may impair our ability to complete financial or banking transactions. Any of the foregoing factors could have a material adverse effect on our business, financial results and stock price.

The material reduction in sales from any of our principal customers, due to acquisition activity, insolvency or otherwise, could materially and adversely affect our business, results of operations, cash flows and financial condition.

For the year ended December 31, 2023, our top two customers were Lear and Adient, which comprised 15% and 13%, respectively, of our product revenues. Combined, approximately 66% of product revenues to these customers was sourced directly by the OEMs. Our products supplied to General Motors and Hyundai represented 13% and 10% of our total product revenues for the year ended December 31, 2023. The continued growth, viability and financial stability of our principal customers, as well as the OEMs to which our products are supplied, are critical to our success. The loss of the useany significant portion of our Ukrainian facility, whichsales from either of these customers or other significant customers, whether due to acquisition activity, insolvency or otherwise, would have a material adverse effect on our business.business, results of operations, cash flows and financial condition. We sometimes experience, and we expect to continue to experience, a delay in our collection of accounts receivable balances from our customers, which may be significant and could be at risk in the event of their bankruptcy or other restructuring.

Unexpected failuresIn addition, if any of our equipment and machinery also maysignificant customers successfully insources products that we currently manufacture, whether by the acquisition of one of our competitors or otherwise, the discontinuation or loss of business as a result in production delays, revenue loss and significant repair costs, injuries to our employees, and customer claims. Any interruption in production capability may require us to delay fulfilling orders, utilize less efficient internal facilities on a temporary basis and make large capital expenditures to remedy the situation, which couldwould have a negativean adverse impact on our profitabilitybusiness and cash flows.

We maintain property damage insurancefinancial performance. For example, Lear acquired certain companies in 2023 that we believehave competed with us historically and it announced its intent to be adequate to provide for reconstructioninsource more products and technologies in the future, and Lear may compete with us directly in the future. The impact of facilities and equipment,Lear’s acquisitions on our business with Lear, as well as business interruption insurance to mitigate losses resulting from any production interruption or shutdown caused by an insured loss.  However, any recovery underwith OEMs and other Tier 1s, is unknown and could adversely impact our insurance policies may not be offset the lost sales or increased costs that may be experienced during the disruption of operations, and such proceeds may be received and accounted for in  a different reporting period, which could materially and adversely affect our business, financial condition, results of operations and cash flow generally or for a specific reporting period.flows.

Our global operations subject us to risks that may harm our operations and financial resultsresults.

In 2017, 54%2023, 63% of our product revenue was generated from sales to customers outside the United States. We have significant personnel, property, equipment and operations in a number of countries outside of the United States, including Canada, China, Germany, Hungary, North Macedonia, Mexico, South Korea, Czech Republic, Ukraine and Vietnam.  We have also engaged third parties to produce products for usVietnam and are investing in China and Japan. We and these third parties maintain production facilitiesa manufacturing facility in lower-cost countries for cost containment reasons.Morocco. Our exposure to the risks described below is substantial and increasing.substantial. We also derive a significant portion of revenues from Europe and Asia and conduct certain investing and financing activities in local currencies.

In addition to the general risks relating to our operations, our international operations are subject to unique risks inherent in doing business abroad, including:

exposure to local economic, conditionspolitical, social and infrastructure;

labor practices and conditions;

different, complex and complexcontinuously changing local laws and regulations and enforcement thereof,thereof;

changes in government leadership;
compliance with the requirements of an increasing body of applicable anti-bribery and anti-corruption laws, including those relating to governance, taxes, litigation, anti-corruption, employment, employee benefits, environmental, competition, permitting, investment, product regulations, repatriation, and export/import restrictions or requirements;

compliance by any acquired companies;

increased uncertainty regarding social, political, immigrationincreases in costs of and trade policiesdisruptions in the U.S.international shipping related to global conflicts and abroad, such as recent U.S. legislation and policies and the U.K.’s pending Brexit (as defined below);

environmental conditions;

political, economicincreases in duties, tariffs and taxation on our products related to U.S. trade disputes, trade restrictions, potential trade wars and other global conflicts;

exposure to infectious disease and epidemics, including the effects on our business operations, and those of our customers and suppliers, in geographic locations impacted by an outbreak;
violence and civil instabilityunrest (including acts of terrorism, civil unrest, drug-cartel related and other forms of violence and outbreaks of war);

expropriation, nationalization or other protectionist activities;

18


currency exchange rate fluctuations and currency controls; in particular, a significant portion of our revenues and expenses are denominated in currencies other than the U.S. Dollar, including the Euro, the Chinese Renminbi, the Vietnamese Dong, the Hungarian Forint, the Macedonian Denar, the Ukrainian Hryvnia, and the Mexican Peso;

increases in working capital requirements and greater potential for production and delivery delays due to extended logistics and geo-political developments;

currency exchange rate fluctuations and currency controls;

22


local business and cultural factors that differ from our customary standards and practices,practices;
withholding and other taxes on repatriated funds and other payments by subsidiaries;
other cultural and linguistic differences;
difficulties in managing or overseeing foreign operations and agents;
potentially longer payment cycles;
different credit risks; and
difficulty of enforcing agreements, collecting receivables and protecting intellectual property and other assets through non-U.S. legal systems.

Additionally, our primary manufacturing locations are in Mexico, China, Vietnam, North Macedonia, Czech Republic and Ukraine, all countries that have historically experienced a heightened degree of political, civil and labor uncertainty.

Chinese-based OEMs are growing market share in global markets. However, continued U.S.-China trade tensions and weakening economic conditions, among other factors, may result in reduced sales, profitability and margins, increased operating costs and challenges to gaining or holding market share. Furthermore, certain risks and uncertainties of doing business in China are solely within the control of the Chinese government, including Chinese regulation of the scope of our business practicesand investments in China, as well as our ability to provide cash to and repatriate cash from our business entities in China. In order to maintain access to the Chinese market, we may be required to comply with significant technical and other regulatory requirements that are unique to the Chinese market, at times with challenging lead times. These actions may increase the cost of doing business in China or limit how and under what conditions we may do business in China, which could materially and adversely affect our profitability and financial condition.

Our ongoing efforts to optimize our global supply chain could cause supply disruptions and be more costly, time-consuming and resource-intensive than expected.

Our ongoing efforts to optimize the efficiency of our global supply chain could cause supply disruptions and could be more expensive, time-consuming and resource-intensive than expected. Furthermore, certain of our suppliers have and others may decide to discontinue business with us or limit the allocation of products to us, or we may become too dependent on one or more suppliers, which could result in our inability to fill our supply needs and jeopardize our ability to fulfill our contractual obligations, which could in turn, result in a decrease in revenues and profitability, contract penalties or terminations, and damage to customer relationships.

We manage our business based on projected future sales volume, which is highly dependent on information received from customers and general market data, and any inaccuracies or changes in such information could adversely affect our business, results of operations and financial condition.

We manage our business based upon projected future sales volumes, which are based upon many factors, including awarded business and assumptions of conversion rates thereof, customers’ forecasts and general macroeconomic and industry market data. Our product revenues generally are based upon purchase orders issued by our customers, with updated production schedules for volume adjustments, and our customers generally do not guarantee sales volumes. As such, we typically do not have a backlog of firm orders at any point in time. In addition, awarded business may include business under arrangements that our customers have the right to terminate without penalty at any time. Further, our customers’ forecasts are subject to numerous assumptions, and such forecasts often are changed rapidly with limited notice. Therefore, our actual sales volumes, and thus the ultimate amount of revenue that we derive from such sales, are prohibitednot committed. We also must incur costs and make commitments well in advance of the receipt of orders and resulting revenues from engagingcustomers. If actual production orders from our customers are not consistent with our projected future sales volumes, especially for our higher-margin products, we could realize substantially less revenue and incur greater expenses over the life of vehicle programs.

The receipt of orders and resulting revenues from customers is significantly affected by global automotive production levels. Recent macroeconomic, geopolitical and industry factors noted above have made it particularly challenging for us to project future sales volumes and manage our business.

23


We use important intellectual property in dueour business. If we are unable to anti-corruption lawsprotect our intellectual property or if a third party makes assertions against us or our customers relating to intellectual property rights, our business could be adversely affected.

We own important intellectual property, including patents, trademarks, copyrights and regulations;trade secrets. Our intellectual property plays an important role in maintaining our competitive position in many of the markets that we serve.

We cannot guarantee, however, that we will be able to secure all desired protection, nor that the steps we have taken to protect our intellectual property will be adequate, to prevent infringement of our rights or misappropriation or theft of our technology, trade secrets or know-how. For example, effective patent, trademark, copyright and

global sovereign fiscal matters trade secret protection may be unavailable or limited in some of the countries in which we operate. In addition, while we generally enter into confidentiality agreements with our employees and creditworthiness, including potential defaultsthird parties to protect our trade secrets, know-how, business strategy and other proprietary information, such confidentiality agreements could be breached or otherwise may not provide meaningful protection for our trade secrets and know-how related to the design, manufacture or operation of our products. If it became necessary for us to resort to litigation to protect our intellectual property rights, any proceedings could be burdensome and costly, and we may not prevail. Further, adequate remedies may not be available in the event of an unauthorized use or disclosure of our trade secrets and manufacturing expertise. Finally, for those products in our portfolio that rely on patent protection, once a patent has expired, the product is generally open to competition. Products under patent protection usually generate higher revenues and profitability than those not protected by patents. If we fail to successfully enforce our intellectual property rights, our competitive position and the related impacts on economic activity,value of our brands and other intangible assets could suffer, which could harm our business, financial condition, results of operations and cash flows.

In addition, our competitors may develop technologies that are similar or superior to our proprietary technologies or design around the patents we own or license. Further, as we expand our operations in jurisdictions where the protection of intellectual property rights is less robust, the risk of others duplicating our proprietary technologies increases, despite efforts we undertake to protect them. Foreign governments may adopt regulations, and foreign governments or courts may render decisions, requiring compulsory licensing of intellectual property rights, or foreign governments may require products to meet standards that serve to favor local companies or provide reduced protection relative to other countries.

Legal, Regulatory and Compliance Risks

Economic and trade policy, including the possible effects on credit markets, currency values, monetary unions, international treatiestariffs and fiscal policies.

See “Our business is subject to risks associated with manufacturing processes” above for a description of certain specific risks associated with our facility in Ukraine.

Modification of the North American Free Trade Agreement (“NAFTA”) or other international trade agreements, or the imposition of significant tariffs on imports into the United States,customs regulations, could have a material and adverse effect on our businessbusiness.

AThe U.S. has established free trade laws and regulations that set certain duties and tariffs for qualifying imports and exports, subject to compliance with the applicable classification and other requirements. Changes in laws or policies governing the terms of foreign trade, and in particular increased trade restrictions, tariffs or taxes on imports from countries where we manufacture products, such as China and Mexico, could have a material adverse effect on our business and financial results. In recent years, the U.S. and Chinese governments have imposed a series of significant portionincremental retaliatory tariffs to certain imported products. Most notably with respect to the automotive industry, the U.S. imposed tariffs on imports of certain steel, aluminum and automotive components, and China imposed retaliatory tariffs on imports of U.S. vehicles and certain automotive components. Depending upon their duration and implementation, as well as our ability to mitigate their impact, these tariffs and any other future regulatory actions implemented on a broader range of products or raw materials could materially affect our business, including in the form of increased cost of goods sold, decreased margins, increased pricing for customers, reduced sales and disruption in our supply chain.

In addition, various countries regulate cross-border transactions of certain products through import permitting and licensing requirements. The exportation, re-exportation, transfers within foreign countries and importation of our business activitiesproducts, including by our suppliers and vendors, must comply with these laws and regulations, and any violations may result in reputational harm, government investigations and penalties, and a denial or curtailment of importing or exporting activities. Complying with export control and sanctions laws, including recent sanctions against Russia and related persons and entities, may be time consuming, may increase our costs, and may result in the delay or loss of sales opportunities. If we are conductedfound to be in foreign countries, including Mexico.  President Trumpviolation of U.S. sanctions or export control laws, or similar laws in other jurisdictions, we and his administration previously announced thatthe individuals working for us could incur substantial fines and penalties. Changes in export, sanctions or import laws or regulations may delay the introduction and sale of our products in the U.S. intended to renegotiate or withdraw from NAFTA, although such matters remain uncertain. If the United States were to renegotiate trade such trade agreements or impose such tariffs, it is likely to make it more costly forand international markets, require us to manufacture goods atspend resources to seek necessary government authorizations or to develop different versions of our Mexican facilities forproducts, or, in some cases, prevent the North American market.  As a result,export or import of our products to certain countries, regions, governments, persons or entities, which could adversely affect our business, financial condition and resultsoperating results.

24


We may face particular privacy, data security and data protection risks.

We are subject to several data privacy and data security laws and regulations in the various jurisdictions that we operate. An increasing number of operations could be materiallyU.S. states have enacted data privacy and adversely affected. Further,security laws and regulations that govern the collection, use, disclosure, transfer, storage, disposal, and protection of personal information, such as social security numbers, financial information and other information. For example, several U.S. territories and all 50 states have adopted data breach rules that require timely notification if a complete withdrawal from NAFTA couldcompany has experienced the unauthorized access or acquisition of personal information. Similarly, many of the requirements mandated by the California Consumer Protection Act (“CCPA”) that went into effect on January 1, 2020 have not yet been interpreted by courts, and best practices are still being developed by the industry, all of which increase the risk of compliance failure and related adverse impacts. Furthermore, on January 1, 2023, substantive provisions of the California Privacy Rights Act (“CPRA”) became effective, in some cases requiring new or modified practices and operations. Other states enacted similar privacy laws in recent years and other states are considering doing so. These privacy laws may impose substantial penalties for violations, impose significant adverse consequences tocosts for investigations and compliance, allow private class-action litigation and carry significant potential liability for our business and reputation.

Legislators and/or regulators in foreign countries in which we operate are increasingly adopting or revising privacy, information security and data protection laws as well. In particular, the European Union’s General Data Protection Regulation (“GDPR”), which became effective on May 25, 2018, imposes additional obligations and risk upon our business and which increases substantially the penalties to which we could be subject in the event of any non-compliance. Many countries have enacted similar types of legislative and regulatory requirements concerning data protection, and additional countries are considering similar legal frameworks.

The CCPA, CPRA, GDPR and other similar laws and regulations including those recently or soon to be enacted (such as the SECs proposed cybersecurity disclosure regulations), as well as any associated inquiries or investigations or any other government actions, may be costly and burdensome to comply with, lead to a decline in consumer engagement, result in negative publicity, increase our operating costs, require significant management time and attention to monitor and be in compliance with, and subject us to remedies that may harm our business, including fines or demands or orders that we modify or cease existing business practices. Moreover, regulatory actions seeking to impose significant financial penalties for noncompliance and/or legal actions (including pursuant to laws providing for private rights of action by consumers) could be brought against us in the event of a data compromise, misuse of consumer information, or perceived or actual non-compliance with data protection or privacy requirements, privacy, or artificial intelligence requirements. The rapid evolution and increased adoption of artificial intelligence technologies may intensify these risks.

Defects or quality issues associated with our automotive and medical products, as well as a significant product liability lawsuit, warranty claim or product recall involving us or one of our major customers, or an investigation regarding vehicle safety generally, could adversely affect the results of our operations.

Our design, manufacture and marketing of automotive products may subject us to warranty claims and product liability in the event that our products (or the products of our customers that incorporate our products) fail to perform as expected and, in the case of product liability, such failure of our products (or the products of our customers that incorporate our products) results or is alleged to result in bodily injury or property damage. This risk may be enhanced for any new developed products or recently acquired products, which has been a significant part of our growth in recent years. If any of our products are or are alleged to be defective, we also may be required by our customers or regulators to participate in a recall or other corrective action involving such products, which we have been subject to periodically. Automotive manufacturers are increasingly looking to their suppliers for contribution when faced with recalls and product liability claims, as well as requiring their suppliers to guarantee or warrant their products and bear the costs of repair and replacement of such products under new vehicle warranties. OEMs historically have recalled vehicles for perceived defects in seat heaters, and we have incurred liabilities in connection with the recalls and other field actions. In addition, governmental regulatory agencies throughout the world, such as NHTSA in the U.S., have safety standards that require manufacturers to remedy defects related to vehicle safety through safety recall campaigns, and a manufacturer is obligated to recall vehicles if it determines that the vehicles do not comply with a safety standard.

Any large liability claims, if made, could exceed our insurance coverage limits and insurance may not continue to be available on commercially acceptable terms, if at all, and we may incur significant costs to defend these claims. In addition, we may not be successful in recovering amounts from third parties, including suppliers, in connection with these claims. In certain instances, allegedly defective products may be the result of components supplied by our supply chain, and we may be limited in our ability to

25


obtain recovery from our suppliers of materials or services included within our products that are associated with product liability and warranty claims, particularly if the affected items relate to global platforms or involve defects that are identified years after production. A recall, product liability or warranty claim brought against us that is not insured or is in excess of our available insurance, and if other third parties do not contribute or indemnify us, could have an adverse impact on our results of operations and create uncertainty forreputation or market acceptance of our future business activitiesproducts.

The design, manufacture and marketing of medical products involve certain inherent risks. Manufacturing or design defects, component failures, unapproved or improper use of our products, or inadequate disclosure of risks or other information relating to the use of our products can lead to regulatory action, injury or other serious adverse events. These events could lead to recalls or safety alerts relating to our products (either voluntary or as required by the FDA or similar governmental authorities in Mexico.

19


The United Kingdom's departureother countries), and could result, in certain cases, in the removal of a product from the European Unionmarket. A recall, inadequate disclosure or defect could materiallyresult in significant costs and adversely affect our business.

In June, 2016, the United Kingdom (U.K.) voted to exit the European Union (“Brexit”) in a referendum vote. In March, 2017, the U.K. formally notified the European Union of its intention to withdraw pursuant to Article 50 of the Lisbon Treaty, which provides a two-year time period through March 2019 for the U.K.lost sales and the European Union countries to negotiate a withdrawal. The announcement of Brexitcustomers, enforcement actions and/or investigations by state and the ongoing negotiations for the withdrawal of the U.K. from the European Union has created and may continue to create global economic uncertainty, which may continue to impact global light vehicle production, and affect the business of and/federal governments or our relationships with our customers and suppliers,other enforcement bodies, as well as alternegative publicity and damage to our reputation that could reduce future demand for our products. Personal injuries relating to the relationship among tariffs and currencies. The long-term effectsuse of Brexit remains uncertain, and Brexit has and may continue to contribute to volatility in stock prices of companies that have significant operations in Europe. Brexit’s impact on currency exchange rates mayour products can also impact operations; we generate certain revenues in Euro, but do not generate revenues denominated in the British Pound. In addition, Brexit could result in legal uncertainty and potentially divergent national laws and regulations as new legal relationships between the United Kingdom and the European Union are established.  The ultimate effects of Brexit on ussignificant product liability claims being brought against us. In some circumstances, such adverse events could also will depend on the terms of any agreements the U.K. and the European Union make to retain access to each other's respective markets either during a transitional period or more permanently.

Significant price volatility, or uncertaintycause delays in future pricing, or oil and natural gas may materially and adversely impact our Gentherm Global Power Technologies (GPT) business

A large portion of our GPT products is sold to companies in the oil and gas industry, in particular, pertaining to new oil and gas pipelines and wells.  Prices for oil and natural gas historically have been volatile and are expected to continue to be volatile. Significant changes in the price of oil and natural gas or uncertainty as to future pricing can adversely impact the numberregulatory approval of new oil explorationsproducts or the imposition of post-market approval requirements, such as further clinical testing. Such clinical testing is costly and installations,time-consuming and causecould delay market approval or the postponement or cancellationmeeting of existing projects, any of which would adversely affect our GPT business.additional post-market requirements.

Tax matters, including the changes in the corporate tax rates, disagreement with taxing authorities and imposition of new taxes could impact our results of operations and financial condition.

We are subject to income and other taxes in the U.S. and our operations, plans and results are affected by tax and other initiatives. On December 22, 2017, the Tax Cuts and Jobs Act (H.R. 1) (the “Tax Act”) was signed into law by President Trump. The Tax Act contains significant changes to corporate taxation, including reduction of the corporate tax rate from 35% to 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small business), limitation of the deduction for net operation losses (“NOLs”) to 80% of current year taxable income and elimination of NOL carrybacks, one time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), new taxes on certain foreign earnings, a new minimum tax related to payment to foreign subsidiaries and affiliates, immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits. The decrease in the corporate tax rate will result in changes in the valuation of our deferred tax assets and liabilities which will have a material impact on our income tax expense and deferred tax balances.  Notwithstanding the reduction in the corporate income tax rate, the overall impact of the new federal tax law is uncertain.  In addition, it is uncertain if, and to what extent, various states will conform to the new tax law and foreign countries will react by adopting tax legislation or taking other actions.  It is not currently anticipated that this change in law will have a material impact on our financial performance.

internationally. We are also subject to regular reviews, examinations, and audits by the Internal Revenue Service and other taxing authorities with respect to our taxes. Although we believe our tax estimates are reasonable, if a taxing authority disagrees with the positions we have taken, we could face additional tax liability, including interest and penalties. There can be no assurance that payment of such additional amounts upon final adjudication of any disputes will not have a material impact on our result of operations and financial position.

We also need to comply with new, evolving or revised tax laws and regulations.regulations, such as the European Union’s Pillar Two Directive, which has effective dates for different aspects of the directive of January 1, 2024, and January 1, 2025. The enactment of or increases in tariffs, or other changes in the application or interpretation of the Tax Act,tax legislation and other initiatives, or on specific products that we sell or with which our products compete, may have an adverse effect on our business or on our results of operations.


The value of our deferred tax assets may not be realized, which could materially and adversely affect our operating results.

20As of December 31, 2023, we had approximately $64 million in net deferred tax assets, inclusive of a $36 million valuation allowance. These deferred tax assets include net operating loss carryovers and tax credits that can be used to offset taxable income in future periods and reduce income taxes payable in those future periods. Each quarter, we determine the probability of the realization of deferred tax assets, using significant judgments and estimates with respect to, among other things, historical operating results and expectations of future earnings and tax planning strategies. If we determine in the future that there is not sufficient positive evidence to support the valuation of these assets, due to the risk factors described herein or other factors, we may be required to further adjust the valuation allowance to reduce our deferred tax assets. Such a reduction could result in material non-cash expenses in the period in which the valuation allowance is adjusted and could have a material adverse effect on our financial statements.


Our patient temperature management systems business is subject to extensive industry regulation and failure to comply with all applicable rules and regulation may adversely impact usus.

Our patient temperature management products are subject to extensive, complex, costly and evolving government regulation. In the United States, this is principally administered by the Food and Drug Administration (“FDA”). Various regulatory agencies in foreign countries where our medical products are sold also regulate that business. Under theseboth United States and foreign country regulations, we are subject to periodic inspection of our facilities (including third-party facilities that are performing services for us), procedures and operations and testing of our products. Following such FDA inspections, should any noncompliance with regulations or other quality issues be noted, we may receive observations, notices, citations and/or warning letters that could require us to get FDA approval of a corrective action plan and modify certain activities identified during the inspection, possibly at a significant cost. We are also required to report adverse events associated with our medical products to the FDA and other foreign regulatory authorities.authorities where our products have been approved or received market clearance. Unexpected or serious health or safety concerns could result in

26


liability claims, recalls, market withdrawals or other regulatory actions. Changes in laws or regulations could require us to change the way we operate or to utilize resources to maintain compliance, which could increase costs or otherwise disrupt operations. In addition, failure to comply with any applicable laws or regulations could result in fines or revocation of our operating permits and licenses or, in rare circumstances, market withdrawal of the product.

The process for obtaining governmental approval to manufacture and market new medical devices is time-consuming and costly. We are dependent on receiving FDA and other governmental or third-party approvals prior to manufacturing, marketing and shipping any new medical products. We cannot be certain that any new medical products we develop will receive FDA or other necessary approvals. Also receipt of approval in one country does not guarantee approval by the FDA or any other foreign regulatory agency.

Any failure to comply with anti-corruption laws and regulations could have a material and adverse effect on our reputation, business and financial resultsresults.

Our operations outside of the United States require us to comply with various anti-bribery and anti-corruption regulations, including but not limited to the U.S. Foreign Corrupt Practices Act, the United Kingdom Bribery Act and the China Anti-Unfair Competition Law. Recent yearsCompliance with these laws and regulations have seen a substantial increase in anti-bribery law enforcement activity, with more frequentbecome increasingly complex due to the increasing global operations of OEMs and aggressive investigations and enforcement proceedings by both U.S. and non-U.S. regulators, and increases in criminal and civil proceedings brought against companies and individuals. We operate in many partsautomotive component suppliers, including us. Violations of the world that are recognized as having governmental and commercial corruption and local customs and practices that can be inconsistent with anti-bribery laws. We have internal control policies and procedures, and we have implemented training and compliance programs for our employees and agents, with respect to these regulations.  However, our policies, procedures and programs may not always protect us from negligent, reckless or criminal acts committed by our employees or agents.  We could incur significant expenses in investigating any potential violation and could incur severe criminal or civil sanctions and/or fines as a result of violations or settlements regarding such laws.  In addition, any allegations, settlements or violations could materially and adversely impact our reputation and our relationships with current and future customers, suppliers, employees and agents.  Also, some of our competitors may not be subject to, or similarly comply with, the same anti-corruption laws, which could provide them a competitive advantage.  

We are subject to significant currency risk related to our global operations

A significant portion of our global transactions is conducted in currencies other than the U.S. Dollar. While we sometimes employ financial instruments to hedge some of our transactional foreign exchange exposure, developing an effective and economical foreign currency risk strategy is complex and expensiveoften difficult to interpret and no strategy can completely insulate us from those exposures.  Hedging arrangements also may expose us to additional risks, includingapply, could result in significant criminal penalties or sanctions that a counterparty may fail to honor its obligations, and additional costs, including transaction fees and breakage costs.  Changes in the exchange rates of foreign currencies could significantlyadversely affect our reportedbusiness, financial condition, results of operations and financial condition. For example, a significant portioncash flows. Additionally, we have, in recent years, and may in the future complete acquisitions of our business activities is conductedand investments in Euros, and the weakening of the U.S. dollar against the Euro had a positive effect on our reported revenues in 2017.

In addition, concerns persist regarding the debt burden of certain European countriescompanies that have adopted the Euro currency (the "Euro Zone")had different policies, practices and their abilitystandards, prior to meet future financial obligations, as well as concerns regarding the overall stability of the Euro to function as a single currency among the diverse economic, social and political circumstances within the Euro Zone. For example, the announcement of the United Kingdom’s decision to exit the European Union caused significant volatility in currency exchange rates, especially between the U.S. dollar and British pound sterling.  If one of the Euro Zone countries were to default on its debt or other Euro Zone countries withdraw from the Euro currency, the impact on global markets, and on our business, results of operations and financial condition, could be significant, andacquisition, that impact would intensify substantially if the Euro currency were dissolved entirely. Such a development could also cause financial and capital markets across the globe to constrict, reducing liquidity and increasing borrowing costs, and could have a significant negative impact on consumer confidence and spending.

21


Any failure to protect our intellectual property developed or licensed could harm our business and competitive position

We believe that patents and proprietary rights have been and will continue to be very important in enabling us to compete.  If our patents are circumvented, rendered invalid or unenforceable, or narrowed in scope, the patent coverage afforded to our products would be impaired, which could significantly impede our ability to market our products, negatively affect our competitive position and materially and adversely affect our business and results of operations.

There can be no assurance that any new or pending patents will be issued, that our or our licensors’ proprietary rights will not be challenged, invalidated, circumvented or rendered unenforceable, or that our patents will provide us with meaningful competitive advantages. Furthermore, there can be no assurance that others will not independently develop similar products or will not design around any patents that have been or may be issued to our licensors or us. Also, failure to seek or obtain patents in certain foreign countries may materially and adversely affect our ability to compete effectively in those international markets.  Further, as we expand our operations in jurisdictions where the protection of intellectual property rights is less robust, such as China,increase the risk of others duplicating our proprietary technologies increases, despite effortscompliance with various regulations while we undertakeintegrate such companies.

Our business may be negatively impacted by the effects of climate change and by regulatory and stakeholder-imposed requirements to protect them.  Foreign governments may adopt regulations—address climate change and foreign governments or courts may render decisions—requiring compulsory licensingother sustainability issues.

As evidenced by shifting industry and consumer behaviors, including the development and use of intellectual property rights, or foreign governments may require products to meet standards that serve to favor local companies.

Because of rapid technological developments inelectric vehicles, the automotive industry and consumers have a heightened focus on climate change and the competitive natureenvironmental impact of product manufacturing and end use. This increased focus on sustainability and the environmental impact of the market,automotive industry and manufacturing processes has caused our customers and other stakeholders to impose additional requirements on us and our suppliers, which often exceed regulatory standards. These customer requirements include increased tracking and reporting of greenhouse gas emissions and other environmental metrics, reduced waste and wastewater from operations, increased use of sustainable materials in our products, and the patent positionuse of any component manufacturer is subjectrenewable energy sources in our factory operations. We expect to uncertaintiesincur increased operating costs and may involve complex legalcapital expenditures to procure renewable energy and factual issues. Consequently, although we either ownadditional equipment or have licensesmake operational and process changes to certain patents,comply with customer requirements in addition to state and are currently processing a significant number of additional patent applications, it is possible that no patents will issue from any pending applications or that claims allowed in any existing or future patents issued or licensed to us will be challenged, invalidated, circumvented, or that any rights granted under such patents will not provide us adequate protection. There is an additional risk that wefederal regulations. Furthermore, our practices may be requiredjudged against sustainability standards that are continually evolving and not always clear. Prevailing sustainability standards, expectations and regulations may also reflect contrasting or conflicting values or agendas. To the extent we are unable to participatemeet or exceed customer sustainability requirements, demand for our products and our revenues could be adversely impacted. A failure to adequately meet other stakeholder expectations may result in interference proceedingsthe loss of business, diluted market valuation, an inability to determine the priorityattract customers or an inability to attract and retain top talent.

Climate change is continuing to receive ever increasing attention worldwide. Many scientists, legislators and others attribute climate change to increased levels of inventionsgreenhouse gases, including carbon dioxide, which has led to and we expect will continue to lead to legislative and regulatory efforts in many jurisdictions to limit greenhouse gas emissions. New federal or state restrictions on emissions of carbon dioxide that may be requiredimposed on vehicles and automobile fuels could adversely affect demand for vehicles, annual miles driven or the products we sell, lead to commencechanges in automotive technology, and expedite the transition to electric vehicles. Compliance with any new or more stringent laws or regulations, or stricter interpretations of existing laws, could require increased capital expenditures to improve our product portfolio to meet such new laws, regulations and standards. Such legislative developments could adversely impact our business by increasing costs and could require us to make changes to our operations and result in substantial additional capital expenditures and operating costs. Such regulations may also subject us to new disclosure requirements, new supply chain requirements, new trade restrictions and increased risk of litigation to protect our rights,or regulatory action, which could result in substantialincreased costs (in our operations and divert the attention of managementsupply chain) and technical and engineering personnel.  

In addition to patents, we rely on a combination of trademarks, copyrights, know-how, confidentiality provisions and licensing agreements to establish and protect our proprietary rights. We cannot guarantee, however, that the steps we have taken to protect our intellectual property will be adequate to prevent infringement of our rights or misappropriate thereof.

To the extent that consultants, key employees or other third parties apply technological information independently developed by them or by othersrisks to our proposed projects, disputes may arise as to the proprietary rights to such information that may not be resolved in our favor. Additionally, with respect to licensed technology, there can be no assurance that the licensor of the technology will have the resources, financialreputation or otherwise, or desire to defend against any challenges to the rights of such licensor to its patents.

Our products may conflict with patents that have been or may be granted to competitors or other

Other persons could bring legal actions against us claiming damages and seeking to enjoin manufacturing and marketing ofconsumer demand for our products for allegedly conflicting with patents held by them. Any such litigationif we do not meet increasingly demanding stakeholder expectations and standards. These additional costs, changes in operations, or loss of revenues could result in substantial cost to us, divert the attention of management and engineering and technical personnel, and harm our reputation. If any such actions are successful, in addition to any potential liability for damages, we could be required to cease selling or using infringing products, obtain a license in order to continue to manufacture or market the affected products, or redesign the infringing products. There can be no assurance that we would prevail in any such action, that any license required under any such patent would be made available on acceptable terms, if at all, or that we could redesign such products on a timely basis and at a reasonable cost, if at all. Failure to obtain needed patents, licenses or proprietary information held by others may have a material adverse effect on our business, financial condition, and results of operationsoperations.

27


Finally, the effects of climate change, such as increased intensity, frequency or duration of storms, floods, droughts, wildfires or other severe weather events have and may continue create financial condition. From timeor physical risk to time, we receive notices from third parties suggesting thatus. Physical risks include disrupting the manufacturing, logistics and procurement activities and employee working conditions of us, our supply chain and our customers. Financial risks include the fluctuating demand for our products infringeand technologies based on the proprietary rights of others and historically we have had litigation regarding such matters. While we do not believe that any current claim of patent is valid and material, we must spend time and resources reviewing, defending and resolving such claims.

We rely on trade secret protection through confidentiality agreements and the agreements could be breached or information may be otherwise stolen

We rely on trade secrets that we seek to protect, in part, through confidentiality and non-disclosure agreements with employees, customers and other parties. There can be no assurance that these agreements will not be breached, that we would have adequate

22


remedies for any such breach or thatclimate where consumers live, since our trade secrets will not otherwise become known to or independently developed by competitors.

The theft or unauthorized use or publication of our trade secrets and other confidential business information could harm our competitive position and reduce acceptance of our products,involves thermal management technologies, as well as potential additional costs of insurance and maintaining facilities in certain regions prone to climate risk. We could also face indirect financial risks passed through the value ofsupply chain, and process disruptions due to physical climate changes could result in price modifications for our investment in research and development, product development and marketing.  In addition, third parties might make claims against us related to losses of confidential or proprietary information, end-user data or system reliability. These incidents and claims could severely disrupt our business, and we could suffer losses, including the cost of product recalls and returns and reputational harm.  In addition, we may be required to incur significant costs to protect against damage caused by these disruptions or security breaches in the future.

Our most significant customers typically reserve the right unilaterally to cancel contracts or reduce prices,products and the exercise of such right could reduce or eliminate any financial benefitresources needed to us anticipated from such contract

Due to their purchasing size, automotive customers typically reserve the right unilaterally to cancel contracts completely or to require price reductions during the termproduce them. Any of the contract. Although these customers generally agree as a commercial practice to reimburse companies for actual out-of-pocket costs incurred with respect to the particular contract up to the point of cancellation, these reimbursements typically do not cover costs associated with acquiring general purpose assets, such as facilities and capital equipment, or for increases in employee count and related costs, and may be subject to negotiation and substantial delays in receiving payment on such actual out-of-pocket costs. Any unilateral cancellation of, or price reduction with respect to, any contract could reduce or eliminate any financial benefits anticipated from such contract.  If we are not able to offset pricing reductions through improved operating efficiencies and reduced expenditures, such price reductionforegoing could have a material adverse effect on our financial condition and results of operations.

The third parties that have agreed to reimburse portions of our research and development expenses generally also reserve the right to unilaterally terminate those contracts. There can be no assurance that we will continue to receive the third party reimbursements for any of our research and development efforts.

A significant product liability lawsuit, warranty claim or product recall involving us or one of our major customers, or an investigation regarding vehicle safety generally, could materially and adversely affect our financial performance

In the event that our products fail to perform as expected, whether allegedly due to our fault or that of one of our suppliers, and such failure results in, or is alleged to result in, bodily injury and/or property damage or other losses, we may be subject to product liability lawsuits and other claims or we may be required or requested by our customers or regulators to participate in a recall or other corrective action involving such products.  We also are a party to agreements with certain of our customers, whereby these customers may pursue claims against us for contribution of all or a portion of the amounts sought in connection with product liability and warranty claims.  We carry insurance for certain product liability claims , but such coverage may be limited.  In addition, we may not be successful in recovering amounts from third parties, including suppliers, in connection with these claims.  These types of claims could materially and adversely affect our financial condition, operating results and cash flows.

Over the past couple of years, there has been a significant increase in the level of scrutiny given to vehicle safety issues. Inquiries are being conducted not only by traditional regulators but also by state Attorneys General. Furthermore, the U.S. Department of Justice has commenced investigations and U.S. Congressional hearings have also been conducted in which vehicle manufacturers and in some cases suppliers are being called to testify as to particular safety risks. This increased scrutiny could materially and adversely affect the business of our customers and suppliers and subject us to fines, penalties, sanctions and/or investigations.

Our success will depend in large part on retaining key personnel and effective succession planning

Our success will depend to a large extent upon the continued contributions of key personnel. The loss of the services of one or more of our executive officers could have a material adverse effect on the success of our business. Effective succession planning is also important to our long-term success.  Failure to ensure effective transfer of knowledge and smooth transitions involving key employees could hinder our strategic planning and execution. Further, our success will depend, in part, upon our ability to retain qualified engineering and other technical and marketing personnel. There is significant competition for technologically qualified personnel in our business and we may not be successful in recruiting or retaining sufficient qualified personnel.

23


We are required to comply with environmental laws and regulations that could cause us to incur significant costscosts.

Our manufacturing facilities are subject to numerous laws and regulations designed to protect the environment, inside and outside the United States, and we expect that additional requirements with respect to environmental matters will be imposed on us in the future. We may also assume, or be deemed to assume, significant environmental liabilities in acquisitions. Environmental liability may be imposed without regard to fault, and under certain circumstances, can be joint and several, resulting in one party being held responsible for the entire obligation. Material future expenditures may be necessary if compliance standards change or material unknown conditions that require remediation are discovered. No assurance can be given that all environmental liabilities have been identified or that no prior owner or operator of our properties or former properties has created an environmental condition not known to us.  Environmental laws could also restrict our ability to expand our facilities or could require us to acquire costly equipment or to incur other significant expenses in connection with our business. Violations of these requirements could result in fines or sanctions, obligations to investigate or remediate contamination, third party property damage or personal injury claims due to the migration of contaminants off-site, or modification or revocation of our operating permits, which could materially and adversely affect our financial condition, operating results of operations and cash flows.

We are involved from time to time in various legal and regulatory proceedings and claims, which could adversely affect our financial performance.

We are involved in various legal and regulatory proceedings and claims that, from time to time, are significant. These are typically claims that arise in the normal course of business including, without limitation, commercial or contractual disputes, including disputes with our customers, suppliers or competitors, intellectual property matters, personal injury claims, environmental matters, tax matters and employment matters. Such legal and regulatory proceedings could result in an adverse outcome for the Company that would adversely affect our financial condition, results of operations and cash flows.

Financial Risks

We may not realize significant benefits from acquisitions or joint ventures because of integration difficulties and other challenges

We have recently completed a few acquisitions, and we are actively pursuing additional acquisitions to expand the breadth of products derived from core thermal technologies as well as the markets in which they are applied.  Identifying suitable potential acquisitions, conducting due diligence, successfully negotiating and closing an acquisition and the acquisition integration process are complex, costly and time-consuming. The difficulties of completing and integrating an acquisition include, among others:

incurring additional debt and/or issuing additional securities, increasing leverage risks or dilution;

unsatisfactory returns on our investments and our inabilitybe unable to realize the expected benefits of such acquisitions or joint ventures;our restructuring actions, which could adversely affect our profitability and operations.

difficultiesWe have undertaken significant restructuring activities in implementingrecent years that remain ongoing and may take future restructuring actions to realign and resize our business plan for the combined business, including achieving anticipated synergies in amountproduction capacity and cost structure, lower our cost base, improve our financial performance and cash flow generation, and create a simplified organization best positioned to deliver on time;

required significant capital expenditures to integrate our operations and pursue synergies;

unanticipated issues in integrating manufacturing, logistics,key financial and other internal controls, communications and other systems;

diversion of management attention and capital from ongoing business concernsoperational priorities. Charges related to integration matters;

challenges assimilating management and other personnel, including because of differences in culture, language and background for international acquisitions;

difficulty maintaining oversight over internal controls and preventing misconductthese actions or other violations of applicable laws by any investment which we do not exercise control;

the size of operations acquired relative to our existing business;

unanticipated changes in applicable laws and regulations;

failure to obtain regulatory or other approvals;

failure to retain key employees, customers and suppliers of the combined business;

assumption of known and unknown liabilities, some of whichfurther restructuring actions may be difficult or impossible to quantify; and

non-cash impairment charges or other accounting charges relating to the acquired assets.

To the extent we complete an acquisition inhave a new industry, the above risks will be heightened due to our lack of familiarity with such business.

24


In the future, we may not be able to successfully identify suitable acquisition or joint venture opportunities or complete any particular acquisition, combination, joint venture or other transactionmaterial adverse effect on acceptable terms. Our identification of suitable acquisition candidates and joint venture opportunities and the integration of acquired business operations involve risks inherent in assessing the values, strengths, weaknesses, risks and profitability of these opportunities, as well as significant competition for such acquisition opportunities. Our focus on acquisition opportunities may require significant financial, management and related resources that would otherwise be used for the ongoing development of our existing operations and internal expansion.

We may not generate enough liquid assets to fund our ongoing operations and investments and service our debt

Based on our current business plan, we believe our cash on hand along with cash flows from operating activities will be sufficient to meet operating and capital expenditure needs and to service our debt for the foreseeable future.  However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and materially and adversely affect our results of operations and financial condition. In addition,We cannot ensure that any current or future restructuring will be completed as planned, on a timely basis or at all, will be on budget, or achieve the desired results.

We are subject to significant foreign currency risk and foreign exchange exposure related to our global operations.

A significant portion of our global transactions is conducted in currencies other than the U.S. Dollar, including the Euro, the Chinese Renminbi, the Vietnamese Dong, the Hungarian Forint, the North Macedonian Denar, the Ukrainian Hryvnia, the South Korean Won and the Mexican Peso. While we may needsometimes employ financial instruments to complete one or more equity or debt financings if we consummate any significant acquisitions.  Therehedge some of our transactional foreign exchange exposure, developing an effective and economical foreign currency risk strategy is complex and expensive and no strategy can completely insulate us from those exposures. Exchange rates can be no assurance that such capital will be available at all or on reasonable terms, whichvolatile and could materially and adversely affect our future operationsfinancial results and comparability of results from period to period. Such exchange rate volatility could also increase the costs of raw materials or components from foreign suppliers, and as a result, our profitability could be adversely affected.

28


Our existing indebtedness and the inability to access capital markets could restrict our business strategy.

We may not be ableactivities or our ability to generate sufficient cash flows to meetexecute our substantial debt service obligations, and such substantial debt service obligations could materially andstrategic objectives or adversely affect our business, resultsfinancial performance.

As of operationsDecember 31, 2023, our total consolidated indebtedness was $222.8 million, with $278.0 million available for additional borrowings under the Second Amended and financial condition

Our abilityRestated Credit Agreement subject to make payments on and to refinance our debt obligations depends on our ability to generate cash flows from operationsspecified conditions that Gentherm currently satisfies. We may incur additional indebtedness in the future. This, to a certain extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyondfuture, including in connection with acquisitions or significant capital expenditures. If our control. We may not be able to refinance anyoutstanding borrowings increase, including under existing availability of revolving credit or if we incur additional indebtedness, the amount of our indebtedness on commercially reasonable terms, or at all.

If we cannot service our indebtedness, we may have to take actions such as selling assets, seeking additional equity or reducing or delaying capital expenditures, strategic acquisitions, investments and alliances, any of which could impede the implementation of our business strategy or prevent us from entering into transactions that would otherwise benefit our business. Additionally, we may not be able to effect such actions, if necessary, on commercially reasonable terms, or at all.

Ouroutstanding debt obligations could have important, adverse consequences to us and our business, resultsinvestors, including:

requiring a substantial portion of our cash flow from operations and financial condition. For example:

to make interest payments;

we may bemaking it more vulnerabledifficult to satisfy other obligations;

increasing our vulnerability to general adverse economic and industry conditions;

we may be required to dedicate a substantial portion of our cash flows from operations to payments on our indebtedness, thereby reducing the availability of cash flows for other purposes, including for working capital, dividends,flow available to fund capital expenditures business development effortsand other corporate purposes and to finance mergers and acquisitions;

grow our businesses;

our ability to borrow additional debt for operations, working capital or to finance future mergers and acquisitions may be limited;

our ability to refinance or repay other debt obligations when they become due may be limited;

we are exposed to the risk of increased interest rates because a portion of our borrowings, including under our credit facilities, are at variable rates of interest; and

limiting our flexibility in planning for, or reacting to, changes in our businesses and industries; and

limiting our ability to borrow additional funds as needed or take advantage of business and the industries in which we operate may be limited, thereby placing us at a competitive disadvantage compared to our competitors that have less indebtedness.

opportunities as they arise.

Our debt agreements contain certain restrictive covenants and customary events of default. These restrictive covenants limit our ability to take certain actions, such as, among other things: incur additional debt, create liens, make certain payments or distributions (including for the repurchase or redemption of our shares), engage in mergers or consolidations, make certain dispositions and transfers of assets, enter into transactions with affiliates and guarantee indebtedness. While not unusual for financings of the type that we have, the restrictions in our credit facilities may prevent us from taking actions that we believe would be in the best interest of our business and may make it difficult for us to execute our business plans, take advantage of business opportunities, or react to changing industry conditions.

25


UponTo the extent that we incur additional indebtedness, the risks described above could increase. In addition, our actual cash requirements in the future may be greater than expected. Our ability to make payments of principal and interest on our indebtedness depends upon our future performance. If our cash flow from operations is not sufficient to service our outstanding debt or to repay the outstanding debt as it becomes due, we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to service or refinance our debt and we may have to reduce or delay planned capital or operating expenditures. The occurrence of any of such events could have a material adverse effect upon our business, cash flows, financial condition and results of operations. If an event of default if not waived bywould occur under our existing debt agreements or any additional indebtedness, our lenders our lenders maycould declare all amounts outstanding asto be immediately due and payable, which may cause cross-defaults under our other debt obligations. If our lenders accelerate the maturity of our indebtedness, we may not have sufficient capital available at that time to pay the amounts due to all lenders on a timely basis, and there is no guarantee that we would be able to repay, refinance, or restructure the payments on such debt. Further, under our existing credit facilities, the lenders would have the right to foreclose on certain of our assets, which could have a material adverse effect on our business, results of operations and financial condition.

Our resultsWe utilize various strategies to move funds between countries to manage global liquidity needs without material adverse tax consequences. Any repatriation of operations and financial conditioncash to the U.S. may be adversely impacted from a decrease in or cessation or clawback of government incentives related to investments

We receive economic benefits from national, state, and local governmentsresult in various regionstax consequences and the movement of the world in the form of incentives designedcapital remains subject to encourage manufacturers to establish, maintain, or increase investment, workforce, or production. These incentives may take various forms, including grants, loan subsidies, and tax abatements or credits.  The impact of these incentives can be significant in a particular market during a reporting period. A decrease in, expiration without renewal of, or other cessation or clawback ofevolving government incentives for any of our business units, as a result of administrative decision or otherwise,regulation, which could have an adverse impact on our liquidity and cash flows.

We continue to expect to be able to move funds between different countries to manage our global liquidity needs without material adverse tax implications, subject to current monetary policies and the terms of the Second Amended and Restated Credit Agreement. We utilize a combination of strategies and currently there are no significant restrictions on the ability of our subsidiaries to pay dividends or make other distributions to Gentherm Incorporated. As of December 31, 2023, the Company’s cash and cash equivalents held by our non-U.S. subsidiaries totaled $125.3 million. If additional non-U.S. cash was needed for our U.S. operations, we may be required to accrue and pay withholding if we were to distribute such funds from non-U.S. subsidiaries to the U.S. In addition, the movement of capital between our subsidiaries and us in different countries remains subject to evolving government regulation and geopolitical stability, and our liquidity and cash flows could be impacted adversely upon regulatory and geopolitical changes in the future.

29


We are exposed to risks related to accounts receivable sales agreements.

We have entered into a receivables factoring arrangement that permits us to sell certain accounts receivable on a revolving basis, subject to outstanding balances and concentration limits. These agreements permit us to recover on our accounts receivable for specific customers sooner than if they were not in place and help reduce the risk of non-payment by such customers. A limited number of our customers participate in these programs to date. If we do not enter into these agreements, our financial condition, results of operations and cash flows could be materially and adversely affected by delays or failures in collecting trade accounts receivables for the applicable customers. In addition, if any of the financial condition,institutions with which we have these agreements experiences financial difficulties or otherwise modifies or terminates these agreements, such modification, termination or other loss of these arrangements could have a material and adverse effect upon our liquidity and cash flows.

Common Stock Investment Risks

The price of our Common Stock may fluctuate significantly.

The price of our common stock, no par value ("Common Stock") on the Nasdaq Global Select Market has experienced substantial price volatility and may continue to do so in the future. Additionally, the Company, the automotive industry and the stock market as a whole have experienced significant stock price and volume fluctuations that have affected stock prices in ways that may have been unrelated to these companies’ operating performance. In particular, while stock price multiples had increased in recent years for OEMs and automotive component suppliers to reflect the growth opportunity of the rapid shift to EV production, stock price multiples have declined more recently during this period of uncertainty regarding EV adoption. Price volatility over a given period may cause the average price at which the Company repurchases its stock to exceed the stock’s price at a given point in time. If the Company fails to meet expectations related to future growth, profitability, share repurchases or other market expectations, its stock price may decline significantly, which could have a material adverse impact on investor confidence and employee retention.

On December 11, 2020, the Board of Directors authorized a stock repurchase program, pursuant to which the Company is authorized to repurchase up to $150 million of Common Stock over a three-year period. Repurchases may be made, from time to time, in amounts and at prices the Company deems appropriate, subject to market conditions, applicable legal requirements, debt covenants and other considerations. Any Company stock repurchases under the program may result in stock price and volume fluctuations. During the year ended December 31, 2023, the Company repurchased shares under the 2020 Stock Repurchase Program for $92.5 million and had a remaining repurchase authorization of $37.5 million as of December 31, 2023. On November 1, 2023, the Board of Directors extended the maturity date of the program from December 15, 2023 to June 30, 2024.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 1C. CYBERSECURITY

Our corporate information technology, communication networks, enterprise applications, accounting and financial reporting platforms, and related systems are necessary for the operation of our business. We use these systems, among others, to manage our product development and manufacturing, to communicate internally and externally, to operate our accounting and record-keeping functions, and for many other key aspects of our business. Our business operations rely on the secure collection, storage, transmission, and other processing of proprietary, confidential, and sensitive data.

Risk Management and Strategy

We recognize the importance of assessing, identifying, and managing material risks associated with cybersecurity threats, as such term is defined in Item 106(a) of Regulation S-K. These risks include, among other things: operational risks, intellectual property theft, fraud, extortion, harm to employees or customers, violation of data privacy or security laws, litigation, and legal, financial and reputational risk.

We have implemented and maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats to our critical systems and our proprietary, strategic or competitive data. Depending on the environment, we implement and maintain various technical, physical, and organizational measures, processes, standards, and/or policies designed to manage and mitigate material risks from cybersecurity threats to our information systems and data, including risk

30


assessments, incident detection and response, vulnerability management, disaster recovery and business continuity plans, internal controls within our accounting and financial reporting functions, encryption of data, network security controls, access controls, physical security, asset management, systems monitoring, vendor risk management program and employee training. We conduct regular reviews and tests of our information security program and also leverage audits by our internal audit team, tabletop exercises, penetration and vulnerability testing, and other exercises to evaluate the effectiveness of our information security program and improve our security measures and planning. We have an incident response process that relies on a multidisciplinary team for assessing and managing cybersecurity incidents, including an escalation framework based on the materiality of incidents. The multidisciplinary team includes members of our IT security function, executive management of our legal, finance, human resources, corporate communications and internal audit/risk functions and third party service providers of technical, legal and insurance services, as well as coordination with law enforcement as appropriate. Our IT security function also addresses cybersecurity threats through regular vulnerability reviews, risk registry reviews and global team meetings.

Our information security processes are integrated into our abilityoverall enterprise risk management (“ERM”) process and system. Our ERM process relies on designated risk managers to fund new investments.identify and assess material risks from cybersecurity threats. The risk managers form a multidisciplinary group including members of our IT security, finance, human resources and legal functions, operations and executive management, and are responsible for timely reporting of risks on an ongoing basis. Our ERM process includes an annual evaluation and ranking of the top risks captured in our ERM system against leading third party benchmark reports on global risks.

We work with third parties from time to time that assist us to identify, assess, and manage cybersecurity risks, including professional services firms, consulting firms, threat intelligence service providers, and penetration testing firms.

To operate our business, we utilize certain third-party service providers to support a variety of functions. We seek to engage reliable, reputable service providers that maintain cybersecurity programs. Depending on the nature of the services provided, the sensitivity and quantity of information processed, and the identity of the service provider, our vendor management process may include reviewing the cybersecurity practices of such provider, contractually imposing obligations on the provider, conducting security assessments, and conducting periodic reassessments during their engagement.

Our systems periodically experience directed attacks that may be intended to lead to financial loss, interruptions and delays in our operations as well as loss, misuse or theft of personal information (of third parties, employees, and other stakeholders) and other data, confidential information or intellectual property. However, we are not aware of any risks from cybersecurity threats, including as a result of any cybersecurity incidents, which have materially affected or are reasonably likely to materially affect our Company, including our business strategy, results of operations, or financial condition. Refer to “Item 1A. Risk factors” in this annual report on Form 10-K, including “Security breaches and other disruptions to our information technology networks and systems, including a disruption related to cybersecurity, could interfere with our operations and could compromise the confidentiality of our proprietary information or personal information”, for additional discussion about cybersecurity-related risks.

We rely upon information technology networksGovernance

Our Board of Directors holds oversight responsibility for the Company’s strategy and systems, some of which are managed or hosted by third-parties, to process, transmit and store electronic information, and to manage or support a variety of business processes and activities, including electronic communications among our locations around the world and between Company personnel and our customers and suppliers, supply chain management, manufacturing, and invoicing and collection of payments. We use these information technology network and systems to process financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting and legal and tax requirements. Additionally we collect and store sensitive data, including intellectual property, proprietary business information, the proprietary business information of our customers and suppliers, as well as personally identifiable information of our employees, customers and suppliers, in data centers, on information technology networks and systems, some of which are operated by third parties and third party locations. The secure operation of these data centers, information technology networks, and systems and the processing, maintenance, confidentiality, integrity and availability of this information, is critical to our business operations and strategy.

The Company maintains an information risk management, program whichincluding material risks related to cybersecurity threats. This oversight is supervisedexecuted directly by information technology management and reviewed by a cross-functional committee. As part of this program, reports that include analysis of emerging risks as well as the Company’s plans and strategies to address them are regularly prepared and presented to senior management and the Board of Directors. Despite securityDirectors and through its committees. Our Board members also engage in ad hoc conversations with management on cybersecurity-related news events and discuss any updates to our cybersecurity risk management and strategy programs.

The Audit Committee of the Board of Directors (the “Audit Committee”) oversees the quality and effectiveness of the control and enterprise risk management processes of systemic risks, including cybersecurity, in accordance with its charter. The Audit Committee receives reports and engages in regular discussions with management regarding the Company’s significant financial risk exposures and the measures such as disaster recoveryimplemented to monitor and business continuity plans,reasonably manage these risks, including those measuresthat may result from material cybersecurity threats. The Audit Committee also receives reports on material cybersecurity and data privacy incidents (if any), which would include plans to mitigate and respond to such incidents, and status on key information security initiatives. These discussions include the Company’s enterprise risk assessment and risk management policies.

The Technology Committee of the Board of Directors oversees the management of risks associated with the Company’s products and technologies, including cybersecurity risks related to new product technologies or significant innovations to existing product technologies, in accordance with its charter.

31


Our Vice President & Chief Information Officer (the “CIO”) leads our global information security organization and reports to the Board of Directors on matters related to cybersecurity these data centers,on behalf of the Company’s management. Our CIO has over 20 years of industry experience, including serving in similar roles leading and overseeing cybersecurity programs at other public companies. Team members who support our information security program have relevant educational and industry experience, including holding similar positions at large industrial and technology networkscompanies.

Our CIO leads an internal IT Security Committee that meets regularly to oversee company-wide efforts to address cybersecurity threats, to assess the effectiveness of our information security program and systems may be vulnerable to damage, disruptions or shutdowns dueprioritize efforts to attacks by hackers or breaches due to errors or malfeasance by employees, contractorsimprove our security measures and others who have access toplanning. Our IT Security Committee includes members of our networksIT security function and systems, or other disruptions during the processexecutive management of upgrading or replacing computer software or hardware, power outages, computer viruses, telecommunication or utility failures, geopolitical events, or natural disasters or other catastrophic events.our legal, finance and internal audit/risk, human resources and corporate communications and technology functions.

Cyber threatsITEM 2. PROPERTIES

As of December 31, 2023, we operate in more than 30 locations across 13 countries, which are constantly evolving, thereby increasing the difficultyprimarily for manufacturing, assembly, distribution, warehousing, engineering and testing. The majority of detecting and successfully defending against them. The occurrence of anyour Automotive facilities located outside of the aforementioned events, manyU.S. are principally used in manufacturing and distribution and are located in China, Hungary, Mexico, North Macedonia, South Korea, Ukraine, Czech Republic, Germany, and Vietnam. Our global headquarters is located in Northville, Michigan, our European headquarters is located in Odelzhausen, Germany and our Asia-Pacific headquarters is located in Shanghai, China. Our Medical business is principally comprised of which are outside our control, could compromiseheadquarters and manufacturing site located in Cincinnati, Ohio and our systems or networksmanufacturing sites in Germany and China. We also have sales offices, warehouses and engineering centers, strategically located throughout the information stored there, which may include confidential or proprietary information or personal information of third parties, could be accessed, publicly disclosed, compromised, corrupted, lost or stolen. Any such access, disclosure or other loss or corruption of information could result in legal claims or proceedings, liability or regulatory penalties under laws protecting the privacy of personal information, disrupt operations, cause a loss of confidence in our reputation, goodwill, products and services, reduce the competitive advantage we expect to derive from our investment in advanced technologies and adversely affect our financial condition, operating results, and cash flows. We maintain cyber risk insurance, but this insurance may not be sufficient to coverworld. Nearly all of our losses from any future breachesmanufacturing and distribution sites in Mexico and Asia are leased, while most of our systems.European sites are owned.

We may face particular privacy, data security and data protection risks due to the new European General Data Protection RegulationITEM 3. LEGAL PROCEEDINGS

We may face particular privacy, data security and data protection risks in Europe due to the new European General Data Protection Regulation (“GDPR”). Data protection regulation is an area of increase focus and changing requirements. On May 25, 2018

26


the GDPR will go into effect, which imposes additional obligations and risk upon our business and which increases substantially the penalties to which we could be subject in the event of any non-compliance. The GDPR requires companies to satisfy new requirements regarding the handling of personal data, including its use, protection and the rights of affected persons regarding their data. Failure to comply with GDPR requirements could result in penalties of up to 4% of worldwide revenue. The GDPR and other similar laws and regulations, as well as any associated inquiries or investigations or any other government actions, may be costly to comply with, result in negative publicity, increase our operating costs, require significant management time and attention, and subject us to remedies that may harm our business, including finds or demands or orders that we modify or cease existing business practices. The company is evaluating its processes and taking measures to ensure compliance with the GDPR. Due to the lack of experience with the interpretation of this new regulation and its enforcement some measures initially might not satisfy the best practices that will be established in the coming years. As personal data is processed using information technology, the risks disclosed with respect to “Security breaches and other disruptions” apply accordingly.

Risks Related to Our Common Stock

We have anti-takeover defenses that could make it more difficult for a third party to acquire a majority of our outstanding voting stock, which could cause the market price of our Common Stock to decline

Various provisions of our articles of incorporation and bylaws, as well as the Michigan Business Corporation Act (the “MBCA”), could have the effect of discouraging, delaying or preventing a third party from accumulating a large block of our capital stock, engaging in a tender offer and making offers to acquire us, and of inhibiting a change in control, all of which could adversely affect our shareholders’ ability to receive a premium for their shares in connection with any such transaction. For example, our Articles of Incorporation authorize our Board of Directors (our “Board”) to issue up to 4,991,000 shares of Preferred Stock and to determine the price, rights (including conversion rights), preferences and privileges of those shares without any further vote or action by the shareholders.   If we issue preferred stock in the future that has preference over our Common Stock with respect to the payment of dividends or upon our liquidation, dissolution or winding up, or if we issue preferred stock with voting rights that dilute the voting power of our Common Stock, the rights of holders of our Common Stock or the market price of our Common Stock could be adversely affected.

Consistent with this authority, in January 2009 our Board adopted a Shareholder Rights Plan (as amended the “Rights Plan”) in which one purchase right was distributed as a dividend on each share of Company Common Stock held of record as of the close of business on February 10, 2009 (the “Rights”). If exercisable, each Right will entitle its holder to purchase from the Company one one-thousandth of a share of a newly created Series B Preferred Stock of the Company for $20.00 (the “Purchase Price”). The Rights will become exercisable if any person or group becomes the beneficial owner of 15% or more of the Company’s Common Stock or has commenced a tender or exchange offer which, if consummated, would result in any person or group becoming the beneficial owner of 15% or more of the Company’s Common Stock. If any person or group becomes the beneficial owner of 15% or more of the Company’s Common Stock, each right will entitle its holder, other than the acquiring person, to purchase a number of shares of the Company’s or, in the case of a merger or change in control in favor of the acquirer,  the acquirer’s Common Stock having a value of twice the Purchase Price.

The Rights are deemed attached to the certificates representing outstanding shares of Common Stock.  The Rights Plan is designed to assure that all of our shareholders receive fair and equal treatment in the event of any proposed takeover of the Company and to guard against partial tender offers, open market accumulations and other abusive or coercive tactics without paying shareholders a control premium.  The Rights Plan may have anti-takeover effects by discouraging potential proxy contests and other takeover methods, particularly those that have not been negotiated with the Board, and the Rights Plan may also inhibit the acquisition of a controlling position in our Common Stock.  Therefore, transactions may not occur that shareholders would otherwise support and/or from which they would receive a substantial premium for their shares over the current market price.  The Rights Plan may also make it more difficult to remove members of the current Board or management.  

In addition, the anti-takeover provisions of Michigan law impose various impediments to the ability of a third party to acquire control of Gentherm, even if a change of control would be beneficial to our existing shareholders.  For example, the Company is subject to Chapter 7A of the MBCA, which prohibits us from engaging in a business combination with an interested shareholder for a period of five years after the person becomes an interested shareholder, unless certain conditions are satisfied.  

We are currently prohibited from making dividend payments on our Common Stock. Furthermore, we do not anticipate paying

27


dividends on our Common Stock in the future

Our bank credit facilities generally prohibit payment of dividends on our Common Stock so long as such facilities are outstanding. We have never paid any cash dividends on our Common Stock and do not anticipate paying dividends in the near future.

The price of our Common Stock may fluctuate significantly

The price of our Common Stock on the NASDAQ Global Select Market may fluctuate significantly in response to many factors, including:

general market and economic conditions;

actual or anticipated variations in our quarterly operating results due to such factors as acceptance of our product by automotive manufacturers and consumers, timing of our product introductions, availability and pricing of components from third parties, competition, timing of orders, foreign currency exchange rates, new product development, material acquisitions or dispositions, technological changes, resources spent on litigation activities and economic conditions generally;

changes in earnings guidance by us or earnings estimates by securities analysts with respect to us;

publication of research reports about us, the automotive industry generally or automotive component industry, and recommendations by securities or financial analysts with respect to us or other automotive suppliers;

adverse market reaction to the amount of our outstanding debt at any time, the amount of our maturing debt in the near and medium term and our ability to refinance such debt and the terms thereof or our plans to incur additional debt in the future;

the ability of our customers to pay us and meet their other obligations to us under current contract terms and our ability to hold and expand our customer base;

changes in market valuations of similar companies;

adverse market reaction to any securities we may register or issue or additional debt we incur in the future;

additions or departures of key management personnel;

actions by institutional shareholders;

speculation in the press or investment community;

continuing high levels of volatility in the capital and credit markets; and

the realization of any of the other risk factors included in, or incorporated by reference to, this Report on Form 10-K.

Many of the factors listed above are beyond our control. These factors may cause the market price of our Common Stock to decline, regardless of our financial performance and condition and prospects. It is impossible to provide any assurance that the market price of our Common Stock will not fall in the future, and it may be difficult for holders to resell shares of our Common Stock at prices they find attractive, or at all. We expect that the market price of our Common Stock will continue to fluctuate. In addition, the stock market in general has experienced extreme volatility that has often been unrelated to the operating performance of a particular company. These broad market fluctuations may materially and adversely affect the market price of our Common Stock.

Our shareholders may experience dilution if we issue additional equity securities

Subject to the limitations set forth in our Articles of Incorporation, we are not restricted from issuing additional shares of our Common Stock or preferred stock, including securities convertible or exchangeable for, or that represent the right to receive, Common Stock or preferred stock.  In most circumstances, common shareholders will not be entitled to vote on whether or not we issue additional equity securities.  Future issuances of Common Stock will reduce the percentage of our Common Stock owned by shareholders who do not participate in such issuances.  In addition, depending on the terms and pricing of additional offerings of our Common Stock and the value of our assets, our shareholders may experience dilution in the book value and fair value of their shares.  The market price of our Common Stock could decline as a result of sales of substantial amounts of additional shares of our Common

28


Stock in the public market or in connection with future acquisitions, or the perception that such sales could occur. This could also impair our ability to raise additional capital through the sale of equity securities at a time and price favorable to us.

ITEM 1B.

UNRESOLVED STAFF COMMENTS

None.

ITEM 2.

PROPERTIES

The following table presents the Company’s significant properties currently in use:

Facility

 

Location

 

Purpose

 

Segment

 

Sq.
Footage

 

 

Owned
or leased

 

Monthly Rent

 

 

Lease
Expiration

 

Gentherm Headquarters

 

Northville, MI U.S.A.

 

Corporate headquarters

 

Automotive

 

 

82,000

 

 

Owned

 

$

 

 

 

Gentherm North America

 

Farmington Hills, MI U.S.A.

 

Research and development

 

Automotive and Industrial

 

 

44,000

 

 

Owned

 

$

 

 

 

Gentherm North America

 

Irvine, CA U.S.A.

 

Research and development

 

Industrial

 

 

21,000

 

 

Leased

 

$

26,200

 

 

June 30, 2018

 

Gentherm Research Facility

 

Azusa, CA U.S.A.

 

Research and development

 

Industrial

 

 

12,200

 

 

Leased

 

$

9,800

 

 

July 1, 2022

 

Gentherm Materials Research Facility

 

Azusa, CA U.S.A.

 

Materials research and development

 

Industrial

 

 

   10,100

 

 

Leased

 

$

11,800

 

 

October 31, 2020

 

CSZ Headquarters

 

Cincinnati, OH U.S.A.

 

CSZ headquarters

 

Industrial

 

 

265,300

 

 

Owned

 

$

 

 

 

Gentherm GmbH

 

Odelzhausen, Germany

 

Customer service center

 

Automotive

 

 

170,600

 

 

Owned

 

$

 

 

 

Gentherm Hungary

 

Pilisszentivan, Hungary

 

Customer service center and warehouse

 

Automotive

 

 

298,700

 

 

Owned

 

$

 

 

 

Gentherm Ukraine

 

Vinogradov, Ukraine

 

Manufacturing and warehouse

 

Automotive

 

 

209,500

 

 

Owned

 

$

 

 

 

Gentherm Macedonia

 

Prilep, Macedonia

 

Manufacturing

 

Automotive

 

 

111,400

 

 

Owned

 

$

 

 

 

Gentherm China

 

Langfang, China

 

Manufacturing

 

Automotive

 

 

279,900

 

 

Owned

 

$

 

 

 

Gentherm Asia Electronics

 

Shenzhen, China

 

Manufacturing

 

Automotive

 

 

74,400

 

 

Leased

 

$

54,800

 

 

December 31, 2019

 

Gentherm Vietnam

 

Ha Nam, Vietnam

 

Manufacturing

 

Automotive

 

 

245,300

 

 

Owned

 

$

 

 

 

Gentherm Mexico

 

Acuña, Mexico

 

Manufacturing

 

Automotive

 

 

101,100

 

 

Leased

 

$

27,900

 

 

June 1, 2020

 

Gentherm Mexico

 

Acuña, Mexico

 

Manufacturing

 

Automotive

 

 

101,100

 

 

Leased

 

$

44,700

 

 

July 1, 2020

 

Gentherm Mexico

 

Celaya, Mexico

 

Manufacturing

 

Automotive

 

 

143,700

 

 

Leased

 

$

65,300

 

 

October 1, 2025

 

Global Power Technologies

 

Calgary, Canada

 

GPT headquarters

 

Industrial

 

 

61,400

 

 

Leased

 

$

50,400

 

 

January 31, 2026

 

Global Power Technologies

 

Bassano, Canada

 

Manufacturing

 

Industrial

 

 

36,000

 

 

Owned

 

$

 

 

 

Etratech Canada

 

Burlington, Canada

 

Etratech headquarters manufacturing

 

Automotive

 

 

46,000

 

 

Leased

 

$

23,100

 

 

November 30, 2022

 

Etratech Shenzhen

 

Shenzhen, China

 

Manufacturing

 

Automotive

 

 

49,300

 

 

Leased

 

$

24,600

 

 

November 30, 2022

 

ITEM 3.

LEGAL PROCEEDINGS

We are subject to litigation from time to time in the ordinary course of our business, however, there is no current material pending litigation to which we are a party and no material legal proceedings were terminated, settled or otherwise resolved during the fourth quarter of the fiscal year ended December 31, 2017.2023.

ITEM 4. MINE SAFETY DISCLOSURES.

ITEM 4.

MINE SAFETY DISCLOSURES.

Not applicable.

32


PART II

ITEM 5. MARKET FOR THE REGISTRANT’S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

29


PART II

ITEM 5.

MARKET FOR THE REGISTRANT’S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our Common Stock trades on the NASDAQNasdaq Global Select Market under the symbol “THRM.” The following table sets forth the high and low sale prices for our Common Stock as reported on the NASDAQ Global Select Market for each quarterly period from January 1, 2016 through December 31, 2017.

 

  

High

 

  

Low

 

2016

  

 

 

 

  

 

 

 

1st Quarter

  

$

45.55

  

  

$

36.23

  

2nd Quarter

  

 

44.23

  

  

 

31.37

  

3rd Quarter

  

 

38.00

  

  

 

30.13

  

4th Quarter

  

 

35.95

  

  

 

27.40

  

2017

  

 

 

 

  

 

 

 

1st Quarter

  

$

39.25

  

  

$

33.15

  

2nd Quarter

  

 

39.45

  

  

 

34.65

  

3rd Quarter

  

 

40.70

  

  

 

29.90

  

4th Quarter

  

 

37.55

  

  

 

31.75

  

Holders

As of February 22, 2018,15, 2024, our Common Stock was held by 74 stockholders39 shareholders of record. A substantially greater number of holders are beneficial owners whose shares of record are held by banks, brokers and other nominees.

Dividends

We have not paid any Common Stock cash dividends since formation, and we do not expect to pay any in the foreseeable future. The payment of future dividends is within the discretion of our Board of Directors and will depend upon business conditions, our earnings and financial condition and other factors. Currently, our bank credit facilities limit payment of dividends on our Common Stock.

Stock Repurchase Program

OnIn December 16, 2016,2020, the Board of Directors authorized a three-year, $100 million stock repurchase program. Underprogram (the “2020 Stock Repurchase Program”). pursuant to which the Company is authorized to repurchase up to $150 million of its issued and outstanding Common Stock over a three-year period, expiring December 15, 2023. On November 1, 2023, the Board of Directors extended the maturity date of the program wefrom December 15, 2023 to June 30, 2024.

On November 1, 2023, following the above-noted extension, the Company entered into a Confirmation of Issuer Forward Repurchase Transaction agreement (the “ASR Agreement”) with Bank of America, N.A. (“Bank of America”) that provides for the Company to purchase shares of Common Stock in an aggregate amount of $60 million (the “ASR Repurchase Amount”) under the 2020 Stock Repurchase Program. See Note 15, “Equity,” to the consolidated financial statements included in this Annual Report for additional information.

Repurchases under the 2020 Stock Repurchase Program may repurchase,be made, from time to time, our common stock in amounts and at prices as we deemthe Company deems appropriate, taking into accountsubject to market conditions, applicable legal requirements, debt covenants and other considerations. The number of shares repurchased and the time of theAny such repurchases under the stock repurchase program will be determined by our management. Repurchases may be made on theexecuted using open market or inpurchases, privately negotiated transactions. Repurchases may also be made under aagreements or other transactions (including Rule 10b5-1 plan, which would permit shares totrading plans), and may be repurchased when we might otherwise be precludedfunded from doing so under securities laws.cash on hand, available borrowings or proceeds from potential debt or other capital markets sources. The authorization of this stock repurchase program does not require we repurchase any specific dollar value or number of shares and2020 Stock Repurchase Program may be modified, extended or terminated by our Board of Directors at any time. No repurchases were madetime without prior notice.

33


Issuer Purchases of Equity Securities During Fourth Quarter 2023

Period

 

(a)
Total Number of Shares Purchased

 

 

Average Price
Paid Per Share

 

 

(a)
Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs

 

 

(a)
Approximate Dollar Value of Shares That May Yet Be Purchased Under the 2020 Stock Repurchase Program

 

October 1, 2023 to October 31, 2023

 

 

33,437

 

 

$

42.35

 

 

 

33,437

 

 

$

97,490,518

 

November 1, 2023 to November 30, 2023 (b)

 

 

1,224,490

 

 

 

39.20

 

 

 

1,224,490

 

 

 

37,490,518

 

December 1, 2023 to December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

37,490,518

 

(a)
On November 2, 2023, pursuant to the ASR agreement, we paid $60 million to Bank of America for an initial purchase of approximately 1.22 million shares of Common Stock, representing 80% of ASR Repurchase Amount. The final settlement date is scheduled to occur no later than the second quarter of 2024 and may end earlier at the option of Bank of America. As of the final settlement date, Bank of America may be required to deliver additional shares of Common Stock to the Company or the Company may be required to deliver shares of Common Stock to Bank America, such that the Company’s repurchase of Common Stock under the stock repurchase programASR Agreement in aggregate will equal the ASR Repurchase Amount (based on the average of the daily volume-weighted average prices of the Common Stock during the fourth quarterterm of 2017. Total repurchases to date under this program through February 22, 2018 were $5.2 million at anthe ASR Agreement, less a specified discount).
(b)
The average price paid per share represents the price used in calculating the initial delivery of $32.39shares under the ASR. The final price per share.share will be based on the average of the daily volume-weighted average prices of the Common Stock during the term of the ASR Agreement, less a specified discount.

34


Performance graph

30


ITEM 6.

SELECTED FINANCIAL DATA

The following table sets forth selected financial data and should be readgraph reflects the comparative changes in conjunction with the consolidated financial statementsvalue from December 31, 2018 through December 31, 2023, assuming an initial investment of $100 and the notes thereto, as well as Item 7 “Management’s Discussionreinvestment of dividends, if any, in (1) our Common Stock, (2) the NASDAQ Composite index, (3) the Russell 2000 Index and Analysis(4) the Dow Jones U.S. Auto Parts Index. Historical performance may not be indicative of Financial Condition and Results of Operations” included in this Report.future shareholder returns.

img34360860_0.jpg 

 

 

 

 

 

As of December 31,

 

 

 

 

 

 

2019

 

 

2020

 

 

2021

 

 

2022

 

 

2023

 

Gentherm Incorporated

 

$

100.00

 

 

$

111.03

 

 

$

163.12

 

 

$

217.36

 

 

$

163.31

 

 

$

130.97

 

NASDAQ Composite

 

$

100.00

 

 

$

136.69

 

 

$

198.10

 

 

$

242.03

 

 

$

163.28

 

 

$

236.17

 

Russell 2000

 

$

100.00

 

 

$

125.52

 

 

$

150.58

 

 

$

172.90

 

 

$

137.56

 

 

$

160.85

 

Dow Jones US Auto Parts

 

$

100.00

 

 

$

127.43

 

 

$

149.74

 

 

$

181.18

 

 

$

133.28

 

 

$

133.22

 

ITEM 6. RESERVED

 

 

Year Ended December 31,

 

 

 

(In thousands except per share data)

 

 

 

2017

 

 

2016

 

 

2015

 

 

2014

 

 

2013

 

Product revenues

 

$

985,683

 

 

$

917,600

 

 

$

856,445

 

 

$

811,300

 

 

$

662,082

 

Operating income

 

 

97,324

 

 

 

106,119

 

 

 

121,319

 

 

 

98,434

 

 

 

50,384

 

Net income

 

 

35,227

 

 

 

76,598

 

 

 

95,393

 

 

 

70,119

 

 

 

35,133

 

Income (loss) attributable to non-controlling interest

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,313

 

Net income attributable to Gentherm Incorporated

 

 

35,227

 

 

 

76,598

 

 

 

95,393

 

 

 

70,119

 

 

 

33,820

 

Convertible preferred stock dividends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,622

 

Net income attributable to common shareholders

 

 

35,227

 

 

 

76,598

 

 

 

95,393

 

 

 

70,119

 

 

 

32,198

 

Basic earnings per share

 

 

0.96

 

 

 

2.10

 

 

 

2.65

 

 

 

1.98

 

 

 

0.96

 

Diluted earnings per share

 

 

0.96

 

 

 

2.09

 

 

 

2.62

 

 

 

1.95

 

 

 

0.94

 

35


ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

 

As of December 31,

 

 

 

(In thousands)

 

 

 

2017

 

 

2016

 

 

2015

 

 

2014

 

 

2013

 

Working capital(a)(b)

 

$

289,754

 

 

$

295,130

 

 

$

270,320

 

 

$

187,432

 

 

$

116,786

 

Total assets(b)

 

 

883,405

 

 

 

843,030

 

 

 

648,343

 

 

 

555,911

 

 

 

482,564

 

Long term obligations

 

 

158,216

 

 

 

189,002

 

 

 

118,596

 

 

 

112,465

 

 

 

96,683

 

Accumulated earnings

 

 

293,645

 

 

 

256,922

 

 

 

180,324

 

 

 

84,931

 

 

 

14,812

 

a)

Represents current assets less current liabilities.

b)

Total assets for all prior periods presented have been adjusted to conform with the current year presentation. Working capital and total assets for the years ended December 31, 2017, 2016 and 2015 reflect the noncurrent presentation of deferred tax liabilities and assets, as well as related valuation allowance. For the years ended December 31, 2014 and 2013, working capital and total assets include $6,247 and $10,616, respectively, in current deferred tax assets and $0, and $710, respectively, in current deferred tax liabilities.

ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our consolidated financial statements (and notes related thereto) and other more detailed financial information appearing elsewhere in this Annual Report. Further, you should read the following discussion and analysis of our financial condition and results of operations together with the “Risk Factors” included elsewhere in this Annual Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. See also “Forward-Looking Statements” in Item 1Part I of this Annual Report.

Overview

Gentherm Incorporated is athe global technology and industrymarket leader in the design, development, and manufacturing of innovative thermal management technologies.  Our products provide solutionsand pneumatic comfort technologies for the automotive passenger comfortindustry and convenience, battery thermal management, remote power generation,a leader in medical patient temperature management, environmental product testingmanagement. Automotive products include variable temperature Climate Control Seats® (“CCS”), heated automotive interior systems (including heated seats, steering wheels, armrests and other consumercomponents), battery performance solutions, cable systems, lumbar and industrial temperature control needs.massage comfort solutions, fuel management valves and other valves for brake and engine systems, and other electronic devices. Our automotive products can be found on the vehicles ofmanufactured by nearly all the major automotiveoriginal equipment manufacturers ("OEMs") operating in North America and Europe, and several major OEMs in Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilitiescapabilities. Medical products include patient temperature management systems. Our medical products can be found in hospitals throughout the world, primarily in the U.S., China, Germany and to identify future thermal technology product opportunities in both automotive and other markets.   We concentrate our research on the developmentBrazil. The Company is also developing a number of new technologies and products that will help enable improvements to existing products, improve health, wellness and patient outcomes and will lead to new product applications for existing and new and adjacent markets.

Our Automotive sales are driven by the number of vehicles produced by the OEMs, which is ultimately dependent on consumer demand for automotive vehicles, our product content per vehicle, and other factors that may limit or otherwise impact production by us, our supply chain and our customers. Historically, new vehicle demand and product content (i.e. vehicle features) have been driven by macroeconomic and other factors, such as interest rates, automotive manufacturer and dealer sales incentives, fuel prices, consumer confidence, employment levels, income growth trends and government and tax incentives. Vehicle content has also been driven by trends in consumer preferences, such as preferences for smart devices and features, personalized user experience, and comfort, health and wellness. Economic volatility or weakness in North America, Europe or Asia, as well as global geopolitical factors, have had and could result in a significant reduction in automotive sales and production by our customers, which have had and would have an adverse effect on our business, results of operations and financial condition. We believe our diversified OEM customer base and geographic revenue base, along with our flexible cost structure, have well positioned us to withstand the impact of industry downturns and benefit from existing technologiesindustry upturns in the ordinary course. However, shifts in the mix of global automotive production to higher cost regions or to vehicles that contain less of our product content as well as continuing production challenges and inflationary pressures could adversely impact our profitability. In addition, we may be adversely impacted by volatility or weakness in markets for hybrid or electric vehicles specifically. We believe our products offer certain advantages for hybrid and electric vehicles, including improved energy efficiency, and position us well to withstand changes in the volume mix between vehicles driven by internal combustion engines and hybrid and other electric vehicles. We believe our industry is increasingly progressing towards a focus on human comfort and health and wellness, which is evidenced by increasing adoption rates for comfort products. We believe that products we are developing, such as ClimateSense®, WellSense™ and our acquisition of Alfmeier’s pneumatic comfort solutions, position us well to address trends in consumer preferences such as personalized user experience, comfort, health and wellness.

Recent Trends

Global Conditions

Since 2020, the global economy has experienced significant volatility and supply chain disruption, which has had a widespread adverse effect on the global automotive industry. These macroeconomic conditions have resulted in fluctuating demand and production disruptions, facility closures, labor shortages and work stoppages. In addition, global inflation has increased significantly beginning in 2021. Although supply chain conditions have steadily improved and certain inflationary pressures have moderated throughout fiscal year 2023, rising costs of materials, labor, equipment and other inputs used to manufacture and sell our products, including freight and logistics costs, have impacted, and may in the future impact, operating costs and operating results. We continue

36


to employ measures to mitigate the impact of cost increases through identification of sourcing and manufacturing efficiencies where possible. However, we have been unable to fully mitigate or pass through the increases in our operating costs, which may continue in the future.

We are exposed to foreign currency risk due to the translation and remeasurement of the results of certain international operations into U.S. Dollars as part of the consolidation process. Therefore, fluctuations in foreign currency exchange rates can create volatility in the results of operations and may adversely affect our financial condition.

We have a global manufacturing footprint that enables us to serve our customers in the regions they operate and shift production between regions to remain competitive. Throughout the year there have been various ongoing geopolitical conflicts, such as the current conflicts between Russia and Ukraine, and between Israel and Hamas, heightened tensions in the Red Sea, and potential tensions in the South China Sea. These conflicts have interrupted ocean freight shipping and if prolonged or intensified, could have a substantial adverse effect on our financial results. We, like other manufacturers, have a high proportion of fixed structural costs, and therefore relatively small changes in industry vehicle production can have a substantial effect on our financial results. If industry vehicle sales were to decline to levels significantly below our planning assumption, the decline could have a substantial adverse effect on our financial condition, results of operations, and cash flow.

In the second half of 2023, several North American OEMs experienced union-led labor strikes at certain of their facilities. As the automotive industry relies heavily on “just-in-time” delivery of components, these strikes led to labor shortages, work stoppages and other related disruptions. These disruptions limited the purchases of our products, which resulted in an insignificant impact on product revenues; however, any such future strikes could have a significant negative impact on our business.

Despite these various challenges, global light vehicle production in 2023 in the Company’s key markets of North America, Europe, China, Japan and market opportunitiesKorea, increased 11.4% as compared to 2022, according to the forecasting firm S&P Global Mobility (February 2024 release).

On December 15, 2022, the European Union (“EU”) Member States formally adopted the EU’s Pillar Two Directive, which generally provides for a wide arrayminimum effective tax rate of thermal management solutions.  

31


Etratech

On November 1, 2017, we acquired substantially all15%, as established by the Organization for Economic Co-operation and Development Pillar Two Framework. The effective dates for different aspects of the assetsdirective are January 1, 2024, and assumed substantially allJanuary 1, 2025. Upon adoption of this directive, the Company does not expect it to have a material impact to the Company’s financial statements. The Company will continue to evaluate the potential impact on future periods of these tax regulations.

Fit-for-Growth 2.0

During the first half of 2023, the Company launched Fit-for-Growth 2.0 to execute our long-term growth strategy. Fit-for-Growth 2.0 is expected to deliver significant cost reductions through sourcing excellence, value engineering, manufacturing productivity, manufacturing footprint optimization, product profitability and cost synergies from the Alfmeier acquisition. Additionally, the program is intended to drive operating expense efficiency to leverage scale.

Acquisitions

On July 13, 2022, the Company completed the acquisition of Jiangmen Dacheng Medical Equipment Co. Ltd (“Dacheng”) and its wholly owned subsidiary, IOB Medical, Inc. Dacheng is a manufacturer of medical materials and medical equipment, including patient temperature management solutions, for numerous local and international customers. The acquisition provided Gentherm Medical a local presence in China’s high-growth market for patient warming devices and other medical device products, and expanded overall manufacturing capacity to include a low-cost manufacturing site. The total consideration transferred was $35.0 million.

On August 1, 2022, the Company acquired 100% of the operating liabilitiesequity interests of Etratech Inc.Alfmeier Präzision SE (“Alfmeier”), an Ontario corporationa global leader in automotive lumbar and allmassage comfort solutions and a leading provider of advanced valve systems, integrated electronics and software. The acquisition further expanded the outstanding shares  of Etratech Hong Kong, an entity organized under the laws of Hong Kong,Company's value proposition beyond thermal in an all-cash transaction.  Etratech manufactures advanced electronic controlscomfort, health, wellness, and control systemsenergy efficiency and aligned well with global consumer demand for the automotive, RV and marine, security, medical and other industries. Etratech’s world headquarters and North American manufacturing operations are locatedexpanded offerings in Burlington, Canada. vehicle passenger comfort. The total consideration for this acquisition was $170.7 million.

See Note 4, “Acquisitions” of the consolidated financial statements included in this Annual Report for additional information.

37


Impairments – Non-Automotive Electronics Business

On December 31, 2022, the Company approved a plan to exit its non-automotive electronics business to strengthen the Company’s core business and focus its resources and equipment with businesses and investments that are more strategic and profitable. As of December 31, 2023, the Company has substantially completed the exit of this business.

During the year ended December 31, 2023, the Company recorded non-cash impairment charges of $6.1 million for the write down of inventory within the Automotive segment. This charge is recorded in Cost of sales.

During the year ended December 31, 2022, the Company recorded non-cash impairment charges of $9.4 million, $5.6 million and $0.7 million for write downs of inventory, intangible assets and property and equipment, respectively, within the Automotive segment.

Impairments - Medical Segment

As of December 31, 2022, the estimated fair value of the Medical reporting unit exceeded its carrying value by less than 10%. During the second quarter of 2023, the Company’s Medical reporting unit did not perform in-line with forecasted results primarily driven by slower than anticipated revenue growth. As a result, an indicator of impairment was identified and the Company performed an interim quantitative assessment as of June 30, 2023. The results of this quantitative analysis indicated the carrying value of the reporting unit exceeded the fair value, and accordingly, an impairment expense was recorded for $19.5 million.

The primary factors leading to the decline in value from the analysis performed at December 31, 2022 were a reduction in expected future cash flows, due to the Company re-evaluating its forecasted results and an increase in the discount rate that is based on the Medical reporting unit’s weighted average cost of capital. The decline in expected future cash flows resulted primarily from a reduction of forecasted revenue growth rates. If the Company’s revised expectation of revenue growth is not achieved or if the estimated growth rates are reduced because of new information or experience, the fair value of the Medical reporting unit could decrease, which could result in further impairment of goodwill. No further impairment was recorded as of December 31, 2023.

2023 Manufacturing Footprint Rationalization

On September 19, 2023, the Company committed to a restructuring plan (“2023 Plan”) to improve the Company’s manufacturing productivity and rationalize its footprint. Under this 2023 Plan, the Company will relocate certain existing manufacturing and related activities in its Greenville, South Carolina facility to a new facility in Monterrey, Mexico.

The Company expects to incur total costs of between $12 million and $16 million, of which between $11 million and $15 million are expected to be cash expenditures. The actions under the 2023 Plan are expected to be substantially completed by the end of 2025 and generate annual benefits of between $5 million and $6 million. The actual timing, costs and savings of the 2023 Plan may differ materially from the Company’s current expectations and estimates. During the year ended December 31, 2023, the Company recognized restructuring expense of $0.5 million for employee separation costs and $0.2 million for other costs.

See Note 5, “Restructuring and Impairments” to the consolidated financial statements included in this Annual Report for additional information regardingrelated to this plan.

Light Vehicle Production Volumes

Our sales are driven by the acquisitionnumber of Etratech.  vehicles produced by the automotive manufacturers, which is ultimately dependent on consumer demand for automotive vehicles, and our content per vehicle, and other factors that may limit or otherwise impact production by us, our supply chain and our customers. According to the forecasting firm S&P Global Mobility (February 2024 release), global light vehicle production in 2023 in the Company’s key markets of North America, Europe, China, Japan and Korea, as compared to 2022, are shown below (in millions of units):

 

 

2023

 

 

2022

 

 

% Change

 

North America

 

 

15.7

 

 

 

14.3

 

 

 

9.7

 %

Europe

 

 

17.9

 

 

 

15.8

 

 

 

12.9

 %

Greater China

 

 

29.0

 

 

 

26.4

 

 

 

10.0

 %

Japan / South Korea

 

 

12.8

 

 

 

11.1

 

 

 

14.6

 %

Total light vehicle production volume in key markets

 

 

75.4

 

 

 

67.7

 

 

 

11.4

 %

Cincinnati Sub-Zero

On April 1, 2016, we acquired all38


The S&P Global Mobility report (February 2024 release) forecasted light vehicle production volume in the Company’s key markets for full year 2024 to decrease to 75.0 million units, a 0.5% decrease from full year 2023 light vehicle production volumes. Forecasted light vehicle production volumes are a component of the equitydata we use in forecasting future business. However, these forecasts generally are updated monthly, and future forecasts have been and may continue to be significantly different from period to period due to changes in macroeconomic conditions or matters specific to the automotive industry. Further, due to differences in regional product mix at our manufacturing facilities, as well as material production schedules from our customers for our products on specific vehicle programs, our future forecasted results do not directly correlate with the global and/or regional light vehicle production forecasts of privately-held CSZS&P Global Mobility or other third-party sources.

New Business Awards

We believe that innovation is an important element to gaining market acceptance of our products and related assets instrengthening our market position. During 2023, we secured an all-cash transaction.  CSZ manufactures both high quality patient temperature management systemsestimated $2,630 million of automotive new business awards, which set a new record of annual new business awards for the health care industry and custom testing equipment usedCompany. Automotive new business awards represent the aggregate projected lifetime revenue of new awards provided by a wide range of industrial manufacturing companies for product testing.  CSZ’s world headquarters and manufacturing operations are locatedour customers to Gentherm in Cincinnati, Ohio. See Note 17 to the consolidated financial statements for additional information regarding the acquisition of CSZ.  

North American Reorganization

On January 4, 2016 and January 5, 2016, the Company completed reorganization transactions (the “Reorganization”) related to our North American business (the “Windsor Operations”).  As part of our original integration plan to eliminate redundancies associatedapplicable period, with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG),value based on the Windsor Operations have been consolidated into our existing Europeanprice and North American facilities.  As a resultvolume projections received from each customer as of the Reorganization, someaward date. Although automotive new business awards are not firm customer orders, we believe that new business awards are an indicator of thefuture revenue. New business activities previously performed by the Windsor Operationsawards are now being performed by other subsidiaries.

Related to the Reorganization, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agencynot projections of $7,600,000 during 2016.  Additionally, the Company incurred income tax expense of $2,500,000 related to the intercompany dividends. These amounts incurred are expected to cover allrevenue or future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.

In addition to the $7,600,000 of withholding tax and $2,500,000 of income taxes, the Reorganization required the Company to make a one-time income tax payment of approximately $32,600,000.  The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. The withholding tax payment was paid entirely in 2016. The income tax payments of $2,500,000 and $32,600,000 that were included in the accrued liabilitiesbusiness as of December 31, 2016, were paid during2023, the first halfdate of 2017.this Annual Report or any other date. Customer projections regularly change over time, and we do not update our calculation of any new business award after the date initially communicated. Automotive new business awards in 2023 also do not reflect, in particular, the impact of macroeconomic and geopolitical challenges on future business. Revenues resulting from automotive new business awards also are subject to additional risks and uncertainties as described in Item 1 under “Forward-Looking Statements” of this Annual Report.

Reportable Segments

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial.  Medical.

See Note 1119, “Segment Reporting,” to the consolidated financial statements included in this Annual Report for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income.  The financial information used by

39


Results of Operations Year Ended December 31, 2023 Compared to Year Ended December 31, 2022

This section discusses our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.

Critical Accounting Policies

The discussion and analysis of our financial condition andconsolidated results of operations are based uponfor the year ended December 31, 2023 compared to the year ended December 31, 2022. For a detailed discussion of our consolidated results of operations for the years ended December 31, 2022 compared to the year ended December 31, 2021, see Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operation” under “Results of Operations Year Ended December 31, 2022 Compared to December 31, 2021” in our annual report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 24, 2023.

The results of operations for the years ended December 31, 2023 and 2022, in thousands, were as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Product revenues

 

$

1,469,076

 

 

$

1,204,656

 

 

$

264,420

 

Cost of sales

 

 

1,117,452

 

 

 

931,006

 

 

 

(186,446

)

Gross margin

 

 

351,624

 

 

 

273,650

 

 

 

77,974

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Net research and development expenses

 

 

94,358

 

 

 

85,722

 

 

 

(8,636

)

Selling, general and administrative expenses

 

 

155,579

 

 

 

132,693

 

 

 

(22,886

)

Impairment of goodwill

 

 

19,509

 

 

 

 

 

 

(19,509

)

Impairment of intangible assets and property and equipment

 

 

4,739

 

 

 

637

 

 

 

(4,102

)

Restructuring expenses

 

 

 

 

 

6,291

 

 

 

6,291

 

Total operating expenses

 

 

274,185

 

 

 

225,343

 

 

 

(48,842

)

Operating income

 

 

77,439

 

 

 

48,307

 

 

 

29,132

 

Interest expense, net

 

 

(14,641

)

 

 

(4,294

)

 

 

(10,347

)

Foreign currency loss

 

 

(5,918

)

 

 

(6,778

)

 

 

860

 

Other (loss) income

 

 

(1,926

)

 

 

1,147

 

 

 

(3,073

)

Earnings before income tax

 

 

54,954

 

 

 

38,382

 

 

 

16,572

 

Income tax expense

 

 

14,611

 

 

 

13,941

 

 

 

(670

)

Net income

 

$

40,343

 

 

$

24,441

 

 

$

15,902

 

Product revenues by product category, in thousands, for the years ended December 31, 2023 and 2022 were as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

% Change

 

Climate Control Seat

 

$

482,665

 

 

$

426,046

 

 

 

13.3

%

Seat Heaters

 

 

308,588

 

 

 

283,970

 

 

 

8.7

%

Steering Wheel Heaters

 

 

153,943

 

 

 

120,949

 

 

 

27.3

%

Lumbar and Massage Comfort Solutions (a)

 

 

144,923

 

 

 

56,980

 

 

 

154.3

%

Valve Systems (a)

 

 

106,262

 

 

 

41,980

 

 

 

153.1

%

Automotive Cables

 

 

79,993

 

 

 

76,962

 

 

 

3.9

%

Battery Performance Solutions

 

 

75,484

 

 

 

71,907

 

 

 

5.0

%

Electronics

 

 

40,387

 

 

 

44,106

 

 

 

(8.4

)%

Other Automotive

 

 

30,707

 

 

 

38,716

 

 

 

(20.7

)%

Subtotal Automotive segment

 

 

1,422,952

 

 

 

1,161,616

 

 

 

22.5

%

Medical segment (a)

 

 

46,124

 

 

 

43,040

 

 

 

7.2

%

Total Company

 

$

1,469,076

 

 

$

1,204,656

 

 

 

21.9

%

(a)
Includes product revenues from acquisitions since their respective acquisition dates (see Note 4).

Product Revenues

Below is a summary of our Product revenues, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

Variance Due To:

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

 

 

Automotive Volume

 

 

FX

 

 

Acquisition

 

 

Pricing/ Other

 

 

Total

 

Product revenues

 

$

1,469,076

 

 

$

1,204,656

 

 

$

264,420

 

 

 

$

123,773

 

 

$

879

 

 

$

152,844

 

 

$

(13,076

)

 

$

264,420

 

Product revenues for the year ended December 31, 2023 increased 21.9% as compared to the year ended December 31, 2022. The increase in product revenues is due to favorable volumes in several product lines within the Automotive segment, favorable

40


foreign currency impacts primarily attributable to the Euro, and the inclusion of sales from Alfmeier and Dacheng since the acquisitions, partially offset by lower cost recoveries from customers and unfavorable foreign currency impacts primarily attributable to the Chinese Renminbi, the Korean Won and the Japanese Yen.

Cost of Sales

Below is a summary of our Cost of sales and Gross margin, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

Variance Due To:

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

 

 

Automotive Volume

 

 

FX

 

 

Operational Performance

 

 

Acquisitions and Other

 

 

Total

 

Cost of sales

 

$

1,117,452

 

 

$

931,006

 

 

$

(186,446

)

 

 

$

(74,166

)

 

$

(8,847

)

 

$

52,253

 

 

$

(155,686

)

 

$

(186,446

)

Gross margin

 

 

351,624

 

 

 

273,650

 

 

 

77,974

 

 

 

$

49,607

 

 

$

(7,968

)

 

$

41,235

 

 

$

(4,900

)

 

$

77,974

 

Gross margin - Percentage of product revenues

 

 

23.9

%

 

 

22.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales for the year ended December 31, 2023 increased by 20.0% as compared to the year ended December 31, 2022. The increase in cost of sales is primarily due to increased volumes in our Automotive segment, inflation associated with wages and material costs, non-automotive electronics inventory charges related to the exit of such business, the full inclusion of expenses from the acquired businesses and unfavorable foreign currency impacts primarily attributable to the Mexican Peso and the Euro. These increases were partially offset by lower freight and duties costs, and favorable foreign currency impacts primarily attributable to the Chinese Renminbi and the Ukrainian Hryvnia.

Net Research and Development Expenses

Below is a summary of our Net research and development expenses, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Research and development expenses

 

$

125,692

 

 

$

105,914

 

 

$

(19,778

)

Reimbursed research and development expenses

 

 

(31,334

)

 

 

(20,192

)

 

 

11,142

 

Net research and development expenses

 

$

94,358

 

 

$

85,722

 

 

$

(8,636

)

Percentage of product revenues

 

 

6.4

%

 

 

7.1

%

 

 

 

Net research and development expenses for the year ended December 31, 2023 increased 10% as compared to the year ended December 31, 2022. The increase in net research and development expenses is primarily related to the full inclusion of net expenses from Alfmeier, and increased investments to support new program wins, partially offset by higher customer reimbursements, excluding those from Alfmeier.

Selling, General and Administrative Expenses

Below is a summary of our Selling, general and administrative expenses, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Selling, general and administrative expenses

 

$

155,579

 

 

$

132,693

 

 

$

(22,886

)

Percentage of product revenues

 

 

10.6

%

 

 

11.0

%

 

 

 

Selling, general and administrative expenses for the year ended December 31, 2023 increased 17% as compared to the year ended December 31, 2022. The increase in selling, general and administrative expenses is primarily related to the full inclusion of expenses from acquired businesses and higher compensation expense, partially offset by lower acquisition costs.

41


Impairment of Goodwill

Below is a summary of our Impairment of goodwill, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Impairment of goodwill

 

$

19,509

 

 

$

 

 

$

(19,509

)

Impairment of goodwill is related to the recorded Medical reporting unit goodwill impairment.

Impairment of Intangible Assets and Property and Equipment

Below is a summary of our Impairment of intangible assets and property and equipment, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Impairment of intangible assets and property and equipment

 

$

4,739

 

 

$

637

 

 

$

(4,102

)

Impairment of intangible assets and property and equipment is primarily related to the intangible asset and property and equipment impairment recorded as a result of the Company’s exit of its non-automotive electronics business.

Restructuring Expenses

Below is a summary of our Restructuring expenses, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Restructuring expenses

 

$

 

 

$

6,291

 

 

$

6,291

 

Restructuring expenses primarily relate to the 2023 Plan and other discrete restructuring activities focused on optimizing our manufacturing and engineering footprint and the reduction of global overhead expenses. See Note 5, "Restructuring and Impairments," in the notes to the consolidated financial statements included in this Annual Report for additional information.

Interest Expense

Below is a summary of our Interest expense, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Interest expense, net

 

$

(14,641

)

 

$

(4,294

)

 

$

(10,347

)

The increase in interest expense during the year ended December 31, 2023 compared to 2022 primarily relates to higher interest rates on the revolving credit agreement and larger debt balances throughout the year, as well as less benefit from the change in fair value of the interest rate swap derivative. See Note 9, "Debt," in the notes to the consolidated financial statements included in this Annual Report for additional information.

Foreign Currency Loss

Below is a summary of our Foreign currency loss, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Foreign currency loss

 

$

(5,918

)

 

$

(6,778

)

 

$

860

 

42


Foreign currency loss for the year ended December 31, 2023 included net realized foreign currency gain of $3.2 million and unrealized net foreign currency loss of $9.1 million.

Foreign currency gain for the year ended December 31, 2022 included net realized foreign currency loss of $2.1 million and unrealized net foreign currency loss of $4.7 million.

Other (Loss) Income

Below is a summary of our Other (loss) income, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Other (loss) income

 

$

(1,926

)

 

$

1,147

 

 

$

(3,073

)

The decrease in other income primarily is driven by an impairment in our investment in Carrar Ltd. See Note 2, "Summary of Significant Accounting Policies," in the notes to the consolidated financial statements included in this Annual Report for additional information.

Income Tax Expense

Below is a summary of our Income tax expense, in thousands, for the years ended December 31, 2023 and 2022:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

Favorable /
(Unfavorable)

 

Income tax expense

 

$

14,611

 

 

$

13,941

 

 

$

(670

)

Income tax expense was $14.6 million for the year ended December 31, 2023, on earnings before income tax of $55.0 million, representing an effective tax rate of 26.6%. The effective tax rate differed from the U.S. Federal statutory rate of 21% primarily due to the unfavorable impact of the global intangible low-tax income ("GILTI"), withholding taxes, other non-deductible expenses, the impact of income taxes on foreign earnings at tax rates varying from the U.S statutory tax rate and the tax effect of a goodwill impairment, partially offset by research development credits and prior year adjustments in various jurisdictions.

Income tax expense was $13.9 million for the year ended December 31, 2022, on earnings before income tax of $38.4 million, representing an effective tax rate of 36.3%. The effective tax rate differed from the U.S. Federal statutory rate of 21% primarily due to the unfavorable impact of the GILTI, withholding taxes, other non-deductible expenses and acquisition costs and uncertain tax positions, partially offset by certain favorable tax effects on equity vesting, research and development credits in various jurisdictions and the impact of income taxes on foreign earnings taxed at rates varying from the U.S. statutory rate.

43


Liquidity and Capital Resources

Overview

Our primary sources of liquidity and capital resources are cash flows from operations and borrowings available under our Second Amended and Restated Credit Agreement. Our cash requirements consist principally of working capital, capital expenditures, research and development, operating lease payments, income tax payments and general corporate purposes. We generally reinvest available cash flows from operations into our business, while opportunistically utilizing our authorized stock repurchase program. Further, we continuously evaluate acquisition and investment opportunities that will enhance our business strategies.

As of December 31, 2023, the Company had $149.7 million of cash and cash equivalents and $278.0 million of availability under our Second Amended and Restated Credit Agreement. See Note 13, “Financial Instruments” of the consolidated financial statements included in this Annual Report for details regarding our factoring arrangements. We may issue debt or equity securities, which may provide an additional source of liquidity. However, there can be no assurance equity or debt financing will be available to us when we need it or, if available, the terms will be satisfactory to us and not dilutive to our then-current shareholders.

We continue to expect to be able to move funds between different countries to manage our global liquidity needs without material adverse tax implications, subject to current monetary policies and the terms of the Second Amended and Restated Credit Agreement. We utilize a combination of strategies, including dividends, cash pooling arrangements, intercompany loan repayments and other distributions and advances to provide the funds necessary to meet our global liquidity needs. There are no significant restrictions on the ability of our subsidiaries to pay dividends or make other distributions to Gentherm Incorporated. As of December 31, 2023, the Company’s cash and cash equivalents held by our non-U.S. subsidiaries totaled approximately $125.3 million. If additional non-U.S. cash was needed for our U.S. operations, we may be required to accrue and pay withholding if we were to distribute such funds from non-U.S. subsidiaries to the U.S.; however, based on our current liquidity needs and strategies, we do not anticipate a need to accrue and pay such additional amounts.

We currently believe that our cash and cash equivalents and borrowings available under our Second Amended and Restated Credit Agreement, receivables factoring arrangements, and cash flows from operations will be adequate to meet anticipated cash requirements for at least the next twelve months and the foreseeable future.

Cash and Cash Flows

The table below summarizes our cash activity for each of the last two fiscal years (in thousands):

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Cash and cash equivalents at beginning of period

 

$

153,891

 

 

$

190,606

 

Net cash provided by operating activities

 

 

119,265

 

 

 

14,947

 

Net cash used in investing activities

 

 

(24,123

)

 

 

(239,899

)

Net cash (used in) provided by financing activities

 

 

(106,051

)

 

 

189,927

 

Foreign currency effect on cash and cash equivalents

 

 

6,691

 

 

 

(1,690

)

Cash and cash equivalents at end of period

 

$

149,673

 

 

$

153,891

 

Cash Flows From Operating Activities

Net cash provided by operating activities totaled $119.3 million and $14.9 million for the years ended December 31, 2023 and 2022, respectively. Cash flow provided by operating activities for the year ended December 31, 2023 consisted primarily of net income of $40.3 million, increased by $66.2 million for non-cash charges for depreciation, amortization, stock based compensation, loss on disposition of property and equipment and other, $6.9 million for inventory provisions, and $19.5 million of goodwill impairment, partially offset by non-cash charges of $13.1 million for deferred income taxes and $0.6 million related to changes in assets and liabilities. Cash flow provided by operating activities for the year ended December 31, 2022 consisted primarily of net income of $24.4 million, increased by $51.8 million for non-cash charges for depreciation, amortization, non-cash stock based compensation, and loss on disposition of property and equipment, $15.9 million for inventory provisions, and impairments of intangible assets and property and equipment of $6.3 million related to the planned exit of the non-automotive electronics business, partially offset by non-cash charges of $7.3 million for deferred income taxes and other, and $76.9 million related to changes in assets and liabilities.

44


Cash Flows From Investing Activities

Net cash used in investing activities totaled $24.1 million and $239.9 million for the years ended December 31, 2023 and 2022, respectively. The decrease in usage is primarily attributable to 2022 payments for the Alfmeier and Dacheng acquisitions of $205.5 million, which did not recur, partially offset by the inclusion of a full year of proceeds from deferred purchase price of factored receivables related to Alfmeier during the year ended December 31, 2023 as compared to the year ended December 31, 2022.

Cash Flows From Financing Activities

Net cash used in financing activities totaled $106.1 million for the year ended December 31, 2023 and net cash provided by financing activities totaled $189.9 million for the year ended December 31, 2022. Cash flows used in financing activities for the year ended December 31, 2023 primarily included $91.1 million of cash paid for the repurchase of Common Stock, $72.3 million of debt repayments and $2.9 million paid for employee taxes related to the net settlement of restricted stock units that vested during the year, partially offset by $60.0 million of debt borrowings. Cash flows provided by financing activities for the year ended December 31, 2022 primarily included $207.0 million of debt borrowings to fund acquisitions and $1.7 million of proceeds from the exercise of common stock options, partially offset by $13.1 million of debt repayments and $5.5 million paid for employee taxes related to the net settlement of restricted stock units that vested during the year.

Debt

The following table summarizes the Company’s debt at December 31, 2023 and 2022 (dollars in thousands):

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

 

Interest
Rate

 

 

Principal
Balance

 

 

Interest
Rate

 

 

Principal
Balance

 

Credit Agreement:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Revolving Note (U.S. Dollar denominations)

 

 

6.58

%

 

$

222,000

 

 

 

5.80

%

 

$

232,000

 

Other loans

 

 

3.90

%

 

 

233

 

 

3.89% - 5.21%

 

 

 

2,011

 

Finance leases

 

 

3.53

%

 

 

605

 

 

 

3.57

%

 

 

1,085

 

Total debt

 

 

 

 

 

222,838

 

 

 

 

 

 

235,096

 

Current maturities

 

 

 

 

 

(621

)

 

 

 

 

 

(2,443

)

Long-term debt, less current maturities

 

 

 

 

$

222,217

 

 

 

 

 

$

232,653

 

Credit Agreement

Gentherm, together with certain of its subsidiaries, maintain a revolving credit note (“U.S. Revolving Note”) under its Second Amended and Restated Credit Agreement (the “Second Amended and Restated Credit Agreement”) with a consortium of lenders and Bank of America, N.A. as administrative agent. The Second Amended and Restated Credit Agreement was entered into on June 10, 2022 and amends and restates in its entirety the Amended and Restated Credit Agreement dated June 27, 2019, by and among Gentherm, certain of its direct and indirect subsidiaries, the lenders party thereto and the Agent. The Second Amended and Restated Credit Agreement has a maximum borrowing capacity of $500 million and matures on June 10, 2027. The Second Amended and Restated Credit Agreement contains covenants, that, among other things, (i) prohibit or limit the ability of the borrowers and any material subsidiary to incur additional indebtedness, create liens, pay dividends, make certain types of investments (including acquisitions), enter into certain types of transactions with affiliates, prepay other indebtedness, sell assets or enter into certain other transactions outside the ordinary course of business, and (ii) require that Gentherm maintain a minimum Consolidated Interest Coverage Ratio and a maximum Consolidated Net Leverage Ratio (based on consolidated EBITDA for the applicable trailing four fiscal quarters) as of the end of any fiscal quarter.

Finance Leases

As of December 31, 2023 and 2022, there was $0.6 million and $1.1 million of outstanding finance leases, respectively.

45


Other Sources of Liquidity

Receivable Factoring

The Company is party to receivable factoring agreements with unrelated third parties under which we can sell receivables for certain account debtors, on a revolving basis, subject to outstanding balances and concentration limits. The receivable factoring agreements are transferred in their entirety to the acquiring entities and are accounted for as a sale. Some of the agreements, including those assumed through the acquisition of Alfmeier, have deferred purchase price arrangements. See Note 13, “Financial Instruments” of the consolidated financial statements included in this Annual Report for further details regarding our factoring arrangements.

Material Cash Requirements

The following table summarizes current and long-term material cash requirements as of December 31, 2023, which we expect to fund primarily with operating cash flows.

 

 

Payments Due by Period

 

Material Cash Requirements (in thousands)

 

Total

 

 

Less than 1 year

 

 

1 to 3 years

 

 

3 to 5 years

 

 

More than 5 years

 

Long-term debt obligations (1)

 

$

222,233

 

 

$

233

 

 

$

 

 

$

222,000

 

 

$

 

Operating lease obligations (2)

 

 

27,429

 

 

 

8,533

 

 

 

9,244

 

 

 

3,825

 

 

 

5,827

 

Finance lease obligations (2)

 

 

624

 

 

 

402

 

 

 

222

 

 

 

 

 

 

 

Purchase obligations (3)

 

 

15,645

 

 

 

15,645

 

 

 

 

 

 

 

 

 

 

Capital commitments (4)

 

 

19,307

 

 

 

19,307

 

 

 

 

 

 

 

 

 

 

Other

 

 

150

 

 

 

50

 

 

 

100

 

 

 

 

 

 

 

Total

 

$

285,388

 

 

$

44,170

 

 

$

9,566

 

 

$

225,825

 

 

$

5,827

 

(1)
Long-term debt obligations do not include an amount payable for interest. See Note 9, “Debt,” to the consolidated financial statements included in this Annual Report for additional information.
(2)
See Note 8, “Leases,” to the consolidated financial statements included in this Annual Report for additional information.
(3)
Purchase obligations are comprised of commitments to secure the supply of certain semiconductor chips. We have entered into agreements with various suppliers to reserve the rights to certain semiconductor chips, with volume commitments determined based on our anticipated production requirements. Such agreements provide the Company with priority access to semiconductor chips as they become available, however, these agreements do not guarantee that our suppliers will meet our requested timing and quantity. We have not included amounts for other material and component purchase obligations related to standard recurring purchases of materials for use in our manufacturing operations as these amounts are generally consistent from year to year, closely reflect our levels of production, and are not long-term in nature.
(4)
Capital commitments is comprised of commitments for capital expenditures. Such commitments are typically less than one year.

Other Commitments

In September 2023, the Company committed to a restructuring plan to improve the Company’s manufacturing productivity and rationalize its footprint. As of December 31, 2023, the Company expects to incur total costs of between $12 million and $16 million, of which between $11 million and $15 million are expected to be cash expenditures. See Note 5, “Restructuring and Impairments” to the consolidated financial statements included in this Annual Report for additional information.

In December 2021, the Company committed to make a $5 million investment in Autotech Fund III, L.P., pursuant to a limited partnership agreement. As a limited partner, the Company will periodically make capital contributions toward this total commitment amount over the expected ten year life of the fund. The Company has made contributions of approximately $0.8 million to the Autotech Fund III, LP as of December 31, 2023. Timing of the capital contributions is unknown and therefore amounts have been excluded from the Material Cash Requirements table above.

Capital Expenditures

We anticipate capital expenditures in fiscal year 2024 of approximately $65 million to $75 million. This anticipated spending is higher than prior years due to increased investments for the ramp-up of new capacity including the two new plants as a result of our

46


record new awards. We will continue support organic growth through capacity expansion in our facilities and make capital improvements as necessary. We believe cash on hand, cash generated from operations, and the borrowing capacity available under our Second Amended and Restated Credit Agreement will be sufficient to support our capital expenditures.

Stock Repurchase Program

On December 11, 2020, the Board of Directors authorized the 2020 Stock Repurchase Program, pursuant to which the Company is authorized to repurchase up to $150 million of its issued and outstanding Common Stock over a three-year period, expiring December 15, 2023. On November 1, 2023, the Board of Directors extended the maturity date of the program from December 15, 2023 to June 30, 2024. During the year ended December 31, 2023, the Company repurchased shares under the 2020 Stock Repurchase Program for $92.5 million and have a remaining repurchase authorization of $37.5 million as of December 31, 2023.

Repurchases may be made, from time to time, in amounts and at prices the Company deems appropriate, subject to market conditions, applicable legal requirements, debt covenants and other considerations. Any such repurchases may be executed using open market purchases, privately negotiated agreements or other transactions. Repurchases may be funded from cash on hand, available borrowings or proceeds from potential debt or other capital markets sources.

On November 1, 2023, following the above-noted extension, the Company entered into a Confirmation of Issuer Forward Repurchase Transaction agreement (the “ASR Agreement”) with Bank of America, N.A. (“Bank of America”) that provides for the Company to purchase shares of Common Stock in an aggregate amount of $60 million (“ASR Repurchase Amount”) under the 2020 Stock Repurchase Program.

Under the terms of the ASR Agreement, on November 2, 2023, the Company paid $60 million to Bank of America for an initial purchase of approximately 1.22 million shares of Common Stock, representing 80% of ASR Repurchase Amount. The final settlement date is scheduled to occur no later than the second quarter of 2024 and may end earlier at the option of Bank of America. As of the final settlement date, Bank of America may be required to deliver additional shares of Common Stock to the Company or the Company may be required to deliver shares of Common Stock to Bank America, such that the Company’s repurchase of Common Stock under the ASR Agreement in aggregate will equal the ASR Repurchase Amount (based on the average of the daily volume-weighted average prices of the Common Stock during the term of the ASR Agreement, less a specified discount). There is no cash requirement as of the final settlement date and therefore it is not reflected in the Material Cash Requirements table above.

The ASR Agreement contains provisions customary for agreements of this type, including the mechanisms to determine the number of shares of Common Stock that will be delivered at settlement, the required timing of delivery of the shares of Common Stock, the circumstances under which Bank of America is permitted to make adjustments to the transaction terms, the circumstances under which the ASR Agreement may be accelerated, extended or terminated early by Bank of America and specified representations and warranties of each party to the other party.

For further information related to our stock repurchase program, see Note 15, "Equity" in the notes to the consolidated financial statements included in this Annual Report.

Effects of Inflation

The automotive component supply industry has historically been subject to inflationary pressures with respect to materials and labor. Since 2021, the automotive industry has experienced a period of significant volatility in the costs of certain materials and components, labor and transportation. Although supply chain conditions have steadily improved and certain inflationary pressures have moderated throughout fiscal year 2023, rising costs of materials, labor, equipment and other inputs used to manufacture and sell our products, including freight and logistics costs, have impacted, and may in the future impact, operating costs and operating results. These higher costs and cost increases due to inflation are expected to continue for the foreseeable future as demand remains elevated and supply remains constrained. Although the Company has developed and implemented strategies to mitigate the impact of higher material component costs and transportation costs through sourcing and manufacturing efficiencies where possible, these strategies together with commercial negotiations with Gentherm's customers and suppliers have not fully offset to date and may not

47


fully offset our future cost increases. Such inflationary cost increase may increase the cash required to fund our operations by a material amount.

Critical Accounting Estimates

Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation ofAmerica (“GAAP”). In preparing these consolidated financial statements, requires usmanagement was required to make estimates and judgmentsassumptions that affect the reported amountamounts of assets, and liabilities, revenues and expenses, and related disclosures at the date of our financial statements. Actual results may differ from these estimates under different assumptions or conditions.expenses. These estimates and assumptions include, but are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of uncertainty. Because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material to our financial statements.

We have identified the following estimates as our most critical accounting estimates, which are those that are most important to aid in fully understanding and evaluating the Company’s financial condition and results of operations, and that require management’s most subjective and complex judgments. Information regarding our other significant accounting estimates and policies are disclosed in Note 2, "Summary of Significant Accounting Policies", of the notes to the consolidated financial statements.

Impairments of Goodwill

Critical estimates: Goodwill is tested for impairment at least annually as of December 31 and whenever events or changes in circumstances indicate that the carrying value may not limited to:

Product revenues;

Warranty reserves;

Litigation reserves;

32


Allowances for doubtful accounts;

Income taxes;

Inventory reserves;

Stock compensation;be recoverable. In conducting our annual impairment assessment testing, we first perform a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount. If not, no further goodwill impairment testing is performed. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if we elect not to perform a qualitative assessment of a reporting unit, we then compare the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and

Pension plans.

Product Revenues recognized.

The Company sells its products under long term supply or purchase order contracts issued by its customers. These contracts involveutilizes an income approach to estimate the salefair value of goodsa reporting unit and services at fixed prices and provide for related transfer of ownership riska market valuation approach to further support this analysis. The income approach is based on projected debt-free cash flow that is discounted to the customer upon shipmentpresent value using discount factors that consider the timing and risk of cash flows. We believe that this approach is appropriate because it provides a fair value estimate based on the reporting unit’s expected long-term operating cash flow performance. This approach also mitigates the impact of cyclical trends that occur in our industry. Fair value is estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used is the value-weighted average of our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital is adjusted to reflect risk, if necessary. Other significant assumptions include terminal value growth rates and terminal value margin rates. To further support the fair value estimate determined by the income approach, the Company utilizes a market valuation approach to estimate the fair value of a reporting unit. The market approach considers historical and/or anticipated financial metrics of a reporting unit and applies valuation multiples based on recent observed transactions involving companies similar enough to the reporting units from which to draw meaningful conclusions.

Judgments and uncertainties: These fair value calculations contain uncertainties as they require management to make assumptions about future cash flows and appropriate discount rates to reflect the risk inherent in the future cash flows and to derive a reasonable enterprise value and related premium. Our ability to realize the future cash flows used in our fair value calculations is affected by factors such as the success of strategic initiatives, changes in economic conditions, changes in our operating performance and changes in our business strategies. The estimated future cash flows reflect management's latest assumptions of the financial projections based on current and anticipated competitive landscape, including estimates of revenue based on production volumes over the foreseeable future and long-term growth rates, and operating margins based on historical trends and future cost containment activities.

Also, the market valuation approach is highly subjective as it requires the selection of comparable companies and valuation multiples.

48


Impact if actual results differ from assumptions: As of December 31, 2023, our goodwill balance included $76.7 million related to our Automotive segment and $27.4 million related to our Medical segment. These balances could be fully or partially impaired if management does not achieve the expected cash flows assumed in the fair value estimates or if assumptions and cash flow estimates change in future periods.

The Company’s Medical segment is comprised of one reporting unit (the “Medical Reporting Unit”). The estimated fair value of the Medical Reporting Unit exceeded its carrying value by less than 10% as of December 31, 2022. During the second quarter of 2023, the Company’s Medical reporting unit did not perform in-line with forecasted results primarily driven by slower than anticipated revenue growth. As a result, an indicator of impairment was identified and the Company performed an interim quantitative assessment as of June 30, 2023. The results of this quantitative analysis indicated the carrying value of the reporting unit exceeded the fair value, and accordingly an impairment expense was recorded for $19.5 million.

The primary factors leading to the decline in value from the analysis performed at December 31, 2022 were a reduction in expected future cash flows, due to the Company re-evaluating its forecasted results and an increase in the discount rate that is based on the Medical reporting unit’s weighted average cost of capital. The decline in expected future cash flows resulted primarily from a reduction of forecasted revenue growth rates. If the Company’s warehouse locationrevised expectation of revenue growth is not achieved or in some cases upon receiptif the estimated growth rates are reduced because of new information or experience, the fair value of the goodsMedical reporting unit could decrease, which could result in further impairment of goodwill. No further impairment was recorded as of December 31, 2023.

As of December 31, 2023, the estimated fair value of the Medical Reporting Unit exceeded it's carrying value by less than 15%. The Medical Reporting Unit is at risk of failing future impairment tests, as the customer’s facility,estimate of fair value does not substantially exceed its carrying value. The Company’s estimated future cash flow projections for the Medical Reporting Unit for the period of 2024 through 2028 assume a compound annual growth rate for revenue of approximately 18.3%, which we deem to be a critical assumption in the fair value determination as of December 31, 2023. This forecasted revenue growth, which is significantly higher than historical periods, is primarily driven by our anticipated participation in China's high-growth market for patient warming devices and anticipated product launches that are expected to increase volume and price due to new features and product capabilities. Realization of this assumed revenue growth is dependent on the successful launch of these new products and product features and the acceptance of customers. If this revenue growth is not achieved or completionif the estimated growth rates are reduced because of services. Shipping and handlingnew information or experience, the fair value of the Medical Reporting Unit could decrease, which could result in a material impairment of goodwill. Additionally, forecasted cash flows assume margin expansion as a direct result of the forecasted revenue growth. If we experience higher costs are recognized in cost of sales. With only a few minor exceptions, payment terms for these contracts range from 30 to 120 days from the date of shipment. Cash discounts for early payment are only extended to customer purchases recognized within the Industrial reporting segment. Unless a payment is for a distinct good or service, any consideration paid to a customer is recognized directly against the revenue earned from that customer.

For construction-type contract revenues recognizedthan assumed in our Industrialforecast or if we experience other deviations from forecasted results and/or external factors (e.g., continued increasing of interest rates), it could result in a material impairment.

The Company's reporting units in its Automotive segment each have a fair value that is substantially in excess of its respective carrying value as of December 31, 2023.

Income Taxes

Critical estimates: The Company is subject to income taxes in the completed-contract methodUnited States and numerous international jurisdictions. In calculating our effective income tax rate, we make judgments regarding certain tax positions, including the timing and amount of deductions and allocations of income among various tax jurisdictions. When determining whether we will be able to realize deferred tax assets, judgment is used to determine revenueevaluate the positive and the cost of earned revenue.negative evidence, including forecasting taxable income using historical and future operating results. The transfer of ownership upon shipment is used to determine substantial completion and the recognition of revenueprovision for these construction-type contracts.

Accrued Warranty Costs

The Company accrues warranty obligations for products sold based on management estimates of future failure rates andincome taxes includes current claim cost experience, with support from the sales, engineering, quality and legal functions.  While we believe our warranty reserve is adequate and that the judgment applied is appropriate, such estimates could differ materially from what will actually transpire in the future. The warranty policy is reviewed by management annually. Using historical information available to the Company, including claims already filed by customers, the warranty accrual is adjusted quarterly to reflect management’s best estimate of future claims.

Litigation Reserves

We record estimated future costs related to new or ongoing litigation based on input from legal counsel and our best estimate of potential loss. These estimates include costs associated with attorney fees and potential claims and assessments less any amounts we anticipate are recoverable under insurance policies. Final resolution of the litigation contingencies could result in amounts different from current accruals and, therefore, have an impact on our consolidated financial results in future reporting periods.

Allowance for Doubtful Accounts

We record an allowance for doubtful accounts once exposure to collection risk of an accounts receivable is specifically identified. We analyze the length of time an account receivable is outstanding,income taxes as well as a customer’s payment history to determine the need for and amount of an allowance for doubtful accounts.

Income Taxes

We recorddeferred income tax expense using the liability method which specifies that deferredtaxes. Deferred tax assets and liabilities beare measured each year based on the difference between the financial statement and tax basesbase of assets and liabilities at the applicable enacted tax rates. A valuation allowance is provided

Judgments and uncertainties: We have various tax filing positions with regard to the timing and amount of deductions and credits and the allocation of income among various tax jurisdictions, based on our interpretation of local tax laws, supported by external advisor review for material positions.

Valuation allowances are established when necessary on a jurisdictional basis to reduce deferred tax assets to the amounts expected to be realized when management considers it more likely than not that thesome portion or all of a deferred tax asset will not be realized. At December 31, 2017The determination as to whether a deferred tax asset will be realized is based on the evaluation of positive and 2016,negative evidence, which includes historical profitability, future market growth, future taxable income, the expected timing of the reversals of

49


existing temporary differences and tax planning strategies. The Company assesses deferred taxes and the adequacy or need for a valuation allowance on a quarterly basis.

The Company is subject to ongoing tax examinations and assessments in various jurisdictions. At any time, multiple tax years are subject to audit by the various tax authorities and a number of years may elapse before a particular matter, for which a liability has been providedestablished, is audited and fully resolved or clarified. In evaluating the exposures associated with various tax filing positions, the Company may record liabilities for certainsuch exposures. The Company generally adjusts its liabilities for unrecognized tax benefits and related indemnification obligations through earnings in the period in which an uncertain tax position is effectively settled, the statute of limitations expires for the relevant taxing authority to examine the tax position, or when more information becomes available. Although management believes that the judgments and estimates discussed herein are reasonable, actual results could differ, and may materially increase or decrease the effective tax rate, as well as impact the Company’s operating results.

Impact if actual results differ from assumptions: Some or all of management’s judgments are subject to review by the taxing authorities. If one or more of the taxing authorities were to successfully challenge our right to realize some or all of the tax benefit we have recorded, and we were unable to realize this benefit, it could have a material adverse effect on our financial results and cash flows. Further, if the Company is unable to generate sufficient future taxable income, there is a material change in the actual effective tax rates, a change to the time period within which the underlying temporary differences become taxable or deductible, or if the tax laws change unfavorably, then the Company could be required to increase the valuation allowance against deferred tax assets, which we have concluded are more likely than not to not be realized.  If future annual taxable income were to be significantly less than current and projected levels, there is a risk that certain of our deferred tax assets not already provided for by the valuation allowance would expire prior to utilization.

We recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position followingresulting in an audit. For tax positions meeting the more-likely-than-not threshold, the amount

33


recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. We recognize interest and penalties related to income tax mattersincrease in income tax expense.

Inventory Reserves

We recognize a reserve for obsolete and slow moving inventories based on estimates of future sales and an inventory item’s capacity to be repurposed for a different use. We consider the number of months supply on hand based on current planned requirements, uncommitted future projections and historical usage in estimating the inventory reserve.  Additional provisions are made for supplier claims for obsolete materials, prototype inventory, spare or customer service inventory and, for all periods other than at year-end, estimates for physical inventory adjustments.

Stock Based Compensation

We account for grants of employee stock options and restricted stock as compensation expense based upon the fair value on the date of grant and such expense is recognized over the vesting period. We determine fair value of awards using the Black-Scholes option pricing model. The Black-Scholes option pricing model incorporates certain assumptions, such as expected volatility, expected life of options, risk-free interest rate and expected dividend yield, in order to arrive at a fair value estimate. Expected volatilities are based on the average of the historical volatility of the Company’s Common Stock and that of an index of companies in our industry group. To evaluate our assumptions for the expected lives of options, we consider the average holding period of previously exercised options and the remaining terms of outstanding options. The risk free interest rate is based upon quoted market yields for United States Treasury debt securities. The expected dividend yield is based upon the Company’s history of having never issued a dividend, the limitations to issue a dividend under the Amended Credit Agreement and management’s current expectation regarding future dividends. We believe that the assumptions selected by management are reasonable; however, significant changes could materially impact the results of the calculation of fair value.  

Pension Plans

The Company’s obligations and expenses for its pension plans are substantially dependent on the Company’s selection of discount rate and, for the Gentherm GmbH Plan, expected long-term rate of return on plan assets assumptions used by actuaries to calculate these amounts.  Actual results that differ from assumptions used are accumulated and amortized over future periods and generally affect recognized expense in future periods. As such, assumptions used to calculate benefit obligations as of the annual measurement date directly impact the expense to be recognized in future periods.  See Note 12 to our consolidated financial statements for additional information about the pension plans, including their impact to Gentherm’s financial statements.  

Results of Operations Year Ended December 31, 2017 Compared to Year Ended December 31, 2016

Product Revenues. Product revenues for 2017 were $985,683,000 compared with product revenues of $917,600,000 for 2016, an increase of $68,083,000, or 7.4%.  This increase included the full year effect of the 2016 acquisition of CSZ, which operated as a part of Gentherm for a full year in 2017 but only for nine months during 2016, $8,398,000 in additional revenue attributable to the 2017 acquisition of Etratech after it was acquired on November 1, 2017, and a $4,995,000 favorable impact of foreign currency translation.  Adjusting for these effects, our pro-forma product revenue growth was 4.6% and included a 2.7% increase in Automotive segment product revenues to $879,457,000 and a 23.4% increase in Industrial segment product revenue to 106,226,000.

The increase in the Automotive segment occurred despite lower global automotive production volumes and a special rebate of $2,000,000 recorded during 2017.  The increases included higher revenue volume for seat heaters, totaling $18,370,000, or 6.4%, steering wheel heaters of $12,609,000, or 25.5%, automotive cable systems of $6,810,000, or 8.0%, and battery thermal management products of $3,497,000, or 53.4%.  These higher amounts were attributable to new program awards, higher vehicle application rates and higher component content.  Higher component content in seat heaters, for example, included a greater number of programs for which Gentherm provides the electronic controlling device along with the heating element.  These increases were partially offset by lower Climate Controlled Seats (“CCS”) product revenues which decreased by $17,834,000 or 4.4%.  CCS product revenue was disproportionately impacted by the lower global production volumes which were more unfavorable in our primary CCS market, North America, which was down by 4%, compared to an increase of 2% for the global automotive industry.  CCS revenues were also reduced as a result of certain vehicle programs changing technologies from the higher priced active cooling seat application to the lower priced heated and ventilated seat technology. 

34


Product revenues from Global Power Technologies (“GPT”) totaled $31,891,000 which represented an increase of $13,263,000, or 71%.  Continuing market weakness in North America was more than offset by higher sales to other markets.  Product sales in this business unit are typically large custom remote power systems having long lead times and, during 2017, there were more shipments than in the prior year.  During 2016, demand for GPT’s products sold in North America was unfavorably impacted by lower oil prices.  While we do not generally sell our products for oil exploration, production or transportation activities, the impact of lower oil prices reduced capital investments for the natural gas industry being made by GPT’s principal customers.  As a result, those customers curtailed orders during that year.

CSZ product revenue increased by $22,791,000 which included both an acquisition related increase of $15,905,000 and organic growth of $6,886,000, or 10%.   This increase included higher revenue of environmental chamber products totaling $8,106,000 or 22% partially offset by lower revenue of patient temperature management products of $1,220,000 or 3.9%.  The higher revenue for environmental chambers included several large custom orders as well as stronger demand for standard chambers.  Patient temperature management product revenue equally benefited 2017 and 2016 from a temporary surge in demand for the Hemotherm product, a blood heater cooler used in hospital operating rooms during open heart surgery, but did not yet show improvements associated with a transition to a direct sales force that occurred throughout 2017.

Cost of Sales. Cost of sales increased to $674,570,000 in 2017 from $622,563,000 in 2016. The increase of $52,007,000, or 8%, was due to increased sales volume, unfavorable inventory adjustments, other increased expenses and changes in product mix partially offset by a one-time $3,973,000 expense from the purchase accounting effect of inventory for the CSZ acquisition which occurred in 2016.  The gross margin rate was 31.6% during 2017 representing a decrease of 60 basis points as compared with the 2016 gross margin rate of 32.2%.  This decrease was due to the special rebate and the inventory adjustments and the higher expenses.  The unfavorable inventory adjustments totaled $2,307,000 and were mainly comprised of a reserve recorded for inventory held for the heated and cooled mattress product line based upon a reduced sales outlook.  Increased expenses totaling approximately $7,000,000 included higher fixed costs associated with our new manufacturing facilities in Mexico and Macedonia, labor expense inflation at our Ukraine factory, and factory launch expenses for the new advanced battery thermal management product and electronics.

Net Research and Development Expenses. Net research and development expenses were $82,478,000 during 2017 compared to $72,923,000 in 2016, an increase of $9,555,000, or 13%. This increase was primarily driven by higher costs for additional resources, including personnel focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products.  New product development includes automotive cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices, battery management systems, advanced automotive electronics solutions and other potential products. 

Increases in research and development were partially offset by research and development reimbursement totaling $12,037,000 during 2017 and $6,660,000 during 2016.  We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

Many new products have begun to reach the more cost intensive phases that typically occur after we receive firm customer orders or later as we ramp up our manufacturing operations specific to these products.  Important examples include battery thermal management, which began shipping at the end of 2017, and a new automotive electronic control module, which will launch in early 2019.  During 2017 and 2016 we incurred expenses of $5,477,000 and $3,400,000, respectively, associated with battery thermal management and $2,600,000 and $2,000,000, respectively for the electronic module. We estimate that these two products will add over $65,000,000 in annual revenue by the time they reach their full run rate in 2020 based on current awarded programs and are likely to grow rapidly in later periods.  The growth in the battery thermal management product is expected to mirror an expected rapid growth in 48-volt mild hybrid automotive drive trains for which it is designed whereas the growth in the electronic control module product is anticipated to be driven by market share penetration due to an important design innovation that we believe gives us an important competitive advantage.  

Acquisition Transaction Expenses. During 2017, we incurred $789,000 in fees and expenses associated with the acquisition of Etratech which was completed on November 1, 2017.  During 2016, we incurred $743,000 in fees and expenses associated with the acquisition of CSZ which was completed on April 1, 2016.

35


Selling, General and Administrative Expenses. Selling, general and administrative expenses were $130,522,000, which included $1,080,000 in selling, general and administrative expenses for Etratech and $6,100,000 in higher expenses for CSZ due to the additional three months of operations during 2017 as compared to 2016, the year CSZ was acquired.   Excluding the Etratech expenses and additional CSZ expenses, selling, general and administrative expenses increased by $8,090,000, or 7%, from $115,252,000 in the prior year.  This increase was partly due to expenses associated with the transition to a new chief executive officer, higher selling costs for CSZ’s medical products business, and increased management incentive compensation costs partially offset by a one-time expense associated with a management reorganization totaling $2,000,000 incurred in 2016 but not 2017.  On June 28, 2017 we announced the planned retirement of Daniel R. Coker, our CEO, and related retirement package.  During 2017, we recorded expenses totaling $6,694,000 which included accelerated stock compensation amortization and accrued cash bonus.  The amount also included a signing bonus and a make whole bonus  for Mr. Coker’s successor and fees associated with the recruitment process.  CSZ’s selling expenses include an increase of $3,869,000 associated with a direct sales force for its medical division started during 2017.  Our management incentive program includes various forms of equity compensation including stock options, restricted stock and stock appreciation rights (“SARs”).  Stock options and restricted stock are accounted for using the equity method and are valued at the grant date fair value and amortized over the respective service period of the employee beneficiary.  SARs are accounted for using the liability method since they are settled in cash which requires mark-to-market adjustments based on the current trading price of Gentherm Common Stock.  Expenses for this program were $968,000 higher during 2017 as compared to 2016.

Foreign currency gain (loss).  During 2017 we incurred a net foreign currency loss of $23,108,000 which included a net realized loss of $1,289,000 and a net unrealized loss of $21,819,000.  During 2016, we incurred a net foreign currency gain of $7,810,000 which included a net realized gain of $1,706,000 and a net unrealized gain of $6,104,000.  The unrealized loss in 2017 and the unrealized gain in 2016 was primarily the result of holding significant amounts of U.S. Dollar (“USD”) cash at our subsidiaries in Europe which have the European Euro (“EUR”) as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies.  During 2017, the USD significantly weakened relative to the EUR but strengthened during 2016.  If the USD continues to weaken, we will likely have further unrealized currency losses whereas if the USD strengthens we will likely have unrealized gains.

Income Tax Expense. We recorded an income tax expense of $34,028,000 during 2017 which included the one-time transition tax of $20,153,000 relating to the 2017 Tax Cut and Jobs Act (the “Tax Act”).  Excluding this one-time expense, our income tax expense would have been $13,875,000 representing an effective tax rate of 20% on earnings before income tax of $69,255,000.  We recorded an income tax expense of $33,965,000 during 2016 which included the one-time withholding tax expense of $7,600,000 and income tax expense of $2,500,000 related to Reorganization.  Excluding these one-time expenses, our income tax expense would have been $23,865,000 representing an effective tax rate of 22% on earnings before income tax of $110,563,000.rate.

The Tax Act was enacted on December 22, 2017.  The Tax Act reduces the U.S. federal corporate tax rate from 35% to 21%, requires companies to pay a one-time transition tax on all offshore earnings that were previously tax deferred and creates new taxes on certain foreign sourced earnings.  As of December 31, 2017, in accordance with guidance provided by Staff Accounting Bulletin No. 118 (SAB 118), we have not completed our accounting for the tax effects of the Tax Act; however, in certain cases, as described below, we have made a provisional estimate of the effects on our existing deferred tax balances and the one-time transition tax.  InFor the year ended December 31, 2017,2023, each change of the provision for income taxes includes a provisionaleffective tax rate by one percentage point would impact income tax expense by $0.5 million.

Recent Accounting Pronouncements

For a complete description of $20,153,000 related to items forrecent accounting standards which we were ablehave not yet been required to determine a reasonable estimate.  In all cases, we will continue to make and refine our calculations as additional analysis is completed.  In addition, our estimatesimplement which may be affectedapplicable to our operations, as additional regulatory guidance is issued with respect to the Tax Act.  Any adjustments to the provisional amounts will be recognizedwell as a component of the provision for income taxes in the period in which such adjustments are determined, but in any event, no later than the fourth quarter of 2018, in accordance with SAB 118.  

Deferred tax assets and liabilities.  We remeasured our U.S. deferred tax assets and liabilities at 21%.  However, we are still analyzing certain aspects of the Tax Act and refining our calculations, which could potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts.  Insignificant accounting standards that have been adopted during the year ended December 31, 2017, the provision for income taxes includes provisional income tax expense of $5,808,000 related to the remeasurement of deferred tax balances.

36


Transition Tax on Deferred Foreign Earnings.  The one-time transition tax is based on our post-1986 earnings and profits (“E&P”) that were previously deferred from U.S. income taxes.  In the year ended December 31, 2017, the provision for income taxes includes provisional income tax expense of $23,923,000 related to the one-time transition tax liability of our foreign subsidiaries.  We have not completed our calculation of the total post-1986 E&P for these foreign subsidiaries.  Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets.  This amount may change when we finalize the calculation of post-1986 E&P previously deferred from U.S. income taxes and the amounts held in cash or other specified assets.  A benefit of $9,578,000 was included in the provision for income taxes to offset the one-time transition tax related to the previous deferred tax liability that existed for the undistributed foreign earnings that were not permanently reinvested.  However, we continue to recognize a deferred tax liability related to foreign withholding tax that will be incurred for undistributed foreign earnings that are not permanently reinvested. See2023, see Note 2 to our consolidated financial statements for additional information about the one-time transition tax.

Industrial Segment Operating Loss.  The Industrial segment, which includes CSZ, GPT and our advanced research and development activities, reported an operating loss totaling $14,751,000 and $16,702,000 during 2017 and 2016, respectively.  The loss during 2016 included the one-time purchase accounting adjustment related to the CSZ acquisition.  After adjusting for this one-time expense, the 2017 loss was $2,022,000, or 16%, higher than the loss in the Industrial segment, as adjusted, in 2016.  We incurred these losses for three reasons.  First, the advanced research and development activities, the total cost for which were $13,899,000 and $12,106,000, during 2017 and 2016, respectively, are focused on products and technologies that are currently not generating product revenues.  We expect that many of the individual projects included in the business unit will generate profitable revenue in future periods.  Second, CSZ incurred approximately $2,000,000 in cost overruns on several large customer environmental test chambers during 2017.  These cost overruns are not expected to recur in future periods.  Finally, CSZ’s $3,869,000 in higher expenses in 2017 associated with the new direct sales force was not yet offset by a corresponding increase in the amount of revenue and related operating income.  We continue to believe that the direct sales force will lead to higher CSZ product revenue in future periods that will generate operating profits in excess of the cost for the direct sales persons.

Results of Operations Year Ended December 31, 2016 Compared to Year Ended December 31, 2015

Product Revenues. Product revenues for 2016 were $917,600,000 compared with product revenues of $856,445,000 for 2015, an increase of $61,155,000, or 7%. This increase was attributable to the acquisition of CSZ, which we acquired on April 1, 2016, and continued growth in our automotive products, partially offset by lower product revenues from GPT.  Revenues for CSZ during 2016 were $51,540,000.   Our automotive product revenues were higher during 2016 including higher sales for CCS which increased by $9,778,000, or 2% to $412,053,000, higher sales for automotive Seat Heaters which increased by $21,956,000, or 8% to $293,543,000 and Steering Wheel Heaters which increased by $7,482,000, or 18% to $49,689,000.  Product revenues from GPT totaled $18,624,000 which represented a decrease of $27,254,000, or 59%.  This decrease partly reflects continued softness in the demand for GPT’s products in North America, which continues to be unfavorably impacted by the market weakness in the oil industry that has carried over to and reduced capital investments being made by GPT’s principal customers that build and operate natural gas pipelines and related natural gas exploration and production companies. During 2015, this weakness had been offset by higher sales of products that are sold into geographical markets outside of GPT’s home market of North America.  However, these are typically larger custom products which are more impacted by the timing of shipments which favor some periods over others.  Fewer of these custom systems were shipped during 2016.  

Our 2015 product revenues were negatively affected by the strengthening of the U.S. Dollar against the Euro when compared to 2016 product revenues.

Cost of Sales. Cost of sales increased to $622,563,000 in 2016 from $580,066,000 in 2015. This increase of $42,497,000, or 7%, was due to was due to increased sales volume, including the new product revenues from CSZ, higher overhead for our new production facilities in Vietnam and Macedonia and a one-time $3,973,000 expense from the purchase accounting effect of inventory for the CSZ acquisition.  The gross margin percentage was 32.2% during 2016.  This amount would have been 32.5% without the impact of the one-time purchase accounting impact for CSZ which is 0.2% higher than the gross margin percentage of 32.3% during 2015.  The higher gross margin was due to the CSZ revenue, which has a higher than average gross margin percentage, and a favorable foreign currency impact on production expenses.  These were offset partially by the lower GPT revenue, which also has a higher than average gross margin percentage.  

Net Research and Development Expenses. Net research and development expenses were $72,923,000 during 2016 compared to $59,604,000 in 2015, an increase of $13,319,000, or 22%. This increase was primarily driven by higher costs for additional resources,

37


including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products.  New product development includes automotive cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices, battery management systems, advanced automotive electronics solutions and other potential products.  The CSZ acquisition also increased our net research and development expenses by $1,856,000.  

Increases in research and development were partially offset by research and development reimbursement totaling $6,660,000 during 2016 and $9,607,000 during 2015.  

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

Acquisition Transaction Expenses. During 2016, we incurred $743,000 in fees and expenses associated with the acquisition of CSZ which was completed on April 1, 2016. During 2015, we did not incur any acquisition transaction expenses.  

Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $115,252,000, which included $16,258,000 in selling, general and administrative expenses for CSZ, during 2016 from $95,456,000 during 2015.  Excluding the CSZ expenses, selling, general and administrative expenses increased by $3,538,000, or 4%.   This increase primarily resulted from new human resource management system and product lifecycle management business software implementation projects totaling $3,513,000, a one-time expense during the fourth quarter associated with a management reorganization totaling $2,000,000 and higher wages and benefits costs resulting from new employee hiring, merit increases and administrative costs associated with the new facilities in Vietnam and Macedonia, partially offset by lower management incentive expenses.

Since the trading price of our Common Stock decreased during 2016 but increased during 2015, we recorded a SAR related compensation benefit totaling $738,000 for 2016 as compared with an expense of $6,298,000 during 2015, a change that reduced our total selling, general and administrative expense by $7,035,000 during 2016 compared with 2015.

Foreign currency gain (loss).  During 2016 we incurred a net foreign currency gain of $7,810,000 which included a net realized gain of $1,706,000 and a net unrealized gain of $6,104,000.  The unrealized gain is primarily the result of holding significant amounts of USD cash at our subsidiaries in Europe which have the EUR as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies.  Much of the gain was recorded during the fourth quarter when the USD strengthened relative to the EUR.  During 2015, we had a foreign currency loss of $1,121,000.  This amount was lower than 2016 mainly due to lower cash balances and due to a higher ratio of cash held as Euro at our European subsidiaries.

Income Tax Expense. We recorded an income tax expense of $33,965,000 during 2016 which included the one-time withholding tax expense of $7,600,000 and income tax expense of $2,500,000 related to the Reorganization.  Excluding these one-time expenses, our income tax expense would have been $23,865,000 representing an effective tax rate of 22% on earnings before income tax of $110,563,000.  We recorded an income tax expense of $33,545,000 during 2015 representing an effective tax rate of 26% on earnings before income tax of $128,938,000.  This reduction was due to lower average tax rates on our foreign income.  The effective tax rates for 2016, excluding the one-time expense related to the Reorganization, and 2015 were lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions.

Liquidity and Capital Resources

Cash and Cash Flows

The Company has funded its financial needs primarily through cash flows from operating activities and equity and debt financings. Based on its current operating plan, management believes cash and cash equivalents at December 31, 2017, together with cash flows from operating activities, and borrowing available under our credit agreement, are sufficient to meet operating and capital expenditure needs, and to service debt, for at least the next 12 months. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of  operations and financial condition.  In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisition or a

38


number of smaller acquisitions.  There can be no assurance that such capital will be available at all or on reasonable terms, which could adversely affect our future operations and business strategy.  

The following table represents our cash and cash equivalents and short-term investments:

 

  

December 31,
2017

 

  

December 31,
2016

 

 

  

(in Thousands)

 

Cash and cash equivalents at beginning of period

 

$

177,187

 

 

$

144,479

 

Cash from operating activities

 

 

49,880

 

 

 

108,400

 

Cash used in investing activities

 

 

(117,688

)

 

 

(144,338

)

Cash from financing activities

 

 

(31,564

)

 

 

79,858

 

Foreign currency effect on cash and cash equivalents

 

 

25,357

 

 

 

(11,212

)

Cash and cash equivalents at end of period

 

$

103,172

 

 

$

177,187

 

Cash Flows From Operating Activities

We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. The following table compares the cash flows from operating activities earned during 2017 with those earned in 2016:

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

Change

 

Operating Activities:

 

(in Thousands)

 

Net income

 

$

35,227

 

 

$

76,598

 

 

$

(41,371

)

Non-cash adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

44,972

 

 

 

37,764

 

 

 

7,208

 

Deferred income taxes

 

 

5,135

 

 

 

(8,843

)

 

 

13,978

 

Stock compensation

 

 

12,507

 

 

 

9,186

 

 

 

3,321

 

Loss on sale of property and equipment

 

 

1,042

 

 

 

468

 

 

 

574

 

Provision for doubtful accounts

 

 

(469

)

 

 

108

 

 

 

(577

)

Defined benefit pension plan expense

 

(23

)

 

 

184

 

 

 

(207

)

Net income before non-cash adjustments

 

 

98,391

 

 

 

115,465

 

 

 

(17,074

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

6,033

 

 

 

(17,971

)

 

 

24,004

 

Inventory

 

 

(4,348

)

 

 

(5,933

)

 

 

1,585

 

Prepaid expenses and other assets

 

 

(12,334

)

 

 

9,106

 

 

 

(6,984

)

Accounts payable

 

 

(7,691

)

 

 

4,419

 

 

 

(12,110

)

Accrued liabilities

 

 

(39,171

)

 

 

3,314

 

 

 

(47,941

)

Net cash provided by operating activities

 

 

49,880

 

 

 

108,400

 

 

 

(58,520

)

Cash provided by operating activities during 2017 was $49,880,000, representing a decrease of $58,520,000 or 54% from cash provided by operating activities during 2016, which was $108,400,000. The following table highlights significant differences between the operating cash flows for the periods ending December 31, 2017 and 2016, respectively:

39


(in Thousands)

Net cash provided by operating activities during 2016

$

108,400

 

Decrease from lower net income before non-cash adjustments

 

(17,074

)

Taxes paid related to the Reorganization

 

(35,100

)

Other changes in working capital, net.

 

(6,346

)

Net cash provided by operating activities during 2017

$

49,880

 

Net income before non-cash adjustments decreased due to higher net research and development expense, higher selling, general and administrative expenses and higher interest expense in 2017 as compared to 2016. These amounts were partially offset by higher product revenue and gross margin. Other changes in working capital, net exclude changes in accrued liabilities associated with the Reorganization tax payments and primarily consist of favorable cash flows related to accounts receivable and inventory and unfavorable amounts related to accounts payable.

Working Capital

The following table illustrates changes in working capital during 2017:

(in Thousands)

Working capital at December 31, 2016

$

290,740

 

Decrease in cash and cash equivalents

 

(74,015

)

Foreign currency effect on working capital

 

13,916

 

Working capital acquired with Etratech

 

11,430

 

Prepaid expenses and other assets

 

12,334

 

Tax payments associated with the Reorganization

 

35,100

 

Other items

 

249

 

Working capital at December 31, 2017

$

289,754

 

Our working capital decreased due to our lower cash balance which was offset by four significant increases, including currency translation, an acquisition, an increase in our prepaid and other assets and tax payments made during 2017.  The currency impact of $13,916,000 on working capital is mainly the result of the currency translation of working capital at our European subsidiaries. At December 31, 2017 the U.S. Dollar/European Euro exchange rate was $1.20  as compared with an exchange rate of $1.05 at December 31, 2016. Approximately 22% of our product revenues are generated in Europe. Working capital also increased due to the acquisition of Etratech which had $11,430,000 in working capital when it was acquired on November 1, 2017. Prepaid expenses and other assets were higher primarily due to higher prepaid income tax receivables in Europe. Finally, the Reorganization tax payment, which was accrued as of December 31, 2016, and therefore part of working capital, was paid during the first half of 2017.

Cash Flows From Investing Activities

Cash used in investing activities was $117,688,000 during 2017, reflecting the acquisition of Etratech and purchases of property and equipment related to expansion of production capacity, including at our newest facilities in Mexico, Vietnam and Macedonia, and replacement of existing equipment.  See Note 43, “New Accounting Pronouncements,” to the consolidated financial statements included herein for information regarding the acquisition of Etratech.in this Annual Report.

Cash Flows From Financing Activities

Cash used in financing activities was $31,564,000 during 2017, reflecting payments of principal on the U.S. Revolving Note, DEG China Loan and the DEG Vietnam Loan (each as defined below) totaling $27,156,000 in aggregate.  As of December 31, 2017, the total availability under the Revolving Note was $220,859,000. Cash was also paid for cancellations of restricted stock awards totaling $1,837,000.ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Debt

The Company together with certain direct and indirect subsidiaries, has an outstanding credit agreement (the “Credit Agreement”) with a consortium of lenders and Bank of America, N.A., as administrative agent.  The Credit Agreement provides the Company a revolving credit note (“U.S. Revolving Note”) with a maximum borrowing capacity of $350,000,000.

40


All subsidiary borrowers and guarantors participating in the Credit Agreement have entered into a related pledge and security agreement. The security agreement grants  a security interest to the lenders in substantially all of the personal property of subsidiaries designated as borrowers to secure their respective obligations under the Credit Agreement, including the stock and membership interest of specified subsidiaries (limited to 66% of the stock in case of certain non-US subsidiaries). The Credit Agreement restricts the amount of dividend payments the Company can make to shareholders.  

The Credit Agreement requires the Company to maintain a minimum Consolidated Interest Coverage Ratio and a Consolidated Leverage Ratio.  Definitions for these financial ratios are provided in the Credit Agreement.

Under the Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). The base rate is equal to the highest of the Federal Funds Rate (1.33% at December 31, 2017) plus 0.50%, Bank of America’s prime rate (4.50% at December 31, 2017), or a one month Eurocurrency rate (0.00% at December 31, 2017) plus 1.00%. The Eurocurrency rate for loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate (1.56% at December 31, 2017). All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable at least quarterly.

The Applicable Rate varies based on the Consolidated Leverage Ratio reported by the Company.  As long as the Company is not in default of the terms and conditions of the Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.00%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.00%, respectively, for Base Rate Loans.  

The Company also has two fixed interest rate loans with the German Investment Corporation (“DEG”), a subsidiary of KfW banking group, a German government-owned development bank.  The first, a loan we used to fund capital investments in China (the “DEG China Loan”), is subject to semi-annual principal payments that began March, 2015 and will end September, 2019.  Under the terms of the DEG China Loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio, as defined by the DEG China Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Automotive Systems (China) Ltd.

The Company’s second fixed interest rate senior loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”).  The DEG Vietnam Loan is subject to semi-annual principal payments that began November, 2017 and will end May, 2023.  Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum Currency Ratio, Equity Ratio and Enhanced Equity Ratio, each as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.  

The following table summarizes the Company’s debt at December 31, 2017 (in thousands).

 

 

  

Interest
Rate

 

 

Principal
Balance

 

Credit Agreement:

 

 

 

 

 

 

 

 

     U.S. Revolving Note (U.S. Dollar Denominations)

 

 

3.07

%

 

$

129,000

 

DEG China Loan

 

 

4.25

%

 

 

1,919

 

DEG Vietnam Loan

 

 

5.21

%

 

 

13,750

 

Total debt

 

 

 

 

 

 

144,669

 

Current portion

 

 

 

 

 

 

(3,460

)

Long-term debt, less current maturities

 

 

 

 

 

$

141,209

 

As of December 31, 2017, we were in compliance with all terms as outlined in the Credit Agreement, DEG China Loan and DEG Vietnam Loan. Undrawn borrowing capacity under the U.S. Revolving Note was $220,859,000 as of December 31, 2017.

Recent Accounting Pronouncements

Derivatives and Hedging. In August, 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.” ASU 2017-12 expands the number and type of nonfinancial and interest rate risk components an entity has the ability to designate as the hedged risk in a qualifying hedging relationship.  ASU 2017-12 requires entities to present the earnings  effect of the hedging instrument in the same income statement line item in which the earnings effect of the hedge item is reported.  This approach simplifies the financial statement reporting for qualifying hedging relationships by

41


eliminating the requirement to separately report the portion of the hedge deemed to be ineffective.  For cash flow hedges, the entire change in the fair value of the hedging instrument included in the assessment of hedge effectiveness is recorded in other comprehensive income and reclassified to earnings when the hedged item affects earnings.  Furthermore, income statement effects from fair value and cash flow hedges are to be presented in tabular disclosure.

ASU 2017-12 is effective for annual and any interim periods beginning after December 15, 2018.  Early adoption of the amendments in this update are permitted. For cash flow hedges existing at the date of adoption, an entity should apply a cumulative catch-up adjustment related to eliminating the separate measurement of ineffectiveness to accumulative other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year  that an entity adopts the amendments in this update. We are currently in the process of determining the impact the implementation of ASU 2017-12 will have on the Company’s financial statements.

Share-Based Payment Awards. In May, 2017, the FASB issued ASU 2017-09, “Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 clarifies which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting, in accordance with Topic 718. An entity should account for the effect of a modification unless all of the following are met:

1)

The fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified. If the modification does not affect any of the inputs of the valuation technique that the entity uses to value the award, the entity is not required to estimate the value immediately before and after the modification.

2)

The vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified.

3)

The classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified.

ASU 2017-09 is effective for annual and any interim periods beginning after December 15, 2017. Early adoption of the amendments in this update is permitted. The amendments in ASU 2017-09 should be applied on a prospective basis and in the initial period of adoption, entities must disclose the nature of and reason for the change in accounting principle. The Company has not historically made changes to the terms or conditions of shared-based payment awards and does not expect adoption of ASU 2017-09 to have a material impact the consolidated financial statements when it is adopted in the first quarter of 2018.

Goodwill Impairment. In January, 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 modified the concept of impairment of goodwill to be a condition that exists when the carrying value of a reporting unit that includes goodwill exceeds its fair value. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill allocated to that reporting unit. Entities no longer will determine goodwill impairment by calculating the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if the reporting unit had been acquired in a business combination.

ASU 2017-04 is effective for annual and any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption of the amendments in this update is permitted. The amendments in ASU 2017-04 must be applied on a prospective basis and in the initial period of adoption, entities must disclose the nature of and reason for the change in accounting principle. The Company expects adoption of ASU 2017-04 will reduce the complexity of evaluating goodwill for impairment.

Business Combinations. In January, 2017, the FASB issued ASU 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business” to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. To be considered a business, the integrated set of activities and assets to be evaluated must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create an output. If substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, the integrated set or activities and assets is not considered a business. ASU 2017-01 provides a framework to assist entities in evaluating whether an integrated set of activities and assets include both an input and a substantive process when the assets’ fair value is not concentrated in a single identifiable asset or group of similar identifiable assets.

42


ASU 2017-01 is effective for fiscal years and interim periods beginning after December 15, 2017. The amendments in ASU 2017-01 should be applied on or after the effective date. No disclosure is required at adoption. The Company expects the impact from adopting this update to be immaterial to the consolidated financial statements.

Income Taxes. In October, 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” ASU 2016-16 modifies the current prohibition to recognize deferred income taxes from differences between the tax basis of assets in the buyer’s tax jurisdiction and their cost resulting from an intra-entity transfer from one tax-paying component to another tax-paying component of the same consolidated group.  Under current GAAP, deferred income taxes for intra-entity asset transfers are not recognized until the asset is sold to an outside party.  ASU 2016-16 allows entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs.  

ASU 2016-16 is effective for fiscal years and interim periods beginning after December 15, 2017.  For entities that issue interim financial statements and whose current fiscal year end date is December 31, 2016, early adoption can be made during the three-month period ending March 31, 2017.  The amendments in ASU 2016-16 should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption.  We have evaluated the impact the amendments in ASU 2016-16 will have on the Company's consolidated financial statements and determined that a favorable adjustment of approximately $27,771,000 will be recorded directly to retained earnings during the three-month period ending March 31, 2018.

Statement of Cash Flows. In August, 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.”  ASU 2016-15 provides guidance on the classification of eight specific cash receipt and cash payment transactions in the statement of cash flows. The Company focused its evaluation on the following transactions to determine the effect ASU 2016-15 will have on the Company’s Consolidated Statements of Cash Flows:

4)

Debt extinguishment payments and debt prepayments are to be shown as cash outflows for financing activities.  Presently, Gentherm classifies debt extinguishment payments within operating activities.  

5)

Payments made to settle contingent consideration liabilities not made soon after the acquisition date of a business combination should be recognized as cash outflows for financing activities up to the amount of the liability recognized at the acquisition date.  Payments, or the portion of a payment, to settle contingent consideration liabilities that exceed the amount of the liability recognized at the acquisition date will be recognized as cash outflows for operating activities.

6)

Cash receipts from the settlement of insurance claims, excluding those related to corporate-owned life insurance policies  shall be classified on the basis of the related insurance coverage.  For example, proceeds received to cover claims issued under product recall liability insurance would be classified as cash inflows from operating activities.

7)

Cash receipts from the settlement of corporate-owned life insurance policies shall be classified as cash inflows from investing activities.  

For public companies, ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017 and must be applied retrospectively to all periods presented. Early adoption of the amendments in this update is permitted. None of the cash receipt and cash payment transactions, including those that were not the focus of management’s evaluation, addressed by the update are transactions that are typical or customary to Gentherm business.  According, management does not expect the amendments in this update have a material impact to the Company.  Gentherm will adopt the amendments in ASU 2016-15 during the three-month period ending March 31, 2018.

Stock Compensation. In March, 2016, the FASB issued ASU 2016-09, “Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.”  ASU 2016-09 involves several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows.  Under the new standard, income tax benefits and deficiencies are to be recognized as income tax expense or benefit in the income statement and the tax effects of exercised or vested awards should be treated as discrete items in the reporting period in which they occur.  An entity should also recognize excess tax benefits regardless of whether the benefit reduces taxes payable in the current period.  ASU 2016-09 requires excess tax benefits to be classified along with other income tax cash flows as an operating activity and clarifies that cash paid by an employer when directly withholding shares for tax-withholding purposes should be classified as a financing activity.

43


ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016. The Company adopted ASU 2016-09 the first quarter of 2017 and recognized a $1,496,000 adjustment to the beginning balance of retained earnings for previously unrecognized excess tax benefits on share-based payment awards. Amendments related to the presentation of employee taxes paid on the statements of cash flows when an employer withholds shares to meet the minimum statutory withholding requirement were applied retrospectively to all periods presented.   Amendments requiring recognition of excess tax payments in the income statement and the classification of those excess tax benefits on the statement of cash flows were applied prospectively, beginning with the three-month period ended March 31, 2017. Excess tax benefits on share-based payment awards in the statement of cash flows in prior years have not been adjusted.

Leases. In February, 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).”  ASU 2016-02 requires lessees to recognize on their balance sheet a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. Payments to be made in optional periods should be included in the measurement of lease assets and liabilities if the lessee is reasonably certain it will exercise an option to extend the lease or not exercise an option to terminate the lease.  While ASU 2016-02 continues to differentiate between finance or capital leases and operating leases, the principal change from current lease accounting guidance is that lease assets and liabilities arising from operating leases should be recognized on the balance sheet.  

  ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update are permitted.  Lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach which includes a number of practical expedients, including the ability to use hindsight in evaluating lessee options to extend or terminate a lease.  An entity that elects to apply the practical expedients will be required to recognize a right-of-use asset and lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental payment that were tracked and disclosed under previous GAAP.  We are currently in the process of determining the impact the implementation of ASU 2016-02 will have on the Company’s financial statements.

Revenue from Contracts with Customers. In May, 2014, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update’s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Companies are to use a five-step contract review model to ensure revenue gets recognized, measured and disclosed in accordance with this principle. The FASB issued several amendments to the new standard, including a one-year deferral of the original effective date, and new methods for identifying  performance obligation aimed at reducing the cost and complexity or compliance.  

This update permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the cumulative catch-up transition method). We have chosen to use the cumulative catch-up transition method.  

Gentherm is in the process of completing the five-step contract review process for all existing contracts with customers, across all business units. While we continue to assess all potential impacts from the update, we currently believe the most significant impact relates to our accounting for options that give customers the right to  purchase additional goods under long-term supply agreements in the future.  Due to the complexity of certain of our automotive supply contracts, the actual revenue recognition treatment for customer purchase options will depend on contract-specific terms and could vary from other contracts that are similar in nature. An unfavorable adjustment will be recorded directly to retained earnings during the three-month period ending March 31, 2018. Our current estimate for this adjustment is $3,600,000. We are not aware of any impacts to revenue from contracts with customers at Etratech as a result of our assessment of potential impacts from the update.

Off-Balance Sheet Arrangements

We use letters of credit to guarantee our performance under specific construction contracts executed by our subsidiaries, GPT and CSZ.  The expiration dates of the letter of credit contracts coincide with the expected completion date of the contract.  Extensions are normally made if performance obligations continue beyond the expected completion date.  At December 31, 2017, we had outstanding letters of credit of $141,000.  

44


Tabular Disclosure of Contractual Obligations

As of December 31, 2017, the following amounts, aggregated by type of contract obligation, are known to come due in the periods stated:

Contractual Obligations

  

Total

 

  

Less than
1 Yr

 

  

1-3 Yrs

 

  

3-5 Yrs

  

  

More than
5 Yrs

Long-Term Debt Obligations(1)

  

$

144,669

  

  

$

3,460

  

  

$

5,959

 

  

$

134,000

 

 

$

1,250

Operating Lease Obligations

  

$

29,058

  

  

$

10,630

  

  

$

10,595

 

  

$

4,022

 

 

$

3,811

Totals

  

$

173,727

  

  

$

14,090

  

  

$

16,554

 

  

$

138,022

 

 

$

5,061

(1)

Long-Term Debt Obligations do not include an amount payable for interest.

The Company does not have any outstanding capital lease agreements or purchase obligations that exceed one year.

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK   

Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U. S. government, and in high-quality corporate issuers.

We are exposed to various market risk fromrisks including, but not limited to, changes in foreign currency exchange rates, short-termchanges in interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to ourthe Company's debt obligations under ourthe Second Amended and Restated Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, acquisitions denominated in foreign currencies, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, North Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won, Czech Koruna and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum lengthdecision of time over which we hedge ourwhether and when to execute derivative financial instruments, along with the duration of the instrument, may vary from period to period depending on market conditions, the relative costs of the instruments and capacity to hedge. The duration is linked to the timing of the underlying exposure, to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $29,273,000 and $29,538,000 outstanding at December 31, 2017 and 2016, respectively.

the connection between the two being regularly monitored. The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years.  We had copper commodity swap contracts with a notional value of $404,250 and $407,000 outstanding at December 31, 2017 and 2016, respectively.  

We doCompany does not enter into derivative financial instruments for speculative or trading purposes. OurSome derivative contracts do not qualify for hedge accounting; for other derivative contracts, we elect to not apply hedge accounting.

The Company’s designated hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts whichthat can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulatedAccumulated other comprehensive loss in the consolidated balance sheet.sheets. When the underlying hedge transaction is realized, the gain or loss included in accumulatedAccumulated other comprehensive loss is recorded in earnings in the consolidated statementstatements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We recordThe Company records the ineffective portion of foreign currency and copper commodity hedging

50


instruments, if any, to foreign currency gain (loss)cost of sales, and the ineffective portion of interest rate swaps, if any, to interest expense in the consolidated statements of income. See Note 16 to our consolidated financial statements for the amount of unrealized lossCash flows associated with copper commodity derivatives are reported in accumulated other comprehensive income as of December 31, 2016 that was reclassified into earnings during 2017. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

45


In December 2015, our subsidiary, Gentherm GmbH, entered into an agreement settling all claims against UniCredit Bank AG pertaining to a 10 year currency related swap (“CRS”) entered intonet cash provided by Gentherm Germany in March 2008.  Prior to the settlement, a lawsuit filed by Gentherm GmbH in 2011 was pending appeal at the Higher Regional Court in Munich, Germany.  As a result of the settlement, the CRS and its related liability to Gentherm have been terminated and Gentherm’s remaining interest in an offsetting derivative contract designed to limit the market risk of payments due under the CRS was sold.  Gentherm realized a one-time, pre-tax gain of $9,949,000operating activities in the fourth quarterCompany’s consolidated statements of 2015. Gentherm made a final cash settlement payment of $7,593,000 during the fourth quarter of 2015.flows.

Information related to the fair values of all derivative instruments in our consolidated balance sheet as of December 31, 20172023 is as follows (in thousands):set forth in Note 13, “Financial Instruments” in the consolidated financial statements included in this Annual Report.

 

  

 

  

 

  

Asset Derivatives

 

  

Liability Derivatives

 

 

Net Asset/
(Liabilities)

 

 

  

Hedge

Designation

  

Fair Value

Hierarchy

  

Balance Sheet
Location

 

  

Fair
Value

 

  

Balance Sheet
Location

  

Fair
Value

 

 

Foreign currency derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

 

  

 

141

 

  

Current liabilities

 

$

(1,050

)

 

$

(909

)

Commodity derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

  

  

$

72

  

  

 

 

 

 

 

 

$

72

 

Information related to the fair values of derivative instruments in our consolidated balance sheet as of December 31, 2016 is as follows (in thousands):

 

  

 

  

 

  

Asset Derivatives

 

  

Liability Derivatives

 

 

Net Asset/
(Liabilities)

 

 

  

Hedge

Designation

  

Fair Value

Hierarchy

  

Balance Sheet
Location

 

  

Fair
Value

 

  

Balance Sheet
Location

  

Fair
Value

 

 

Foreign currency derivatives

  

Cash flow hedge

  

Level 2

  

 

 

 

  

 

 

 

  

Current liabilities

 

$

(1,395

)

 

$

(1,395

)

Commodity derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

  

  

$

18

  

  

 

 

 

 

 

 

$

18

 

Information related to the effect of derivative instruments on our consolidated income statement and statement of comprehensive income is as follows (in thousands):

 

 

Location

  

Year
Ended
December 31,
2017

 

 

Year
Ended
December 31,
2016

 

Foreign currency derivatives

 

Product revenues

 

 

(3

)

 

 

 

 

 

Cost of sales

 

 

2,209

 

 

 

(608

)

 

 

Selling, general and administrative

 

 

(216

)

 

 

139

 

 

 

Other comprehensive (loss) income

 

 

302

 

 

 

(1,395

)

 

 

Foreign currency gain

 

 

(112

)

 

 

102

 

Total foreign currency derivatives

 

 

 

$

2,180

 

 

$

(1,762

)

Commodity derivatives

 

Cost of sales

 

$

202

 

 

$

(666

)

 

 

Other comprehensive income (loss)

 

 

54

 

 

 

743

 

Total commodity derivatives

 

 

 

$

256

 

 

$

77

 

46


Interest Rate Sensitivity

The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations.obligations, excluding finance leases. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in U.S. dollars ($USD) or European Euros (€EUR),

 

 

Expected Maturity Date

 

 

 

2024

 

 

2025

 

 

2026

 

 

2027

 

 

Total

 

 

Fair Value

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-Term Debt:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Variable rate

 

$

 

 

$

 

 

$

 

 

$

222,000

 

 

$

222,000

 

 

$

222,000

 

Variable interest rate as of December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

6.58

%

 

 

6.58

%

 

 

 

Fixed rate

 

$

233

 

 

$

 

 

$

 

 

$

 

 

$

233

 

 

$

233

 

Fixed interest rate

 

 

3.90

%

 

 

 

 

 

 

 

 

 

 

 

3.90

%

 

 

 

Based on the amounts outstanding as indicated in parentheses.

of December 31, 20172023, a hypothetical 100 basis point change (increase or decrease) in interest rates would impact annual interest expense by $2.2 million. To hedge the Company's exposure to interest payment fluctuations on a portion of the borrowings, we entered into a floating-to-fixed interest rate swap agreement with a notional amount of $100.0 million.

 

 

Expected Maturity Date

 

 

 

2018

 

 

2019

 

 

2020

 

 

2021

 

 

2022

 

 

Thereafter 

 

 

Total

 

 

Fair
Value

 

 

 

(In Thousands except rate information)

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long Term Debt:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed Rate (€EUR)

 

$

960

 

 

$

959

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

1,919

 

 

$

2,000

 

Average Interest Rate

 

 

4.25

%

 

 

4.25

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.25

%

 

 

 

 

Variable Rate ($USD)

 

$

 

 

$

 

 

$

 

 

$

129,000

 

 

$

 

 

$

 

 

$

129,000

 

 

$

129,000

 

Average Interest Rate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.07

%

 

 

 

 

 

 

 

 

 

 

3.07

%

 

 

 

 

Fixed Rate ($USD)

 

$

2,500

 

 

$

2,500

 

 

$

2,500

 

 

$

2,500

 

 

$

2,500

 

 

$

1,250

 

 

$

13,750

 

 

$

13,600

 

Average Interest Rate

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

5.21

%

 

 

 

 

Exchange Rate Sensitivity

The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

 

 

Expected Maturity or Transaction Date

 

 

 

 

Anticipated Transactions and Related Derivatives

 

2024

 

 

2025

 

 

Total

 

 

Fair Value

 

USD Functional Currency

 

 

 

 

 

 

 

 

 

 

 

 

Forward Exchange Agreements:

 

 

 

 

 

 

 

 

 

 

 

 

(Receive MXN / Pay USD)

 

 

 

 

 

 

 

 

 

 

 

 

Total contract amount

 

$

67,406

 

 

$

33,703

 

 

$

101,109

 

 

$

8,655

 

Average contract rate

 

 

16.91

 

 

 

16.91

 

 

 

16.91

 

 

 

 

December 31, 2017

 

 

Expected Maturity or Transaction Date

 

Anticipated Transactions And Related Derivatives

 

2018

 

 

2019

 

 

2020

 

 

2021

 

 

2022

 

 

Thereafter

 

 

Total

 

 

Fair
Value

 

 

 

(In thousands except rate information)

 

$US functional currency

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forward Exchange Agreements:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Receive MXN/Pay USD$)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Contract Amount ($)

 

$

23,420

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

23,420

 

 

$

(1,050

)

Average Contract Rate

 

 

19.21

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19.21

 

 

 

 

 

(Receive CAD/Pay USD$)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Contract Amount ($)

 

$

5,853

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

5,853

 

 

$

141

 

Average Contract Rate

 

 

1.28

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.28

 

 

 

 

 

47


Commodity Price Sensitivity

The table below provides information about the Company’s futures contracts that are sensitive to changes in commodity prices, specifically copper prices. For the futures contracts the table presents the notional amountspotential gain and loss in metric tons (MT),fair value for the weighted average contract prices, and the total dollar contract amount by expected maturity dates. Contract amounts are used to calculate the contractual payments and quantity of copper to be exchanged under the futures contracts.foreign currency derivative contracts from a hypothetical 10% change in quoted currency exchange rates.

 

 

2023

 

 

2022

 

Exchange Rate Sensitivity

 

Potential loss in fair value

 

 

Potential gain in fair value

 

 

Potential loss in fair value

 

 

Potential gain in fair value

 

Forward Exchange Agreement:(Receive MXN / Pay USD)

 

$

7,179

 

 

$

9,798

 

 

$

3,999

 

 

$

4,888

 

51


ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

December 31, 2017

 

 

Carrying
Amount

 

 

Fair
Value

 

On Balance Sheet Commodity Position and Related Derivatives (in thousands)

 

$

72

 

 

$

72

 

 

 

Expected Maturity

 

 

 

2018

 

 

Fair
Value

 

Related Derivatives

 

 

 

 

 

 

 

 

Futures Contracts (Long):

 

 

 

 

 

 

 

 

Contract Volumes (metric tons)

 

 

70

 

 

 

 

 

Weighted Average Price (per metric ton)

 

$

5,775

 

 

 

 

 

Contract Amount (in thousands) ($)

 

$

404

 

 

$

72

 

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Supplementary Financial Information – Selected Quarterly Financial Data

Unaudited Quarterly Financial Data

For the Years Ended December 31, 2017 and 2016

(In thousands, except per share data)

 

  

For the three months ended,

 

 

  

March 31,
2017

 

 

June 30,
2017

 

 

September 30,
2017

 

 

December 31,
2017

 

Product revenues

  

$

249,267

  

 

$

243,378

  

 

$

235,853

  

 

$

257,185

  

Gross margin

  

 

85,160

  

 

 

78,405

  

 

 

70,229

  

 

 

77,319

  

Operating income

  

 

34,849

  

 

 

25,223

  

 

 

16,177

  

 

 

21,075

  

Net income

  

 

25,402

  

 

 

8,513

  

 

 

6,554

  

 

 

(5,242

)

Basic earnings per share

  

$

0.69

  

 

$

0.23

  

 

$

0.18

  

 

$

(0.14

)

Diluted earnings per share

  

$

0.69

  

 

$

0.23

  

 

$

0.18

  

 

$

(0.14

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

For the three months ended,

 

 

  

March 31,
2016

 

 

June 30,
2016

 

 

September 30,
2016

 

 

December 31,
2016

 

Product revenues

  

$

215,714

  

 

$

232,720

  

 

$

232,625

  

 

$

236,541

  

Gross margin

  

 

68,242

  

 

 

71,495

  

 

 

76,694

  

 

 

78,606

  

Operating income

  

 

29,885

  

 

 

22,353

  

 

 

27,415

  

 

 

26,466

  

Net income

  

 

11,893

 

 

 

18,446

  

 

 

20,223

  

 

 

26,036

  

Basic earnings per share

  

$

0.33

 

 

$

0.51

 

 

$

0.55

 

 

$

0.71

  

Diluted earnings per share

  

$

0.33

 

 

$

0.50

 

 

$

0.55

 

 

$

0.71

  

The sum of the quarterly amounts shown above may not be the same as the annual totals shown in our consolidated financial statements or elsewhere in this report due to rounding. The audited consolidated financial statements and related financial information required to be filed hereunder are indexed on page F-1 of this reportAnnual Report and are incorporated herein by reference.

48


ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A.

CONTROLS AND PROCEDURES

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

DisclosureManagement of the Company, under the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of December 31, 2023. As defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (as amended, the “Exchange Act”), disclosure controls and procedures are controls and procedures designed to ensureprovide reasonable assurance that information required to be disclosed by us in the reports that we filefiled or submitsubmitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securitieson a timely basis, and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executivethe Chief Executive Officer and principal financial officers,Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

In designing Based upon this evaluation, the Chief Executive Officer and evaluatingChief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of December 31, 2023.

Management’s Report on Internal Control Over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f), for the Company. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, management recognizesconducted an evaluation of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2023 based on the framework set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in “Internal Control-Integrated Framework (2013).” Based on that anyevaluation, management has concluded that the Company’s internal control over financial reporting was effective as of December 31, 2023.

The attestation report of the Company’s independent registered public accounting firm, regarding the effectiveness of the Company’s internal control over financial reporting, is set forth in Item 15, "Exhibits and Financial Statement Schedules," included under the caption "Report of Independent Registered Public Accounting Firm".

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designedwell-designed and operated, can provide only reasonable, not absolute, assurance of achievingthat the desired objectives. Also, thecontrol system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. BecauseFurther, because of the inherent limitations ofin all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.  These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of a simple error or mistake.  The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Our management has evaluated, with the participation of our principal executive and principal financial officers, the effectiveness of our disclosure controls and proceduresITEM 9B. OTHER INFORMATION

Except as of December 31, 2017.  Based on their evaluation, our principal executive and principal financial officers have concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of December 31, 2017.

Management’s Report On Internal Control Over Financial Reporting

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of assets, (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, including the possibility of collusion or improper management override of controls, misstatements due to error or fraud, internal control over financial reporting may not prevent or detect misstatements on a timely basis or not at all. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management of the Company assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2017. In making this assessment, management used the criteria set forth bybelow, during the Committee of Sponsoring Organizations of the Treadway Commission (COSO) 2013 Internal Control-Integrated Framework. We have excluded from our assessment the internal control over financial reporting of Etratech, Inc. (“Etratech”), which we acquired on November 1, 2017. Total assets and revenues of this acquisition represent approximately 7% and 1%, respectively, of the related consolidated financial statement amounts as of and for the yearthree months ended December 31, 2017.2023, none of the Company's directors or Section 16 officers adopted or terminated (i) any contract, instruction or written plan for the purchase or sale of Company securities that was

52


intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

Based on this assessment, management concluded that, as of

On December 31, 2017, the Company’s internal control over financial reporting was effective at the reasonable assurance level.

Our independent registered public accounting firm, Grant Thornton LLP, independently assessed the effectiveness6, 2023, Phillip Eyler, our President and Chief Executive Officer and a director of our internal control over financial reporting as stated in its report included herein.Board, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act. The trading plan provides for the sale of up to 134,684 shares of our Common Stock upon the exercise of stock options; such stock options have an expiration date of December 4, 2024. The trading plan expires on November 29, 2024 or such earlier date when all transactions under the trading plan are completed.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

49None.

53


Changes in Internal Control Over Financial Reporting

PART III

There was no change in our internal control over financial reporting identified in connection with such evaluation that occurred during our fourth quarter ended December 31, 2017 that has materially affected, or is reasonable likely to materially affect, our internal control over financial reporting.ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

ITEM 9B.

OTHER INFORMATION

None

50


PART III

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this item is set forth under the following captions in our proxy statement to be filed with respect to the 20182024 annual meeting of shareholders (the “Proxy Statement”), all of which is incorporated herein by reference: “Proposal No. 1 – Election of Directors”, “Board Matters – The Board of Directors”, “Board Matters – Standing Committees of the Board”, “Board Matters – Corporate Governance”, “Additional  Information – Section 16(a) Beneficial Ownership Reporting Compliance”“Executive Officers” and “Additional Information – Requirements for Submission of Shareholder Proposals and Nominations for 20192025 Annual Meeting.”

ITEM 11. EXECUTIVE COMPENSATION.

ITEM 11.

EXECUTIVE COMPENSATION.

The information required by this item set forth under the following captions in our Proxy Statement, all of which is incorporated herein by reference: “Board Matters – Director Compensation”, “Compensation Discussion & Analysis”, “Compensation and Analysis”Talent Committee Report”, “Named Executive Officer Compensation Tables”, “Board Matters – Director Compensation”, “Compensation Committee Interlocks“Pay Versus Performance” and Insider Participation”“CEO Pay Ratio.”

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

The information required by this item is set forth under the following caption in our Proxy Statement, which is incorporated herein by reference: “Security Ownership of Certain Beneficial Owners and “Compensation Committee Report.Management.

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

The information required by this item is set forth under the following captions in our Proxy Statement, all of which is incorporated herein by reference: “Additional Information“Board MattersEquity Compensation Plans”A Board Substantially Consisting of Independent Directors” and “Security Ownership of Certain Beneficial Owners and Management.“Related Person Transactions.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

The information required by this item is set forth under the following captions in our Proxy Statement, all of which is incorporated herein by reference: “Related Person Transactions” and “Proposal No. 1 – Election of Directors – Director Independence.”

ITEM 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES.

The information required by this item is set forth under the following captionscaption in our Proxy Statement, which is incorporated by reference herein by reference: “Audit Committee Matters.”

54


PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

51


PART IV

ITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

The following documents are filed as part of this Annual Report:

1.

Financial Statements.

1.
Financial Statements.

The following financial statements of the Company and reports of independent accountants are included in Item 15 of this Annual Report:

Page

Reports of Ernst & Young LLP, Independent Registered Public Accounting Firm (PCAOB ID: 42).

FF-2

2

Consolidated Balance Sheets

FF-5

5

Consolidated Statements of Income

FF-6

6

Consolidated Statements of Comprehensive Income

FF-7

7

Consolidated Statements of Changes in Shareholders’ Equity

FF-8

8

Consolidated Statements of Cash Flows

FF-9

9

Notes to the Consolidated Financial Statements

FF-10

10

2.
Financial Statement Schedule.

2.

Financial Statement Schedule.

The following Schedule to Financial Statements is included herein:

Schedule II — Valuation and Qualifying Accounts.

5255


3.

Exhibits.

3.
Exhibits.

The exhibits to this Annual Report are as follows:

 

 

 

 

 

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

Filed/Furnished Herewith

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

2*

 

Share Purchase and Transfer Agreement, dated May 4, 2022, by and among Gebhardt Holding GmbH, ELBER GmbH, Gentherm GmbH, and Andreas Gebhardt, Markus Gebhardt and Dr. Johann Vialberth

 

 

 

10-Q

 

3/31/22

 

2.1

 

5/4/22

 3.1

Second Amended and Restated Articles of Incorporation of Gentherm Incorporated

 

 

 

8-K

 

 

 

3.2

 

3/5/18

 3.2

Amended and Restated Bylaws of Gentherm Incorporated

 

 

 

8-K

 

 

 

3.1

 

5/26/16

 4

Description of Securities

 

 

 

10-K

 

12/31/19

 

4

 

2/20/20

10.1**

Summary of Non-Employee Director Compensation (effective starting with the 2021 annual meeting of shareholders)

 

10-Q

6/30/21

10.3

7/30/21

10.2**

Second Amended and Restated Gentherm Incorporated Senior Level Performance Bonus Plan

 

8-K

10.1

3/15/21

10.3.1**

2013 Equity Incentive Plan

Schedule 14A

A

4/22/13

10.3.2**

Amendment to the Gentherm Incorporated 2013 Equity Incentive Plan

8-K

10.2

5/19/17

10.3.3**

Second Amendment to the Gentherm Incorporated 2013 Equity Incentive Plan, effective as of May 21, 2020

8-K

10.1

5/26/20

10.3.4**

Form of Stock Option Award Agreement under the 2013 Equity Incentive Plan

8-K

10.1

6/27/13

10.3.5**

Form of Stock Appreciation Right Award Agreement under the 2013 Equity Incentive Plan

8-K

10.2

6/27/13

10.3.6**

Form of Restricted Stock Award Agreement under the 2013 Equity Incentive Plan

8-K

10.3

6/27/13

10.3.7**

Form of Restricted Stock Award Agreement (Retention Award) under the 2013 Equity Incentive Plan

8-K

10.1

10/4/17

10.3.8**

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan

8-K

10.1

6/13/18

10.3.9**

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan

8-K

10.2

6/13/18

10.3.10**

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan – Anversa

8-K

10.2

12/12/18

10.3.11**

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan – Anversa

8-K

10.3

12/12/18

10.3.12**

Form of Restricted Stock Unit Award Agreement (Performance-Based) under the 2013 Equity Incentive Plan (effective as of 2020 grants)

 

10-Q

 

3/31/20

 

10.1

 

5/7/20

10.3.13**

Form of Restricted Stock Unit Award Agreement (Time-Based) under the 2013 Equity Incentive Plan (effective as of 2020 grants)

 

10-Q

 

3/31/20

 

10.2

 

5/7/20

10.3.14**

Form of Restricted Stock Award Agreement (Director) under the Gentherm Incorporated 2013 Equity Incentive Plan

 

10-Q

 6/30/20

10.7

8/4/20

56


 

 

 

 

 

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

Filed/Furnished Herewith

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

10.3.15**

 

Form of Restricted Stock Award Agreement (Director) (effective as of 2021 grants)

 

 

 

10-Q

 

6/30/21

 

10.2

 

7/30/21

10.3.16**

 

Form of Restricted Stock Unit Award Agreement under the 2013 Equity Incentive Plan (effective as of 2021 grants)

 

 

 

8-K

 

 

 

10.2

 

3/15/21

10.3.17**

 

Form of Performance Stock Unit Award Agreement under the 2013 Equity Incentive Plan (effective as of 2021 grants)

 

 

 

8-K

 

 

 

10.3

 

3/15/21

10.4.1**

 

Gentherm Incorporated 2023 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

5/18/23

10.4.2**

 

Form of Performance Stock Unit Award Agreement under the Gentherm Incorporated 2023 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

5/18/23

10.4.3**

 

Form of Restricted Stock Unit Award Agreement under the Gentherm Incorporated 2023 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.3

 

5/18/23

10.4.4**

 

Form of Restricted Stock Award Agreement (Director) under the Gentherm Incorporated 2023 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.4

 

5/18/23

10.5.1

 

Second Amended and Restated Credit Agreement, dated as of June 10, 2022, by and among Gentherm Incorporated, Gentherm (Texas), Inc., Gentherm Licensing, Limited Partnership, Gentherm Medical, LLC, Gentherm GmbH, Gentherm Enterprises GmbH and Gentherm Licensing GmbH, the lenders party thereto, and Bank of America, N.A., as administrative agent, swing line lender and L/C issuer.

 

 

 

8-K

 

 

 

10.1

 

6/13/22

10.5.2

 

Second Amended and Restated Pledge and Security Agreement, dated as of June 10, 2022, by and among Gentherm Incorporated, Gentherm (Texas), Inc., Gentherm Medical, LLC, Gentherm Properties I, LLC, Gentherm Properties II, LLC and Bank of America, N.A.

 

 

 

8-K

 

 

 

10.2

 

6/13/22

10.6.1**

Employment Contract between Gentherm Incorporated and Phillip Eyler, dated as of September 18, 2017

8-K

10.1

10/3/17

10.6.2**

Amendment to Employment Terms between Gentherm Incorporated and Phillip Eyler, dated as of December 7, 2018

8-K

10.1

12/7/18

10.6.3**

Second Amendment to Employment Terms between Gentherm Incorporated and Phillip Eyler dated as of April 21, 2020

 

 

10-Q

 

6/30/20

 

10.4

 

8/4/20

10.7.1**

Offer Letter between Gentherm Incorporated and Matteo Anversa, dated as of October 22, 2018

8-K

10.1

12/12/18

10.7.2**

First Amendment to Offer Letter Agreement between Gentherm Incorporated and Matteo Anversa dated as of April 21, 2020

 

 

10-Q

 

6/30/20

 

10.5

 

8/4/20

10.7.3**

 

Second Amendment to Offer Letter Agreement between Gentherm Incorporated and Matteo Anversa, dated as of March 12, 2021

 

 

 

8-K

 

 

 

10.5

 

3/15/21

10.8.1**

Employment Contract between Gentherm GmbH and Thomas Stocker, effective September 1, 2019

10-Q

9/30/19

10.1

10/29/19

10.8.2**

 

First Amendment to the Employment Agreement between Gentherm Enterprises GmbH and Thomas Stocker, effective June 28, 2021

 

 

 

10-Q

 

6/30/21

 

10.1

 

7/30/21

10.9.1**

Offer Letter between Gentherm Incorporated and Hui (Helen) Xu, effective November 4, 2019

 

10-K

12/31/19

10.11

2/20/20

57


 

 

 

 

 

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

Filed/Furnished Herewith

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

10.9.2**

 

Amendment to Offer Letter between Gentherm Incorporated and Helen Xu, dated as of August 21, 2023

 

 

 

10-Q

 

9/30/23

 

10.1

 

10/26/23

10.10**

 

Severance Pay Plan for Eligible Employees of Gentherm Incorporated

 

 

 

8-K

 

 

 

10.4

 

3/15/21

10.11**

 

Form of First Amendment to Executive Offer Letter

 

 

 

8-K

 

 

 

10.7

 

3/15/21

10.12.1**

Amended and Restated Gentherm Incorporated Deferred Compensation Plan, dated May 20, 2019 (and effective January 1, 2019)

10-Q

6/30/19

10.4

7/26/19

10.12.2**

Deferred Compensation Agreement, between Gentherm Incorporated and Phillip Eyler, dated as of December 31, 2018.

8-K

10.2

1/4/19

10.13

 

Confirmation of Issuer Forward Repurchase Transaction between Gentherm Incorporated and Bank of America, N.A., dated as of November 1, 2023

 

 

 

8-K

 

 

 

10

 

11/2/23

10.14**

 

Summary of Non-Employee Director Compensation (effective starting with the 2024 annual meeting of shareholders)

 

X

 

 

 

 

 

 

 

 

21

List of Subsidiaries (Direct and Indirect) of the Company

 

X

 

 

 

 

 

 

 

 

23.1

Consent of Ernst & Young LLP

X

24

 

Power of Attorney

 

X

 

 

 

 

 

 

 

 

31.1

Section 302 Certification - CEO

 

X

 

 

 

 

 

 

 

 

31.2

Section 302 Certification – CFO

 

X

 

 

 

 

 

 

 

 

32.1***

Section 906 Certification – CEO

 

X

 

 

 

 

 

 

 

 

32.2***

Section 906 Certification - CFO

 

X

 

 

 

 

 

 

 

 

97

 

Gentherm Incorporated Policy for the Recovery of Erroneously Awarded Compensation

 

X

 

 

 

 

 

 

 

 

101.INS

Inline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

X

101.SCH

Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

X

104

 

Cover Page Interactive Date File – the cover page XBRL tags are embedded within the Inline XBRL document

 

X

 

 

 

 

 

 

 

 

* Schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish any omitted schedules or exhibits upon the request of the SEC.

** Indicates management contract or compensatory plan or arrangement.

*** Documents are furnished not filed.

ITEM 16. Form 10-K Summary

None.

 

 

 

 

 

  

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

 

Filed/Furnished Herewith

  

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

  2.1**

  

Membership Interest Purchase Agreement dated April 1, 2016 by and among the Company, Cincinnati Sub-Zero Products, LLC, CSZ Holdings, Inc., The Leonard Berke Q-Tip Trust, The Leonard Berke Exempt Q-Tip Trust, The Leonard Berke Credit Shelter Trust, Cincinnati Sub-Zero Trust F/B/O Steven Berke DTD 5/20/1999 and Steven J. Berke

 

 

 

8-K

 

 

 

2.1

 

4/4/16

  2.2**

 

Real Estate Purchase Agreement

 

 

 

8-K

 

 

 

2.2

 

4/4/16

  2.3**

 

Share and Asset Purchase Agreement, dated as of November 1, 2017, by and among Gentherm Incorporated, certain of its subsidiaries, Etratech Inc., Etratech Enterprises Inc., and certain subsidiaries and all of the shareholders of Etratech Enterprises Inc.

 

 

 

8-K

 

 

 

2.1

 

11/1/17

  3.1

  

Restated Articles of Incorporation of Gentherm Incorporated (the “Company”)

 

 

 

8-K

 

 

 

3.1

 

5/28/15

  3.2

  

Amended and Restated Bylaws of the Company

 

 

 

8-K

 

 

 

3.1

 

5/26/16

  4.1

  

Rights Agreement dated January 26, 2009 by and between the Company and Computershare Trust Company, N.A., as Rights Agent

 

 

 

8-K

 

 

 

4.1

 

1/27/09

  4.2

  

Amendment to Rights Agreement, dated as of March 30, 2011, by and between the Company and Computershare Trust Company, N.A., as Rights Agent

 

 

 

8-K

 

 

 

4.2

 

3/31/11

10.1*

  

Summary of Non-Employee Director Compensation

 

X

 

 

 

 

 

 

 

 

10.2.1*

  

2006 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

A

 

4/24/06

10.2.2*

  

First Amendment to 2006 Equity Incentive Plan

 

 

 

10-K

 

12/31/06

 

10.3.2

 

2/20/07

10.2.3*

  

Second Amendment to 2006 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

3/20/07

10.2.4*

  

Third Amendment to 2006 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

B

 

4/20/09

10.2.5*

  

Fourth Amendment to 2006 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.8

 

3/31/11

10.2.6*

  

Fifth Amendment to 2006 Equity Incentive Plan

 

 

 

10-K

 

12/31/11

 

10.3.6

 

3/15/12

10.2.7*

 

Sixth Amendment to 2006 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

5/20/13

10.3.1*

  

2011 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

A

 

5/20/11

10.3.2*

  

First Amendment to 2011 Equity Incentive Plan

 

 

 

10-K

 

12/31/11

 

10.3.8

 

3/15/12

10.3.3*

  

Second Amendment to 2011 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.3

 

5/11/12

10.3.4*

  

Third Amendment to 2011 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.3

 

5/20/13

10.4.1*

 

2013 Equity Incentive Plan

 

 

 

Schedule 14A

 

 

 

A

 

4/22/13

10.4.2*

 

Amendment to the Gentherm Incorporated 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

5/19/17

10.4.3*

 

Form of Stock Option Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

6/27/13

10.4.4*

 

Form of Stock Appreciation Right Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.2

 

6/27/13

10.4.5*

 

Form of Restricted Stock Award Agreement under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.3

 

6/27/13

58


53INDEX TO FINANCIAL STATEMENTS


 

 

 

 

 

  

Incorporated by Reference

Exhibit
Number

 

Exhibit Description

 

Filed/Furnished Herewith

  

Form

 

Period Ending

 

Exhibit / Appendix Number

 

Filing Date

10.4.6*

 

Form of Restricted Stock Award Agreement (Retention Award) under the 2013 Equity Incentive Plan

 

 

 

8-K

 

 

 

10.1

 

10/4/17

10.5.1*

  

The Executive Nonqualified Defined Benefit Plan of Gentherm Incorporated effective as of April 1, 2008

 

 

 

10-Q

 

6/30/08

 

10.18

 

8/11/08

10.5.2*

 

Amendment To The Executive Nonqualified Benefit Plan Adoption Agreement

 

 

 

8-K

 

 

 

10.1

 

5/19/17

10.6.1

  

Credit Agreement, dated as of August 7, 2014, by and among the Company, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm Canada Ltd., Global Thermoelectric Inc., the lenders party thereto and Bank of America, N.A., as administrative agent

 

 

 

8-K

 

 

 

10.1

 

8/7/14

10.6.2

  

First Amendment to Credit Agreement, dated as of April 15, 2015, by and among Gentherm Incorporated, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm Canada Ltd., Global Thermoelectric Inc., Gentherm Properties II, LLC, the lenders party thereto, and Bank of America, N.A., as administrative agent.

 

 

 

8-K

 

 

 

10.1

 

4/16/15

10.6.3

 

Second Amendment to Credit Agreement, dated March 17, 2016, by and among Gentherm Incorporated, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm GmbH, Gentherm Global Power Technologies Inc., Gentherm Canada ULC, Gentherm Licensing, LP, Gentherm Enterprises GmbH, Gentherm Licensing GmbH, Gentherm Enterprises, Gentherm Properties III, LLC,  the lenders party thereto, and Bank of America, N.A., as administrative agent.

 

 

 

8-K

 

 

 

10.1

 

3/18/16

10.6.4

 

Designated Borrower Request and Assumption Agreement

 

 

 

8-K

 

 

 

10.1

 

4/4/16

10.6.5

 

Third Amendment to Credit Agreement, dated December 15, 2016, by and among Gentherm Incorporated, Gentherm GmbH, Gentherm (Texas), Inc., Gentherm Licensing, LP, Gentherm GmbH, Gentherm Enterprises GmbH, Gentherm Licensing GmbH, Gentherm Global Power Technologies, Inc., Gentherm Canada ULC,  the lenders party thereto, and Bank of America, N.A., as administrative agent.

 

 

 

8-K

 

 

 

10.1

 

12/16/16

10.6.6

  

Pledge and Security Agreement, dated as of August 7, 2014, by and among the Company, Gentherm (Texas), Inc., Westridge Haggerty LLC and Bank of America, N.A.

 

 

 

8-K

 

 

 

10.2

 

8/7/14

10.7*

 

Amended and Restated Gentherm Incorporated Performance Bonus Plan dated as of February 12, 2018

 

 

 

8-K

 

 

 

10.1

 

2/14/18

10.8.1*

  

Executive Relocation and Employment Agreement, dated August 1, 2015, by and between Gentherm Incorporated and Frithjof Oldorff

 

 

 

8-K

 

 

 

10.1

 

8/3/15

 

10.8.2*

 

Extension of Executive Relocation and Employment Agreement dated as of October 3, 2017

 

 

 

10-Q

 

9/30/17

 

10.2.2

 

10/30/17

10.9*

 

Retirement Agreement between Gentherm Incorporated and Daniel R. Coker, dated as of June 28, 2017

 

 

 

8-K

 

 

 

10.1

 

6/28/17

10.10*

 

Employment Contract between Gentherm Incorporated and Phillip Eyler, dated as of September 18, 2017

 

 

 

8-K

 

 

 

10.1

 

10/3/17

21

  

List of Subsidiaries (Direct and Indirect) of the Company

 

X

 

 

 

 

 

 

 

 

23.1

  

Consent of Grant Thornton LLP

 

X

 

 

 

 

 

 

 

 

24

 

Power of Attorney

 

X

 

 

 

 

 

 

 

 

31.1

  

Section 302 Certification - CEO

 

X

 

 

 

 

 

 

 

 

31.2

  

Section 302 Certification – CFO

 

X

 

 

 

 

 

 

 

 

32.1

  

Section 906 Certification – CEO

 

X

 

 

 

 

 

 

 

 

54


Page

Incorporated by Reference

Exhibit
Number

Exhibit Description

Filed/Furnished Herewith

Form

Period Ending

Exhibit / Appendix Number

Filing Date

32.2

Section 906 Certification - CFO

X

101.INS

XBRL Instance Document.

X

101.SCH

XBRL Taxonomy Extension Schema Document.

X

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document.

X

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document.

X

101.LAB

XBRL Taxonomy Extension Label Linkbase Document.

X

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document.

X

*

Indicates management contract or compensatory plan or arrangement.

**

Gentherm Incorporated agrees to furnish any omitted schedules or exhibits upon the requestReports of the Securities and Exchange Commission.

55


INDEX TO FINANCIAL STATEMENTS

Page

Reports ofErnst & Young LLP, Independent Registered Public Accounting Firm(PCAOB ID: 42)

FF-2

2

Consolidated Balance Sheets as of December 31, 20172023 and 20162022

FF-5

5

Consolidated Statements of Income for the years ended December 31, 2017, 20162023, 2022, and 20152021

FF-6

6

Consolidated Statements of Comprehensive Income for the years ended December 31, 2017, 20162023, 2022, and 20152021

FF-7

7

Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2017, 20162023, 2022, and 20152021

FF-8

8

Consolidated Statements of Cash Flows for the years ended December 31, 2017, 20162023, 2022, and 20152021

FF-9

9

Notes to the Consolidated Financial Statements

FF-10

10

F-1


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

F-1


Report of Independent Registered Public Accounting Firm

To the Shareholders and the Board of Directors and Shareholders

of Gentherm Incorporated

Opinion on the financial statementsFinancial Statements

We have audited the accompanying consolidated balance sheets of Gentherm Incorporated (a Michigan corporation) and subsidiaries (the “Company”)Company) as of December 31, 20172023 and 2016,2022, the related consolidated statements of income, comprehensive income, changes in shareholders’shareholders' equity and cash flows for each of the three years in the period ended December 31, 2017,2023, and the related notes and financial statement schedule listed in the Index at Item 15 (collectively referred to as the “financial“consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as ofat December 31, 20172023 and 2016,2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2017,2023, in conformity with accounting principlesU.S. generally accepted in the United States of America.accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB), the Company’sCompany's internal control over financial reporting as of December 31, 2017,2023, based on criteria established in the 2013 Internal Controls – Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”),(2013 framework) and our report dated February 23, 201821, 2024 expressed an unqualified opinion.opinion thereon.

Basis for opinionOpinion

These financial statements are the responsibility of the Company’sCompany's management. Our responsibility is to express an opinion on the Company’s financial statementstatements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks orof material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supportingregarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinionopinion.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.

F-2


Valuation of Goodwill

Description of the Matter

As of December 31, 2023, the Company’s goodwill was $104.1 million consisting of $76.7 million in the automotive segment and $27.4 million in the medical segment. As discussed in Note 2 to the consolidated financial statements, goodwill is tested for impairment at least annually as of December 31 and whenever events or changes in circumstances indicate that it is more likely than not that a reporting unit’s fair value is less than it’s carrying amount.

As discussed in Note 7, during the second quarter of 2023, an indicator of impairment was identified in the medical segment (reporting unit) and the Company performed an interim quantitative assessment as of June 30, 2023. The results of this quantitative analysis indicated the carrying value of the reporting unit exceeded the fair value of the reporting unit, and accordingly an impairment expense was recorded for $19.5 million.

Auditing management’s interim and annual goodwill impairment assessments for the medical reporting unit and a reporting unit within its automotive segment were complex and highly judgmental due to the significant estimation required to determine the fair value of the reporting units. In particular, the fair value estimates used in the valuation of these reporting units were sensitive to significant assumptions depending on the reporting unit, such as changes in the discount rate, revenue growth rates, including the terminal growth rate and operating margins, which are affected by expectations about future market or economic conditions.

How We Addressed the Matter in our Audit

We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s interim and annual goodwill assessment, and annual forecasting process whereby the Company develops significant assumptions that are used in its analyses. This included controls over management's review of the valuation model and the significant assumptions used in the fair value measurements discussed above.

To test the estimated fair value of the Company’s reporting units, we performed audit procedures that included, among others, assessing the methodologies used and directly testing the significant assumptions and the underlying data used by the Company in its analyses, including assessing the completeness and accuracy of such underlying data. We utilized internal valuation specialists to assist in the evaluation of the assumptions and other relevant information that are most significant to the fair value estimate of the reporting units, such as assessing the fair value methodologies applied and evaluating the reasonableness of the discount rate selected by management. We compared the significant assumptions used by management to current industry and economic trends, historical performance, guideline public companies in the same industry and strategic plans. We performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting units that would result from changes in the assumptions. Furthermore, we assessed the appropriateness of the disclosures in the consolidated financial statements.

/s/ GRANT THORNTONERNST & YOUNG LLP

We have served as the Company’s auditor since 2007.2020.

Southfield,Detroit, Michigan

February 23, 201821, 2024

F-2F-3


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and the Board of Directors and Shareholders

of Gentherm Incorporated

Opinion on Internal Control Over Financial Reporting

We have audited Gentherm Incorporated’s internal control over financial reporting

We have audited the internal control over financial reporting of Gentherm Incorporated (a Michigan corporation) and subsidiaries (the “Company”) as of December 31, 2017,2023, based on criteria established in the 2013 Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO)(2013 framework) (the COSO criteria). In our opinion, the CompanyGentherm Incorporated (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017,2023, based on criteria established in the 2013 Internal Control –Integrated Framework issued by COSO.COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”)(PCAOB), the consolidated financial statementsbalance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of income, comprehensive income, changes in shareholders' equity and cash flows for each of the yearthree years in the period ended December 31, 2017,2023, and the related notes and financial statement schedule listed in the Index at Item 15 and our report dated February 23, 201821, 2024 expressed an unqualified opinion on those financial statements.thereon.

Basis for opinionOpinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control overOver Financial Reporting (“Management’s Report”).Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Our audit of, and opinion on, the Company’s internal control over financial reporting does not include the internal control over financial reporting of Etratech Enterprises, Inc, a wholly-owned subsidiary, whose financial statements reflect total assets and revenues constituting 7 and 1 percent, respectively, of the related consolidated financial statement amounts as of and for the year ended December 31, 2017. As indicated in the accompanying Management’s Report, Etratech Enterprises, Inc was acquired during 2017. Management’s assertion on the effectiveness of the Company’s internal control over financial reporting excluded internal control over financial reporting of Etratech Enterprises, Inc.

Definition and limitationsLimitations of internal control over financial reportingInternal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

F-3


Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ GRANT THORNTONERNST & YOUNG LLP

Southfield,Detroit, Michigan

February 23, 201821, 2024

F-4


F-4


GENTHERM INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

  

December 31,

 

 

December 31,

 

  

2017

 

 

2016

 

 

2023

 

 

2022

 

ASSETS

  

 

 

 

 

 

 

 

 

 

 

Current Assets:

  

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

  

$

103,172

  

 

$

177,187

  

 

$

149,673

 

 

$

153,891

 

Accounts receivable, less allowance of $973 and $1,391, respectively

  

 

185,058

  

 

 

170,084

  

Accounts receivable, net

 

 

253,579

 

 

 

247,131

 

Inventory, net

  

 

121,409

  

 

 

105,074

  

 

 

205,892

 

 

 

218,248

 

Derivative financial instruments

  

 

213

  

 

 

18

  

Prepaid expenses and other assets

  

 

51,217

  

 

 

32,000

  

Other current assets

 

 

78,420

 

 

 

64,597

 

Total current assets

  

 

461,069

  

 

 

484,363

  

 

 

687,564

 

 

 

683,867

 

Property and equipment, net of accumulated depreciation of $83,404 and $47,267, respectively

  

 

200,294

  

 

 

172,052

  

Property and equipment, net

 

 

245,234

 

 

 

244,480

 

Goodwill

  

 

69,685

  

 

 

51,735

  

 

 

104,073

 

 

 

119,774

 

Other intangible assets, net of accumulated amortization of $77,622 and $53,965, respectively

  

 

83,286

  

 

 

57,557

  

Deferred financing costs

  

 

936

  

 

 

1,221

  

Other intangible assets, net

 

 

66,482

 

 

 

73,933

 

Operating lease right-of-use assets

 

 

27,358

 

 

 

29,945

 

Deferred income tax assets

  

 

30,152

  

 

 

35,299

  

 

 

81,930

 

 

 

69,840

 

Other non-current assets

  

 

37,983

  

 

 

40,803

  

 

 

21,730

 

 

 

17,461

 

Total assets

  

$

883,405

  

 

$

843,030

 

 

$

1,234,371

 

 

$

1,239,300

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

  

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

  

 

 

 

 

 

 

 

 

 

 

Accounts payable

  

$

89,596

  

 

$

84,511

  

 

$

215,827

 

 

$

182,225

 

Accrued liabilities

  

 

77,209

  

 

 

105,625

  

Current lease liabilities

 

 

7,700

 

 

 

7,143

 

Current maturities of long-term debt

  

 

3,460

  

 

 

2,092

  

 

 

621

 

 

 

2,443

 

Derivative financial instruments

  

 

1,050

  

 

 

1,395

  

Other current liabilities

 

 

100,805

 

 

 

93,814

 

Total current liabilities

  

 

171,315

  

 

 

193,623

  

 

 

324,953

 

 

 

285,625

 

Pension benefit obligations

  

 

7,913

  

 

 

7,419

  

Other Liabilities

  

 

2,747

  

 

 

4,092

  

Long-term debt, less current maturities

  

 

141,209

  

 

 

169,433

  

 

 

222,217

 

 

 

232,653

 

Deferred tax liabilities

  

 

6,347

 

 

 

8,058

  

Non-current lease liabilities

 

 

16,175

 

 

 

20,538

 

Pension benefit obligation

 

 

3,209

 

 

 

3,638

 

Other non-current liabilities

 

 

23,095

 

 

 

24,573

 

Total liabilities

  

 

329,531

  

 

 

382,625

  

 

$

589,649

 

 

$

567,027

 

Shareholders’ equity:

  

 

 

 

 

 

 

 

 

 

 

Common Stock:

  

 

 

 

 

 

 

 

 

 

 

No par value; 55,000,000 shares authorized, 36,761,362 and 36,534,464 issued and outstanding at December 31, 2017 and 2016, respectively

  

 

265,048

  

 

 

262,251

  

No par value; 55,000,000 shares authorized 31,542,001 and 33,202,082 issued and outstanding at December 31, 2023 and December 31, 2022, respectively

 

 

50,503

 

 

 

122,658

 

Paid-in capital

  

 

15,625

 

 

 

10,323

 

 

 

 

 

 

5,447

 

Accumulated other comprehensive income

  

 

(20,444

)

 

 

(69,091

)

Accumulated other comprehensive loss

 

 

(30,160

)

 

 

(46,489

)

Accumulated earnings

  

 

293,645

 

 

 

256,922

 

 

 

624,379

 

 

 

590,657

 

Total shareholders’ equity

  

 

553,874

  

 

 

460,405

  

 

 

644,722

 

 

 

672,273

 

Total liabilities and shareholders’ equity

  

$

883,405

  

 

$

843,030

  

 

$

1,234,371

 

 

$

1,239,300

 

The accompanying notes are an integral part of these consolidated financial statements

F-5


F-5


GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

  

Year Ended December 31,

 

 

Year Ended December 31,

 

  

2017

 

 

2016

 

 

2015

 

 

2023

 

 

2022

 

 

2021

 

Product revenues

  

$

985,683

  

 

$

917,600

  

 

$

856,445

  

 

$

1,469,076

 

 

$

1,204,656

 

 

$

1,046,150

 

Cost of sales

  

 

674,570

  

 

 

622,563

  

 

 

580,066

  

 

 

1,117,452

 

 

 

931,006

 

 

 

742,519

 

Gross margin

  

 

311,113

  

 

 

295,037

  

 

 

276,379

  

 

 

351,624

 

 

 

273,650

 

 

 

303,631

 

Operating costs and expenses:

  

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

  

 

94,515

  

 

 

79,583

  

 

 

69,211

  

Reimbursed research and development expenses

  

 

(12,037

 

 

(6,660

 

 

(9,607

Operating expenses:

 

 

 

 

 

 

 

Net research and development expenses

  

 

82,478

  

 

 

72,923

  

 

 

59,604

  

 

 

94,358

 

 

 

85,722

 

 

 

75,214

 

Acquisition transaction expenses

  

 

789

  

 

 

743

  

 

 

  

Selling, general and administrative expenses

  

 

130,522

  

 

 

115,252

  

 

 

95,456

  

 

 

155,579

 

 

 

132,693

 

 

 

109,554

 

Total operating costs and expenses

  

 

213,789

  

 

 

188,918

  

 

 

155,060

  

Impairment of goodwill

 

 

19,509

 

 

 

 

 

 

 

Restructuring expenses

 

 

4,739

 

 

 

637

 

 

 

3,857

 

Impairment of intangible assets and property and equipment

 

 

 

 

 

6,291

 

 

 

 

Total operating expenses

 

 

274,185

 

 

 

225,343

 

 

 

188,625

 

Operating income

  

 

97,324

  

 

 

106,119

  

 

 

121,319

  

 

 

77,439

 

 

 

48,307

 

 

 

115,006

 

Interest expense

  

 

(4,885

)

 

 

(3,257

)

 

 

(2,610

Revaluation of derivatives loss

  

 

 

 

 

 

 

 

(1,102

Gain on settlement of lawsuit

  

 

 

 

 

 

 

 

9,949

 

Interest expense, net

 

 

(14,641

)

 

 

(4,294

)

 

 

(2,758

)

Foreign currency (loss) gain

  

 

(23,108

)

 

 

7,810

 

 

 

1,121

 

 

 

(5,918

)

 

 

(6,778

)

 

 

1,487

 

Other (loss) income

  

 

(76

)

 

 

(109

 

 

261

 

 

 

(1,926

)

 

 

1,147

 

 

 

117

 

Earnings before income tax

  

 

69,255

  

 

 

110,563

  

 

 

128,938

  

 

 

54,954

 

 

 

38,382

 

 

 

113,852

 

Income tax expense

  

 

34,028

  

 

 

33,965

  

 

 

33,545

  

 

 

14,611

 

 

 

13,941

 

 

 

20,418

 

Net income

  

$

35,227

  

 

$

76,598

  

 

$

95,393

  

 

$

40,343

 

 

$

24,441

 

 

$

93,434

 

Basic earnings per share

  

$

0.96

  

 

$

2.10

  

 

$

2.65

  

 

$

1.23

 

 

$

0.74

 

 

$

2.82

 

Diluted earnings per share

  

$

0.96

  

 

$

2.09

  

 

$

2.62

  

 

$

1.22

 

 

$

0.73

 

 

$

2.79

 

Weighted average number of shares—basic

  

 

36,721

  

 

 

36,448

  

 

 

36,032

  

Weighted average number of shares—diluted

  

 

36,814

  

 

 

36,601

  

 

 

36,475

  

Weighted average number of shares – basic

 

 

32,778

 

 

 

33,126

 

 

 

33,086

 

Weighted average number of shares – diluted

 

 

33,067

 

 

 

33,503

 

 

 

33,510

 

The accompanying notes are an integral part of these consolidated financial statements

F-6


F-6


GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Net Income

 

$

35,227

 

 

$

76,598

 

 

$

95,393

 

Other comprehensive loss, gross of tax:

 

 

 

 

 

 

 

 

 

 

 

 

Net gain (loss) on pension benefit obligations

 

 

244

 

 

 

(675

)

 

 

847

 

Foreign currency translation adjustments

 

 

48,059

 

 

 

(16,678

)

 

 

(25,904

)

Unrealized gain (loss) on foreign currency derivative securities

 

 

301

 

 

 

(1,395

)

 

 

10

 

Unrealized gain (loss) on commodity derivative securities

 

 

55

 

 

 

743

 

 

 

(725

)

Other comprehensive loss, gross of tax

 

$

48,659

 

 

$

(18,005

)

 

$

(25,772

)

Other comprehensive loss, related tax effects:

 

 

 

 

 

 

 

 

 

 

 

 

Net gain (loss) on pension benefit obligations

 

 

(60

)

 

 

185

 

 

 

(234

)

Foreign currency translation adjustments

 

 

148

 

 

 

297

 

 

 

(417

)

Unrealized gain (loss) on foreign currency derivative securities

 

 

(81

)

 

 

375

 

 

 

 

Unrealized gain (loss) on commodity derivative securities

 

 

(19

)

 

 

(273

)

 

 

496

 

Other comprehensive loss, related tax effect

 

$

(12

)

 

$

584

 

 

$

(155

)

Other comprehensive loss, net of tax:

 

$

48,647

 

 

$

(17,421

)

 

$

(25,927

)

Comprehensive income:

 

 

83,874

 

 

 

59,177

 

 

 

69,466

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Net income

 

$

40,343

 

 

$

24,441

 

 

$

93,434

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

Pension benefit obligations

 

 

56

 

 

 

1,826

 

 

 

558

 

Foreign currency translation adjustments

 

 

13,439

 

 

 

(14,081

)

 

 

(21,551

)

Unrealized gain (loss) on foreign currency derivative securities, net of tax

 

 

2,834

 

 

 

2,693

 

 

 

(952

)

Unrealized (loss) gain on commodity derivative securities, net of tax

 

 

 

 

 

(5

)

 

 

5

 

Other comprehensive income (loss), net of tax

 

 

16,329

 

 

 

(9,567

)

 

 

(21,940

)

Comprehensive income

 

$

56,672

 

 

$

14,874

 

 

$

71,494

 

The accompanying notes are an integral part of these consolidated financial statements

F-7


F-7


GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (Loss)

 

 

Earnings

 

 

Total

 

Balance at December 31, 2020

 

 

32,921

 

 

$

121,073

 

 

$

7,458

 

 

$

(14,982

)

 

$

472,782

 

 

$

586,331

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

93,434

 

 

 

93,434

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(21,940

)

 

 

 

 

 

(21,940

)

Stock compensation, net

 

 

327

 

 

 

17,573

 

 

 

(1,592

)

 

 

 

 

 

 

 

 

15,981

 

Stock repurchase

 

 

(240

)

 

 

(20,000

)

 

 

 

 

 

 

 

 

 

 

 

(20,000

)

Balance at December 31, 2021

 

 

33,008

 

 

$

118,646

 

 

$

5,866

 

 

$

(36,922

)

 

$

566,216

 

 

$

653,806

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

24,441

 

 

 

24,441

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

(9,567

)

 

 

 

 

 

(9,567

)

Stock compensation, net

 

 

194

 

 

 

4,012

 

 

 

(419

)

 

 

 

 

 

 

 

 

3,593

 

Balance at December 31, 2022

 

 

33,202

 

 

$

122,658

 

 

$

5,447

 

 

$

(46,489

)

 

$

590,657

 

 

$

672,273

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

40,343

 

 

 

40,343

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

16,329

 

 

 

 

 

 

16,329

 

Stock compensation, net

 

 

129

 

 

 

9,147

 

 

 

(68

)

 

 

 

 

 

 

 

 

9,079

 

Stock repurchase

 

 

(1,789

)

 

 

(81,302

)

 

 

(5,379

)

 

 

 

 

 

(6,621

)

 

 

(93,302

)

Balance at December 31, 2023

 

 

31,542

 

 

$

50,503

 

 

$

 

 

$

(30,160

)

 

$

624,379

 

 

$

644,722

 

 

 

Common

 

 

 

 

 

Loss on
Pension

 

 

Currency

 

 

Foreign
Currency

 

 

Commodity

 

 

 

 

 

 

 

 

 

Stock

 

 

Paid-in

 

 

Benefit

 

 

Translation

 

 

Hedge

 

 

Hedge

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Obligation

 

 

Adjustment

 

 

Adjustment

 

 

Adjustment

 

 

Earnings

 

 

Total

 

Balance at December 31, 2014

 

 

35,697

 

 

$

243,255

 

 

$

(8,224

)

 

$

(2,673

)

 

$

(23,060

)

 

$

(10

)

 

$

 

 

$

84,931

 

 

$

294,219

 

Exercise of Common Stock options for cash

 

 

571

 

 

 

12,146

 

 

 

(2,873

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,273

 

Tax benefit from Exercises of Common Stock options

 

 

 

 

 

 

 

 

6,681

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,681

 

Common Stock issued to Board of Directors and employees

 

 

108

 

 

 

3,734

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,734

 

Stock option compensation

 

 

 

 

 

 

 

 

3,025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,025

 

Cancelation of restricted stock

 

 

(54

)

 

 

(2,216

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,216

)

Net loss on pension benefit obligation, net

 

 

 

 

 

 

 

 

 

 

 

613

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

613

 

Currency translation, net

 

 

 

 

 

 

 

 

109

 

 

 

 

 

 

(26,321

)

 

 

 

 

 

 

 

 

 

 

 

(26,212

)

Foreign currency hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

10

 

Commodity hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(229

)

 

 

 

 

 

(229

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

95,393

 

 

 

95,393

 

Balance at December 31, 2015

 

 

36,322

 

 

$

256,919

 

 

$

(1,282

)

 

$

(2,060

)

 

$

(49,381

)

 

$

 

 

$

(229

)

 

$

180,324

 

 

$

384,291

 

Exercise of Common Stock options for cash

 

 

113

 

 

 

1,939

 

 

 

(501

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,438

 

Tax benefit from Exercises of Common Stock options

 

 

 

 

 

 

 

 

7,509

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,509

 

Common Stock issued to Board of Directors and employees

 

 

137

 

 

 

4,589

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,589

 

Stock option compensation

 

 

 

 

 

 

 

 

 

4,597

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,597

 

Cancelation of restricted stock

 

 

(38

)

 

 

(1,196

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,196

)

Net gain on pension benefit obligation, net

 

 

 

 

 

 

 

 

 

 

 

(490

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(490

)

Currency translation, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(16,381

)

 

 

 

 

 

 

 

 

 

 

 

(16,381

)

Foreign currency hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,020

)

 

 

 

 

 

 

 

 

(1,020

)

Commodity hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

470

 

 

 

 

 

 

470

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

76,598

 

 

 

76,598

 

Balance at December 31, 2016

 

 

36,534

 

 

$

262,251

 

 

$

10,323

 

 

$

(2,550

)

 

$

(65,762

)

 

$

(1,020

)

 

$

241

 

 

$

256,922

 

 

$

460,405

 

Exercise of Common Stock options for cash

 

 

202

 

 

 

3,662

 

 

 

(907

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,755

 

Cumulative effect of accounting change due to adoption of ASU 2016-09

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,496

 

 

 

1,496

 

Common Stock issued to Board of Directors and employees

 

 

242

 

 

 

6,298

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,298

 

Stock repurchase

 

 

(164

)

 

 

(5,326

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,326

)

Stock option compensation

 

 

 

 

 

 

 

 

6,209

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,209

 

Cancelation of restricted stock

 

 

(53

)

 

 

(1,837

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,837

)

Net loss on pension benefit obligation, net

 

 

 

 

 

 

 

 

 

 

 

184

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

184

 

Currency translation, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

48,207

 

 

 

 

 

 

 

 

 

 

 

 

48,207

 

Foreign currency hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

220

 

 

 

 

 

 

 

 

 

220

 

Commodity hedge, net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

36

 

 

 

 

 

 

36

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

35,227

 

 

 

35,227

 

Balance at December 31, 2017

 

 

36,761

 

 

$

265,048

 

 

$

15,625

 

 

$

(2,366

)

 

$

(17,555

)

 

$

(800

)

 

$

277

 

 

$

293,645

 

 

$

553,874

 

The accompanying notes are an integral part of these consolidated financial statements

F-8


F-8


GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

  

Year Ended December 31,

 

 

  

2017

 

 

2016

 

 

2015

 

Operating Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Net income

  

$

35,227

 

 

$

76,598

 

 

$

95,393

 

Adjustments to reconcile net income to cash provided by operating activities:

  

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

  

 

44,972

 

 

 

37,764

 

 

 

31,029

 

Deferred income taxes

  

 

5,135

 

 

 

(8,843

)

 

 

(711

)

Gain on CRS settlement

  

 

 

 

 

 

 

 

(9,949

)

Revaluation of derivatives

  

 

 

 

 

 

 

 

(490

)

Stock compensation

  

 

12,507

 

 

 

9,186

 

 

 

6,018

 

Loss on sale of property and equipment

  

 

1,042

 

 

 

468

 

 

 

20

 

Loss from write-off of intangible assets

 

 

 

 

 

 

 

 

358

 

Provision for doubtful accounts

  

 

(469

)

 

 

108

 

 

 

(120

)

Defined benefit pension plan (income) expense

  

 

(23

)

 

 

184

 

 

 

668

 

Changes in operating assets and liabilities:

  

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

  

 

6,033

 

 

 

(17,971

)

 

 

(12,399

)

Inventory

  

 

(4,348

)

 

 

(5,933

)

 

 

(10,954

)

Prepaid expenses and other assets

  

 

(12,334

)

 

 

9,106

 

 

 

(11,122

)

Accounts payable

  

 

(7,691

)

 

 

4,419

 

 

 

8,049

 

Accrued liabilities

  

 

(30,171

)

 

 

3,314

 

 

 

8,922

 

Net cash provided by operating activities

  

 

49,880

 

 

 

108,400

 

 

 

104,712

 

Investing Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Settlement of derivative financial instruments

  

 

 

 

 

 

 

 

(7,593

)

Investment in subsidiary, net of cash acquired

  

 

(66,994

)

 

 

(73,593

)

 

 

107

 

Investment in development-stage entity

  

 

 

 

 

(4,486

)

 

 

 

Purchases of property and equipment

  

 

(50,785

)

 

 

(66,316

)

 

 

(55,490

)

Proceeds from the sale of property and equipment

  

 

91

 

 

 

57

 

 

 

248

 

Net cash used in investing activities

  

 

(117,688

)

 

 

(144,338

)

 

 

(62,728

)

Financing Activities:

  

 

 

 

 

 

 

 

 

 

 

 

Cash paid for financing costs

  

 

 

 

 

(649

)

 

 

 

Borrowing of Debt

  

 

 

 

 

115,000

 

 

 

15,000

 

Repayments of Debt

  

 

(27,156

)

 

 

(42,244

)

 

 

(5,053

)

Cash paid for the cancellation of restricted stock

  

 

(1,837

)

 

 

(1,196

)

 

 

(1,475

)

Cash paid for the repurchase of common stock

 

 

(5,326

)

 

 

 

 

 

 

Excess tax benefit from equity awards

  

 

 

 

 

7,509

 

 

 

6,681

 

Proceeds from the exercise of Common Stock options

  

 

2,755

 

 

 

1,438

 

 

 

9,273

 

Net cash (used in) provided by financing activities

  

 

(31,564

)

 

 

79,858

 

 

 

24,426

 

Foreign currency effect on cash and cash equivalents

  

 

25,357

 

 

 

(11,212

)

 

 

(7,631

)

Net (decrease) increase in cash and cash equivalents

  

 

(74,015

)

 

 

32,708

 

 

 

58,779

 

Cash and cash equivalents at beginning of period

  

 

177,187

 

 

 

144,479

 

 

 

85,700

 

Cash and cash equivalents at end of period

  

$

103,172

 

 

$

177,187

 

 

$

144,479

 

Supplemental disclosure of cash flow information:

  

 

 

 

 

 

 

 

 

 

 

 

Cash paid for interest

  

$

4,540

 

 

$

3,029

 

 

$

2,826

 

Cash paid for taxes

  

$

76,741

 

 

$

21,608

 

 

$

32,376

 

Supplemental disclosure of non-cash transactions:

  

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued to directors and employees

  

$

6,298

 

 

$

4,589

 

 

$

3,734

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Operating Activities:

 

 

 

 

 

 

 

 

 

Net income

 

$

40,343

 

 

$

24,441

 

 

$

93,434

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

50,948

 

 

 

44,394

 

 

 

38,780

 

Deferred income taxes

 

 

(13,072

)

 

 

(7,322

)

 

 

(150

)

Stock based compensation

 

 

11,627

 

 

 

6,599

 

 

 

14,530

 

Loss on disposition of property and equipment

 

 

721

 

 

 

771

 

 

 

973

 

Impairment of intangible assets and property and equipment

 

 

 

 

 

6,291

 

 

 

 

Impairment of goodwill

 

 

19,509

 

 

 

 

 

 

 

Provisions for inventory

 

 

6,867

 

 

 

15,923

 

 

 

2,499

 

Other

 

 

2,920

 

 

 

721

 

 

 

(271

)

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

(4,195

)

 

 

(44,221

)

 

 

25,099

 

Inventory

 

 

6,907

 

 

 

(40,322

)

 

 

(42,372

)

Other assets

 

 

(26,179

)

 

 

(11,906

)

 

 

10,307

 

Accounts payable

 

 

31,029

 

 

 

28,314

 

 

 

8,166

 

Other liabilities

 

 

(8,160

)

 

 

(8,736

)

 

 

(7,919

)

Net cash provided by operating activities

 

 

119,265

 

 

 

14,947

 

 

 

143,076

 

Investing Activities:

 

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(37,602

)

 

 

(39,703

)

 

 

(38,468

)

Proceeds from the sale of property and equipment

 

 

391

 

 

 

248

 

 

 

22

 

Acquisition of businesses, net of cash acquired

 

 

 

 

 

(205,487

)

 

 

(2,827

)

Proceeds from deferred purchase price of factored receivables

 

 

13,903

 

 

 

5,538

 

 

 

 

Cost of technology investments

 

 

(815

)

 

 

(495

)

 

 

(7,557

)

Net cash used in investing activities

 

 

(24,123

)

 

 

(239,899

)

 

 

(48,830

)

Financing Activities:

 

 

 

 

 

 

 

 

 

Borrowings on debt

 

 

60,000

 

 

 

207,000

 

 

 

 

Repayments of debt

 

 

(72,280

)

 

 

(13,272

)

 

 

(153,243

)

Proceeds from the exercise of Common Stock options

 

 

263

 

 

 

1,670

 

 

 

8,279

 

Taxes withheld and paid on employees' share-based payment awards

 

 

(2,940

)

 

 

(5,471

)

 

 

(4,108

)

Cash paid for the repurchase of Common Stock

 

 

(91,094

)

 

 

 

 

 

(20,000

)

Acquisition contingent consideration payment

 

 

 

 

 

 

 

 

(69

)

Net cash (used in) provided by financing activities

 

 

(106,051

)

 

 

189,927

 

 

 

(169,141

)

Foreign currency effect

 

 

6,691

 

 

 

(1,690

)

 

 

(2,844

)

Net decrease in cash and cash equivalents

 

 

(4,218

)

 

 

(36,715

)

 

 

(77,739

)

Cash and cash equivalents at beginning of period

 

 

153,891

 

 

 

190,606

 

 

 

268,345

 

Cash and cash equivalents at end of period

 

$

149,673

 

 

$

153,891

 

 

$

190,606

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

 

Cash paid for taxes

 

$

23,273

 

 

$

21,645

 

 

$

14,857

 

Cash paid for interest

 

$

13,242

 

 

$

6,338

 

 

$

2,378

 

Non-Cash Investing Activities:

 

 

 

 

 

 

 

 

 

Period-end balance of accounts payable for property and equipment

 

$

7,754

 

 

$

2,526

 

 

$

2,147

 

Deferred purchase price of receivables factored in the period

 

$

13,885

 

 

$

3,769

 

 

$

 

The accompanying notes are an integral part of these consolidated financial statements

F-9


F-9


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except share and per share data)

Note 1 — The CompanyOverview

Gentherm Incorporated, a Michigan corporation, and its consolidated subsidiaries (“Gentherm”, “we”, “us”, “our” or the “Company”) is athe global technology and industrymarket leader in the design, development, and manufacturing of innovative thermal management technologies. Unlessand pneumatic comfort technologies for the context otherwise requires, the terms “Company”, “we”, “us”automotive industry and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation,a leader in medical patient temperature management, environmental product testingmanagement. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other consumercomponents), battery performance solutions, cable systems, lumbar and industrial temperature control needs.massage comfort solutions, fuel management valves and other valves for brake and engine systems, and other electronic devices. Our automotive products can be found on the vehicles ofmanufactured by nearly all the major automotiveoriginal equipment manufacturers (“OEMs”) operating in North America and Europe, and several major OEMs in Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilitiescapabilities. Medical products include patient temperature management systems. Our medical products can be found in hospitals throughout the world, primarily in the U.S., China, Germany and to identify future thermal technology product opportunities in both automotive and other markets.   We concentrate our research on the developmentBrazil. The Company is also developing a number of new technologies and new applications fromproducts that will help enable improvements to existing technologiesproducts, improve health, wellness and patient outcomes and will lead to create product and market opportunities for a wide array of thermal management solutions.  

Etratech

On November 1, 2017, we acquired substantially all of the assets and assumed substantially all of the operating liabilities of Etratech Inc., an Ontario corporation and all of the outstanding shares  of Etratech Hong Kong, an entity organized under the laws of Hong Kong,  in an all-cash transaction.  Etratech manufactures advanced electronic controls and control systems for the automotive, recreational vehicle, marine, security, medical and other industries. Etratech’s world headquarters and North American manufacturing operations are located in Burlington, Canada. See Note 4 to the consolidated financial statements for additional information regarding the acquisition of Etratech.  

Investment

On December 22, 2016, Gentherm entered into a subscription agreement to purchase preferred shares of stock from a development-stage technology company for approximately $4,500. The proceeds will be used to finance the development of new technologies we hope to be able to leverage in our design and development of new electric power generation applications. The investment was accounted for using the cost-method. Management did not observe any event or changes in circumstances that would indicate the carrying amount of our investment may not be recoverable during the years ended December 31, 2017 and 2016.  No dividends were paid to Gentherm during the years ended December 31, 2017 and 2016.  The investment was recorded to other non-current assets in the Company’s consolidated balance sheet.  

Cincinnati Sub-Zero

On April 1, 2016, we acquired all of the equity of privately-held Cincinnati Sub-Zero Products, LLC (“CSZ”) and related assets in an all-cash transaction.  CSZ manufactures both high quality patient temperature management systems for the health care industry and custom testing equipment used by a wide range of industrial manufacturing companies for product testing. CSZ’s world headquarters and manufacturing operations are located in Cincinnati, Ohio. See Note 17 for additional information regarding the acquisition of CSZ.

North American Reorganization

On January 4, 2016 and January 5, 2016, the Company completed reorganization transactions (the “Reorganization”) related to our North American business (the “Windsor Operations”).  As part of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG), the Windsor Operations have been consolidated into our existing European and North American facilities.  As a result of the Reorganization, some of the business activities previously performed by the Windsor Operations are now being performed by other subsidiaries.

F-10


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 1 — The Company (Continued)

Related to the Reorganization, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agency of $7,600 during 2016.  Additionally, the Company incurred income tax expense of $2,500 related to the intercompany dividends. These amounts incurred are expected to cover all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.  

In addition to the $7,600 of withholding tax and $2,500 of income taxes, the Reorganization required the Company to make a one-time income tax payment of approximately $32,600.  The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. The withholding tax payment was paid entirely in 2016. The income tax payments of $2,500 and $32,600 were paid during the first quarter of 2017.

Reportable Segments

The Company has two reportable segments for financial reporting purposes: Automotive and Industrial.

Automotive

The Automotive reporting segment is comprised of the results from our global automotive businesses. Operating results from our major products, including automotive seat comfort systems, specialized automotive cable systems, advanced electronic controls and control systems, and other automotive and non-automotive thermal convenience products are all reported in the Automotive segment because of their complementary focus on automotive content and/or individual comfort and convenience. All of our activities with respect to electronics are also included in our Automotive segment because a majority of these activities relate to the manufacture of electronic components for our automotive products or the automotive products of third parties. Etratech’s operating results are included within Gentherm’s Automotive segment due to the concentration of product applications with the automotive, RVfor existing and marine industries.

Automotive seat comfort systems include seat heaters, variable temperature Climate Control SeatsTM  (“CCS”) designed to provide individualized thermal comfort to automobile passengers,new and integrated electronic components, such as advanced electronic controls and control systems, that utilize our proprietary electronics technology . Specialized automotive cable system products include ready-made wire harnesses and related wiring products. Automotive products include the automotive steering wheel heater, heated and cooled cup holder and thermal storage bin.  Revenues from our non-automotive products include the heated and cooled mattress and furniture.adjacent markets.

Our Automotive segment customers include light vehicle original equipment manufacturers (“OEMs”), commercial vehicle OEMs, and Tier 1 suppliers to the automotive OEMs, including automotive seat manufacturers. We also directly supply CCS and seat heaters to aftermarket seat distributors and installers.

Industrial

The Industrial reporting segment represents the combined results from our remote power generation systems business, our patient temperature management systems business, our environmental testing equipment business and our advanced research and product development division.  Our remote power generation systems business is managed by our subsidiary Gentherm Global Power Technologies (“GPT”) and our patient temperature management and environment test equipment is managed by our subsidiary CSZ. The advanced research and product development division is engaged in projects to improve the efficiency of thermal management technologies and to develop, market, and distribute products based on these new technologies.  The operating results from these businesses and division are presented together as one reporting segment because of their joint concentration on identifying new, non-automotive markets and product applications based on thermal management technologies.  

F-11


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 1 — The Company (Continued)

See Note 11 for information regarding the Company’s segment revenues from external customers, including geographic composition, operating income, goodwill and changes to the presentation of prior year information.

Note 2 — Summary of Significant Accounting Policies and

Basis of Presentation

Consolidation

The consolidated financial statements at and forhave been prepared in accordance with accounting principles generally accepted in the years ended December 31, 2017, 2016 and 2015, reflect theUnited States of America (“GAAP”).

Principles of Consolidation

The consolidated financial position and consolidated operating resultsstatements include the accounts of the Company.Company, its wholly owned subsidiaries and those entities in which it has a controlling financial interest. The Company evaluates its relationship with other entities for consolidation and to identify whether such entities are variable interest entities (“VIE”) and to assess whether the Company is the primary beneficiary of such entities. Investments in affiliates in which Gentherm does not have control but does have the ability to exercise significant influence over operating and financial policies are accounted for under the equity method. When Gentherm does not have the ability to exercise significant influence (generally when ownership interest is less than 20%), investments in affiliates are measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer.

Intercompany accountstransactions and balances between consolidated businesses have been eliminatedeliminated.

Use of Estimates

In preparing these consolidated financial statements, management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in consolidation. Certain reclassificationsthe industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of prior years’ amounts have been madeuncertainty. We are not presently aware of any events or circumstances that would require us to conformupdate such estimates and assumptions or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.

Business combinations

In accordance with ASC Topic 805, “Business Combinations,” acquisitions are recorded using the acquisition method of accounting. The Company includes the operating results of acquired entities from their respective dates of acquisition. The Company


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

recognizes and measures the identifiable assets acquired, liabilities assumed, and any non-controlling interest as of the acquisition date fair value. The excess, if any, of total consideration transferred in a business combination over the fair value of identifiable assets acquired, liabilities assumed and any non-controlling interest is recognized as goodwill. Costs incurred as a result of a business combination other than costs related to the issuance of debt or equity securities are recorded in the period the costs are incurred. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to assets acquired and liabilities assumed with the current year’s presentation. Specifically,corresponding offset to goodwill.

Segment Reporting

The Company has two reportable segments: Automotive and Medical.

The Automotive reporting segment is comprised of the results from our global automotive businesses, including the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, lumbar and massage comfort solutions, valve systems, and automotive electronic and software systems.

The Medical reporting segment is comprised of the results from our patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute and chronic care departments and non-hospital facilities.

Revenue Recognition

Revenue is recognized from agreements containing enforceable rights and obligations, when promised goods are delivered or services are completed. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company changedfrom a customer, are excluded from Product revenues. Shipping and handling fees billed to customers are included in Product revenues, while costs of shipping and handling are included in Cost of sales.

Automotive Revenues

The Company provides production parts to its classificationcustomers under long-term supply agreements (“LTAs”). The duration of prepayments made duringan LTA is generally consistent with the constructionlife cycle of planta vehicle; however, a LTA does not reach the level of a performance obligation until Gentherm receives either a purchase order and/or a materials release from its customer for a specific number of production parts at a specified price, at which point an enforceable contract exists. Revenue is recognized when control of the production parts has transferred to the customer according to the terms of the contract, which typically occurs when the parts are shipped or delivered to the customer’s premises. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring production parts.

Certain LTAs provide for annual price reductions over the production life of the vehicle. Agreements that are determined to provide customers with purchase option discounts that would not be received without entering into the contract are considered to contain a material right (for example, a discount given to a customer that is incremental to the range of discounts typically given to that class of customer). The material right represents a purchase option that provides the customer with the ability to purchase additional production parts at a set price in the future and is accounted for as a separate performance obligation. Under these circumstances, each transfer of production parts under the LTA requires allocation of the purchase price to the production part and the purchase option. As a practical alternative to estimating the standalone selling price of an option, the Company allocates transaction price to the purchase option by reference to the production part volumes expected to be ordered and the consideration expected to be received over the life of the vehicle program.

The production part’s relative standalone selling price observed under the LTA is subtracted from the total amount of consideration expected to be received in exchange for transferring of parts under the current contract and the difference is allocated to the purchase option. Revenue from options containing a material right is recognized when the amounts billed to the customer for production parts transferred, under the LTA, is less than the standalone selling price of those production parts.

F-11


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Medical Revenues

Revenues from our patient temperature management business unit are generated from the sale of products and equipment. Our medical products and equipment focus on body and blood temperature management. The Company sells medical products and equipment primarily through distributor and group purchasing organization agreements. These agreements allow member participants to the distributor or group purchasing organization to make purchases at discounted prices negotiated by the distributor or group purchasing organization. A rebate is incurred at the point in time a member participant purchases product covered under these types of agreements. Rebates are accounted for as variable consideration, using an expected value, probability weighted approach, based on the level of sales to the distributor and the time lag between the initial sale and the rebate claim in determining the transaction price of a contract. Revenue is recognized at the point in time the medical products or equipment is transferred to the customer.

Assets Recognized from the Costs to Obtain a Contract with a Customer

The Company has no material contract assets from prepaid expensesor contract liabilities as of December 31, 2023.

The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the benefits of those costs are expected to be realized for a period greater than one year. Total capitalized costs to obtain a contract were $7,305 and other assets to other$2,239 as of December 31, 2023 and 2022, respectively. These amounts are recorded in Other non-current assets onand are being amortized into Product revenues over the consolidated balance sheet. The Company reclassified $4,390 from prepaid expenses and other assets to other non-current assets onexpected production life of the applicable program. During the year ended December 31, 2016 consolidated balance sheet in order to conform with the current year’s presentation.  2023 and 2022, $179 and $78, respectively, was amortized into Product revenues.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with original maturities of less than 90 days to be cash equivalents. Cash balances in individual banks may exceed the federally insured limit by the Federal Deposit Insurance Corporation.  The Company had cashCash and cash equivalents of $88,440$125,251 and $162,881$108,620 held in foreign jurisdictions as of December 31, 20172023 and 2016,2022, respectively.

Disclosures About Fair Value of Financial Instruments

The carrying amounts of financial instruments comprising cash and cash equivalents, short-term investments and accounts receivable approximate fair value because of the short maturities of these instruments. The carrying amount of the Company’s U.S. Revolving Note approximates its fair value because interest charged on the loan balance is variable.  See Note 13 for information about the techniques used to assess the fair value of financial assets and liabilities, including our fixed rate debt instruments.


F-12


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation (Continued)

Use of Estimates

The presentation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Accrued Warranty Costs

The Company accrues warranty obligations for products sold based on management estimates of future failure rates and current claim cost experience, with support from the sales, engineering, quality and legal functions.  Using historical information available to the Company, including claims already filed by customers, the warranty accrual is adjusted quarterly to reflect management’s best estimate of future claims. The following is a reconciliation of the changes in accrued warranty costs for the reporting period:  

 

 

December 31,

 

 

 

2017

 

 

2016

 

Balance at beginning of year

 

$

5,443

 

 

$

4,558

 

Warranty claims paid or retired

 

 

(979

)

 

 

(1,096

)

Expense

 

 

507

 

 

 

2,053

 

Adjustment due to currency translation

 

 

411

 

 

 

(72

)

Balance at end of year

 

$

5,382

 

 

$

5,443

 

Concentration of Credit Risk

Financial assets, which subject the Company to concentration of credit risk, consist primarily of cash equivalents, short-term investments, accounts receivable and accountsnotes receivable. Cash equivalents consist primarily of money market funds managed by major financial services companies. The credit risk for these cash equivalents is considered low. The Company does not require collateral from its customers. As of December 31, 2017, Lear,2023, the Company’s Automotive customers, Adient and Magna comprised 24%, 20%Lear both individually represented 19% and 7%17%, respectively, of the Company’s accounts receivable balance. As of December 31, 2016, Lear,2022, the Company’s Automotive customers, Adient and Faurecia comprised 25%, 24%Lear both individually represented 18% and 7%17%, respectively, of the Company’s accounts receivable balance. These accounts

Accounts Receivable

Accounts receivable are currently in good standing.

Allowance for Doubtful Accounts

We record anstated at the invoiced amount, less allowance for doubtful accounts once exposurefor estimated amounts not expected to collection riskbe collected, and do not bear interest. The Company determines the allowances based on historical write-off experience by industry and regional economic data, current expectations of anfuture credit losses and historical cash discounts. The Company’s accounts receivables are continually assessed for collectability and any allowance is recorded based upon the age of outstanding receivables, historical payment experience and customer creditworthiness. We write-off accounts receivable is specifically identified. We analyze the length of time an account receivable is outstanding, as well as a customer’s payment history and ability to pay to determine the need to record anwhen they become uncollectible. The allowance for doubtful accounts.  accounts was $1,171 and $1,220 as of December 31, 2023 and 2022, respectively.

F-12


GENTHERM INCORPORATED

InventoryNOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The allowance for doubtful accounts related to accounts receivable and related activity are summarized below:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Balance at beginning of year

 

$

1,220

 

 

$

1,399

 

 

$

1,161

 

Charged to costs and expenses

 

 

195

 

 

 

1,088

 

 

 

1,066

 

Currency translation and other

 

 

4

 

 

 

 

 

 

(12

)

Deductions from reserves

 

 

(248

)

 

 

(1,267

)

 

 

(816

)

Balance at end of year

 

$

1,171

 

 

$

1,220

 

 

$

1,399

 

In the Asia-Pacific region, the Company receives bank notes from certain customers to settle trade receivables. The collection of such bank notes is included in operating cash flows based on the substance of the underlying transactions, which are operating in nature. Bank notes held by the Company are classified as notes receivable within other current assets. The Company may hold such bank notes until maturity, exchange them with suppliers to settle liabilities, or sell them to third-party financial institutions in exchange for cash.

Inventory

The Company’s inventory is measured at the lower of cost or market, with cost being determinednet realizable value. Raw materials, components and consumables are measured using the first-in first-out basis. Raw materials, consumables and commodities are measured atweighted average cost of purchase and unfinishedmethod. Work-in-process and finished goods are measured at cost of production, using the weighted averagefirst-in first-out method. If the net realizable value expected on the reporting date is below cost, a write-down is recorded to adjust inventory to its net realizable value. We recognize a reserve for obsolete and slow movingslow-moving inventories based on estimates of future sales and an inventory item’s capacity to be repurposed for a different use. We consider the number of monthsmonths' supply on hand based on current planned requirements, uncommitted future projections and historical usage in estimating the inventory reserve.  Additional provisions are made for supplier claims for obsolete materials, prototype inventory, spare or customer service inventory and, for all periods other than at year-end, estimates for physical inventory adjustments.

F-13


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation (Continued)

The following is a reconciliation of the changes in the inventory reserve:

 

  

December 31,

 

 

  

2017

 

 

2016

 

Balance at beginning of year

  

$

4,790

  

 

$

4,308

  

Expense

  

 

3,521

  

 

 

876

  

Inventory write off

  

 

(726

 

 

(326

Adjustment due to currency translation

  

 

302

 

 

 

(68

)

Balance at end of year

  

$

7,887

  

 

$

4,790

  

Property and Equipment

Property and equipment, including additions and improvements, are recorded at cost less accumulated depreciation. Expenditures for general repairs and maintenance are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded as operatingOperating income or expense. The Company evaluates the recoverability of long-lived assets when events and circumstances indicate that the assets may be impaired and the undiscounted net cash flows estimated to be generated by those assets are less than their carrying value. If the net carrying value exceeds the fair value, an impairment loss exists and is calculated based on either estimated salvage value or estimated orderly liquidation value.

Depreciation and amortization areis computed using the straight-line method. The estimated useful lives of the Company’s propertyProperty and equipment are as follows:

Asset Category

Useful Life

Buildings and building improvements

51 to 5030 years

Plant and Equipmentequipment

1 to 2010 years

Production tooling

2 to 710 years

Leasehold improvements

Term of lease

Computer equipment and softwareInformation technology

1 to 105 years

Capital Leases

Term of lease

The Company recognized depreciation expense of $32,224, $24,873$42,186, $33,730 and $18,399$29,622 for the years ended December 31, 2017, 20162023, 2022 and 2015,2021, respectively.

Tooling

Goodwill and Other Intangible Assets

Goodwill and other intangible assets recorded in conjunction with business combinations are based on the Company’s estimate of fair value, as of the date of acquisition. A roll forward of goodwill from December 31, 2015 to December 31, 2017 is as follows:

December 31, 2015

  

$

27,765

  

Goodwill arising from the acquisition of CSZ

 

 

24,622

 

Exchange rate impact

  

 

(652

)

December 31, 2016

  

$

51,735

  

Goodwill arising from the acquisition of Etratech

 

 

14,866

 

Exchange rate impact

  

 

3,084

 

December 31, 2017

  

$

69,685

  

F-14


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation (Continued)

The fair value and corresponding useful lives for acquired intangible assets are listed below as follows:

Asset Category

Useful Life

Customer relationships

8-15 years

Technology

5-10 years

Production Development Costs

4 years

Our business strategy largely centers on designing products based upon internally developed and purchased technology. When possible, we protect these technologies with patents. Our policy is to expense all costs associated with the development and issuance of new patents as incurred. Such costs are classified as research and development expenses in our consolidation statements of income.

Patents purchased as part of a business combination are capitalized based on their fair values.  Periodically, we review the recoverability and remaining lives of our capitalized patents, and if necessary, make adjustments to reported amounts, based upon unfavorable impacts from market conditions, the emergence of competitive technologies and changes in our projected business plans.

A total of $12,425, $12,675 and $12,751 in other intangible assets, including capitalized patent costs, were amortized in 2017, 2016 and 2015, respectively.

An estimate of intangible asset amortization by year, is as follows:

2018

  

$

12,968

  

2019

  

 

10,041

  

2020

  

 

8,230

  

2021

  

 

10,762

  

2022

  

 

10,334

  

Thereafter

  

 

30,950

  

Impairments of Long-Lived Assets, Other Intangible Assets and Goodwill

Whenever events or changes in circumstances indicate that an asset’s carrying amount may not be recoverable, the Company will compare the carrying amount of the asset to the recoverable amount of the asset. The recoverable amount is defined as the greater of the asset’s fair value less costs to sell or its value in use. An impairment loss is recognized if the carrying amount of an asset exceeds the recoverable or fair value amount. An assessment of fair value could utilize quoted market prices, fair value appraisals, management forecasts or discounted cash flow analyses.

Annually on December 31st, and at interim periods when circumstances require, the Company tests the recoverability of its goodwill. The goodwill test utilizes a two-step analysis, whereby the Company compares the carrying value of each identified reporting unit to its fair value. If the carrying value of the reporting unit is greater than its fair value, the second step is performed, where the implied fair value of goodwill is compared to its carrying value. The Company recognizes an impairment charge for the amount by which the carrying amount of goodwill exceeds its fair value. The fair values of the reporting units are estimated using the net present value of discounted cash flows, excluding any financing costs or dividends, generated by each reporting unit and a comparison of market values of a group of comparable companies. The Company’s discounted cash flows are based upon reasonable and appropriate assumptions, which are weighted for their likely probability of occurrence, about the underlying business activities of the Company’s reporting units. An impairment of goodwill did not occur during the periods ending December 31, 2017, 2016 and 2015, respectively.

F-15


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation (Continued)

Product Revenues

The Company sells its products under long term supply or purchase order contracts issued by its customers. These contracts involve the sale of goods and services at fixed prices and provide for related transfer of ownership risk to the customer upon shipment from the Company’s warehouse location or in some cases upon receipt of the goods at the customer’s facility, or completion of services. Shipping and handling costs are recognized in cost of sales. With only a few minor exceptions, payment terms for these contracts range from 30 to 120 days from the date of shipment. Cash discounts for early payment are extended to customer purchases recognized within the Industrial reporting segment. Unless the payment is for a distinct good or service, any consideration paid to a customer is recognized directly against the revenue earned from that customer.

For construction-type contract revenues recognized in our Industrial segment, the completed-contract method is used to determine revenue and the cost of earned revenue.  The transfer of ownership upon shipment is used to determine substantial completion and the recognition of revenue for these construction-type contracts.

For 2017, our revenues from sales to our three largest customers, Lear, Adient and Bosch Automotive were $192,756, $173,964 and $75,370, respectively, representing 20%, 18% and 8% of our total revenues, respectively.

Tooling

The Company incurs costs related to tooling used in the manufacture of products sold to its customers. In some cases, the Company enters into contracts with its customers whereby the Company incurs the costs to design, develop and purchase tooling and is then reimbursed by the customer under a reimbursement contract. Tooling costs that will be reimbursed by customers are included

F-13


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

in prepaid expenses and otherOther current assets in the accompanying consolidated balance sheets at the lower of accumulated cost or the customer reimbursable amount. Approximately $6,994As of December 31, 2023 and $5,6042022, the Company had $16,877 and $15,267, respectively, of reimbursable tooling was capitalized within prepaid expenses and other current assets as of December 31, 2017 and 2016, respectively.costs capitalized. Company-owned tooling is included in propertyProperty and equipment and depreciated over its expected useful life, generally two to seven years. Management periodically evaluates the recoverability of tooling costs,ten years.

Goodwill and Other Intangible Assets

Goodwill and other intangible assets recorded in conjunction with business combinations are based on estimated future cash flows,the Company’s estimate of fair value, as of the date of acquisition.

Amortization of other intangible assets is computed using the straight-line method. The fair value and makes provisions, where appropriate,corresponding useful lives for toolingacquired intangible assets are listed below as follows:

Asset Category

Useful Life

Customer relationships

8 to 15 years

Technology

5 to 12 years

Product development costs

5 to 10 years

Trade names

Indefinite

Software development costs

4 to 5 years

Our business strategy largely centers on designing products based upon internally developed and purchased technology, and we protect certain technology with patents that have value to our business strategy. All costs associated with the development and issuance of new patents are expensed as incurred. Such costs are classified as Net research and development expenses in the accompanying consolidated statements of income.

Impairments of Other Intangible Assets and Goodwill

Goodwill is tested for impairment at least annually as of December 31 and whenever events or changes in circumstances indicate that willthe carrying value may not be recovered.recoverable. In conducting our annual impairment assessment testing, we first perform a qualitative assessment of whether it is more likely than not that a reporting unit’s fair value is less than its carrying amount. If not, no further goodwill impairment testing is performed. If it is more likely than not that a reporting unit’s fair value is less than its carrying amount, or if we elect not to perform a qualitative assessment of a reporting unit, we then compare the fair value of the reporting unit to the related net book value. If the net book value of a reporting unit exceeds its fair value, an impairment loss is measured and recognized.

The Company utilizes an income approach to estimate the fair value of a reporting unit and a market valuation approach to further support this analysis (level 3). The income approach is based on projected debt-free cash flow that is discounted to the present value using discount factors that consider the timing and risk of cash flows. We believe that this approach is appropriate because it provides a fair value estimate based on the reporting unit’s expected long-term operating cash flow performance. This approach also mitigates the impact of cyclical trends that occur in our industry. Fair value is estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used is the value-weighted average of our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital is adjusted to reflect risk, if necessary. Other significant assumptions include terminal value growth rates and terminal value margin rates. While there are inherent uncertainties related to the assumptions used and to management’s application of these assumptions to this analysis, we believe that the income approach provides a reasonable estimate of the fair value of a reporting unit.

The Company performs its indefinite-lived intangible asset impairment assessment annually as of December 31, and between annual assessments if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. See Note 7, "Goodwill and Other Intangibles," for additional information about the goodwill impairment analysis.

F-14


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Investments in non-consolidated affiliates

During 2021, the Company’s Automotive segment invested $5,200 for an ownership interest in Carrar Ltd. (“Carrar”), an Israel-based technology developer of advanced thermal management systems for the electric mobility market. In June 2023, the Company made an additional investment in Carrar of $500, totaling $5,700 invested in Carrar as of December 31, 2023. In December 2023, we recorded a non-cash impairment charge of $2,900 in Other (loss) income. The Company determined that Carrar is a VIE; however, the Company does not have a controlling financial interest or have the power to direct the activities that most significantly affect the economic performance of the investment. Therefore, the Company has concluded that it is not the primary beneficiary. Gentherm’s investment in Carrar is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

During 2021, the Company’s Automotive segment invested $2,357 for an ownership interest in Forciot Oy (“Forciot”), a Finland-based technology developer of sensors for touch, motion and force measurement. Gentherm’s investment in Forciot is measured at cost, less impairments, adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer, and is recorded in Other non-current assets.

In December 2021, the Company committed to make a $5,000 investment in Autotech Fund III, L.P., pursuant to a limited partnership agreement. As a limited partner, the Company will periodically make capital contributions toward this total commitment amount over the expected ten-year life of the fund. The Company has made contributions totaling approximately $810 to the Autotech Fund III, L.P. as of December 31, 2023. This fund focuses broadly on the automotive industry and compliments the Company’s innovation strategy.

Research and Development Expenses

Research and development activities are expensed as incurred. The Company groups development and prototypeSuch costs and related reimbursements inare classified as Net research and development. development expenses in the accompanying consolidated statements of income.

Leases

The Company has operating leases for office, manufacturing and research and development facilities, as well as land leases for certain manufacturing facilities that are accounted for as operating leases. We also have operating leases for office equipment and automobiles.Excluding land leases, our leases have remaining lease terms ranging from less than 1 year to 8 years and may include options to extend the lease. Land leases have remaining lease terms that range from 2 to 39 years and some which specify that the end of the lease term is at the discretion of the lessee. We do not have lease arrangements with related parties.

The Company determines whether a contractual arrangement is or contains a lease at inception. Leases that are operating in nature are recognized in Operating lease right-of-use assets, Current lease liabilities and Non-current lease liabilities in the accompanying consolidated balance sheets. Finance leases are included in property and equipment, net, current maturities of long-term debt, and long-term debt on the Company’s consolidated balance sheets.

Lease liabilities are measured initially at the present value of the sum of the future minimum rental payments at the commencement date of the lease. Lease payments that will vary in the future due to changes in facts and circumstances are excluded from the calculation of rental payments, unless those variable payments are based on an index or rate. Rental payments are discounted using an incremental borrowing rate, unless there is a rate implicit in the lease agreement. The incremental borrowing rate is based on the Company’s credit rating, determined on a fully collateralized loan basis from information available at commencement date, and the duration of the lease term (the “reference rate”). Judgment is used to assess the importance of risk factor inputs during the computation of the Company’s credit rating. For leases at foreign subsidiaries denominated in U.S. Dollars, a risk premium associated with the borrower subsidiary’s country is added to the reference rate. For significant leases at foreign subsidiaries denominated in a foreign currency, the U.S. Dollar risk free rate with a duration similar to that of the lease term is subtracted from the reference rate and a corresponding foreign currency risk free rate with a duration similar to that of the lease term is added to the reference rate.

F-15


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Operating lease right-of-use assets are measured at the amount of the lease liability, adjusted for prepaid or accrued lease payments, lease incentive received, and initial direct costs incurred, as applicable. Periods covered by an option to extend the lease are initially included in the measurement of an operating lease right-of-use asset and lease liability only when it is reasonably certain we will exercise the option. Gentherm’s lease agreements do not contain residual value guarantees or impose restrictions or covenants on the Company.

For all classes of underlying assets, the Company accounts for leases that contain separate lease and non-lease components as containing a single lease component. The Company does not recognize lease right-of-use assets and lease liabilities from leases with an original lease term of 12 months or less and, instead, recognizes amounts due as reimbursements for expenses as these expenses are incurred.  rent payments on a straight-line basis over the lease term in the consolidated statements of income.

Income Taxes

The Company records income tax expense using the liability method which specifies that deferred tax assets and liabilities be measured each year based on the difference between the financial statement and tax base of assets and liabilities at the applicable enacted tax rates. A valuation allowance is provided for deferred tax assets when management considers it more likely than not that the asset will not be realized. At December 31, 20172023 and 2016,2022, a valuation allowance has been provided for certain deferred tax assets which the Company has concluded are more likely than not to not be realized. If future annual taxable income were to be significantly less than current and projected levels, there is a risk that certain of our deferred tax assets not already provided for by the valuation allowance would expire prior to utilization.

The Company recognizerecognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties related to income tax matters in incomeIncome tax expense.

F-16


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 2 — Summary of Significant Accounting Policies and Basis of Presentation (Continued)

Derivative Financial Instruments – Hedge Accounting

All derivative instruments are required to be reported on the balance sheet at fair value unless the transactions qualify and are designated as normal purchases or sales. Changes in fair value are reported currently through earnings unless they meet hedge accounting criteria. The Company’s designated hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment.

The Company accounts for some of its designated derivative financial instruments as cash flow hedges as defined in Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 815.hedges. For derivative contracts which can be classifiedare designated as a cash flow hedge, the effective potionportion of the change in the fair value of the derivative contract is recorded to accumulatedAccumulated other comprehensive incomeloss (“AOCI”) in the accompanying consolidated balance sheet.sheets. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive incomeAOCI is recorded ininto earnings in the accompanying consolidated statementstatements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. Any ineffective portion of the gain or loss is recognized in the accompanying consolidated statements of income statement under Cost of goods sold for foreign currency (loss) gain or revaluation of derivatives gain (loss).and commodity derivatives. These hedging transactions and the respective correlations meet the requirements for hedge accounting.

Exposure to fluctuations in interest rates and certain commodity prices are managed by entering into swaps with various counterparties. The Company does not enter into derivative transactions for speculative or trading purposes. As part of the hedging program approval process, Gentherm identifies the specific financial risk which the derivative transaction will minimize, the appropriate hedging instrument to be used to reduce the risk and the correlation between the financial risk and the hedging instrument. Hedge positions, as well as the correlation between the transaction risks and the hedging instruments, are reviewed on an ongoing basis.

F-16


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Earnings per Share

Basic earnings per share is computed by dividing net income by the weighted average number of shares of the Company's common stock, no par value ("Common StockStock") outstanding during the respective period. The Company’s diluted earnings per common share give effect to all potential shares of Common Stock outstanding during a period that aredo not anti-dilutive.have an anti-dilutive impact to the calculation. In computing the number of diluted shares outstanding, the treasury stock method is used in order to arrive at a net number of shares created upon the conversion of Common Stock equivalents.

Stock Based Compensation

Share based payments that involve the issuance of Common Stock to employees, including grants of employee stock options, and restricted stock, and time-based and performance-based restricted stock units, are recognized in the consolidated financial statements as compensation expense based upon the fair value on the date of grant.

Share based payments that are satisfied only by the payment of cash, such as stock appreciation rights, are accounted for as liabilities. The liability is reported at market value of the vested portion of the underlying units. During each period, the change in the liability is recorded as compensation expense duringexpense.

Note 3 — New Accounting Pronouncements

Recently Adopted Accounting Pronouncements

The Company considers the applicability and impact of all Accounting Standards Updates ("ASUs") issued by the Financial Accounting Standards Board. ASUs effective in 2023 were assessed and determined to be either not applicable or are not expected to have a significant impact on the Company's consolidated financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted

Segment Reporting

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures". ASU 2023-07 requires a public entity to disclose, on an annual and interim basis, significant segment expenses that are included within each reported measure of segment profit or loss and regularly reviewed by the chief operating decision maker ("CODM"), the title and position of the CODM, clarification regarding the CODM's use of multiple measures of a segment's profit or loss in assessing segment performance (this must include a measure that is consistent with the measurement principles under GAAP, but may also include additional measures of a segment's profit or loss), and a description of the composition of amounts within an "Other" segment line item. Further, ASU 2023-07 requires that all annual disclosures about a reportable segment's profit or loss and assets currently required by Topic 280 to be provided in interim periods. This update is effective for fiscals years beginning after December 15, 2023, and interim periods whenwithin fiscal years beginning after December 15, 2024. ASU 2023-07 should be adopted retrospectively to all periods presented in the liability increases or income during periodsfinancial statements and early adoption is permitted. We are currently in which the liability decreases.  

The Company’s stock based compensation expense and related deferred tax benefit were $12,727 and $4,339, respectively, forprocess of determining the year ended December 31, 2017, $8,147 and $2,891, respectively, forimpact the year ended December 31, 2016, and $12,316 and $3,787, respectively, for the year ended December 31, 2015.

Pension Plans

The Company’s obligations and expenses for its pension plans are dependentimplementation of ASU 2023-07 will have on the Company’s selection of discountfinancial statement disclosures.

Income Taxes

In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures". ASU 2023-09 enhances income tax disclosures to further disaggregate the effective tax rate expected long-term rate of return on plan assetsreconciliation and other assumptions used by actuaries to calculate these amounts.  

Subsequent Events

income taxes paid. This update is effective for fiscal years beginning after December 15, 2024. ASU 2023-09 should be adopted prospectively, but retrospective application is permitted. Further, early adoption is permitted. We have evaluated subsequent events through the date that our consolidated financial statements are issued. No events have occurred that would require adjustment to or disclosurecurrently in the consolidatedprocess of determining the impact the implementation of ASU 2023-09 will have on the Company’s financial statements.statement disclosures.

F-17


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 3 — Details of Certain Financial Statement Components

 

  

December 31,

 

 

  

2017

 

 

2016

 

Inventory:

  

 

 

 

 

 

 

 

Raw materials, net of reserve

  

$

64,175

  

 

$

60,525

  

Work in process, net of reserve

  

 

16,139

  

 

 

13,261

  

Finished goods, net of reserve

  

 

41,095

  

 

 

31,288

  

 

  

$

121,409

  

 

$

105,074

  

Property and equipment:

  

 

 

 

 

 

 

 

Buildings, plant and equipment

  

$

213,329

  

 

$

151,977

  

Automobiles

  

 

1,281

  

 

 

861

  

Production tooling

  

 

16,540

  

 

 

12,991

  

Leasehold improvements

  

 

15,263

  

 

 

11,695

  

Computer equipment and software

  

 

27,880

  

 

 

21,048

  

Construction in progress

  

 

9,405

  

 

 

20,747

  

 

  

 

283,698

  

 

 

219,319

  

Less: Accumulated depreciation *

  

 

(83,404

)

 

 

(47,267

)

 

  

$

200,294

  

 

$

172,052

  

Other intangible assets:

  

 

 

 

 

 

 

 

Customer relationships

  

$

101,213

  

 

$

66,542

  

Technology

  

 

47,641

  

 

 

35,378

  

Product development costs

  

 

12,054

  

 

 

9,602

  

 

  

$

160,908

  

 

$

111,522

  

Less: Accumulated amortization

  

 

(77,622

)

 

 

(53,965

)

 

  

$

83,286

  

 

$

57,557

  

Accrued liabilities:

  

 

 

 

 

 

 

 

Tax accruals

  

$

16,169

  

 

$

51,197

  

Accrued warranty

  

 

5,382

  

 

 

5,443

  

Accrued employee liabilities

  

 

25,503

  

 

 

21,323

  

Liabilities from discounts and rebates

  

 

16,057

  

 

 

13,413

  

Other accrued liabilities

  

 

14,098

  

 

 

14,249

  

 

  

$

77,209

  

 

$

105,625

  

* Includes accumulated amortization of capital lease obligations.

Note 4 — Etratech Acquisition– Acquisitions

Etratech designs, develops, manufacturesAlfmeier Präzision SE

On August 1, 2022, the Company acquired 100% of the equity interests of Alfmeier Präzision SE (“Alfmeier”), a global leader in automotive lumbar and sells electronic control modulesmassage comfort solutions and controla leading provider of advanced valve systems technology, integrated electronics and software. The acquisition further expanded the Company's current value proposition beyond thermal to customers across a rangecomfort, health, wellness, and energy efficiency and aligned with global consumer demand for expanded offerings in vehicle passenger comfort.

The total consideration transferred was $170,700. The results of industries, including automotive, recreational vehiclesAlfmeier's operations are reported within the Automotive segment from the acquisition date.

The following table provides product revenues and marine, HVAC systems and medical, amongst others.  Each function is part of an integrated, customer-focused process designed to exceed customer expectations for product quality, reliability and cost. Etratech’s global manufacturing footprint will enable us to provide customers with scalable and flexible manufacturing solutions across a variety of application and geographies.

Results of operations for Etratechoperating income from Alfmeier that are included in the Company’sour consolidated condensed financial statements beginning November 1, 2017.  Etratech contributed $8,398 in product revenues and a net loss of $510 for the year ended December 31, 2017.  2022, following the August 1, 2022 acquisition date:

 

 

Year Ended December 31,

 

 

 

2022

 

Product revenues

 

$

98,960

 

Net loss

 

 

(2,675

)

F-18


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except shareThe acquisition was accounted for as a business combination. The following table summarizes the final purchase consideration and per share data)

Note 4 – Etratech Acquisition (Continued)

Purchase Price Allocation

The purchase price of $64,994, net of cash acquired of $670, has been allocated to theestimated fair values of assets acquired and liabilities assumed as of November 1, 2017.  the acquisition date:

 

 

Initial Allocation
as of
August 1, 2022

 

 

Measurement Period Adjustments

 

 

Final Allocation

 

Purchase price, consideration, net of cash acquired

 

$

164,887

 

 

$

5,813

 

 

$

170,700

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

24,988

 

 

 

(121

)

 

 

24,867

 

Inventory

 

 

36,026

 

 

 

417

 

 

 

36,443

 

Prepaid expenses and other assets

 

 

20,920

 

 

 

(74

)

 

 

20,846

 

Operating lease right-of-use assets

 

 

4,608

 

 

 

 

 

 

4,608

 

Property and equipment

 

 

89,942

 

 

 

1,242

 

 

 

91,184

 

Other intangible assets

 

 

22,668

 

 

 

8,791

 

 

 

31,459

 

Goodwill

 

 

43,678

 

 

 

(9,707

)

 

 

33,971

 

Assumed liabilities

 

 

(55,994

)

 

 

975

 

 

 

(55,019

)

Deferred tax liabilities

 

 

(21,949

)

 

 

4,290

 

 

 

(17,659

)

Net assets acquired

 

$

164,887

 

 

$

5,813

 

 

$

170,700

 

The following table summarizes the allocation of the purchase price is preliminary. The Company is inconsideration to the process of obtaining additionalother intangible assets acquired:

 

 

Preliminary Fair Value

 

 

Weighted Average Life (in years)

 

Definite-lived:

 

 

 

 

 

 

Customer related

 

$

19,812

 

 

 

14

 

Technology

 

 

11,647

 

 

 

9

 

Total

 

$

31,459

 

 

 

 

Assets acquired and liabilities assumed were recorded at estimated fair values based on third-party valuations, management’s estimates, available information, required to finalize the valuation. An appraisal by an independent third party valuation firm will be completed to assistand supportable assumptions that management in determining theconsidered reasonable.

The fair value of acquiredthe intangible assets was based on third-party valuations and assumed liabilities, including identifiable intangible assets. The final purchase price allocation may be materially different than the preliminary allocation recorded.   The purchase price allocationmanagement’s estimates, generally utilizing income and market approaches. Goodwill recognized in this transaction is expectedprimarily attributable to be finalized by March 31, 2018. The allocation as of November 1, 2017 was as follows:

 

 

 

 

 

Accounts receivable

 

$

12,654

 

Inventory

 

 

7,014

 

Prepaid expenses and other assets

 

 

535

 

Property and equipment

 

 

6,205

 

Customer relationships

 

 

24,774

 

Technology

 

 

8,588

 

Goodwill

 

 

14,866

 

Assumed liabilities

 

 

(9,642

)

Net assets acquired

 

 

64,994

 

Cash acquired

 

 

670

 

Purchase price

 

$

65,664

 

The gross contractual amount due of accounts receivable is $12,654, all of which is expected to be collectible.  

Supplemental Pro Forma Information

The unaudited pro forma combined historical results including the amounts of Etratech revenue and earnings that would have been included in the Company’s consolidated statements of income had the acquisition date been January 1, 2017 or January 1, 2016 are as follows:

expected future

 

 

Twelve Months Ended
December 31,

 

 

 

2017

 

 

2016

 

Product revenues

 

$

1,032,273

 

 

$

966,355

 

Net income

 

$

35,911

 

 

$

77,577

 

Basic earnings per share

 

$

0.98

 

 

$

2.13

 

Diluted earnings per share

 

$

0.98

 

 

$

2.12

 

F-18


The pro forma information includes adjustments for the effect of the amortization of intangible assets recognized in the acquisition.  This pro forma information is not indicative of future operating results.

Goodwill

We recorded goodwill of approximately $14,866 arising from the acquisition. The acquired goodwill represents intangible assets that do not qualify for separate recognition. It is estimated that approximately $8,651 of the goodwill recognized will not be deductible for income tax purposes.  

F-19


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 4 – Etratech Acquisition (Continued)economic benefits from combining operations to offer more compelling and high-value solutions across complementary customer relationships as well as expected future synergies. The goodwill is not expected to be deductible for tax purposes.

Intangible Assets

In conjunction withThe following unaudited pro forma information represents our product revenues and net income as if the acquisition intangible assets of $33,362 were recorded. The Company’s estimateAlfmeier had occurred as of January 1, 2021:

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Product revenues

 

$

1,348,295

 

 

$

1,304,505

 

Net Income

 

 

17,645

 

 

 

92,079

 

Jiangmen Dacheng Medical Equipment Co. Ltd

On July 13, 2022, the Company acquired 100% of the fair valueequity interests of Jiangmen Dacheng Medical Equipment Co. Ltd (“Dacheng”) and its wholly owned subsidiary, IOB Medical, Inc. Dacheng, is a manufacturer of medical materials and medical equipment, including patient temperature management solutions, for numerous local and international customers. The acquisition provided Gentherm Medical a local presence in China’s high-growth market for patient warming devices and other medical device products, and expanded overall manufacturing capacity to include a low-cost manufacturing site.

The total consideration was $35,048. The purchase agreement also included potential cash payments contingent upon the achievement of certain performance metrics and continued employment of the former majority shareholder through a series of defined dates. The achievement of these performance metrics resulted in cash payments of $500. These cash payments were accounted for as compensation expense and recorded as a component of Selling, general and administrative expenses ratably over the service period.

The results of Dacheng's operations are reported within the Medical segment from the acquisition date.

The following table provides product revenues and operating income from Dacheng that are included in our consolidated financial statements for the year ended December 31, 2022, following the July13, 2022 acquisition date:

 

 

Year Ended December 31,

 

 

 

2022

 

Product revenues

 

$

3,499

 

Net Loss

 

 

(217

)

The acquisition was accounted for as a business combination. The following table summarizes the final purchase consideration and estimated fair values of assets at the timeacquired and liabilities assumed as of the acquisition was determined with the assistance of an independent third-party valuation firm. As part of the estimated valuation, an estimated useful life for the assets was determined.

Intangible assets, net consisted of the following:

date:

 

 

December 31, 2017

 

  

Gross Value

  

 

Accumulated
Amortization

 

  

Net Value

  

  

Useful Life

Customer relationships

 

$

24,774

 

 

$

358

 

 

$

24,416

 

 

8 -12 yrs

Technology

 

 

8,588

 

 

 

277

 

 

 

8,311

 

 

5 -6 yrs

Total

 

$

33,362

 

 

$

635

 

 

$

32,727

 

 

 

 

 

Initial Allocation
as of
July 13, 2022

 

 

Measurement Period Adjustments

 

 

Final Allocation

 

Purchase price, cash consideration, net of cash acquired

 

$

35,048

 

 

$

 

 

$

35,048

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

746

 

 

 

(124

)

 

 

622

 

Inventory

 

 

1,942

 

 

 

(177

)

 

 

1,765

 

Prepaid expenses and other assets

 

 

152

 

 

 

22

 

 

 

174

 

Operating lease right-of-use assets

 

 

841

 

 

 

 

 

 

841

 

Property and equipment

 

 

684

 

 

 

 

 

 

684

 

Other intangible assets

 

 

19,094

 

 

 

965

 

 

 

20,059

 

Goodwill

 

 

22,995

 

 

 

(3,464

)

 

 

19,531

 

Assumed liabilities

 

 

(2,799

)

 

 

(515

)

 

 

(3,314

)

Deferred tax liabilities

 

 

(8,607

)

 

 

3,293

 

 

 

(5,314

)

Net assets acquired

 

$

35,048

 

 

$

 

 

$

35,048

 

Amortization expense of $635 for the period November 1, 2017 through December 31, 2017 was recorded as follows:

 

 

Three Months Ended
December 31, 2017

 

Twelve Months Ended
December 31, 2017

 

Product revenues

 

$

358

 

$

358

 

Research and development expenses

 

 

277

 

 

277

 

F-19


Amortization expense for the prospective five years is estimated to be as follows:

2018

 

$

3,769

 

2019

 

$

3,769

 

2020

 

$

3,769

 

2021

 

$

3,706

 

2022

 

$

3,278

 

Property, Plant & Equipment

Property and equipment consist of the following:

Asset category

 

Useful life

 

Amount

 

Leashold improvements

 

10 yrs

 

$

342

 

Machinery and equipment

 

4-11 yrs

 

 

5,248

 

Furniture and fittings

 

4 yrs

 

 

230

 

Motor vehicles

 

3 yrs

 

 

25

 

Computer hardware and software

 

1 yrs

 

 

360

 

 

 

 

 

 

 

 

 

 

 

 

$

6,205

 

F-20


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The following table summarizes the allocation of the purchase consideration to the other intangible assets acquired:

 

 

Preliminary Fair Value

 

 

Weighted Average Life (in years)

 

Definite-lived:

 

 

 

 

 

 

Customer related

 

$

12,837

 

 

 

12

 

Technology

 

 

4,749

 

 

 

12

 

Indefinite-lived:

 

 

 

 

 

 

Tradenames

 

 

2,473

 

 

 

 

Total

 

$

20,059

 

 

 

 

Assets acquired and liabilities assumed were recorded at estimated fair values based on third-party valuations, management’s estimates, available information, and supportable assumptions that management considered reasonable.

The fair value of the intangible assets was based on third-party valuations and management’s estimates, generally utilizing income and market approaches. Goodwill recognized in this transaction is primarily attributable to the Company’s expected future economic benefits from the enhanced access to high-growth markets including private label opportunities through Dacheng’s innovative patient temperature management devices. The goodwill is not expected to be deductible for tax purposes.

The pro forma effects of this acquisition would not materially impact the Company’s reported results for any period presented, and as a result no pro forma financial statements are presented.

Note 5 Income TaxesRestructuring and Impairments

U.S. Tax ReformThe Company continuously monitors market developments, industry trends and changing customer needs and in response, may undertake restructuring actions, as necessary, to execute management’s strategy, streamline operations and optimize the Company’s cost structure. Restructuring actions may include the realignment of existing manufacturing footprint, facility closures, or similar actions, either in the normal course of business or pursuant to significant restructuring programs.

The Tax CutsThese actions may result in employees receiving voluntary or involuntary employee termination benefits, which are mainly statutory requirements or other contractual agreements. Voluntary termination benefits are accrued when an employee accepts the related offer. Involuntary termination benefits are accrued upon the commitment to a termination plan and Jobs Act (the “Tax Act”) was enactedwhen the benefit arrangement is communicated to affected employees, or when liabilities are determined to be probable and estimable, depending on December 22, 2017.  The Tax Act reduces the U.S. federal corporate tax rate from 35% to 21%, requires companies to payexistence of a one-time transition tax on all offshore earnings that were previously tax deferred and creates new taxes on certain foreign sourced earnings.  As of December 31, 2017, in accordance with guidance provided by Staff Accounting Bulletin No. 118 (SAB 118),substantive plan for severance or termination.

2023 Manufacturing Footprint Rationalization

On September 19, 2023, the Company has notcommitted to a restructuring plan (“2023 Plan”) to improve the Company’s manufacturing productivity and rationalize its footprint. Under this 2023 Plan, the Company will relocate certain existing manufacturing and related activities in its Greenville, South Carolina facility to a new facility in Monterrey, Mexico.

The Company expects to incur total costs of between $12,000 and $16,000, of which between $11,000 and $15,000 are expected to be cash expenditures. The total expected costs include employee severance, retention and termination costs of between $2,000 and $4,000, capital expenditures of between $7,000 and $8,000 and non-cash expenses for accelerated depreciation and impairment of fixed assets of approximately $1,000. The Company also expects to incur other transition costs including recruiting, relocation, and machinery and equipment move and set up costs of between $2,000 and $3,000. The actions under this 2023 Plan are expected to be substantially completed its accounting forby the tax effectsend of 2025. The actual timing, costs and savings of the Tax Act; however, in certain cases, as described below,2023 Plan may differ materially from the Company has made a provisional estimate of the effects on our existing deferred tax balancesCompany’s current expectations and the one-time transition tax.  Forestimates.

During the year ended December 31, 2017,2023, the provision for income taxes includes a provisional income taxCompany recognized restructuring expense of $20,153 related to items$538 for which the Company was able to determine a reasonable estimate.  In all cases, we will continue to makeemployee separation costs and refine our calculations as additional analysis is completed.  In addition, the Company’s estimates may be affected as additional regulatory guidance is issued with respect to the Tax Act.  Any adjustments to the provisional amounts will be recognized as a component of the provision$159 for income taxes in the period in which such adjustments are determined, but in any event, no later than the fourth quarter of 2018, in accordance with SAB 118.

Deferred tax assets and liabilities  

The Company remeasured its U.S. deferred tax assets and liabilities at 21%.  However, the Company is still analyzing certain aspects of the Tax Act and refining the calculations, which could potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts.  In the year ended December 31, 2017, the provision for income taxes includes provisional income tax expense of $5,808 related to the remeasurement of deferred tax balances.

Transition Tax on Deferred Foreign Earnings

The one-time transition tax is based on the Company’s post-1986 earnings and profits (“E&P”) that were previously deferred from U.S. income taxes.  In the year ended December 31, 2017, the provision for income taxes includes provisional income tax expense of $23,923 related to the one-time transition tax liability of the Company’s foreign subsidiaries.  The Company has not completed its calculation of the total post-1986 E&P for these foreign subsidiaries.  Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets.  This amount may change when the Company finalizes the calculation of post-1986 E&P previously deferred from U.S. income taxes and the amounts held in cash or other specified assets.  A benefit of $9,578 was included in the provision for income taxes to offset the one-time transition tax related to the previous deferred tax liability that existed for the undistributed foreign earnings that were not permanently reinvested.  However, we continue to recognize a deferred tax liability related to foreign withholding tax that will be incurred for undistributed foreign earnings that are not permanently reinvested.costs.

F-21F-20


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Other Restructuring Activities

Note 5 Income Taxes (Continued)The Company has undertaken several discrete restructuring actions. During the years ended December 31, 2023, 2022 and 2021, the Company recognized $3,208, $56 and $2,192 of employee separation costs, respectively, and $834, $581 and $1,665 of other related costs, respectively. These restructuring expenses were primarily associated with restructuring actions focused on the rotation of our manufacturing footprint to best cost locations and the reduction of global overhead costs.

Restructuring Expenses By Reporting Segment

Restructuring expense by reporting segment for the years ended December 31, 2023, 2022 and 2021 was as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Automotive

 

$

3,187

 

 

$

637

 

 

$

2,793

 

Medical

 

 

363

 

 

 

 

 

 

 

Corporate

 

 

1,189

 

 

 

 

 

 

1,064

 

Total

 

$

4,739

 

 

$

637

 

 

$

3,857

 

Restructuring Liability

The deferred taxfollowing table summarizes restructuring activity for all restructuring initiatives for the years ended December 31, 2023 and 2022:

 

 

Employee Separation Costs

 

 

Other Related Costs

 

 

Total

 

Balance at December 31, 2021

 

$

1,494

 

 

$

 

 

$

1,494

 

Additions, charged to restructuring expenses

 

 

6

 

 

 

581

 

 

 

587

 

Change in estimate

 

 

50

 

 

 

 

 

 

50

 

Cash payments

 

 

(881

)

 

 

(581

)

 

 

(1,462

)

Currency translation and other

 

 

(81

)

 

 

 

 

 

(81

)

Balance at December 31, 2022

 

$

588

 

 

$

 

 

$

588

 

Additions, charged to restructuring expenses

 

 

3,892

 

 

 

993

 

 

 

4,885

 

Change in estimate

 

 

(146

)

 

 

 

 

 

(146

)

Cash payments

 

 

(2,224

)

 

 

(878

)

 

 

(3,102

)

Non-cash utilization

 

 

 

 

 

(115

)

 

 

(115

)

Currency translation and other

 

 

40

 

 

 

 

 

 

40

 

Balance at December 31, 2023

 

$

2,150

 

 

$

 

 

$

2,150

 

Impairments

Non-Automotive Electronics Business

On December 31, 2022, the Company approved a plan to exit its non-automotive electronics business to strengthen the Company’s core business and focus its resources and equipment with businesses and investments that are more strategic and profitable. As of December 31, 2023, the Company has substantially completed the exit of this business.

During the year ended December 31, 2023, the Company recorded non-cash impairment charges of $6,064 for the write down of inventory within the Automotive segment. This charge is recorded in Cost of sales in the accompanying consolidated statements of income.

During the year ended December 31, 2022, the Company recorded non-cash impairment charges of $9,378, $5,601 and $690 for write downs of inventory, intangible assets and deferred tax liabilitiesproperty and related valuation allowance were comprisedequipment, respectively, within the Automotive segment. Write downs of inventory are recorded in Cost of sales and write downs of intangible assets and property and equipment are recorded in Impairment of intangible assets and property and equipment in the following:

accompanying consolidated statements of income.

 

  

December 31,

 

 

  

2017

 

 

2016

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating losses

 

 

12,731

 

 

 

13,643

 

Research and development credits

 

 

27,257

 

 

 

23,012

 

Depreciation

 

 

5,571

 

 

 

5,457

 

Valuation reserves and accrued liabilities

 

 

6,020

 

 

 

9,667

 

Foreign tax credit

 

 

 

 

 

6,926

 

Stock compensation

 

 

3,955

 

 

 

4,508

 

Inventory

 

 

2,062

 

 

 

1,571

 

Patents

 

 

163

 

 

 

218

 

Defined benefit obligation

 

 

1,977

 

 

 

2,306

 

Other credits

 

 

589

 

 

 

639

 

Unrealized foreign currency exchange loss

 

 

2,556

 

 

 

 

Other

 

 

36

 

 

 

116

 

 

 

 

62,917

 

 

 

68,063

 

Valuation allowance

 

 

(27,578

)

 

 

(19,304

)

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Intangible assets

 

 

(2,925

)

 

 

(8,442

)

Unrealized foreign currency exchange gains

 

 

 

 

 

(285

)

Undistributed profits of subsidiary

 

 

(6,450

)

 

 

(12,002

)

Property and equipment

 

 

(1,611

)

 

 

(470

)

Other

 

 

(548

)

 

 

(319

)

 

 

 

(11,534

)

 

 

(21,518

)

Net deferred tax asset

 

$

23,805

 

 

$

27,241

 

F-21


F-22


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Medical Segment

Note 5 Income Taxes (Continued)

Reconciliations between the statutory Federal income tax rate of 34% and the effective rate of income tax expense for each ofDuring the three yearsmonths ended June 30, 2023, the Company determined that there were impairment indicators for its Medical reporting unit and conducted an impairment analysis, following which the Company concluded that $19,509 of goodwill was impaired. Such non-cash impairment charge was recorded in Impairment of goodwill in the period ended December 31, 2017 are as follows:accompanying consolidated statements of income. See Note 7, "Goodwill and Other Intangibles," for additional information about the goodwill impairment.

Note 6 — Details of Certain Financial Statement Components

 

 

December 31,

 

 

 

2023

 

 

2022

 

Inventory:

 

 

 

 

 

 

Raw materials, net

 

$

126,013

 

 

$

136,217

 

Work in process, net

 

 

15,704

 

 

 

17,695

 

Finished goods, net

 

 

64,175

 

 

 

64,336

 

Total inventory, net

 

$

205,892

 

 

$

218,248

 

Other current assets:

 

 

 

 

 

 

Notes receivable

 

$

18,226

 

 

$

12,127

 

Billable tooling

 

 

16,877

 

 

 

15,267

 

Income tax and other tax receivable

 

 

16,017

 

 

 

15,041

 

Short-term derivative financial instruments

 

 

10,717

 

 

 

6,564

 

Prepaid expenses

 

 

7,889

 

 

 

6,239

 

Receivables due from factor

 

 

4,422

 

 

 

5,490

 

Other

 

 

4,272

 

 

 

3,869

 

Total other current assets

 

$

78,420

 

 

$

64,597

 

Property and equipment:

 

 

 

 

 

 

Machinery and equipment

 

$

236,277

 

 

$

214,342

 

Buildings and improvements

 

 

130,374

 

 

 

123,714

 

Information technology

 

 

41,543

 

 

 

39,726

 

Production tooling

 

 

28,033

 

 

 

24,839

 

Leasehold improvements

 

 

12,269

 

 

 

12,271

 

Construction in progress

 

 

27,461

 

 

 

29,023

 

Total property and equipment

 

 

475,957

 

 

 

443,915

 

Less: accumulated depreciation

 

 

(230,723

)

 

 

(199,435

)

Total property and equipment, net

 

$

245,234

 

 

$

244,480

 

Other current liabilities:

 

 

 

 

 

 

Accrued employee liabilities

 

$

43,176

 

 

$

32,031

 

Liabilities from discounts and rebates

 

 

22,916

 

 

 

26,640

 

Income tax and other taxes payable

 

 

19,327

 

 

 

14,459

 

Restructuring

 

 

2,150

 

 

 

588

 

Accrued warranty

 

 

3,945

 

 

 

2,380

 

Other

 

 

9,291

 

 

 

17,716

 

Total other current liabilities

 

$

100,805

 

 

$

93,814

 

 

  

Year Ended December 31,

 

 

  

2017

 

 

2016

 

 

2015

 

Statutory Federal income tax rate

  

 

34.0

%

 

 

34.0

%

 

 

34.0

%

Increase (Decrease) resulting from:

  

 

 

 

 

 

 

 

 

 

 

 

U.S. Taxes on foreign income, net of taxes paid credit

  

 

 

 

 

1.3

%

 

 

1.0

%

Change in valuation allowance

  

 

10.6

%

 

 

5.3

%

 

 

(1.9

%)

Foreign, state and local tax, net of Federal benefit

  

 

0.8

%

 

 

1.1

%

 

 

1.6

%

Nondeductible expenses

  

 

2.4

%

 

 

2.4

%

 

 

1.8

%

Stock option compensation

  

 

(2.2

%)

 

 

 

 

 

(0.1

%)

Research and development credits

  

 

(4.6

%)

 

 

(0.7

%)

 

 

(0.9

%)

Effect of different tax rates of foreign jurisdictions

  

 

(20.8

%)

 

 

(15.0

%)

 

 

(12.1

%)

Undistributed profits of subsidiaries

  

 

5.8

%

 

 

7.9

%

 

 

2.4

%

Tax reform items

  

 

29.1

%

 

 

 

 

 

 

Other tax exempt income

  

 

 

 

 

 

 

 

(0.1

%)

Tax effects of intercompany transfers

  

 

(5.0

%)

 

 

(5.3

%)

 

 

 

Other

  

 

(1.0

%)

 

 

(0.3

%)

 

 

0.3

%

Effective rate

  

 

49.1

%

 

 

30.7

%

 

 

26.0

%

F-22


The Company has Net Operating Loss (“NOL”) carryforwards as follows:

Jurisdiction

  

Amount as of
December 31, 2017

 

  

Years of Expiration

 

U.S. Federal and state income tax

  

$

61,302

 

 

 

2018- 2036

  

Foreign

 

$

12,499

 

 

 

2018-2037

 

Foreign

  

$

24,911

 

 

 

Indefinite

  

A portion of the U.S. Federal NOLs was incurred prior to the June 8, 1999 Preferred Financing, which qualified as a change in ownership under Section 382 of the Internal Revenue Code (“IRC”). Due to this change in ownership, the NOL accumulated prior to the change in control can only be utilized against current earnings up to a maximum annual limitation of approximately $591. As a result of the annual limitation, approximately $6,025 remaining of these carryforwards are expected to expire before ultimately becoming available to reduce future tax liabilities in addition to $13,324 in NOLs generated prior to the change in control which have already expired without being utilized.

We have incurred NOLs in various states associated with the benefits of the state dividends received reduction along with the foreign royalty exclusion.  The state net operating loss carryforwards expire at various dates from 2018 to 2036. Management has concluded that it is more likely than not that a majority of these NOLs will not be utilized, and thus has not recognized the benefit of these NOLs.

At December 31, 2017, certain non-U.S. subsidiaries have net operating loss carryforwards totaling $37,410. This amount includes $12,499 in NOLs that expire at various dates from 2018 through 2037 and the remaining $24,911 have no expiration date. The Company has a valuation allowance recorded against $22,294 of the total non-U.S. subsidiaries’ net operating loss carryforwards as of December 31, 2017. In 2014 through 2017, we incurred NOLs in Vietnam associated with the startup activities of new production facilities. In 2015 through 2016, we incurred a loss in Ukraine associated with foreign currency losses. The remaining NOLs are expected to be utilized in 2018 through 2019 as the locations maintain profitability. We also incur NOLs in Luxembourg associated with our foreign holding company legal structure. Management has concluded that it is more likely than not these NOLs will not be utilized, and thus has not recognized the benefit of these NOLs.

F-23


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 7 — Goodwill and Other Intangibles

Note 5 Income Taxes (Continued)Goodwill

On January 1, 2017, the Company adopted Accounting Standards Update (“ASU”) 2016-09, “Improvements to Employee Share-Based Payment Accounting.”  Under the new standard, income tax benefits and deficiencies are recognized as an income tax expense or benefitChanges in the income statementcarrying amount of goodwill, by reportable segment, for the years ended December 31, 2023 and the tax effects2022 were as follows:

 

 

Automotive

 

 

Medical

 

 

Total

 

Balance as of December 31, 2021

 

$

37,329

 

 

$

28,704

 

 

$

66,033

 

Acquisition of Dacheng

 

 

 

 

 

19,016

 

 

 

19,016

 

Acquisition of Alfmeier

 

 

34,494

 

 

 

 

 

 

34,494

 

Currency translation and other

 

 

1,246

 

 

 

(1,015

)

 

 

231

 

Balance as of December 31, 2022

 

$

73,069

 

 

$

46,705

 

 

$

119,774

 

Impairment of goodwill

 

 

 

 

 

(19,509

)

 

 

(19,509

)

Currency translation and other

 

 

3,627

 

 

 

181

 

 

 

3,808

 

Balance as of December 31, 2023

 

$

76,696

 

 

$

27,376

 

 

$

104,073

 

Other Intangible Assets

Other intangible assets and accumulated amortization balances as of exercised or vested awards should be treatedDecember 31, 2023 and 2022 were as discrete items in the period they occur.  The update also requires the Company to recognize excess tax benefits regardless of whether the benefit reduces taxes payable in the current period. The standard also required a modified retrospective adoption for previously unrecognized excess tax benefits.  Accordingly, the Company recognized a deferred tax asset and a corresponding credit to retained earnings equal to $1,496 in conjunction with the adoption.  The effects of adopting the other provisions of ASU 2016-09 resulted in approximately 2% reduction of the effective tax rate during 2017.follows:

 

 

Gross
Carrying Value

 

 

Accumulated
Amortization

 

 

Net Carrying
Value

 

Definite-lived:

 

 

 

 

 

 

 

 

 

Customer relationships

 

$

115,465

 

 

$

(73,737

)

 

$

41,728

 

Technology

 

 

45,861

 

 

 

(29,317

)

 

 

16,544

 

Product development costs

 

 

19,434

 

 

 

(19,270

)

 

 

164

 

Software development

 

 

1,007

 

 

 

 

 

 

1,007

 

Indefinite-lived:

 

 

 

 

 

 

 

 

 

Tradenames

 

 

7,039

 

 

 

 

 

 

7,039

 

Balance as of December 31, 2023

 

$

188,806

 

 

$

(122,324

)

 

$

66,482

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross
Carrying Value

 

 

Accumulated
Amortization

 

 

Net Carrying
Value

 

Definite-lived:

 

 

 

 

 

 

 

 

 

Customer relationships

 

$

112,286

 

 

$

(65,748

)

 

$

46,538

 

Technology

 

 

44,745

 

 

 

(25,709

)

 

 

19,036

 

Product development costs

 

 

18,774

 

 

 

(18,456

)

 

 

318

 

Software development

 

 

1,007

 

 

 

 

 

 

1,007

 

Indefinite-lived:

 

 

 

 

 

 

 

 

 

Tradenames

 

 

7,034

 

 

 

 

 

 

7,034

 

Balance as of December 31, 2022

 

$

183,846

 

 

$

(109,913

)

 

$

73,933

 

The earnings before income taxes and our tax provision are comprised of the following:

 

  

Year Ended December 31,

 

 

  

2017

 

  

2016

 

  

2015

 

Income before income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

$

1,258

 

 

$

12,981

 

 

$

25,508

 

Foreign

 

 

67,997

 

 

 

97,582

 

 

 

103,430

 

Total income before income taxes

 

$

69,255

 

 

$

110,563

 

 

$

128,938

 

 

  

Year Ended December 31,

 

 

  

2017

 

 

2016

 

 

2015

 

Current income tax expense:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

4,140

 

 

$

9,215

 

 

$

8,428

 

State and local

 

 

150

 

 

 

749

 

 

 

606

 

Foreign

 

 

24,672

 

 

 

32,844

 

 

 

24,622

 

Total current income tax expense

 

$

28,962

 

 

$

42,808

 

 

$

33,656

 

Deferred income tax expense (benefit):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

15,207

 

 

$

(10,597

)

 

$

(3,051

)

State and local

 

 

2,308

 

 

 

(742

)

 

 

(183

)

Foreign

 

 

(12,449

)

 

 

2,496

 

 

 

3,123

 

Total deferred income tax expense

 

$

5,066

 

 

$

(8,843

)

 

$

(111

)

Total tax expense

 

$

34,028

 

 

$

33,965

 

 

$

33,545

 

As of December 31, 2017,2022, the previously recognized deferred taxes related to earnings from foreign subsidiaries has been reversed since allestimated fair value of these earnings are subject to the one-time transition taxMedical reporting unit exceeded its carrying value by less than 10%. During the second quarter of 2023, the Company’s Medical reporting unit did not perform in-line with forecasted results primarily driven by slower than anticipated revenue growth. As a result, an indicator of impairment was identified and are not taxable upon repatriation to the United States.  However, the Company continues to provide a deferred tax liabilityperformed an interim quantitative assessment as of June 30, 2023. The results of this quantitative analysis indicated the carrying value of the reporting unit exceeded the fair value of the reporting unit, and accordingly an impairment expense was recorded for foreign withholding tax that will be incurred with respect to the undistributed foreign earnings that are not permanently reinvested.

The Company is subject to taxation in the United States and various state and foreign jurisdictions. As$19,509. No further impairment was recorded as of December 31, 2017,2023.

The Company utilized an income approach to estimate the Company is no longer subjectfair value of the reporting unit and a market valuation approach to U.S. Federal examinations by tax authorities for tax years before 2014further support this analysis (level 3). The income approach was based on projected debt-free cash flow that was discounted to the present value using discount factors that considered the timing and is no longer subject to foreign examinations by tax authorities for tax years before 2009.risk of cash flows. Fair value was estimated using internally developed forecasts, as well as commercial and discount rate assumptions. The discount rate used was the value-weighted average of

F-24F-23


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

our estimated cost of equity and of debt (“cost of capital”) derived using both known and estimated customary market metrics. Our weighted average cost of capital includes a company specific risk premium to address the risks associated with achieving the projected revenue and profitability growth rates. Other significant assumptions included terminal value growth rates and terminal value margin rates. Our ability to realize the future cash flows used in our calculations is affected by factors such as the success of strategic initiatives, changes in economic conditions, changes in our operating performance and changes in our business strategies. To further support the fair value estimate determined by the income approach, the Company utilized a market valuation approach to estimate the fair value of the Medical reporting unit. The market approach considered historical and anticipated financial metrics of the Medical reporting unit and applied valuation multiples based on recent observed transactions involving companies similar enough to the Medical reporting unit from which to draw meaningful conclusions.

On December 31, 2022, the Company approved a plan to exit its non-automotive electronics business, resulting in an impairment of our customer relationships intangible assets of $5,601. See Note 5, Income Taxes (Continued)"Restructuring and Impairments," for additional information.

During 2015, to enticeIn connection with the acquisition of Alfmeier, the Company to construct a new facility in Macedonia,recorded technology of $11,647 and customer relationships of $19,812. These definite-lived assets are being amortized using the governmentstraight-line method over their estimated useful lives of Macedonia grantedapproximately 9 years and 14 years, respectively.

In connection with the acquisition of Dacheng, the Company a tax holidayrecorded technology of $4,749, customer relationships of $12,837, and indefinite-lived tradenames of $2,473. Technology and customer relationships are definite-lived assets that releasedare being amortized using the Company from the obligation to pay corporate income taxesstraight-line method over their estimated useful lives of approximately 12 years for a ten year period, subject to certain limitations.  The amounteach.

A total of corporate income tax savings realized by the Company as a result$8,290, $9,018, and $8,821 in other intangible assets were amortized in 2023, 2022 and 2021, respectively.

An estimate of this tax holiday during 2017 and 2016, respectively, was zero as a resultfuture amortization of operating losses generated during each period. The aggregate dollar effect and per share effect of the corporate income tax holiday during 2017 and 2016 was, therefore, immaterial.

At December 31, 2017, 2016 and 2015, the Company had total unrecognized tax benefits of $4,522, $4,486 and $4,443, respectively, all of which, if recognized, would affect the effective income tax rates. The reconciliation of the beginning and ending amount of unrecognized tax benefitsother intangible assets, is as follows:

2024

 

$

6,991

 

2025

 

 

6,977

 

2026

 

 

6,541

 

2027

 

 

6,454

 

2028

 

 

6,389

 

Note 8 — Leases

 

  

Year Ended December 31, 

 

 

  

2017

 

  

2016

 

2015

 

Balance at beginning of year

 

$

4,486

 

 

$

4,443

 

$

4,651

 

Additions based on tax position related to current year

 

 

1,758

 

 

 

80

 

 

 

Additions based on tax positions related to prior year

 

 

(4

)

 

 

366

 

 

262

 

Reductions from settlements and statute of limitation expiration

 

 

(2,247

)

 

 

(299

)

 

(19

)

Effect of foreign currency translation

 

 

529

 

 

 

(104

)

 

(451

)

Balance at end of year

 

$

4,522

 

 

$

4,486

 

$

4,443

 

The Company classifies income tax-related penalties and net interest as income tax expense.  InComponents of lease expense for the years ended December 31, 2017, 20162023, 2022 and 2015 income tax related interest and penalties2021 were insignificant. The Company believes that it is reasonably possible that there may be a decrease to its unrecognized tax benefits in the next 12 months due to audit settlements and statute expirations, but the amount expected to reverse is insignificant in relation to the consolidated financial statements.as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Lease cost:

 

 

 

 

 

 

 

 

 

Operating lease cost

 

$

9,606

 

 

$

8,040

 

 

$

8,227

 

Amortization of ROU assets - finance leases

 

 

390

 

 

 

168

 

 

 

 

Interest on lease liabilities - finance leases

 

 

28

 

 

 

16

 

 

 

 

Short-term lease cost

 

 

2,651

 

 

 

1,773

 

 

 

1,941

 

Sublease income

 

 

 

 

 

(101

)

 

 

(163

)

Total lease cost

 

$

12,675

 

 

$

9,896

 

 

$

10,005

 

F-25

F-24


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Other information related to leases is as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

 

 

Operating cash flows for operating leases

 

$

9,249

 

 

$

10,381

 

Operating cash flows for finance leases

 

 

81

 

 

 

16

 

Financing cash flows for finance leases

 

 

390

 

 

 

164

 

Right-of-use lease assets obtained in exchange for lease obligations:

 

 

 

 

 

 

Operating leases

 

$

4,704

 

 

$

15,902

 

Finance leases

 

 

 

 

 

1,180

 

 

 

 

 

 

 

 

 

 

December 31, 2023

 

 

December 31, 2022

 

Weighted average remaining lease term:

 

 

 

 

 

 

Operating leases

 

5.6 years

 

 

5.7 years

 

Finance leases

 

1.9 years

 

 

2.7 years

 

Weighted average discount rate:

 

 

 

 

 

 

Operating leases

 

 

4.96

%

 

 

4.35

%

Finance leases

 

 

3.53

%

 

 

3.57

%

A summary of operating leases as of December 31, 2023, under all non-cancellable operating leases with terms exceeding one year is as follows:

2024

 

$

8,533

 

2025

 

 

5,588

 

2026

 

 

3,656

 

2027

 

 

2,027

 

2028

 

 

1,798

 

2029 or later

 

 

5,827

 

Total future minimum lease payments

 

 

27,429

 

Less imputed interest

 

 

(3,554

)

Total

 

$

23,875

 

A summary of finance leases as of December 31, 2023, under all non-cancellable finance leases with terms exceeding one year is as follows:

2024

 

$

388

 

2025

 

 

152

 

2026

 

 

70

 

2027

 

 

 

Total future minimum lease payments

 

 

610

 

Less imputed interest

 

 

(5

)

Total

 

$

605

 

F-25


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 6 9 Debt

The following table summarizes the Company’s debt as of December 31, 2023 and 2022:

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

 

Interest
Rate

 

 

Principal
Balance

 

 

Interest
Rate

 

 

Principal
Balance

 

Credit Agreement:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Revolving Note (U.S. Dollar denominations)

 

 

6.58

%

 

$

222,000

 

 

 

5.80

%

 

$

232,000

 

Other loans

 

 

3.90

%

 

 

233

 

 

3.89% - 5.21%

 

 

 

2,011

 

Finance leases

 

 

3.53

%

 

 

605

 

 

 

3.57

%

 

 

1,085

 

Total debt

 

 

 

 

 

222,838

 

 

 

 

 

 

235,096

 

Current maturities

 

 

 

 

 

(621

)

 

 

 

 

 

(2,443

)

Long-term debt, less current maturities

 

 

 

 

$

222,217

 

 

 

 

 

$

232,653

 

Credit Agreement

TheOn June 10, 2022, the Company together with certain directentered into a Second Amended and indirect subsidiaries, have an outstanding credit agreementRestated Credit Agreement (the “Credit“Second Amended and Restated Credit Agreement”) with a consortium of lenders and Bank of America, N.A., as administrative agent.agent (the “Agent”). The Second Amended and Restated Credit Agreement amended and restated in its entirety the Amended and Restated Credit Agreement dated June 27, 2019, by and among Gentherm, certain of its direct and indirect subsidiaries, the lenders party thereto and the Agent.

The Second Amended and Restated Credit Agreement provides the Companyfor a $500,000 secured revolving credit note (“U.S. Revolving Note”facility (the “Revolving Credit Facility”) (a $25,000 increase from the revolving credit facility under the Amended and Restated Credit Agreement), with a maximum borrowing capacity$50,000 sublimit for swing line loans and a $15,000 sublimit for the issuance of $350,000.standby letters of credit. Any amount of the facility utilized for swing line loans or letters of credit outstanding will reduce the amount available under the Second Amended and Restated Credit Agreement. The Company had no outstanding letters of credit issued as of December 31, 2023 and 2022.

All subsidiarySubject to specified conditions, Gentherm can increase the Revolving Credit Facility or incur secured term loans in an aggregate amount of up to $200,000. The Second Amended and Restated Credit Agreement extended the maturity of the Revolving Credit Facility from June 27, 2024 to June 10, 2027.

The U.S. borrowers and guarantors participating in the Second Amended and Restated Credit Agreement havealso entered into a related pledgeSecond Amended and security agreement.Restated Pledge and Security Agreement (the “Second Amended and Restated Security Agreement”). The security agreementSecond Amended and Restated Security Agreement grants a security interest to the lendersAgent in substantially all of the personal property of the Company and its U.S. subsidiaries designated as borrowers to secure their respective obligations under the CreditSecond Amended and Restated Security Agreement, including the stock and membership interestinterests of specified subsidiaries (limited to 66%66% of the stock in the case of certain non-U.S. subsidiaries). TheIn addition to the security obligations, all obligations under the Second Amended and Restated Credit Agreement (including all obligations of any U.S. or non-U.S. loan party) are unconditionally guaranteed by certain of Gentherm’s domestic subsidiaries, and the German subsidiary borrowers and certain other foreign subsidiaries guarantee all obligations of the non-U.S. loan parties under the Second Amended and Restated Credit Agreement. The Second Amended and Restated Credit Agreement restricts, among other things, the amount of dividend payments the Company can make to shareholders.

The Second Amended and Restated Credit Agreement requirescontains covenants, that, among other things, (i) prohibit or limit the Companyability of the borrowers and any material subsidiary to incur additional indebtedness, create liens, pay dividends, make certain types of investments (including acquisitions), enter into certain types of transactions with affiliates, prepay other indebtedness, sell assets or enter into certain other transactions outside the ordinary course of business, and (ii) require that Gentherm maintain a minimum Consolidated Interest Coverage Ratio and a maximum Consolidated Net Leverage Ratio. DefinitionsRatio (based on consolidated EBITDA for these financial ratios are providedthe applicable trailing four fiscal quarters) as of the end of any fiscal quarter. The Second Amended and Restated Credit Agreement also contains customary events of default. As of December 31, 2023, the Company was in compliance with the terms of the Second Amended and Restated Credit Agreement. The Second Amended and Restated Credit Agreement additionally contains customary

F-26


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

events of default. Upon the occurrence of an event of default, the amounts outstanding under the Revolving Credit Facility may be accelerated and may become immediately due and payable.

Under the Second Amended and Restated Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or EurocurrencyTerm SOFR rate (“EurocurrencyTerm SOFR Rate Loans”), plus a margin (“Applicable Rate”). The base rate for Base Rate Loans is equal to the highest of the Federal Funds Rate (1.33% at December 31, 2017) plus 0.50%0.50%, Bank of America’s prime rate, (4.50% at December 31, 2017), or a one month Eurocurrencythe Term SOFR rate (0.00% at December 31, 2017) plus 1.00%1.00%. The Eurocurrency rate for loansTerm SOFR Rate Loans denominated in U.S. Dollars is equal to the London Interbank Offeredforward-looking Secured Overnight Financing Rate (1.56% at December 31, 2017).(“SOFR”) term rate administered by the CME with a term of one month. All loans denominated in a currency other than the U.S. Dollar must be EurocurrencyTerm SOFR Rate Loans. Interest is payable at least quarterly. Additionally, a commitment fee of between 0.175% to 0.300%, which will vary based on the Consolidated Net Leverage Ratio, as defined in the Second Amended and Restated Credit Agreement, is payable on the average daily unused amounts under the Revolving Credit Facility.

The Applicable Rate varies based on the Consolidated Net Leverage Ratio reported by the Company. As long as the Company is not in default of the terms and conditions of the Second Amended and Restated Credit Agreement, the lowest and highest possible Applicable Rate is 1.25%1.125% and 2.00%2.125%, respectively, for EurocurrencyTerm SOFR Rate Loans and 0.25%0.125% and 1.00%1.125%, respectively, for Base Rate Loans.

The Company also has two fixed interest rate loans with the German Investment Corporation (“DEG”), a subsidiary of KfW banking group, a German government-owned development bank.

DEG China Loan

The first, a loan we used to fund capital investments in China (the “DEG China Loan”),Borrowing availability is subject to, semi-annual principal payments that began March, 2015among other things, the Company’s compliance with the minimum Consolidated Interest Coverage Ratio and end September, 2019.  Under the termsmaximum Consolidated Net Leverage Ratio as of the DEG China Loan,end of any fiscal quarter. Based upon consolidated EBITDA for the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio, as defined by the DEG China Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Automotive Systems (China) Ltd.


F-26


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 6 — Debt (Continued)

DEG Vietnam Loan

The Company’s second fixed interest rate senior loan agreement with DEG was used to finance the construction and set uptrailing four fiscal quarters calculated for purposes of the Vietnam production facility (“DEG Vietnam Loan”).  The DEG Vietnam Loan is subject to semi-annual principal payments that began November, 2017 and will end May, 2023.  Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum CurrencyConsolidated Net Leverage Ratio, Equity Ratio and Enhanced Equity Ratio, as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.

As of December 31, 2017, we were in compliance with all terms as outlined in the Credit Agreement, DEG China Loan and DEG Vietnam Loan. Undrawn borrowing capacity under the U.S. Revolving Note was $220,859$278,000 remained available as of December 31, 2017. The following table summarizes2023 for additional borrowings under the Company’sSecond Amended and Restated Credit Agreement subject to specified conditions that Gentherm currently satisfies.

In connection with the Second Amended and Restated Credit Agreement, the Company incurred debt atissuance costs of $1,520, which have been capitalized and are amortized into interest expense over the term of the Revolving Credit Facility. In addition, unamortized deferred debt issuance costs of $144 were written-off and recognized in Interest expense, net during the twelve months ended December 31, 2017.

2022.

 

Interest
Rate

 

 

Principal
Balance

 

Credit Agreement:

 

 

 

 

 

 

 

U.S. Revolving Note (U.S. Dollar Denominations)

 

3.07

%

 

$

129,000

 

DEG China Loan

 

4.25

%

 

 

1,919

 

DEG Vietnam Loan

 

5.21

%

 

 

13,750

 

Total debt

 

 

 

 

$

144,669

 

Current portion

 

 

 

 

 

(3,460

)

Long-term debt, less current maturities

 

 

 

 

$

141,209

 

The following table summarizes the Company’s debt at December 31, 2016.

 

Interest
Rate

 

 

Principal
Balance

 

Credit Agreements:

 

 

 

 

 

 

 

U.S. Revolving Note (U.S. Dollar Denominations)

 

2.27

%

 

 

154,000

 

DEG China Loan

 

4.25

%

 

 

2,525

 

DEG Vietnam Loan

 

5.21

%

 

 

15,000

 

Total debt

 

 

 

 

$

171,525

 

Current portion

 

 

 

 

 

(2,092

)

Long-term debt, less current maturities

 

 

 

 

$

169,433

 

The scheduled principal maturities of our debt as of December 31, 2017 is2023 were as follows:

 

 

U.S.
Revolving
Note

 

 

Other Debt

 

 

Total

 

2024

 

$

 

 

$

621

 

 

$

621

 

2025

 

 

 

 

 

152

 

 

 

152

 

2026

 

 

 

 

 

70

 

 

 

70

 

2027

 

 

222,000

 

 

 

 

 

 

222,000

 

2028

 

 

 

 

 

 

 

 

 

Total

 

$

222,000

 

 

$

843

 

 

$

222,843

 

Note 10 Pension and Other Post Retirement Benefit Plans

The Company maintains a U.S. defined benefit pension plan covering its former Chief Executive Officer (“U.S. Plan”) and a German defined benefit pension plan covering certain retired executive employees of the Company’s wholly owned subsidiary, Gentherm GmbH (“German Plan”).

Year

 

U.S.
Revolving
Note

 

 

DEG China Loan

 

 

DEG Vietnam Loan

 

 

Total

  

2018

 

$

 

 

$

960

 

 

$

2,500

 

 

$

3,460

 

2019

 

 

 

 

 

959

 

 

 

2,500

 

 

 

3,459

 

2020

 

 

 

 

 

 

 

 

2,500

 

 

 

2,500

 

2021

 

 

129,000

 

 

 

 

 

 

2,500

 

 

 

131,500

 

2022

 

 

 

 

 

 

 

 

2,500

 

 

 

2,500

 

Thereafter

 

 

 

 

 

 

 

 

1,250

 

 

 

1,250

 

Total

 

$

129,000

 

 

$

1,919

 

 

$

13,750

 

 

$

144,669

 

F-27


F-27


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 7 AccountingThe components of net periodic benefit cost for Stock Based Compensation

On May 16, 2013, the Compensation Committee of the Company’s Board of Directors (the “Board”) approved the Gentherm Incorporated 2013 Equity Incentive Plan (the “2013 Plan”), covering 3,500,000 shares of our Common Stock.  On May 19, 2017 the 2013 Plan was amended, increasing the amount of available shares by 2,000,000. The 2013 Plan permits the granting of various awards including stock options (including both nonqualified options and incentive options), stock appreciation rights (“SARs”), restricted stock and restricted stock units, performance shares and certain other awards to employees, outside directors and consultants and advisors of the Company. All shares of our Common Stock that remained available for issuance under the Amended and Restated 2006 Stock Incentive Plan (the “2006 Plan”) and the Gentherm Incorporated 2011 Equity Incentive Plan (the “2011 Plan), were reduced to zero; however, some options under the 2011 and 2006 Plans are still outstanding.  As of December 31, 2017 the Company had an aggregate of 1,751,554 shares of Common Stock available to issue under the 2013 Plan.

Alldefined benefit plans are administered by the Compensation Committee of the Board. The selection of participants, allotment of shares, determination of price and other conditions are determined by the Compensation Committee at its sole discretion, in order to attract and retain personnel instrumental to the success of the Company.  Stock options, for example, granted under such plans have lives for a period of up to ten years from the date of grant at an exercise price which is not less than the fair market value of the Common Stock on the date of the grant.

During the three year period ended December 31, 2017, the Company has issued stock options, stock appreciation rights (“SARs”) and restricted stock awards to employees, directors and consultants.  These awards become available to the recipient upon the satisfaction of a vesting condition, either based on a period of service or based on the performance of a specific achievement.  For equity based awards with a service condition, the requisite service period typically ranges between three to five years for employees and consultants and one year for directors. As of December 31, 2017, no performance based, unvested stock options, SARs or restricted stock were outstanding. All other outstanding, unvested equity based awards were service based.  Equity based award vesting may be accelerated at the discretion of the Board.

Total unrecognized compensation cost related to nonvested options, restricted stock and SARs outstanding under all of the Company’s equity plans was $18,593 and $17,258 as of December 31, 2017 and 2016, respectively. That cost is expected to be recognized over a weighted average period of three years. Compensation expense for the years ended December 31, 2017, 20162023, 2022 and 2015 was $12,727, $8,1472021 were as follows:

 

 

U.S. Plan

 

 

German Plan

 

 

 

Year Ended December 31,

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

2023

 

 

2022

 

 

2021

 

Net periodic benefit cost:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service cost

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

Interest cost

 

 

115

 

 

 

56

 

 

 

42

 

 

 

217

 

 

 

92

 

 

 

91

 

Expected return on plan assets

 

 

 

 

 

 

 

 

 

 

 

(115

)

 

 

(109

)

 

 

(120

)

Amortization of prior service cost and actuarial loss

 

 

 

 

 

22

 

 

 

26

 

 

 

23

 

 

 

114

 

 

 

133

 

Net periodic benefit cost

 

$

115

 

 

$

78

 

 

$

68

 

 

$

125

 

 

$

97

 

 

$

104

 

Assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount rate

 

 

4.65

%

 

 

1.80

%

 

 

1.20

%

 

 

4.10

%

 

 

1.08

%

 

 

1.06

%

Long-term return on assets

 

N/A

 

 

N/A

 

 

N/A

 

 

 

3.20

%

 

 

2.90

%

 

 

2.90

%

A reconciliation of the change in benefit obligation and $12,316, respectively.   No share-based payment arrangements expired during the three-year periodchange in plan assets for the years ended December 31, 2017.  If Gentherm were2023 and 2022 is as follows:

 

 

U.S. Plan

 

 

German Plan

 

 

 

As of December 31,

 

 

As of December 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Change in projected benefit obligation:

 

 

 

 

 

 

 

 

 

 

 

 

Balance at beginning of year

 

$

2,811

 

 

$

3,446

 

 

$

5,398

 

 

$

8,102

 

Interest cost

 

 

115

 

 

 

56

 

 

 

217

 

 

 

92

 

Paid pension distributions

 

 

(342

)

 

 

(342

)

 

 

(290

)

 

 

(281

)

Actuarial loss (gain)

 

 

18

 

 

 

(349

)

 

 

(89

)

 

 

(2,001

)

Exchange rate impact

 

 

 

 

 

 

 

 

170

 

 

 

(514

)

Balance at end of year

 

$

2,602

 

 

$

2,811

 

 

$

5,406

 

 

$

5,398

 

Change in plan assets:

 

 

 

 

 

 

 

 

 

 

 

 

Balance at beginning of year

 

 

 

 

 

 

 

 

3,918

 

 

 

4,069

 

Actual return on plan assets

 

 

 

 

 

 

 

 

98

 

 

 

89

 

Contributions

 

 

 

 

 

 

 

 

 

 

 

 

Paid pension distributions

 

 

 

 

 

 

 

 

 

 

 

 

Exchange rate impact

 

 

 

 

 

 

 

 

129

 

 

 

(240

)

Balance at end of year

 

$

 

 

$

 

 

$

4,145

 

 

$

3,918

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Underfunded Status

 

$

(2,602

)

 

$

(2,811

)

 

$

(1,261

)

 

$

(1,480

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance sheet classification:

 

 

 

 

 

 

 

 

 

 

 

 

Other current liabilities

 

$

(357

)

 

$

(342

)

 

$

(297

)

 

$

(314

)

Pension benefit obligation

 

 

(2,245

)

 

 

(2,469

)

 

 

(964

)

 

 

(1,166

)

Accumulated other comprehensive loss (pre-tax):

 

 

 

 

 

 

 

 

 

 

 

 

Actuarial losses

 

 

223

 

 

 

205

 

 

 

899

 

 

 

965

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

Discount rate

 

 

4.45

%

 

 

4.65

%

 

 

4.56

%

 

 

4.10

%

Pre-tax amounts included in AOCI that are expected to realize expired shared-based payment arrangements, they would be reportedrecognized in net periodic benefit cost during the year ended December 31, 2024 are as a forfeit in the activity roll forward tables below.follows:

 

 

U.S Plan

 

 

German Plan

 

Actuarial losses

 

$

 

 

$

20

 

F-28


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 7 Accounting for Stock Based Compensation (Continued)

Stock Options

The following table summarizes stock option activity during the three year period ended December 31, 2017:

Options

  

Shares

 

 

Weighted-
Average
Exercise
Price

 

  

Weighted-
Average
Remaining
Contractual
Term

 

  

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2014

  

 

1,674,534

  

 

$

19.14

  

  

 

 

  

  

 

 

 

Granted

  

 

524,534

  

 

 

41.97

  

  

 

 

 

  

 

 

 

Exercised

  

 

(571,723

)

 

 

16.21

  

  

 

 

 

  

 

 

 

Forfeited

  

 

(96,500

)

 

 

28.47

  

  

 

 

 

  

 

 

 

Outstanding at December 31, 2015

  

 

1,530,845

  

 

$

27.46

  

  

 

4.97

 

 

$

30,573

 

Granted

  

 

862,000

  

 

 

40.87

  

  

 

 

 

  

 

 

 

Exercised

  

 

(112,875

)

 

 

13.24

  

  

 

 

 

  

 

 

 

Forfeited

  

 

(176,500

)

 

 

39.32

  

  

 

 

 

  

 

 

 

Outstanding at December 31, 2016

  

 

2,103,470

 

 

$

32.72

 

 

 

4.86

 

 

$

12,265

 

Granted

  

 

808,500

  

 

 

37.23

  

  

 

 

 

  

 

 

 

Exercised

  

 

(202,328

)

 

 

13.62

  

  

 

 

 

  

 

 

 

Forfeited

  

 

(57,500

)

 

 

42.54

  

  

 

 

 

  

 

 

 

Outstanding at December 31, 2017

  

 

2,652,142

 

 

$

35.34

 

 

 

4.76

 

 

$

6,964

 

Exercisable at December 31, 2015

  

 

439,561

 

 

$

12.18

 

 

 

3.51

 

 

$

15,480

 

Exercisable at December 31, 2016

  

 

675,152

 

 

$

21.40

 

 

 

3.45

 

 

$

9,646

 

Exercisable at December 31, 2017

  

 

984,374

 

 

$

29.84

 

 

 

3.44

 

 

$

6,534

 

The fair value of each option is estimated on the date of grant using the Black-Scholes option-pricing model in order to measure the compensation cost associated with the award. This model incorporates certain assumptions for inputs including a risk-free interest rate, expected dividend yield of the underlying Common Stock, expected option life and expected volatility in the market value of the underlying Common Stock. The following assumptionsaccumulated benefit obligations were used for options issued in the following periods:

 

  

2017

 

2016

 

2015

Expected volatility

  

33%

 

37%

 

35%

Weighted average expected volatility

  

33%

 

37%

 

35%

Expected lives

  

3 yrs.

 

3 yrs.

 

3 yrs.

Risk-free interest rate

  

1.49-1.93%

 

0.90-1.07%

 

1.00%

Expected dividend yield

  

none

 

none

 

none

Expected volatilities are based on the historical volatility of the Company’s Common Stock. The Company uses historical exercise data and several other factors in developing an assumption for the expected lives of stock options, including the average holding period of outstanding options and their remaining terms.  The risk-free interest rate is based upon quoted market yields for United States Treasury debt securities. The expected dividend yield is based upon the Company’s history of having never issued a dividend, the limitations to issue a dividend under terms of the Credit Agreement and management’s current expectation regarding future dividends. We do not expect any of the options granted to be forfeited for purposes of computing fair value.

The weighted-average grant-date fair value of options granted during the year ended December 31, 2017, 2016 and 2015 was $9.11, $10.74 and $10.60, respectively. The total intrinsic value of options exercised during the year ended December 31, 2017, 2016 and 2015 was $4,715, $2,456 and $18,745, respectively.

F-29


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 7 Accounting for Stock Based Compensation (Continued)

Restricted Stock

The following table summarizes restricted stock activity during the three year period ended December 31, 2017:

Unvested Restricted Shares

  

Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Nonvested at December 31, 2014

  

 

177,084

 

 

23.70

 

Granted

  

 

108,026

 

 

 

44.01

 

Vested

  

 

(82,084

)

 

 

23.86

 

Forfeited

  

 

(24,000

)

 

 

30.87

 

Outstanding at December 31, 2015

  

 

179,026

 

 

$

34.92

 

Granted

  

 

141,784

 

 

 

39.73

 

Vested

  

 

(100,330

)

 

 

32.47

 

Forfeited

  

 

(9,999

)

 

 

40.99

 

Outstanding at December 31, 2016

  

 

210,481

 

 

$

39.02

 

Granted

  

 

237,542

 

 

 

37.30

 

Vested

  

 

(165,923

)

 

 

37.99

 

Forfeited

  

 

 

 

 

 

Outstanding at December 31, 2017

  

 

282,100

 

 

$

38.06

 

The compensation cost associated with restricted shares is estimated on the date of grant using quoted market prices (Level 1 input). The total fair value of restricted shares vested in 2017, 2016 and 2015 was $6,006, $3,865 and $4,088, respectively.

Stock Appreciation Rights

The following table summarizes SARs activity during the three year period ended December 31, 2017:

Stock Appreciation Rights

  

Units

 

 

Weighted-
Average
Exercise
Price

 

  

Weighted-
Average
Remaining
Contractual
Term

 

  

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2014

  

 

1,060,250

 

 

$

29.97

 

 

 

 

 

 

 

 

 

Granted

  

 

259,600

 

 

 

43.97

 

 

 

 

 

 

 

 

 

Exercised

  

 

(167,500

)

 

 

23.90

 

 

 

 

 

 

 

 

 

Forfeited

  

 

(102,500

)

 

 

27.82

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2015

  

 

1,049,850

 

 

$

34.61

 

 

 

5.46

 

 

$

13,425

 

Granted

 

 

244,000

 

 

 

40.64

 

 

 

 

 

 

 

 

 

Exercised

 

 

(18,750

)

 

 

24.28

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(30,500

)

 

 

28.23

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2016

  

 

1,244,600

 

 

$

36.11

 

 

 

4.80

 

 

$

3,511

 

Granted

 

 

235,000

 

 

 

38.05

 

 

 

 

 

 

 

 

 

Exercised

 

 

(94,250

)

 

 

22.21

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(193,000

)

 

 

32.53

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

 

1,192,350

 

 

$

38.17

 

 

 

4.36

 

 

$

2,278

 

Exercisable at December 31, 2015

  

 

153,575

 

 

$

38.12

 

 

 

5.59

 

 

$

1,425

 

Exercisable at December 31, 2016

  

 

424,992

 

 

$

34.49

 

 

 

4.39

 

 

$

2,315

 

Exercisable at December 31, 2017

  

 

613,808

 

 

$

37.68

 

 

 

3.72

 

 

$

1,904

 

F-30


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 7 Accounting for Stock Based Compensation (Continued)

The total intrinsic value of SARs converted during the year ended December 31, 2017, 2016 and 2015 was $1,495, $261 and $4,185, respectively.

Note 8 Earnings Per Share

The Company’s diluted earnings per share give effect to all potential common shares outstanding during a period that do not have an anti-dilutive impact to the calculation. The following summarizes the shares included in the dilutive shares as disclosed in the statements of income:  

 

 

Year ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Weighted average number of shares for calculation of basic EPS – Common Stock

 

 

36,720,749

 

 

 

36,448,138

 

 

 

36,031,792

 

Stock options under equity incentive plans

 

 

92,970

 

 

 

152,665

 

 

 

443,310

 

Weighted average number of shares for calculation of diluted EPS – Common Stock

 

 

36,813,719

 

 

 

36,600,803

 

 

 

36,475,102

 

The accompanying table represents Common Stock issuable upon the exercise of certain stock options and that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive.

 

  

Year ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Stock options outstanding for equity incentive plans

 

 

2,055,784

 

 

 

1,314,784

 

 

 

17,534

 

See Note 7 for information about the Company’s different equity incentive plans.

Note 9 Commitments and contingencies  

The Company’s operating leases cover primarily buildings and underlying real estate, software subscriptions, office equipment and automobiles. We do not have lease arrangements with related parties. A summary of lease and construction commitments as of December 31, 2017, under all non-cancelable operating leases with terms exceeding one year is as follows:

 

  

 

 

2018

  

$

10,630

  

2019

  

 

6,966

  

2020

  

 

3,629

  

2021

  

 

2,106

  

2022

  

 

1,916

  

2023 or later

  

 

3,811

  

Total

  

$

29,058

  

 

 

U.S. Plan

 

 

German Plan

 

 

 

As of December 31,

 

 

As of December 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Accumulated benefit obligation

 

$

2,602

 

 

$

2,811

 

 

$

5,406

 

 

$

5,398

 

The Company does not have any outstanding capital lease agreements or purchase obligations that exceed one year. Rent expense under all of the Company’s operating leases was $8,424, $7,479 and $6,660 for 2017, 2016 and 2015, respectively.

WeInterest costs are subject to litigation from time to time in the ordinary course of our business; however there is no current material pending litigation to which we are a party as of December 31, 2017 and 2016, respectively.  No material legal proceeding was terminated, settled or otherwise resolved during the fiscal year ended December 31, 2017 and 2016, respectively.

F-31


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 10 Shareholder Rights Plan

The Company’s Board has the authority to issue up to 4,991,000 shares of Preferred Stock and to determine the price, rights (including conversion rights), preferences and privileges of those shares without any further vote or action by the shareholders. Consistent with this authority, in January, 2009 our Board adopted a Shareholder Rights Plan (as amended the “Rights Plan”) in which one purchase right was distributed as a dividend on each share of Common Stock held of record as of the close of business on February 10, 2009 (the “Rights”). The Rights Plan will expire in January, 2019. If exercisable, each Right will entitle its holder to purchase from the Company one one-thousandth of a share of a newly created Series B Preferred Stock of the Company for $20.00 (the “Purchase Price”). The Rights will become exercisable if any person or group becomes the beneficial owner of 15% or more of the Company’s Common Stock or has commenced a tender or exchange offer which, if consummated, would result in any person or group becoming the beneficial owner of 15% or more of the Company’s Common Stock. If any person or group becomes the beneficial owner of 15% or more of the Company’s Common Stock, each right will entitle its holder, other than the acquiring person, to purchase a number of shares of the Company’s or the acquirer’s Common Stock having a value of twice the Purchase Price. The Rights are deemed attached to the certificates representing outstanding shares of Common Stock.

Note 11 Segment Reporting

Segment information is used by management for making operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss (see Note 2). As discussed in Note 4, Gentherm acquired Etratech on November 1, 2017. The acquisition enhances key elements of our business strategy by greatly expanding our knowledge and capability to produce in-house electronic components for next generation intelligent thermal management products.

The Company’s reportable segments are as follows:

Automotive — this segment represents the design, development, manufacturing and sales of automotive seat comfort systems, specialized automotive cable systems and certain automotive and non-automotive thermal convenience products. All of our activities with respect to electronics are also included in our Automotive segment because a majority of these activities relate to the manufacture of electronic components for our automotive products or the automotive products of third parties. Etratech’s operating results are included within Gentherm’s Automotive segment due to the concentration of Etratech’s product applications within the automotive, RV and marine industries.

Industrial — the combined operating results of GPT, CSZ and Gentherm’s advanced research and development division.  Advanced research and development includes efforts focused on improving the efficiency of thermoelectric technologies and advanced heating wire technology as well as other applications. Unlike research and development that relates to a specific product application for a customer, advanced research and development activities affect products and technologies that aren’t currently generating product revenue. The segment includes government sponsored research projects.

Reconciling Items — include corporate selling, general and administrative costs and acquisition transaction costs.

F-32


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 11 — Segment Reporting (Continued)

The tables below present segment information about the reported product revenues and operating income of the Company for years ended December 31, 2017, 2016 and 2015. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level. As of December 31, 2017, goodwill assigned to our Automotive and Industrial segments were $38,912 and $30,773, respectively.  As of December 31, 2016, goodwill assigned to our Automotive and Industrial segments were  $20,962 and $30,773, respectively.  

 

  

Automotive

 

  

Industrial

 

  

Reconciling
Items

 

 

Consolidated
Total

 

2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

879,457

 

 

$

106,226

 

 

$

 

 

$

985,683

 

Depreciation and amortization

 

 

36,801

 

 

 

5,399

 

 

 

2,772

 

 

 

44,972

 

Operating income (loss)

 

 

166,604

 

 

 

(14,751

)

 

 

(54,529

)

 

 

97,324

 

2016:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

847,428

 

 

$

70,172

 

 

$

 

 

$

917,600

 

Depreciation and amortization

 

 

31,826

 

 

 

3,789

 

 

 

2,149

 

 

 

37,764

 

Operating income (loss)

 

 

174,027

 

 

 

(16,702

)

 

 

(51,206

)

 

 

106,119

 

2015:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

810,567

 

 

$

45,878

 

 

$

 

 

$

856,445

 

Depreciation and amortization

 

 

27,251

 

 

 

1,726

 

 

 

2,052

 

 

 

31,029

 

Operating income (loss)

 

 

170,358

 

 

 

(2,461

)

 

 

(46,578

)

 

 

121,319

 

The Industrial operating loss is net of reimbursement for developmental expense of $2,116, $641 and $2,483 for the years ended 2017, 2016 and 2015, respectively. Reconciling items include selling, general and administrative costs of $43,457, $39,059 and $32,116, respectively, for the years ended December 31, 2017, 2016 and 2015 and acquisition costs of  $789, $743 and $0 for the years ended December 31, 2017, 2016 and 2015, respectively.

Revenue (based on shipment destination) by geographic area is as follows:

 

 

2017

 

 

%

 

 

2016

 

 

%

 

 

2015

 

 

%

 

United States

 

$

454,669

 

 

 

46

%

 

$

449,065

 

 

 

49

%

 

$

393,206

 

 

 

46

%

China

 

 

93,645

 

 

 

9

%

 

 

80,493

 

��

 

9

%

 

 

76,864

 

 

 

9

%

Germany

 

 

71,768

 

 

 

7

%

 

 

70,258

 

 

 

8

%

 

 

74,003

 

 

 

9

%

South Korea

 

 

64,715

 

 

 

7

%

 

 

75,396

 

 

 

8

%

 

 

84,758

 

 

 

10

%

Japan

 

 

57,467

 

 

 

6

%

 

 

45,103

 

 

 

5

%

 

 

46,058

 

 

 

5

%

Canada

 

 

46,368

 

 

 

5

%

 

 

37,954

 

 

 

4

%

 

 

27,076

 

 

 

3

%

Czech Republic

 

 

38,828

 

 

 

4

%

 

 

38,164

 

 

 

4

%

 

 

28,273

 

 

 

3

%

United Kingdom

 

 

36,033

 

 

 

4

%

 

 

28,540

 

 

 

3

%

 

 

25,952

 

 

 

3

%

Mexico

 

 

22,684

 

 

 

2

%

 

 

22,767

 

 

 

2

%

 

 

28,274

 

 

 

3

%

Other

 

 

99,506

 

 

 

10

%

 

 

69,860

 

 

 

8

%

 

 

71,981

 

 

 

9

%

Total Non U.S.

 

 

531,014

 

 

 

54

%

 

 

468,535

 

 

 

51

%

 

 

463,239

 

 

 

54

%

 

 

$

985,683

 

 

 

100

%

 

$

917,600

 

 

 

100

%

 

$

856,445

 

 

 

100

%

F-33


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 11 — Segment Reporting (Continued)

We rely on three customers, two domestic and one foreign, to derive a significant portion of our product revenues.  The table below lists the percentage of total product revenues generated from sales to these customers:

 

  

2017

 

  

2016

 

  

2015

 

Lear (domestic)

 

 

20

%

 

 

21

%

 

 

22

%

Adient (domestic)

 

 

18

%

 

 

21

%

 

 

23

%

Bosch (foreign)

 

 

8

%

 

 

8

%

 

 

9

%

Note 12 Pension and Other Post Retirement Benefit Plans

On August 8, 2008 the Company established The Executive Nonqualified Defined Benefit Plan of Gentherm Incorporated (the “Plan”), an unfunded executive pension plan, with an effective date of April 1, 2008. The Company’s former Chief Executive Officer, Daniel R. Coker, is the only participant in the Plan.

On May 10, 2017 the Company amended (the “Plan Amendment”) the Plan. Prior to the Plan Amendment, the Plan provided  for 15 annual retirement benefit payments of $300,000 each beginning January 1, 2018. Mr. Coker became fully vested in the benefits under the Benefit Plan on April 1, 2017. The Plan Amendment provided that if Mr. Coker continued to provide employment service to the Company through and including January 1, 2018, the fifteen annual retirement benefit payments would be increased to $342,000, otherwise the 15 annual retirement benefits would remain at $300,000.

On June 28, 2017, the same day a leader transition plan leading up to Mr. Coker’s retirement was announced, the Company entered into a Retirement Agreement with Mr. Coker (the “Retirement Agreement”).  The Retirement Agreement provided that if Mr. Coker’s retirement date was prior to January 1, 2018, the Company would amend the terms of the Plan, as amended, to accelerate the in-service vesting date to ensure an increase in the annual accrued benefit from $300,000 to $342,000.  Mr. Coker became fully vested in the incremental benefit, as described in the Plan Amendment, on December 4, 2017.

The Company records a projected benefit obligation representing the present value of future plan benefits when earned by the participant. The following table sets forth the benefit obligation, amounts recognized in the Company’s financial statements and the principal assumptions used:

 

  

2017

 

  

2016

 

Change in projected benefit obligation:

  

 

 

 

  

 

 

 

Benefit obligation at beginning of year

  

$

3,419

  

  

$

2,898

  

Service cost

  

 

101

  

  

 

387

  

Interest cost

  

 

111

  

  

 

98

  

Actuarial (gain) loss

 

 

78

 

 

 

36

 

Prior service cost

 

 

509

 

 

 

 

Benefit obligation at end of year

  

$

4,218

 

  

$

3,419

 

F-34


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 12 — Pension and Other Post Retirement Benefit Plans (Continued)

The portion of the benefit obligation from the Plan expected to be paid in 2018 is classified as a current liability within accrued liabilities in the Company’s consolidated balance sheet.  The remaining portion is classified as a non-current liability within pension benefit obligations. Service and interest cost is included in selling,Selling, general and administrative expenses in the Company’s consolidated statements of income and actuarial gains and losses are included the Company’s consolidated balance sheetsheets as part of accumulatedAccumulated other comprehensive incomeloss within shareholders’ equity. Actuarial gains or losses are amortized to selling,Selling, general and administrative expense in the Company’s consolidated statements of income based on the average future service life of the U.S Plan or German Plan using the corridor method. A discount rate assumption of 2.95%, 3.25% and 3.40% was used to determine the benefit obligation for the years ended December 31, 2017, 2016 and 2015, respectively.   A discount rate assumption of 3.25%, 3.40% and 3.25% was used to determine and the net periodic service cost for years ended December 31, 2017, 2016 and 2015, respectively. Prior service costs reflect an increase to the projected benefit obligation as a result of the Plan Amendment, which retroactively increased benefits. Prior service cost is included in selling,Selling, general and administrative expenses in the Company’s consolidated statements of income. We do not expect contributions to be paid to the

Plan during the next fiscal year.assets – German Plan

Although the Plan is not funded, the Company has established a separate trust having the sole purpose of paying benefits under the Plan. The only asset of the trust is a corporate-owned life insurance policy (“COLI”). The COLI is valued at fair value using quoted prices listed in active markets (Level 1 input based on the U.S. GAAP fair value hierarchy). The policy value of the COLI was $2,353 and $2,112 as of December 31, 2017 and 2016, respectively, and was included in other non-current assets.

Components of the Plan’s net periodic pension benefit cost for the years ended December 31, 2017, 2016 and 2015 are as follows:

 

  

2017

 

  

2016

 

 

2015

 

Service cost

  

$

101

  

  

$

387

  

  

$

379

 

Interest cost

  

 

111

  

  

 

98

  

  

 

80

 

Amortization of actuarial losses

  

 

  

  

 

  

  

 

27

 

Amortization of prior service cost

  

 

509

  

  

 

  

  

 

 

Net periodic benefit cost

  

$

721

  

  

$

485

  

  

$

486

 

Pretax amounts recognized in other comprehensive income for the years ended December 31, 2017, 2016 and 2015 are as follows

 

  

2017

 

 

2016

 

2015

 

Actuarial Losses/(gains)

 

$

78

 

 

$

36

 

$

(35

)

Amortization of actuarial losses

 

 

 

 

 

 

 

(27

)

Establish prior service cost

 

 

509

 

 

 

 

 

 

Amortization prior service cost

 

 

(509

)

 

 

 

 

 

 

 

$

78

 

 

$

36

 

$

(62

)

Tax benefit of $26 was recognized in other comprehensive income related to the Plan for the year ended December 31, 2017. Tax benefit of $14 was recognized in other comprehensive income related to the Plan for the year ended December 31, 2016. Tax expense of $23 was recognized in other comprehensive income related to the Plan for the years ended December 31, 2015.  

Pretax unrecognized actuarial losses recorded in accumulated other comprehensive loss not yet recognized in net periodic benefit cost were $380 and $302 as of December 31, 2017 and 2016, respectively.  No amount of pretax unrecognized actuarial loss recorded in accumulated other comprehensive income as of December 31, 2017 are expected to be recognized as components of net periodic benefit cost in the year ending December 31, 2018.  

F-35


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 12 — Pension and Other Post Retirement Benefit Plans (Continued)

Gentherm GmbH has an established defined benefit plan for retired and current members of its executive management team.

Gentherm GmbH records a projected benefit obligation representing the present value of future plan benefits when earned by the participant. The following table sets forth the benefit obligation and amounts recognized in the Company’s financial statements:

 

  

2017

 

 

2016

 

Change in projected benefit obligation:

 

 

 

 

 

 

 

 

Benefit obligation at beginning of year

 

$

7,326

 

 

$

6,980

 

Interest cost

 

 

130

 

 

 

154

 

Paid pension distributions

 

 

(272

)

 

 

(261

)

Actuarial (gains)/losses

 

 

(257

)

 

 

691

 

Exchange rate impact

 

 

1,000

 

 

 

(238

)

Benefit obligation at end of year

 

$

7,927

 

 

$

7,326

 

The following table sets forth the fair value of the plan assets for the periods ending December 31, 2017 and 2016:

 

  

2017

 

 

2016

 

Change in plan assets:

  

 

 

 

 

 

 

 

Plan assets at beginning of year

  

$

3,326

  

 

$

3,333

  

Actual return on plan assets

  

 

121

  

 

 

125

  

Contributions

  

 

272

  

 

 

261

  

Paid pension distributions

 

 

(272

)

 

 

(261

)

Actuarial losses

  

 

(28

)

 

 

(27

)

Exchange rate impact

  

 

472

 

 

 

(105

)

Plan assets at end of year

  

$

3,891

  

 

$

3,326

  

The $4,036 and $4,000 net liability from the Gentherm GmbH plan as of December 31, 2017 and 2016, respectively, is classified as a noncurrent liability in pension benefit obligation.

Pretax amounts recognized in other comprehensive (loss) income for the years ended December 31, 2017, 2016 and 2015 are as follows:

 

  

2017

 

 

2016

 

2015

 

Actuarial (gains)/losses

 

$

(229

)

 

$

718

 

$

(154

)

Amortization of actuarial losses

 

 

(78

)

 

 

(48

)

 

(59

)

Amortization of prior service cost

 

 

 

 

 

 

 

(572

)

 

 

$

(307

)

 

$

670

 

$

(785

)

Tax expense of $86 was recognized in other comprehensive income related to the Gentherm GmbH defined benefit plan for the year ended December 31, 2017.  Tax benefit of $171 and tax expense of $211 were recognized in other comprehensive income for the years ended December 31, 2016 and 2015, respectively.  


F-36


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 12 — Pension and Other Post Retirement Benefit Plans (Continued)

Pretax unrecognized actuarial losses recorded in accumulated other comprehensive loss not yet recognized in net periodic benefit cost were $2,416 and $2,406 as of December 31, 2017 and 2016, respectively.  We expect $74 of pretax unrecognized actuarial loss recorded in accumulated other comprehensive income as of December 31, 2017 to be recognized as components of net periodic benefit cost in the year ending December 31, 2018.

Components of the Plan’s net periodic pension benefit cost for the years ended December 31, 2017, 2016 and 2015 are as follows:

 

  

2017

 

  

2016

 

 

2015

 

Interest cost

  

$

130

 

 

$

154

 

 

$

142

 

Return on plan assets

 

 

(121

)

 

 

(125

)

 

 

(126

)

Amortization of prior service cost

 

 

 

 

 

 

 

 

572

 

Amortization of actuarial loss (gains)

  

 

78

 

 

 

48

 

 

 

59

 

Net periodic benefit cost

  

$

87

 

 

$

77

 

 

$

647

 

The Gentherm GmbH defined benefit plan is underfunded by $4,036 and $4,000 as of December 31, 2017 and 2016, respectively. The net periodic benefit cost is included in selling, general and administrative expenses in the Company’s consolidated statements of income and actuarial gains and losses are included the Company’s consolidated balance sheet as part of accumulated other comprehensive income within shareholders’ equity. Actuarial gains or losses are amortized to selling, general and administrative expense in the Company’s consolidated statements of income using the corridor method. The following table describes the actuarial assumptions used to determine the benefit obligation and the net periodic service cost:

 

  

2017

 

 

2016

 

 

2015

 

Discount rate

  

 

1.93

%

 

 

1.69

%

 

 

2.21

%

Expected long term rate of return on plan assets

  

 

3.40

%

 

 

3.40

%

 

 

3.70

%

Plan assets are comprised of Gentherm GmbH’s pension insurance policies and are pledged to the beneficiaries of the plan.German Plan. A market valuation technique, based on observable underlying insurance charges, is used to determine the fair value of the pension plan assets (Level 2).

The expected return on plan assets assumption used to calculate Gentherm GmbH’s pension benefit obligation was determined using actual returns realized on plan assets in the prior year.

Contributions

We do notnot expect contributions to be paid to the Gentherm GmbH defined benefit planU.S. Plan or the German Plan during the next fiscal year.

The schedule of future expected pension payments made to Gentherm GmbH defined benefit plan participants over the next 10 years is as follows:

 

 

Projected Pension
Benefit Payments

 

Year

 

U.S Plan

 

 

German Plan

 

2024

 

$

342

 

 

$

324

 

2025

 

 

342

 

 

 

314

 

2026

 

 

342

 

 

 

303

 

2027

 

 

342

 

 

 

292

 

2028

 

 

342

 

 

 

279

 

2029-2032

 

 

1,368

 

 

 

2,893

 

Total

 

$

3,078

 

 

$

4,405

 

Defined contribution plans

Year

  

 

 

2018

  

$

293

  

2019

  

 

291

  

2020

  

 

289

  

2021

  

 

287

  

2022

  

 

283

  

2023 - 2027

  

 

1,392

  

Total

  

$

2,835

  


F-37


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 12 — Pension and Other Post Retirement Benefit Plans (Continued)

Gentherm has adopted a 401(k) plan to provide allThe Company also sponsors defined contribution plans for eligible employees a means to accumulate retirement savings on a tax-advantaged basis, and eligible executive officers can participate in this plan on the same basis as other participants. Participants may defer specified portions of their compensation.employees. On a discretionary basis, the Company matches a portion of the employee contributions.  The Plan also allows forcontributions and or makes additional discretionary contributions. Gentherm made $1,396, $1,289recognized costs of $2,344, $1,984 and $959 in matching$1,724 related to contributions to its defined contribution plans during the 401(k) plan in 2017, 2016years ended December 31, 2023, 2022 and 2015,2021, respectively.

Note 11 Commitments and Contingencies

Legal and other contingencies

Note 13 Fair Value Measurement

The Company bases fair value onmay be subject to various legal actions and claims in the priceordinary course of its business, including those arising out of breach of contracts, intellectual property rights, environmental matters, regulatory matters and employment-related matters. The Company establishes accruals for matters which it believes that wouldlosses are probable and can be receivedreasonably estimated. Although it is not possible to sell an asset or paid to transfer a liability in an orderly transaction between market participants atpredict with certainty the measurement date. We have adopted a fair value hierarchy to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value,outcome of these matters, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

Except for derivative instruments (see Note 14), pension liabilities, pension plan assets and a corporate owned life insurance policy (see Note 12), the Company has no financial assets and liabilities that are carried at fair value at December 31, 2017 and 2016. The carrying amounts of financial instruments comprising cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to the relatively short maturity of such instruments. The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs).

As of December 31, 2017 and 2016, the carrying valuesis of the Company’s Credit Agreement indebtedness were not materially different than their estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 6). Discount rates used to measure the fair value of Gentherm’s DEG Vietnam Loan and DEG China Loan are based on quoted swap rates.  As of December 31, 2017, the carrying values of the DEG Vietnam Loan and DEG China Loan were $13,750 and $1,919, respectively, as compared to an estimated fair value of $13,600 and $2,000, respectively.  As of December 31, 2016, the carrying value of the DEG Vietnam Loan and DEG China Loan were $15,000 and $2,525, as compared to an estimated fair value of $14,900 and $2,600, respectively.

Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicateopinion that the carrying value may not be recoverable.  Asultimate resolution of December 31, 2017 and 2016, the Company did not realize any changes to the fair value of these assets due to the non-occurrence of events or circumstances that could negatively impact their recoverability.

F-38F-29


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

matters will not have a material adverse effect on its consolidated results of operations or financial position. Product liability and warranty reserves are recorded separately from legal reserves.

Product Liability and Warranty Matters

In the event that the Company’s products fail to perform as expected or result in alleged bodily injury or property damage, our products may subject us to warranty claims and product liability. If any of our products are or are alleged to be defective, we may be required to participate in a recall or other corrective action involving such products. The Company maintains liability insurance coverage at levels based on commercial norms and historical claims experience. The Company can provide no assurances that it will not experience material claims in the future or that it will not incur significant costs to defend such claims.

The Company accrues warranty obligations for products sold based on management estimates of future failure rates and current claim cost experience, with support from the sales, engineering, quality and legal functions. Using historical information available to the Company, including claims already filed by customers, the warranty accrual is adjusted quarterly to reflect management’s best estimate of future claims.

The following is a reconciliation of the changes in accrued warranty costs:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Balance at beginning of year

 

$

2,380

 

 

$

1,916

 

Warranty opening balance from acquired entities

 

 

 

 

 

907

 

Warranty claims paid

 

 

(2,252

)

 

 

(1,841

)

Warranty expense for products shipped during the current period

 

 

3,955

 

 

 

1,584

 

Adjustments to warranty estimates from prior periods

 

 

(174

)

 

 

(274

)

Adjustments due to currency translation

 

 

36

 

 

 

88

 

Balance at end of year

 

$

3,945

 

 

$

2,380

 

Employees

Approximately 33% of the Company’s workforce are members of industrial trade unions and are employed under the terms of various labor agreements. In 2024, certain agreements will require a vote on the terms of their respective labor contracts.

Note 14 12 Earnings Per Share

Basic earnings per share are computed by dividing net income by the weighted average number of shares of Common Stock outstanding during the period. The Company’s diluted earnings per share give effect to all potential shares of Common Stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the diluted earnings per share, the treasury stock method is used in determining the number of shares assumed to be issued from the exercise of Common Stock equivalents.

F-30


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The following table illustrates earnings per share and the weighted average shares outstanding used in calculating basic and diluted earnings per share:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Net income

 

$

40,343

 

 

$

24,441

 

 

$

93,434

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares of Common Stock outstanding

 

 

32,778,055

 

 

 

33,126,202

 

 

 

33,085,732

 

Dilutive effect of stock options, restricted stock awards and restricted stock units

 

 

288,862

 

 

 

376,952

 

 

 

423,988

 

Diluted weighted average shares of Common Stock outstanding

 

 

33,066,917

 

 

 

33,503,154

 

 

 

33,509,720

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

1.23

 

 

$

0.74

 

 

$

2.82

 

Diluted earnings per share

 

$

1.22

 

 

$

0.73

 

 

$

2.79

 

See Note 17, "Accounting for Stock Based Compensation," for information about the Company’s different equity incentive plans.

Note 13 —Financial Instruments

Derivative Financial Instruments

We areThe Company is exposed to various market risk fromrisks including, but not limited to, changes in foreign currency exchange rates, short-termchanges in interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to ourits debt obligations under ourthe Second Amended and Restated Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, North Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won, Czech Koruna and Vietnamese Dong.

The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum lengthdecision of time over which we hedge ourwhether and when to execute derivative financial instruments, along with the duration of the instrument, may vary from period to period depending on market conditions, the relative costs of the instruments and capacity to hedge. The duration is linked to the timing of the underlying exposure, to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $29,273 and $29,538 outstanding at December 31, 2017 and 2016, respectively.

the connection between the two being regularly monitored. The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is two years.  We had copper commodity swap contracts with a notional value of $404 and $407 outstanding at December 31, 2017 and 2016, respectively.  

We doCompany does not enter into derivative financial instruments for speculative or trading purposes. OurSome derivative contracts do not qualify for hedge accounting; for other derivative contracts, we elect to not apply hedge accounting.

The Company’s designated hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulatedAccumulated other comprehensive loss in the consolidated balance sheet.sheets. When the underlying hedge transaction is realized, the gain or loss included in accumulatedAccumulated other comprehensive loss is recorded in earnings in the consolidated statementstatements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We recordThe Company records the ineffective portion of foreign currency and copper commodity hedging instruments, if any, to foreign currency gain (loss)Cost of sales, in the consolidated statements of income. See Note 16 for the amount of unrealized lossCash flows associated with copper commodity derivatives are reported in accumulated other comprehensive income asNet cash provided by operating activities in the Company’s consolidated statements of December 31, 2016 that was reclassified into earnings during 2017. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.cash flows.

The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discountsdiscounting such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.

In December 2015, Gentherm GmbH (“Gentherm Germany”), a subsidiary of Gentherm Incorporated (the “Company”) entered into an agreement settling all claims against UniCredit Bank AG pertaining to a 10 year currency related swap (“CRS”) entered into a by Gentherm Germany in March 2008. Prior to the settlement, a lawsuit filed by Gentherm GmbH in 2011 was pending appeal at the Higher Regional Court in Munich, Germany. As a result of the settlement, the CRS and its related liability to Gentherm have been terminated and Gentherm’s remaining interest in an offsetting derivative contract designed to limit the market risk of payments due under the CRS was sold. Gentherm realized a one-time, pre-tax gain of $9,949 in the fourth quarter of 2015. Gentherm made a final cash settlement payment of $7,593 during the fourth quarter of 2015.F-31


F-39


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

In the second quarter of 2022, the Company entered into a floating-to-fixed interest rate swap agreement with a notional amount of $100,000 and a maturity date of July 2025. This interest rate swap is an undesignated hedge of the Company’s exposure to interest payment fluctuations on a portion of the Revolving Credit Facility borrowings that were drawn for the acquisitions of Alfmeier and Dacheng. The periodic changes in fair value are recognized in Interest expense, net.

Note 14 — Derivative Financial Instruments (Continued)In the second and third quarter of 2022, the Company entered into forward contracts with a notional amount of $128,319 to hedge the foreign currency risk associated with the forecasted purchase of Alfmeier. These contracts matured and were settled in the third quarter of 2022. During the year ended December 31, 2022 the Company recognized expense of $3,806 in Foreign currency (loss) gain within the consolidated income statement.

Information related to the recurring fair value measurement of derivative financial instruments in ourthe consolidated balance sheet as of December 31, 20172023 is as follows:

 

 

 

 

 

 

 

Asset Derivatives

 

 

Liability Derivatives

 

 

 

 

 

 

Fair Value
Hierarchy

 

Notional Amount

 

 

Balance Sheet
Location

 

Fair
Value

 

 

Balance Sheet
Location

 

Fair
Value

 

 

Net Asset/
(Liabilities)

 

Derivatives Designated as Cash Flow Hedges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency derivatives

 

Level 2

 

$

101,109

 

 

Other current assets

 

$

8,655

 

 

Other current liabilities

 

$

 

 

$

8,655

 

Derivatives Not Designated as Hedging Instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

Level 2

 

$

100,000

 

 

Other current assets

 

$

2,062

 

 

Other current liabilities

 

$

 

 

$

2,062

 

 

  

 

  

 

  

Asset Derivatives

 

  

Liability Derivatives

 

 

Net Asset/
(Liabilities)

 

 

  

Hedge

Designation

  

Fair Value

Hierarchy

  

Balance Sheet
Location

 

  

Fair
Value

 

  

Balance Sheet
Location

  

Fair
Value

 

 

Foreign currency derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

 

  

141

 

  

Current liabilities

 

$

(1,050

)

 

$

(909

)

Commodity derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

  

  

$

72

  

  

 

 

 

 

 

 

$

72

 

Information related to the recurring fair value measurement of derivative financial instruments in ourthe consolidated balance sheet as of December 31, 20162022 is as follows:

 

 

 

 

 

 

 

Asset Derivatives

 

 

Liability Derivatives

 

 

 

 

 

 

Fair Value
Hierarchy

 

Notional Amount

 

 

Balance Sheet
Location

 

Fair
Value

 

 

Balance Sheet
Location

 

Fair
Value

 

 

Net Asset/
(Liabilities)

 

Derivatives Designated as Cash Flow Hedges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency derivatives

 

Level 2

 

$

40,063

 

 

Other current assets

 

$

3,791

 

 

Other current liabilities

 

$

 

 

$

3,791

 

Derivatives Not Designated as Hedging Instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

Level 2

 

$

100,000

 

 

Other current assets

 

$

2,772

 

 

Other current liabilities

 

$

 

 

$

2,772

 

F-32


GENTHERM INCORPORATED

 

  

 

  

 

  

Asset Derivatives

 

  

Liability Derivatives

 

 

Net Asset/
(Liabilities)

 

 

  

Hedge

Designation

  

Fair Value

Hierarchy

  

Balance Sheet
Location

 

  

Fair
Value

 

  

Balance Sheet
Location

  

Fair
Value

 

 

Foreign currency derivatives

  

Cash flow hedge

  

Level 2

  

 

 

 

  

 

 

 

  

Current liabilities

 

$

(1,395

)

 

$

(1,395

)

Commodity derivatives

  

Cash flow hedge

  

Level 2

  

 

Current assets

  

  

$

18

  

  

 

 

 

 

 

 

$

18

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Information related to the effect of derivative instrument`s on ourinstruments in the consolidated statements of income is as follows:

 

Location

  

Year
Ended
December 31,
2017

 

 

Year
Ended
December 31,
2016

 

Foreign currency derivatives

 

Product Revenues

 

$

(3

)

 

$

 

 

Cost of sales

 

 

2,209

 

 

 

(608

)

 

Selling, general and administrative

 

 

(216

)

 

 

139

 

 

Year Ended December 31,

 

 

Other comprehensive (loss) income

 

 

302

 

 

 

(1,395

)

 

Location

 

2023

 

 

2022

 

 

2021

 

Derivatives Designated as Cash Flow Hedges

 

 

 

 

 

 

 

Foreign currency derivatives

 

Cost of sales – income

 

$

8,630

 

 

$

1,458

 

 

$

1,609

 

 

Foreign currency gain

 

 

(112

)

 

 

102

 

 

Other comprehensive (loss) income

 

 

3,483

 

 

 

3,496

 

 

 

(1,217

)

Total foreign currency derivatives

 

 

 

$

2,180

 

 

$

(1,762

)

 

$

12,113

 

 

$

4,954

 

 

$

392

 

 

 

 

 

 

 

 

Commodity derivatives

 

Cost of sales

 

$

202

 

 

$

(666

)

 

Cost of sales – income

 

$

 

 

$

19

 

 

$

14

 

 

Other comprehensive income (loss)

 

$

54

 

 

$

743

 

 

Other comprehensive (loss) income

 

 

 

 

 

(6

)

 

 

6

 

Total commodity derivatives

 

 

 

$

256

 

 

$

77

 

 

$

 

 

$

13

 

 

$

20

 

 

 

 

 

 

 

 

Derivatives Not Designated as Hedging Instruments

 

 

 

 

 

 

 

Foreign currency derivatives

 

Foreign currency (loss) gain

 

$

 

 

$

(3,806

)

 

$

 

Total foreign currency derivatives

 

$

 

 

$

(3,806

)

 

$

 

 

 

 

 

 

 

 

Interest rate contracts

 

Interest income (expense), net

 

$

(710

)

 

$

2,772

 

 

$

 

Total interest rate derivatives

 

$

(710

)

 

$

2,772

 

 

$

 

WeThe Company did notnot incur any hedge ineffectiveness during the years ended December 31, 20172023 and 2016.  2022.

Accounts Receivable Factoring

F-40The Company sells certain customer trade receivables on a non-recourse basis under factoring arrangements with designated financial institutions. The sale of receivables under these agreements is considered an off-balance sheet arrangement to the Company and is accounted for as a true sale and excluded from accounts receivable in the consolidated balance sheets. These factoring arrangements include a deferred purchase price component in which a portion of the purchase price for the receivable is paid by the financial institution in cash upon sale and the remaining portion is recorded as a deferred purchase price receivable and paid at a later date. Deferred purchase price receivables are recorded in Other current assets within the consolidated balance sheets. Cash proceeds received upon the sale of the receivables are included in Net cash provided by operating activities and the cash proceeds received on the deferred purchase price receivables are included in Net cash used in investing activities. All factoring arrangements incorporate customary representations, including representations as to validity of amounts due, completeness of performance obligations and absence of commercial disputes.

Receivables factored and availability under receivables factoring agreements balances as of December 31, 2023 and 2022 were as follows:

 

 

December 31,

 

 

 

2023

 

 

2022

 

Receivables factored and outstanding

 

$

18,532

 

 

$

19,108

 

Amount available under the credit limit

 

 

5,891

 

 

 

5,034

 

Collective factoring limit

 

$

24,423

 

 

$

24,142

 

Trade receivables sold and factoring fees incurred during the years ended December 31, 2023 and 2022 were as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022(a)

 

Trade receivables sold

 

$

135,116

 

 

$

61,482

 

Factoring fees incurred

 

 

800

 

 

 

180

 

(a)
Represents trade receivables sold and factoring fees incurred since the acquisition of Alfmeier (acquired on August 1, 2022).

F-33


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 14 Fair Value Measurement

Note 15 — New Accounting Pronouncements

Derivatives and Hedging

In August, 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.” ASU 2017-12 expands the number and type of nonfinancial and interest rate risk components an entity has the ability to designateFair value is defined as the hedgedexchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Fair value measurements are based on one or more of the following three valuation techniques:

Market: This approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

Income: This approach uses valuation techniques to convert future amounts to a single present value amount based on current market expectations.

Cost: This approach is based on the amount that would be required to replace the service capacity of an asset (replacement cost).

The Company uses the following fair value hierarchy to measure fair value into three broad levels, which are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

Level 2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability.

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

Items Measured at Fair Value on a Recurring Basis

Except for derivative financial instruments (see Note 13) and pension plan assets (see Note 10), the Company has no material financial assets and liabilities that are carried at fair value at December 31, 2023 and 2022. In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.

Items Measured at Fair Value on a qualifying hedging relationship.  ASU 2017-12 requires entities to present the earnings  effectNonrecurring Basis

The Company measures certain assets and liabilities at fair value on a non-recurring basis. As these nonrecurring fair value measurements are generally determined using unobservable inputs, these fair value measurements are classified within Level 3 of the hedging instrument in the same income statement line item in which the earnings effect of the hedge item is reported.  This approach simplifies the financial statement reporting for qualifying hedging relationships by eliminating the requirement to separately report the portion of the hedge deemed to be ineffective.  For cash flow hedges, the entire change in the fair value hierarchy. The Company utilized a third-party to assist in the Level 3 fair value estimates of other intangible assets, property and equipment, and inventory for recent acquisitions (see Note 4) and goodwill of the hedging instrument included in the assessmentMedical reporting unit (see Note 7). The estimated fair values of hedge effectiveness is recorded in other comprehensivethese assets were based on third-party valuations and management’s estimates, generally utilizing income and reclassified to earnings when the hedged item affects earnings.  Furthermore, income statement effects frommarket approaches. As of December 31, 2023, and December 31, 2022, there were no other significant assets or liabilities measured at fair value on a non-recurring basis.

Items Not Carried at Fair Value

The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs). As of December 31, 2023, and 2022, the carrying values of the indebtedness under the Company’s Credit Agreement were not materially different than their estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 9). The carrying amounts of financial instruments comprising cash and cash flow hedges are to be presented in tabular disclosure.

ASU 2017-12 is effective for annualequivalents, short-term investments, accounts receivable, notes receivable and any interim periods beginning after December 15, 2018.  Early adoptionaccounts payable approximate fair value because of the amendments in this update are permitted. For cash flow hedges existing at the dateshort maturities of adoption, an entity should apply a cumulative catch-up adjustment related to eliminating the separate measurement of ineffectiveness to accumulative other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year  that an entity adopts the amendments in this update. We are currently in the process of determining the impact the implementation of ASU 2017-12 will have on the Company’s financial statements.these instruments.

Share-Based Payment Awards

In May, 2017, the FASB issued ASU 2017-09, “Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 clarifies which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting, in accordance with Topic 718. An entity should account for the effect of a modification unless all of the following are met:

1)

The fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified. If the modification does not affect any of the inputs of the valuation technique that the entity uses to value the award, the entity is not required to estimate the value immediately before and after the modification.

F-34

2)

The vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified.


3)

The classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified.

ASU 2017-09 is effective for annual and any interim periods beginning after December 15, 2017. Early adoption of the amendments in this update is permitted. The amendments in ASU 2017-09 should be applied on a prospective basis and in the initial period of adoption, entities must disclose the nature of and reason for the change in accounting principle. The Company has not historically made changes to the terms or conditions of shared-based payment awards and does not expect adoption of ASU 2017-09 to have a material impact the consolidated financial statements when it is adopted in the first quarter of 2018.


F-41


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 15 — New Accounting Pronouncements (Continued)Equity

Goodwill ImpairmentCommon Stock

In January, 2017,The Company is authorized to issue up to 59,991,000 shares, of which 55,000,000 shares shall be Common Stock, without par value, and 4,991,000 shall be Preferred Stock, without par value. As of December 31, 2023, an aggregate of 31,542,001 shares of its Common Stock were issued and outstanding. As of December 31, 2023, there are no preferred stock shares issued or outstanding. The Common Stock is listed on the FASB issued ASU 2017-04, “Intangibles – GoodwillNasdaq Global Select Market under the symbol, “THRM”, and Other (Topic 350): Simplifyinghas the Testfollowing rights and privileges:

Voting rights. All shares of the Common Stock have identical rights and privileges. With limited exceptions, holders of common stock are entitled to one vote for Goodwill Impairment.” ASU 2017-04 modified the concepteach outstanding share of impairmentCommon Stock held of goodwill to be a condition that exists when the carrying value of a reporting unit that includes goodwill exceeds its fair value. An entity should recognize an impairment chargerecord by each shareholder on all matters properly submitted for the amount by whichvote of the carrying amount exceedsCompany’s shareholders.
Dividend rights. Subject to applicable law, any contractual restrictions and the reporting unit’s fair value, limitedrights of the holders of outstanding preferred stock, if any, holders of Common Stock are entitled to receive ratably such dividends and other distributions that the Company’s Board of Directors, in its discretion, declares from time to time.
Liquidation rights. Upon the dissolution, liquidation or winding up of the Company, subject to the totalrights of the holders of outstanding preferred stock, if any, holders of Common Stock are entitled to receive ratably the assets of the Company available for distribution to the Company’s shareholders in proportion to the number of shares of Common Stock held by each shareholder.
Conversion, Redemption and Preemptive Rights. Holders of Common Stock have no conversion, redemption, sinking fund, preemptive, subscription or similar rights.

Stock Repurchase Program

In December 2020, the Board of Directors of Gentherm Incorporated (“Board of Directors”) authorized a stock repurchase program (the “2020 Stock Repurchase Program”) to commence upon expiration of the prior stock repurchase program on December 15, 2020. Under the 2020 Stock Repurchase Program, the Company is authorized to repurchase up to $150,000 of its issued and outstanding Common Stock over a three-year period, expiring December 15, 2023. On November 1, 2023, the Board of Directors extended the maturity date of the program from December 15, 2023 to June 30, 2024.

Repurchases may be made, from time to time, in amounts and at prices the Company deems appropriate, subject to market conditions, applicable legal requirements, debt covenants and other considerations. Any such repurchases may be executed using open market purchases, privately negotiated agreements or other transactions. Repurchases may be funded from cash on hand, available borrowings or proceeds from potential debt or other capital markets sources. During the year ended December 31, 2023, the Company repurchased shares under the 2020 Stock Repurchase Program for $92,510 and have a remaining repurchase authorization of $37,491 as of December 31, 2023.

On November 1, 2023, following the above-noted extension, the Company entered into a Confirmation of Issuer Forward Repurchase Transaction agreement (the “ASR Agreement”) with Bank of America, N.A. (“Bank of America”) that provides for the Company to purchase shares of Common Stock in an aggregate amount of goodwill allocated to that reporting unit. Entities no longer will determine goodwill impairment by calculating$60,000 (the “ASR Repurchase Amount”) under the implied fair value of goodwill by assigning2020 Stock Repurchase Program.

Under the fair value of a reporting unit to all of its assets and liabilities as if the reporting unit had been acquired in a business combination.

ASU 2017-04 is effective for annual and any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoptionterms of the amendments in this updateASR Agreement, on November 2, 2023, the Company paid $60,000 to Bank of America for an initial purchase of approximately 1.22 million shares of Common Stock, representing 80% of ASR Repurchase Amount. The final settlement date is permitted. The amendments in ASU 2017-04 must be applied on a prospective basisscheduled to occur no later than the second quarter of 2024 and inmay end earlier at the initial periodoption of adoption, entities must disclose the natureBank of and reason for the change in accounting principle. The Company expects adoption of ASU 2017-04 will reduce the complexity of evaluating goodwill for impairment.

Income Taxes

In October, 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” ASU 2016-16 modifies the current prohibition to recognize deferred income taxes from differences between the tax basis of assets in the buyer’s tax jurisdiction and their cost resulting from an intra-entity transfer from one tax-paying component to another tax-paying componentAmerica. As of the same consolidated group.  Under current GAAP, deferred income taxes for intra-entity asset transfers are not recognized untilfinal settlement date, Bank of America may be required to deliver additional shares of Common Stock to the asset is soldCompany or the Company may be required to an outside party.  ASU 2016-16 allows entitiesdeliver shares of Common Stock to recognizeBank America, such that the income tax consequencesCompany’s repurchase of an intra-entity transferCommon Stock under the ASR Agreement in aggregate will equal the ASR Repurchase Amount (based on the average of an asset other than inventory when the transfer occurs.  

ASU 2016-16 is effective for fiscal years and interim periods beginning after December 15, 2017.  For entities that issue interim financial statements and whose current fiscal year end date is December 31, 2016, early adoption can be madedaily volume-weighted average prices of the Common Stock during the three month period ending March 31, 2017.  The amendments in ASU 2016-16 should be applied onterm of the ASR Agreement, less a modified retrospective basis through a cumulative-effect adjustment directly to retained earningsspecified discount). There is no cash requirement as of the beginning of the period of adoption.  We have evaluated the impact the amendments in ASU 2016-16 will have on the Company's consolidated financial statements and determined that a favorable adjustment of approximately $27,771 will be recorded directly to retained earnings during the three month period ending March 31, 2018.

Statement of Cash Flows

In August, 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.” ASU 2016-15 provides guidance on the classification of eight specific cash receipt and cash payment transactions in the statement of cash flows. The Company focused its evaluation on the following transactions to determine the effect ASU 2016-15 will have on the Company’s Consolidated Statements of Cash Flows:final settlement date.

F-35

1)

Debt extinguishment payments and debt prepayments are to be shown as cash outflows for financing activities.  Presently, Gentherm classifies debt extinguishment payments within operating activities.


2)

Payments made to settle contingent consideration liabilities not made soon after the acquisition date of a business combination should be recognized as cash outflows for financing activities up to the amount of the liability recognized at the acquisition date.  Payments, or the portion of a payment, to settle contingent consideration liabilities that exceed the amount of the liability recognized at the acquisition date will be recognized as cash outflows for operating activities.

3)

Cash receipts from the settlement of insurance claims, excluding those related to corporate-owned life insurance policies  shall be classified on the basis of the related insurance coverage.  For example, proceeds received to cover claims issued under product recall liability insurance would be classified as cash inflows from operating activities.

F-42


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 15 — New Accounting Pronouncements (Continued)

4)

Cash receipts from the settlement of corporate-owned life insurance policies shall be classified as cash inflows from investing activities.  

For public companies, ASU 2016-15 is effectiveThe ASR Agreement contains provisions customary for fiscal years and interim periods beginning after December 15, 2017 and mustagreements of this type, including the mechanisms to determine the number of shares of Common Stock that will be applied retrospectively to all periods presented. Early adoptiondelivered at settlement, the required timing of delivery of the amendments in this updateshares of Common Stock, the circumstances under which Bank of America is permitted. None of the cash receipt and cash payment transactions, including those that were not the focus of management’s evaluation, addressed by the update are transactions that are typical or customarypermitted to Gentherm business.  According, management does not expect the amendments in this update have a material impactmake adjustments to the Company.  Gentherm will adopttransaction terms, the amendments in ASU 2016-15 duringcircumstances under which the three-month period ending March 31, 2018.

Stock Compensation  

In March, 2016, the FASB issued ASU 2016-09, “Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.”  ASU 2016-09 involves several aspectsASR Agreement may be accelerated, extended or terminated early by Bank of the accounting for share-based payment transactions, including the income tax consequences, classificationAmerica and specified representations and warranties of awards as either equity or liabilities, and classification on the statement of cash flows.  Under the new standard, income tax benefits and deficiencies are to be recognized as income tax expense or benefit in the income statement and the tax effects of exercised or vested awards should be treated as discrete items in the reporting period in which they occur.  An entity should also recognize excess tax benefits regardless of whether the benefit reduces taxes payable in the current period.  ASU 2016-09 requires excess tax benefits to be classified along with other income tax cash flows as an operating activity and clarifies that cash paid by an employer when directly withholding shares for tax-withholding purposes should be classified as a financing activity.

ASU 2016-09 is effective for fiscal years and interim periods beginning after December 15, 2016. The Company adopted ASU 2016-09 the first quarter of 2017 and recognized a $1,496 adjustmenteach party to the beginning balance of retained earnings for previously unrecognized excess tax benefits on share-based payment awards. Amendments related to the presentation of employee taxes paid on the statements of cash flows when an employer withholds shares to meet the minimum statutory withholding requirement were applied retrospectively to all periods presented.   Amendments requiring recognition of excess tax payments in the income statement and the classification of those excess tax benefits on the statement of cash flows were applied prospectively, beginning with the three month period ended March 31, 2017. Excess tax benefits on share-based payment awards in the statement of cash flows in prior years have not been adjusted.

Leases  

In February, 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).”  ASU 2016-02 requires lessees to recognize on their balance sheet a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. Payments to be made in optional periods should be included in the measurement of lease assets and liabilities if the lessee is reasonably certain it will exercise an option to extend the lease or not exercise an option to terminate the lease.  While ASU 2016-02 continues to differentiate between finance or capital leases and operating leases, the principal change from current lease accounting guidance is that lease assets and liabilities arising from operating leases should be recognized on the balance sheet.  

  ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update are permitted.  Lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach which includes a number of practical expedients, including the ability to use hindsight in evaluating lessee options to extend or terminate a lease.  An entity that elects to apply the practical expedients will be required to recognize a right-of-use asset and lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental payment that were tracked and disclosed under previous GAAP.  We are currently in the process of determining the impact the implementation of ASU 2016-02 will have on the Company’s financial statements.

F-43


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 15 — New Accounting Pronouncements (Continued)

Revenue from Contracts with Customers.  

In May, 2014, the Financial Accounting Standards Board (FASB) issued ASU 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The update’s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Companies are to use a five-step contract review model to ensure revenue gets recognized, measured and disclosed in accordance with this principle. The FASB issued several amendments to the new standard, including a one-year deferral of the original effective date, and new methods for identifying  performance obligation aimed at reducing the cost and complexity or compliance.  

This update permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the cumulative catch-up transition method). We have chosen to use the cumulative catch-up transition method.  

Gentherm is substantially complete in performing the five-step contract review process for all existing contracts with customers, across all business units. While we continue to assess all potential impacts from the update, we currently believe the most significant impact relates to our accounting for options that give customers the right to  purchase additional goods under long-term supply agreements in the future.  Due to the complexity of certain of our automotive supply contracts, the actual revenue recognition treatment for customer purchase options will depend on contract-specific terms and could vary from other contracts that are similar in nature. An unfavorable adjustment will be recorded directly to retained earnings during the three month period ending March 31, 2018. Our current estimate for the adjustment approximates $3,600. We are not aware of any impacts to revenue from contracts with customers at Etratech as a result of our assessment of potential impacts from the update.party.


F-44


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Note 16 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)Loss

Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the yearyears ended December 31, 2017, December 31, 20162023, 2022 and December 31, 20152021 are as follows:

 

 

Defined
Benefit
Pension
Plans

 

 

Foreign
Currency
Translation
Adjustments

 

 

Commodity Hedge Derivatives

 

 

Foreign
Currency
Hedge
Derivatives

 

 

Total

 

Balance at December 31, 2022

 

$

(1,067

)

 

$

(48,269

)

 

$

 

 

$

2,847

 

 

$

(46,489

)

Other comprehensive income before reclassifications

 

 

54

 

 

 

13,125

 

 

 

 

 

 

13,086

 

 

 

26,265

 

Income tax effect of other comprehensive income before reclassifications

 

 

(15

)

 

 

314

 

 

 

 

 

 

(2,770

)

 

 

(2,471

)

Amounts reclassified from accumulated other comprehensive loss into net income

 

 

23

 

 

 

 

 

 

 

 

 

(9,603

)

a

 

(9,580

)

Income taxes reclassified into net income

 

 

(6

)

 

 

 

 

 

 

 

 

2,121

 

 

 

2,115

 

Net current period other comprehensive income

 

 

56

 

 

 

13,439

 

 

 

 

 

 

2,834

 

 

 

16,329

 

Balance at December 31, 2023

 

$

(1,011

)

 

$

(34,830

)

 

$

 

 

$

5,681

 

 

$

(30,160

)

 

  

Defined Benefit Pension Plans

 

  

Foreign Currency Translation Adjustments

 

  

Commodity Hedge Derivatives

 

 

Foreign Currency Hedge Derivatives

 

 

 

 

Total

 

Balance at December 31, 2016

 

$

(2,550

)

 

$

(65,762

)

 

$

241

 

 

$

(1,020

)

 

$

(69,091

)

Other comprehensive income (loss) before reclassifications

 

 

166

 

 

 

48,059

 

 

 

254

 

 

 

2,123

 

 

 

 

50,602

 

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

(60

)

 

 

148

 

 

 

(93

)

 

 

(570

)

 

 

 

(575

 

)

Amounts reclassified from accumulated other comprehensive income (loss) into net income

 

 

78

 

 

 

 

 

 

(199

 

 

)

 

 

(1,822

)

 

 

 

 

(1,943

 

 

)

Income taxes reclassified into net income

 

 

 

 

 

 

 

 

74

 

 

 

489

 

 

 

563

 

Net current period other comprehensive income (loss)

 

 

184

 

 

 

48,207

 

 

 

36

 

 

 

220

 

 

 

 

48,647

 

Balance at December 31, 2017

 

$

(2,366

)

 

 

(17,555

)

 

 

277

 

 

 

(800

)

 

 

(20,444

)

(a)
The amounts reclassified from Accumulated other comprehensive loss are included in Cost of sales. See Note 13 for information related to the effect of commodity and foreign currency derivative instruments on our consolidated statements of income.

 

 

Defined
Benefit
Pension
Plans

 

 

Foreign
Currency
Translation
Adjustments

 

 

Commodity Hedge Derivatives

 

 

Foreign
Currency
Hedge
Derivatives

 

 

Total

 

Balance at December 31, 2021

 

$

(2,893

)

 

$

(34,188

)

 

$

5

 

 

$

154

 

 

$

(36,922

)

Other comprehensive income (loss) before reclassifications

 

 

2,341

 

 

 

(13,786

)

 

 

13

 

 

 

4,954

 

 

 

(6,478

)

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

(621

)

 

 

(295

)

 

 

(3

)

 

 

(1,092

)

 

 

(2,011

)

Amounts reclassified from accumulated other comprehensive loss into net income

 

 

137

 

 

 

 

 

 

(19

)

a

 

(1,458

)

a

 

(1,340

)

Income taxes reclassified into net income

 

 

(31

)

 

 

 

 

 

4

 

 

 

289

 

 

 

262

 

Net current period other comprehensive income (loss)

 

 

1,826

 

 

 

(14,081

)

 

 

(5

)

 

 

2,693

 

 

 

(9,567

)

Balance at December 31, 2022

 

$

(1,067

)

 

$

(48,269

)

 

$

 

 

$

2,847

 

 

$

(46,489

)

(a)

The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.  See Note 14 for information related to the effect of commodity and foreign currency derivative instrument`s(a)

The amounts reclassified from Accumulated other comprehensive loss are included in Cost of sales. See Note 13 for information related to the effect of commodity and foreign currency derivative instruments on our consolidated statements of income.

F-36


 

  

Defined Benefit Pension Plans

 

  

Foreign Currency Translation Adjustments

 

  

Commodity Hedge Derivatives

 

 

Foreign Currency Hedge Derivatives

 

 

 

 

Total

 

Balance at December 31, 2015

 

$

(2,060

)

 

$

(49,381

)

 

$

(229

)

 

$

 

 

$

(51,670

)

Other comprehensive income (loss) before reclassifications

 

 

(723

)

 

 

(16,678

)

 

 

154

 

 

 

(1,351

)

 

 

 

(18,598

)

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

185

 

 

 

297

 

 

 

(57

)

 

 

363

 

 

 

 

788

 

Amounts reclassified from accumulated other comprehensive income (loss) into net income

 

 

48

 

 

 

 

 

 

589

a

 

 

(44

 

 

)

 

 

a

 

 

 

593

 

Income taxes reclassified into net income

 

 

 

 

 

 

 

 

(216

)

 

 

12

 

 

 

(204

)

Net current period other comprehensive income (loss)

 

 

(490

)

 

 

(16,381

)

 

 

470

 

 

 

(1,020

)

 

 

 

(17,421

)

Balance at December 31, 2016

 

$

(2,550

)

 

$

(65,762

)

 

$

241

 

 

$

(1,020

)

 

$

(69,091

)

(a)

The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.  See Note 14 for information related to the effect of commodity and foreign currency derivative instrument`s on our consolidated statements of income.

F-45


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Defined Benefit
Pension Plans

 

 

Foreign Currency
Translation
Adjustments

 

 

Commodity Hedge Derivatives

 

 

Foreign Currency
Hedge
Derivatives

 

 

Total

 

Balance at December 31, 2020

 

$

(3,451

)

 

$

(12,637

)

 

$

 

 

$

1,106

 

 

$

(14,982

)

Other comprehensive income (loss) before reclassifications

 

 

512

 

 

 

(21,274

)

 

 

20

 

 

 

392

 

 

 

(20,350

)

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

(71

)

 

 

(277

)

 

 

(4

)

 

 

(85

)

 

 

(437

)

Amounts reclassified from accumulated other comprehensive loss into net income

 

$

159

 

 

 

 

 

 

(14

)

a

 

(1,609

)

a

 

(1,464

)

Income taxes reclassified into net income

 

$

(42

)

 

 

 

 

 

3

 

 

 

350

 

 

 

311

 

Net current period other comprehensive income (loss)

 

 

558

 

 

 

(21,551

)

 

 

5

 

 

 

(952

)

 

 

(21,940

)

Balance at December 31, 2021

 

$

(2,893

)

 

$

(34,188

)

 

$

5

 

 

$

154

 

 

$

(36,922

)

(a)
The amounts reclassified from Accumulated other comprehensive loss are included in Cost of sales. See Note 16 – Reclassifications Out13 for information related to the effect of Accumulated Other Comprehensive Income (Loss) – (Continued)

 

  

Defined Benefit Pension Plans

 

  

Foreign Currency Translation Adjustments

 

  

Commodity Hedge Derivatives

 

 

Foreign Currency Hedge Derivatives

 

 

 

 

Total

 

Balance at December 31, 2014

 

$

(2,673

)

 

$

(23,060

)

 

$

 

 

$

(10

)

 

$

(25,743

)

Other comprehensive income (loss) before reclassifications

 

 

761

 

 

 

(25,904

)

 

 

(849

)

 

 

(1,746

)

 

 

 

(27,738

 

)

Income tax effect of other comprehensive income (loss) before reclassifications

 

 

(234

)

 

 

(417

)

 

 

543

 

 

 

473

 

 

 

 

365

 

Amounts reclassified from accumulated other comprehensive income (loss) into net income

 

 

86

 

 

 

 

 

 

124

a

 

 

1,756

a

 

 

 

 

1,966

 

Income taxes reclassified into net income

 

 

 

 

 

 

 

 

(47

)

 

 

(473

)

 

 

(520

)

Net current period other comprehensive income (loss)

 

 

613

 

 

 

(26,321

)

 

 

(229

)

 

 

10

 

 

 

(25,927

)

Balance at December 31, 2015

 

$

(2,060

)

 

$

(49,381

)

 

$

(229

)

 

$

 

 

$

(51,670

)

commodity and foreign currency derivative instruments on our consolidated statements of income.

(a)

The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.  See Note 14 for information related to the effect of commodity and foreign currency derivative instrument`s on our consolidated statements of income.

We expectThe Company expects all of the existing gains and losses related to foreign currency and commodity derivatives reported in accumulatedAccumulated other comprehensive incomeloss as of December 31, 20162023 to be reclassified into earnings during the next twelve month period endingmonths. See Note 13, "Financial Instruments," for additional information about derivative financial instruments and the effects from reclassification to net income.

Note 17 Accounting for Stock Based Compensation

On May 18, 2023 the Company’s shareholders approved the Gentherm Incorporated 2023 Equity Incentive Plan (the “2023 Equity Plan”), covering 3,730,000 shares of the Common Stock, plus the number of shares of Common Stock that, as of the effective date of the 2023 Equity Plan, that were subject to awards granted under the Gentherm Incorporated 2013 Equity Incentive Plan (the “2013 Equity Plan”) and that, on or after the effective date of the 2023 Equity Plan, were forfeited, surrendered, terminated (other than by exercise), cancelled, lapsed or reacquired by the Company prior to vesting, without the delivery of any shares of Common Stock, and otherwise comply with the recycling provisions of the 2013 Equity Plan and 2023 Equity Plan. The 2023 Equity Plan permits the granting of various awards including stock options (including both nonqualified stock options and incentive stock options), stock appreciation rights ("SARs"), restricted stock, restricted stock units ("RSUs"), performance stock units (including performance-based RSUs under the 2013 Equity Plan, "PSUs") and performance units, and other awards to employees, outside directors and consultants and advisors of the Company. As of December 31, 2017.2023, the Company had an aggregate of 3,683,330 shares of Common Stock available to issue under the 2023 Equity Plan.

Note 17 — Cincinnati Sub-Zero Acquisition

CSZ develops, manufactures and sells patient temperature management systems and product testing equipment.  The patient temperature management systems regulateOn May 16, 2013, the body temperatureCompensation Committee of medical patients during and after surgery.  The product testing equipment simulates temperature, humidity, altitude and vibration conditions and is customized for use in a wide variety of industrial manufacturing applications.  

Results of operations for CSZ are included in the Company’s consolidated condensed financial statements beginning April 1, 2016.  CSZ contributed $51,540 in product revenuesBoard of Directors (the “Board”) approved the 2013 Equity Plan. The 2013 Equity Plan permitted the granting of various awards including stock options (including both nonqualified options and a net lossincentive options), SARs, restricted stock, RSUs, PSUs and certain other awards to employees, outside directors and consultants and advisors of $1,092 for the nine monthCompany.

During the three-year period ended December 31, 2016.  2023, the Company has outstanding stock options, SARs, restricted stock awards and RSUs to employees, directors and consultants. These awards become available to the recipient upon the satisfaction of a vesting condition, either based on a period of service or based on the performance of a specific achievement. For equity-based awards with a service condition, the requisite service period typically ranges between two to four years for employees and consultants and one year for directors. As of December 31, 2023, there were 324,977 PSUs outstanding. These awards cliff vest after three-years based on the Company’s achievement of one of four separate performance metrics: a target return on invested capital ratio (“ROIC”), as defined in the award agreement, for a specified fiscal year; a target three-year cumulative Adjusted EBITDA (“Adjusted EBITDA”), as defined in the award agreement; the Company’s relative total shareholder return (“TSR”), as defined in the award agreement, during a specific three-year measurement period; and a target relative revenue growth relative to light vehicle production in the Company's relevant markets ("RRG"), as defined in the award agreement, during a specific three-year measurement period. In each case, awards

F-46F-37


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

will be earned at 50% of the target number of shares for achieving a minimum threshold or up to 200% of the target number of shares for exceeding the target, with a linear adjustment between threshold and target or between target and stretch performance goals. All other outstanding, unvested equity-based awards were service based. Equity-based award vesting may be accelerated at the discretion of the Board under conditions specified in the 2023 Equity Plan and the 2013 Equity Plan.

Note 17 – Cincinnati Sub-Zero Acquisition – (Continued)

Purchase Price Allocation

The purchaseUnder FASB ASC Topic 718, the provisions of the PSUs that vest upon the achievement of relative TSR are considered a market condition, and therefore the effect of that market condition is reflected in the grant date fair value for this portion award. A third party was engaged to complete a Monte Carlo simulation to account for the market condition. That simulation takes into account the beginning stock price of $73,593, netour Common Stock, the expected volatilities for the relative TSR comparator group, the expected volatilities for the Company’s stock price, correlation coefficients, the expected risk-free rate of cash acquiredreturn and the expected dividend yield of $985, has been allocated to the valuesCompany and the comparator group. The single grant-date fair value computed by this valuation method is recognized by the Company in accounting for the awards regardless of assets acquired and liabilities assumed asthe actual future outcome of April 1, 2016.  An appraisal by an independent third party valuation firm was completed to assist management in determining the relative TSR feature. The grant date fair value of acquired assetsthe other PSUs and assumed liabilities, including identifiable intangible assets. RSUs are calculated as the closing price of our Common Stock as quoted on Nasdaq on the grant date multiplied by the number of shares subject to the award. Each of ROIC, Adjusted EBITDA and RRG are considered a performance condition and the grant-date fair value for ROIC PSUs, Adjusted EBITDA PSUs and RRG PSUs correspond with management's expectation of the probable outcome of the performance condition as of the grant date.

The fair values of acquired assetstotal recognized and assumed liabilitiesunrecognized stock-based compensation expense is as follows:

Stock-Based Compensation Expense

 

2023

 

 

2022

 

 

2021

 

 

Unrecognized Stock-Based Compensation Expense at December 31, 2023

 

 

Remaining Weighted Average Vesting Period

 

RSUs

 

$

6,216

 

 

$

5,551

 

 

$

4,594

 

 

$

9,124

 

 

 

1.84

 

PSUs

 

 

4,661

 

 

 

954

 

 

 

5,535

 

 

 

9,724

 

 

 

1.97

 

Restricted Stock

 

 

878

 

 

 

888

 

 

 

1,198

 

 

 

437

 

 

 

0.38

 

SARs

 

 

(128

)

 

 

(794

)

 

 

2,721

 

 

 

 

 

 

 

Stock options

 

 

 

 

 

 

 

 

482

 

 

 

 

 

 

 

Total Stock-Based Compensation

 

$

11,627

 

 

$

6,599

 

 

$

14,530

 

 

$

19,285

 

 

 

1.87

 

The related deferred tax benefit (expense) for the years ended December 31, 2023, 2022 and 2021 was $1,794, $(444), and $2,725, respectively. If Gentherm were determined using the cost approach that relied primarily internal sources of data to make assumptions that are not observablerealize expired share-based payment arrangements, they would be reported as a forfeit in the market (Level 3 inputs).  The purchase price allocation was finalized during the fourth quarter of 2016. The allocation as of April 1, 2016 was as follows:

activity roll forward tables below.

 

 

 

 

 

Accounts receivable

 

$

10,790

 

Inventory

 

 

16,284

 

Prepaid expenses and other assets

 

 

1,143

 

Property and equipment

 

 

12,919

 

Customer relationships

 

 

11,700

 

Technology

 

 

3,200

 

Trade name

 

 

6,370

 

Goodwill

 

 

24,622

a

Assumed liabilities

 

 

(13,435

)

 

 

 

 

 

Net assets acquired

 

 

73,593

 

Cash acquired

 

 

985

 

 

 

 

 

 

Purchase price

 

$

74,578

 

F-38


(a)

The amount of recorded goodwill includes $2,000 of consideration owed to the seller for a tax gross up.

The gross contractual amount due of accounts receivable is $11,126 of which $336 is expected to be uncollectible.  

The purchase price allocation includes an approximate $4,000 step-up in the underlying net book value of the inventory to its fair value.  This inventory was sold to customers and expensed to cost of sales during the three month period ended June 30, 2016.

Supplemental Pro Forma Information

The unaudited pro forma combined historical results including the amounts of CSZ’s revenue and earnings that would have been included in the Company’s consolidated statements of income had the acquisition date been January 1, 2016 or January 1, 2015 are as follows:

 

 

Three Months Ended
December 31,

 

 

Twelve Months Ended
December 31,

 

 

 

2015

 

 

2016

 

 

2015

 

Product revenues

 

$

232,324

 

 

$

933,505

 

 

$

919,651

 

Net income

 

$

27,272

 

 

$

74,485

 

 

$

94,833

 

Basic earnings per share

 

$

0.75

 

 

$

2.04

 

 

$

2.63

 

Diluted earnings per share

 

$

0.75

 

 

$

2.04

 

 

$

2.60

 

The pro forma information includes adjustments for the effect of the amortization of intangible assets recognized in the acquisition.  This pro forma information is not indicative of future operating results.

F-47


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

RSUs

The following table summarizes RSU activity during the years ended December 31, 2023, 2022 and 2021:

Unvested Restricted Stock Units

 

Time Vesting
Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Outstanding at December 31, 2020

 

 

208,905

 

 

$

37.26

 

Granted

 

 

93,539

 

 

 

79.79

 

Vested

 

 

(88,296

)

 

 

38.49

 

Forfeited

 

 

(20,522

)

 

 

48.76

 

Outstanding at December 31, 2021

 

 

193,626

 

 

$

56.02

 

Granted

 

 

117,507

 

 

 

66.86

 

Vested

 

 

(95,692

)

 

 

49.85

 

Forfeited

 

 

(13,863

)

 

 

70.52

 

Outstanding at December 31, 2022

 

 

201,578

 

 

$

64.27

 

Granted

 

 

136,964

 

 

 

58.68

 

Vested

 

 

(82,695

)

 

 

59.43

 

Forfeited

 

 

(23,986

)

 

 

59.47

 

Outstanding at December 31, 2023

 

 

231,861

 

 

$

63.19

 

The total intrinsic value of RSUs vested during the years ended December 31, 2023, 2022 and 2021 was $4,915, $4,774 and $3,398, respectively.

Note 17 – Cincinnati Sub-Zero Acquisition –PSUs

The following table summarizes PSU activity during the years ended December 31, 2023, 2022 and 2021:

Unvested Performance Stock Units

 

Relative TSR Target
Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

ROIC Target
Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

Adjusted EBITDA Target Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

RRG Target Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

Total

 

Outstanding at December 31, 2020

 

 

157,918

 

 

$

56.06

 

 

 

157,916

 

 

$

38.58

 

 

 

 

 

$

 

 

 

 

 

$

 

 

 

315,834

 

Granted

 

 

20,626

 

 

 

118.08

 

 

 

40,580

 

 

 

78.98

 

 

 

39,930

 

 

 

79.49

 

 

 

 

 

 

 

 

 

101,136

 

Performance Adjustment

 

 

30,828

 

 

 

69.18

 

 

 

(30,830

)

 

 

44.92

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2

)

Vested

 

 

(61,656

)

 

 

69.18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(61,656

)

Forfeited

 

 

(16,148

)

 

 

61.10

 

 

 

(17,374

)

 

 

44.32

 

 

 

(2,454

)

 

 

79.49

 

 

 

 

 

 

 

 

 

(35,976

)

Outstanding at December 31, 2021

 

 

131,568

 

 

$

62.09

 

 

 

150,292

 

 

$

47.52

 

 

 

37,476

 

 

$

79.49

 

 

 

 

 

$

 

 

 

319,336

 

Granted

 

 

21,324

 

 

 

103.31

 

 

 

42,640

 

 

 

68.63

 

 

 

42,640

 

 

 

68.63

 

 

 

 

 

 

 

 

 

106,604

 

Performance Adjustment

 

 

45,004

 

 

 

57.46

 

 

 

(2,258

)

 

 

41.61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

42,746

 

Vested

 

 

(90,371

)

 

 

57.46

 

 

 

(43,106

)

 

 

41.61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(133,477

)

Forfeited

 

 

(4,724

)

 

 

68.67

 

 

 

(6,493

)

 

 

56.87

 

 

 

(3,543

)

 

 

75.10

 

 

 

 

 

 

 

 

 

(14,760

)

Outstanding at December 31, 2022

 

 

102,801

 

 

$

65.20

 

 

 

141,075

 

 

$

55.18

 

 

 

76,573

 

 

$

73.66

 

 

 

 

 

$

 

 

 

320,449

 

Granted

 

 

30,622

 

 

 

89.87

 

 

 

30,622

 

 

 

59.91

 

 

 

61,255

 

 

 

59.91

 

 

 

30,622

 

 

 

59.91

 

 

 

153,121

 

Performance Adjustment

 

 

 

 

 

 

 

 

(59,928

)

 

 

33.90

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(59,928

)

Vested

 

 

(59,928

)

 

 

49.25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(59,928

)

Forfeited

 

 

(8,494

)

 

 

75.67

 

 

 

(11,618

)

 

 

55.94

 

 

 

(7,836

)

 

 

70.95

 

 

 

(789

)

 

 

59.91

 

 

 

(28,737

)

Outstanding at December 31, 2023

 

 

65,001

 

 

$

101.15

 

 

 

100,151

 

 

$

69.55

 

 

 

129,992

 

 

$

67.34

 

 

 

29,833

 

 

$

59.91

 

 

 

324,977

 

The total intrinsic value of PSUs vested during the years ended December 31, 2023, 2022 and 2021 was $2,951, $6,986 and $4,265, respectively.

F-39


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Goodwill(In thousands, except share and per share data)

We recorded goodwill of approximately $24,622 arising from

Restricted Stock

The following table summarizes restricted stock activity during the acquisition. years ended December 31, 2023, 2022 and 2021:

Unvested Restricted Stock

 

Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Outstanding at December 31, 2020

 

 

34,906

 

 

$

39.82

 

Granted

 

 

13,742

 

 

 

70.18

 

Vested

 

 

(37,272

)

 

 

41.70

 

Forfeited

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

11,376

 

 

$

70.33

 

Granted

 

 

13,600

 

 

 

73.54

 

Vested

 

 

(11,376

)

 

 

70.33

 

Forfeited

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

13,600

 

 

$

73.54

 

Granted

 

 

17,923

 

 

 

56.96

 

Vested

 

 

(11,900

)

 

 

73.54

 

Forfeited

 

 

(1,700

)

 

 

73.54

 

Outstanding at December 31, 2023

 

 

17,923

 

 

$

56.96

 

The acquired goodwill represents intangible assets that do not qualify for separate recognition. Itcompensation cost associated with restricted stock is estimated that allon the date of the goodwill recognized will be deductible for income tax purposes.  

Intangible Assets

In conjunction with the acquisition, intangible assets of $21,270 were recorded.grant using quoted market prices (Level 1 input). The Company’s estimate of thetotal fair value of these assets atrestricted stock vested in 2023, 2022 and 2021 was $875, $800 and $1,554, respectively.

SARs

The following table summarizes SARs activity during the time of the acquisition was determined with the assistance of an independent third-party valuation firm. As part of the estimated valuation, an estimated useful life for the assets was determined.

Intangible assets, net consisted of the following:

 

 

December 31, 2016

 

  

Gross Value

  

 

Accumulated
Amortization

 

  

Net Value

  

  

Useful Life

Customer relationships

 

$

11,700

 

 

$

585

 

 

$

11,115

 

 

15 yrs

Technology

 

 

3,200

 

 

 

390

 

 

 

2,810

 

 

5 -7 yrs

Trade name

 

 

6,370

 

 

 

 

 

 

6,370

 

 

Indefinite

Total

 

$

21,270

 

 

$

975

 

 

$

20,295

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization expense of $325 and $975 for the three and twelve monthsyears ended December 31, 20162023, 2022 and 2021:

Stock Appreciation Rights

 

Shares

 

 

Weighted-Average
Exercise Price

 

 

Weighted-Average
Remaining
Contractual Term

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2020

 

 

171,600

 

 

$

40.60

 

 

 

2.44

 

 

$

4,224

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(116,000

)

 

 

40.34

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

55,600

 

 

$

41.15

 

 

 

1.28

 

 

$

2,544

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(40,850

)

 

 

42.27

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

14,750

 

 

$

38.05

 

 

 

1.15

 

 

$

402

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(12,500

)

 

 

38.05

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

2,250

 

 

$

38.05

 

 

 

0.15

 

 

$

32

 

Exercisable at December 31, 2023

 

 

2,250

 

 

$

38.05

 

 

 

0.15

 

 

$

32

 

F-40


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

There have been no SARs granted since the year ended December 31, 2017 and all SARs are currently vested. The total intrinsic value of SARs exercised during the years ended December 31, 2023, 2022 and 2021 was recorded$242, $1,348 and $4,301, respectively.

Stock Options

The following table summarizes stock option activity during the years ended December 31, 2023, 2022 and 2021:

Options

 

Shares

 

 

Weighted-Average
Exercise Price

 

 

Weighted-Average
Remaining
Contractual Term

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2020

 

 

428,000

 

 

$

37.61

 

 

 

3.20

 

 

$

11,815

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(215,250

)

 

 

38.46

 

 

 

 

 

 

 

Forfeited

 

 

(6,000

)

 

 

38.05

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

206,750

 

 

$

36.72

 

 

 

2.60

 

 

$

10,375

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(44,116

)

 

 

37.87

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

162,634

 

 

$

36.41

 

 

 

2.68

 

 

$

8,212

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(6,450

)

 

 

40.79

 

 

 

 

 

 

 

Forfeited

 

 

(16,500

)

 

 

41.59

 

 

 

 

 

 

 

Outstanding at December 31, 2023

 

 

139,684

 

 

$

35.59

 

 

 

0.90

 

 

$

2,342

 

Exercisable at December 31, 2023

 

 

139,684

 

 

$

35.59

 

 

 

0.90

 

 

$

2,342

 

There have been no stock options granted since the year ended December 31, 2017 and all stock options are currently vested. The total intrinsic value of stock options exercised during the years ended December 31, 2023, 2022 and 2021 was $201, $1,582 and $8,269, respectively.

Note 18 Income Taxes

The income tax provisions were calculated based upon the following components of earnings before income tax for the years ended December 31, 2023, 2022 and 2021:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Earnings (loss) before income tax:

 

 

 

 

 

 

 

 

 

Domestic

 

$

(37,222

)

 

$

(34,211

)

 

$

(4,547

)

Foreign

 

 

92,176

 

 

 

72,593

 

 

 

118,399

 

Earnings before income tax

 

$

54,954

 

 

$

38,382

 

 

$

113,852

 

F-41


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

The components of the provision for income taxes for the years ended December 31, 2023, 2022 and 2021 are summarized as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Current income tax expense:

 

 

 

 

 

 

 

 

 

Federal

 

$

3,510

 

 

$

3,006

 

 

$

1,944

 

State and local

 

 

414

 

 

 

650

 

 

 

234

 

Foreign

 

 

23,759

 

 

 

17,607

 

 

 

18,390

 

Total current income tax expense

 

 

27,683

 

 

 

21,263

 

 

 

20,568

 

Deferred income tax (benefit) expense:

 

 

 

 

 

 

 

 

 

Federal

 

 

(7,495

)

 

 

(5,971

)

 

 

(4,400

)

State and local

 

 

444

 

 

 

(213

)

 

 

(91

)

Foreign

 

 

(6,021

)

 

 

(1,138

)

 

 

4,341

 

Total deferred (benefit) income tax expense

 

 

(13,072

)

 

 

(7,322

)

 

 

(150

)

Total income tax expense

 

$

14,611

 

 

$

13,941

 

 

$

20,418

 

As of December 31, 2023, deferred U.S. income taxes have not been provided on the undistributed earnings of the Company’s foreign subsidiaries since these earnings will not be taxable upon repatriation to the United States. These earnings will be primarily treated as previously taxed income from either the one-time transition tax or global intangible low-taxed income provision, or they will be offset with a 100% dividend received deduction. However, the Company continues to provide a deferred tax liability for foreign income and withholding tax that will be incurred with respect to the undistributed foreign earnings that are not indefinitely reinvested.

The deferred tax assets and deferred tax liabilities and related valuation allowance were comprised of the following as of December 31, 2023 and 2022:

 

 

December 31,

 

 

 

2023

 

 

2022

 

Deferred tax assets:

 

 

 

 

 

 

Net operating losses

 

$

44,053

 

 

$

43,296

 

Intangible assets

 

 

4,314

 

 

 

4,417

 

Research and development credits

 

 

7,127

 

 

 

7,835

 

Property and equipment

 

 

4,800

 

 

 

6,983

 

Valuation reserves and accrued liabilities

 

 

11,221

 

 

 

8,388

 

Capitalized Research and Development Costs

 

 

23,658

 

 

 

19,087

 

Stock compensation

 

 

3,227

 

 

 

3,051

 

Defined benefit obligation

 

 

1,691

 

 

 

1,265

 

Inventory

 

 

181

 

 

 

6,762

 

Other credits

 

 

8,946

 

 

 

10,296

 

Other

 

 

9,154

 

 

 

790

 

Total deferred tax asset

 

 

118,372

 

 

 

112,170

 

Valuation allowance

 

 

(35,888

)

 

 

(36,671

)

Deferred tax liabilities:

 

 

 

 

 

 

Unrealized foreign currency exchange gains

 

 

 

 

 

(2,413

)

Undistributed profits of subsidiary

 

 

(4,609

)

 

 

(5,981

)

Property and equipment

 

 

(12,627

)

 

 

(15,423

)

Other

 

 

(1,550

)

 

 

(3,056

)

Total deferred tax liability

 

 

(18,786

)

 

 

(26,873

)

Net deferred tax asset

 

$

63,698

 

 

$

48,626

 

F-42


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

 

 

Three Months Ended
December 31, 2016

 

Twelve Months Ended
December 31, 2016

 

Product revenues

 

$

195

 

$

585

 

Research and development expenses

 

 

130

 

 

390

 

AmortizationReconciliations between the statutory Federal income tax rate and the effective rate of income tax expense for the prospective five years ended December 31, 2023, 2022 and 2021 are as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Statutory Federal income tax rate

 

 

21.0

 %

 

 

21.0

 %

 

 

21.0

 %

Increase (decrease) resulting from:

 

 

 

 

 

 

 

 

 

Change in valuation allowance

 

 

(3.1

)%

 

 

6.4

 %

 

 

(1.2

)%

Effect of different tax rates of foreign jurisdictions

 

 

0.9

 %

 

 

(4.9

)%

 

 

(5.2

)%

Tax credits & deductions related to R&D

 

 

(8.5

)%

 

 

(10.1

)%

 

 

(2.3

)%

Goodwill impairment

 

 

4.1

 %

 

 

 

 

 

 

Non-deductible expenses

 

 

6.8

 %

 

 

14.9

 %

 

 

1.7

 %

Non-deductible expenses related to acquisitions

 

 

 

 

 

7.0

 %

 

 

 

Other foreign, state and local taxes

 

 

3.5

 %

 

 

0.7

 %

 

 

1.6

 %

Tax impact of foreign income

 

 

3.6

 %

 

 

4.2

 %

 

 

3.6

 %

Stock option compensation

 

 

 

 

 

(3.8

)%

 

 

(2.0

)%

Prior year adjustments

 

 

0.7

 %

 

 

1.7

 %

 

 

(0.7

)%

Other

 

 

(2.4

)%

 

 

(0.8

)%

 

 

1.4

 %

Effective rate

 

 

26.6

%

 

 

36.3

 %

 

 

17.9

 %

The Company has Net Operating Loss (“NOL”) carryforwards as follows:

Jurisdiction

 

Amount as of December 31, 2023

 

 

Years of Expiration

U.S. state income tax

 

$

51,235

 

 

2024-2042

Foreign

 

$

296,334

 

 

Never

We have NOL carryforwards in various states associated with the benefits of the state dividends received reduction and foreign royalty exclusion. The state NOL carryforwards generally expire at various dates from 2024 to 2042. We have concluded that there is not sufficient evidence these NOL carryforwards will be utilized, and thus have not recognized the benefit of these NOL carryforwards.

At December 31, 2023, certain non-U.S. subsidiaries had NOL carryforwards totaling $296,334 which have no expiration date. The Company has a valuation allowance recorded against $16,413 of the total non-U.S. subsidiaries’ net operating loss carryforwards as of December 31, 2023.

The Company is subject to taxation in the United States and various state and foreign jurisdictions. As of December 31, 2023, the Company was no longer subject to U.S. Federal examinations by tax authorities for tax years before 2020 and was no longer subject to foreign examinations by tax authorities for tax years before 2015.

The Company currently benefits from tax holidays in various non-U.S. jurisdictions with expiration dates from 2024 – 2025. For the years ended December 31, 2023, 2022 and 2021, income in foreign jurisdictions with such holidays was $8,185, $2,414, and $4,721, respectively.

F-43


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

At December 31, 2023, 2022 and 2021, the Company had total unrecognized tax benefits of $5,486, $6,185 and $5,665, respectively, all of which, if recognized, would affect the effective income tax rates. The reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Balance at beginning of year

 

$

6,185

 

 

$

5,665

 

 

$

4,967

 

Additions based on tax position related to current year

 

 

87

 

 

 

972

 

 

 

1,105

 

Additions based on tax position related to prior year

 

 

347

 

 

 

433

 

 

 

160

 

Reductions from settlements and statute of limitation expiration

 

 

(1,266

)

 

 

(610

)

 

$

(312

)

Effect of foreign currency translation

 

 

133

 

 

 

(275

)

 

 

(255

)

Balance at end of year

 

$

5,486

 

 

$

6,185

 

 

$

5,665

 

The Company classifies income tax-related penalties and net interest as income tax expense. In the years ended December 31, 2023, 2022 and 2021, income tax related interest and penalties were not material. It is reasonably possible that audit settlements, the conclusions of current examinations or the expiration of the statute of limitations in several jurisdictions could impact the Company’s unrecognized tax benefits.

Note 19 Segment Reporting

Segment information is used by management for making operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss.

The Company’s reportable segments are as follows:

2017

 

$

1,300

 

2018

 

$

1,300

 

2019

 

$

1,300

 

2020

 

$

1,300

 

2021

 

$

1,135

 

Automotive — the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, lumbar and massage comfort solutions, valve systems, and automotive electronic and software systems.
Medical — this segment represents the results from our patient temperature management business within the medical industry.

Property, Plant & EquipmentThe Corporate categoryincludes unallocated costs related to our corporate headquarter activities, including selling, general and administrative costs and acquisition transaction costs, which do not meet the requirements for being classified as an operating segment.

The tables below present segment information about the reported product revenues and operating income of the Company for years ended December 31, 2023, 2022 and 2021.

 

 

Automotive

 

 

Medical

 

 

Corporate

 

 

Total

 

2023:

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

1,422,952

 

 

$

46,124

 

 

$

 

 

$

1,469,076

 

Depreciation and amortization

 

 

45,845

 

 

 

3,654

 

 

 

1,449

 

 

 

50,948

 

Operating income (loss)

 

 

185,956

 

 

 

(22,234

)

 

 

(86,283

)

 

 

77,439

 

2022:

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

1,161,616

 

 

$

43,040

 

 

$

 

 

$

1,204,656

 

Depreciation and amortization

 

 

39,815

 

 

 

3,344

 

 

 

1,235

 

 

 

44,394

 

Operating income (loss)

 

 

118,433

 

 

 

(4,029

)

 

 

(66,097

)

 

 

48,307

 

2021:

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

1,004,633

 

 

$

41,517

 

 

$

 

 

$

1,046,150

 

Depreciation and amortization

 

 

35,389

 

 

 

2,460

 

 

 

931

 

 

 

38,780

 

Operating income (loss)

 

 

162,994

 

 

 

(1,829

)

 

 

(46,159

)

 

 

115,006

 

F-44


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Automotive and Medical segment product revenues by product category for each of the years ended December 31, 2023, 2022 and 2021 are as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Climate Control Seat

 

$

482,665

 

 

$

426,046

 

 

$

393,816

 

Seat Heaters

 

 

308,588

 

 

 

283,970

 

 

 

270,054

 

Steering Wheel Heaters

 

 

153,943

 

 

 

120,949

 

 

 

102,496

 

Lumbar and Massage Comfort Solutions (a)

 

 

144,923

 

 

 

56,980

 

 

 

 

Valve Systems (a)

 

 

106,262

 

 

 

41,980

 

 

 

 

Automotive Cables

 

 

79,993

 

 

 

76,962

 

 

 

84,114

 

Battery Performance Solutions

 

 

75,484

 

 

 

71,907

 

 

 

69,594

 

Electronics

 

 

40,387

 

 

 

44,106

 

 

 

51,648

 

Other Automotive

 

 

30,707

 

 

 

38,716

 

 

 

32,911

 

Subtotal Automotive segment

 

 

1,422,952

 

 

 

1,161,616

 

 

 

1,004,633

 

Medical segment (a)

 

 

46,124

 

 

 

43,040

 

 

 

41,517

 

Total Company

 

$

1,469,076

 

 

$

1,204,656

 

 

$

1,046,150

 

(a)
Includes product revenues from acquisitions since their respective acquisition dates (see Note 4).

Revenue (based on shipment destination) by geographic area for each of the years ended December 31, 2023, 2022 and 2021 is as follows:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

United States

 

$

537,096

 

 

$

472,468

 

 

$

404,466

 

China

 

 

221,512

 

 

 

183,419

 

 

 

142,816

 

South Korea

 

 

115,854

 

 

 

94,937

 

 

 

93,516

 

Germany

 

 

102,383

 

 

 

75,367

 

 

 

66,929

 

Czech Republic

 

 

69,714

 

 

 

49,293

 

 

 

43,931

 

Japan

 

 

60,879

 

 

 

57,718

 

 

 

63,527

 

Romania

 

 

53,982

 

 

 

47,532

 

 

 

51,367

 

Mexico

 

 

45,733

 

 

 

23,233

 

 

 

18,194

 

Slovakia

 

 

44,946

 

 

 

34,686

 

 

 

30,004

 

Finland

 

 

39,632

 

 

 

33,627

 

 

 

29,325

 

Other

 

 

177,345

 

 

 

132,376

 

 

 

102,075

 

Total Non-U.S.

 

 

931,980

 

 

 

732,188

 

 

 

641,684

 

Total Company

 

$

1,469,076

 

 

$

1,204,656

 

 

$

1,046,150

 

The table below lists the percentage of total product revenues generated from sales to customers which contributed 10% or more to the Company’s total consolidated product revenue for the years ended December 31, 2023, 2022 and 2021:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Lear

 

 

15

%

 

 

16

%

 

 

15

%

Adient

 

 

13

%

 

 

15

%

 

 

15

%

F-45


GENTHERM INCORPORATED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(In thousands, except share and per share data)

Property and equipment, consistnet, for each of the following:geographic areas in which the Company operates as of December 31, 2023 and 2022 is as follows:

 

 

December 31,

 

Property and equipment, net

 

2023

 

 

2022

 

Germany

 

$

46,586

 

 

$

47,342

 

China

 

 

45,429

 

 

 

43,162

 

Mexico

 

 

39,943

 

 

 

31,597

 

United States

 

 

37,413

 

 

 

41,034

 

North Macedonia

 

 

27,675

 

 

 

27,808

 

Vietnam

 

 

21,664

 

 

 

19,808

 

Czech Republic

 

 

11,126

 

 

 

11,381

 

Hungary

 

 

9,097

 

 

 

11,736

 

Ukraine

 

 

5,986

 

 

 

5,077

 

Other

 

 

315

 

 

 

5,535

 

Total

 

$

245,234

 

 

$

244,480

 

Asset category

 

Useful life

 

Amount

 

Land

 

Indefinite

 

$

1,630

 

Buildings

 

20 yrs

 

 

6,024

 

Machinery and equipment

 

5-7 yrs

 

 

3,718

 

Computer hardware and software

 

3-5 yrs

 

 

586

 

Assets under construction

 

 

 

 

961

 

 

 

 

 

 

 

 

 

 

 

 

$

12,919

 

F-46


F-48


GENTHERM INCORPORATED

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

For the Years Ended December 31, 2017, 20162023, 2022 and 20152021

(In thousands)

Description

 

Balance at
Beginning
of Period

 

 

Charged to
Costs and
Expenses

 

 

Other Activity

 

 

Deductions
from
Reserves

 

 

Balance at
End of
Period

 

Allowance for Deferred Income Tax Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2021

 

$

17,197

 

 

$

357

 

 

$

(102

)

 

$

(1,362

)

 

$

16,090

 

Year Ended December 31, 2022

 

 

16,090

 

 

 

2,482

 

 

 

18,099

 

 a

 

 

 

 

36,671

 

Year Ended December 31, 2023

 

 

36,671

 

 

 

(1,746

)

 

 

963

 

 

 

 

 

 

35,888

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reserve for Inventory

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2021

 

$

7,141

 

 

$

2,499

 

 

$

(134

)

 

$

(3,492

)

 

$

6,014

 

Year Ended December 31, 2022

 

 

6,014

 

 

 

15,923

 

 

 

(133

)

 

 

(2,558

)

 

 

19,246

 

Year Ended December 31, 2023

 

 

19,246

 

 

 

6,867

 

 

 

3,876

 

 

 

(1,972

)

 

 

28,017

 

(a)
Includes amount relates to valuation allowance from acquisitions.


Description

 

Balance at
Beginning
of Period

 

  

Charged to
Costs and
Expenses

 

 

Charged to
Other
Accounts

 

 

Deductions
from
Reserves

 

 

Balance at
End of
Period

 

Allowance for Doubtful Accounts

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2015

 

 

1,213

  

  

 

4,174

 

 

 

(373

)

 

 

(4,059

)

 

 

955

 

Year Ended December 31, 2016

 

 

955

  

  

 

1,469

 

 

 

(270

)

 

 

(763

)

 

 

  1,391

 

Year Ended December 31, 2017

 

 

  1,391

 

 

 

1,239

 

 

 

51

 

 

 

(1,708

)

 

 

973

 

 

Allowance for Deferred Income Tax Assets

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2015

 

 

18,037

  

  

 

 

 

 

(2,436

)

 

 

(2,183

)

 

 

13,418

 

Year Ended December 31, 2016

 

 

13,418

  

  

 

5,706

 

 

 

180

 

 

 

 

 

 

19,304

 

Year Ended December 31, 2017

 

 

19,304

  

  

 

6,700

 

 

 

1,574

 

 

 

 

 

 

27,578

 

 

Reserve for Inventory

 

 

 

 

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2015

 

 

4,802

  

  

 

815

 

 

 

(249

)

 

 

(1,060

)

 

 

4,308

 

Year Ended December 31, 2016

 

 

4,308

  

  

 

876

 

 

 

(68

)

 

 

(326

)

 

 

4,790

 

Year Ended December 31, 2017

 

 

4,790

  

  

 

3,521

 

 

 

302

 

 

 

(726

)

 

 

7,887

 

SIGNATURES

F-49


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.

GENTHERM INCORPORATED

GENTHERM INCORPORATED

By:

/S/ Phillip Eyler

By:

/S/    

Phillip Eyler

Phillip Eyler

Chief Executive Officer

Chief Executive Officer

Date: February 23, 201821, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

Signature

Capacity

Date

/s/ PHILLIP EYLERPHILLIP EYLER

Director, President and Chief

February 23, 201821, 2024

PHILLIP EYLERPHILLIP EYLER

Executive Officer (Principal

(Principal Executive Officer)

/s/ BARRY G. STEELEMATTEO ANVERSA

Executive Vice President, of Finance, Chief

February 23, 201821, 2024

BARRY G. STEELEMATTEO ANVERSA

Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer)

*/s/ NICHOLAS BREISACHER

Vice President, Chief Accounting Officer

February 21, 2024

NICHOLAS BREISACHER

(Principal Accounting Officer)

*

Director, Chairman of the Board

February 23, 201821, 2024

FRANCOIS CASTAINGRONALD HUNDZINSKI

*

Director

February 23, 201821, 2024

LEWIS BOOTHSOPHIE DESORMIÈRE

*

Director

February 23, 201821, 2024

DANIEL R. COKERDavid Heinzmann

*

Director

February 23, 201821, 2024

SOPHIE DESORMIERELAURA KOWALCHIK

*

Director

February 23, 201821, 2024

MAURICE GUNDERSONCHARLES KUMMETH

*

Director

February 23, 201821, 2024

YVONNE HAOBETSY METER

*

Director

February 23, 201821, 2024

RONALD HUNDZINSKIBYRON SHAW

*

Director

February 23, 201821, 2024

BYRON SHAWJOHN STACEY

*By:

/s/ Phillip Eyler

*

Director

February 21, 2024

KENNETH WASHINGTON

*By:

 /s/ Phillip Eyler

Phillip Eyler, Attorney-in-Fact